,PMID,Other_terms
1470,31427038,goitre multinodulaire
1470,31427038,hyperthyroïdie infra-clinique
1470,31427038,multinodular goiter
1470,31427038,subclinical hyperthyroidism
1470,31427038,tsh
1470,31427038,thyroid
1470,31427038,thyroïde
1471,31542786,*nodular goiter
1471,31542786,*thyroid cancer cois
1472,31477522,*substernal goiter
1472,31477522,*thyroid
1472,31477522,*thyroidectomy cois disclose.
1473,29950539,american thyroid association (ata)
1473,29950539,european thyroid association (eta)
1473,29950539,grave's disease
1473,29950539,japan thyroid association/ japan endocrine society
1473,29950539,thyroid
1474,31583517,ectopic goiter
1474,31583517,ectopic thyroid
1474,31583517,intrapericardial goiter
1474,31583517,intrathoracic goiter
1475,31129908,*art
1475,31129908,*history
1475,31129908,*thyroid swelling
1478,32233333,nodules
1478,32233333,thyroid
1479,30788771,art
1479,30788771,endemic goiter
1479,30788771,history
1479,30788771,thyroid swelling
1480,30105567,goiter
1480,30105567,iodine deficiency
1480,30105567,prevalence
1480,30105567,school children
1480,30105567,urinary iodine
1481,30224035,fetal ultrasound
1481,30224035,graves’ disease
1481,30224035,maladie de basedow
1481,30224035,multidisciplinarity
1481,30224035,multidisciplinarité
1481,30224035,neonatal monitoring
1481,30224035,surveillance néonatale
1481,30224035,trab
1481,30224035,teratogenicity
1481,30224035,tératogénicité
1481,30224035,échographie fœtale
1485,30193753,antithyroid drugs
1485,30193753,antithyroïdien
1485,30193753,chirurgie
1485,30193753,graves’ disease
1485,30193753,grossesse
1485,30193753,maladie de basedow
1485,30193753,myxœdeme prétibial
1485,30193753,orbitopathie
1485,30193753,orbitopathy
1485,30193753,pregnancy
1485,30193753,radioiode
1485,30193753,radioiodine
1485,30193753,surgery
1485,30193753,thyroid dermopathy
1489,32041923,graves’ ophthalmopathy
1489,32041923,diagnosis
1489,32041923,management
1491,30342794,epidemiology
1491,30342794,graves’ disease
1491,30342794,pathophysiology
1492,31464605,children
1492,31464605,ethiopia
1492,31464605,goiter
1492,31464605,meta-analysis cois
1495,31221571,*continuous neuromonitoring
1495,31221571,*intraoperative neuromonitoring
1495,31221571,*recurrent laryngeal nerve
1495,31221571,*staged thyroidectomy
1495,31221571,*thyroidectomy
1495,31221571,*vagus nerve stimulation
1498,30177259,chirurgie ophtalmologique
1498,30177259,corticotherapy
1498,30177259,corticothérapie
1498,30177259,eugogo
1498,30177259,graves’ orbitopathy
1498,30177259,immunosuppression treatment
1498,30177259,orbitopathie basedowienne
1498,30177259,smoking
1498,30177259,tabac
1498,30177259,traitement immunosuppresseur
1499,30880038,deep vein thrombosis
1499,30880038,goiter
1499,30880038,upper-extremity
1500,30694184,*endocrine disruptor
1500,30694184,*goiter
1500,30694184,*groundwater
1500,30694184,*subclinical hypothyroidism
1502,30180972,adolescent
1502,30180972,carbimazole
1502,30180972,child
1502,30180972,chirurgie
1502,30180972,enfant
1502,30180972,graves’ disease
1502,30180972,hyperthyroidism
1502,30180972,hyperthyroïdie
1502,30180972,iode radioactif
1502,30180972,long term
1502,30180972,long terme
1502,30180972,maladie de basedow
1502,30180972,prognosis
1502,30180972,pronostic
1502,30180972,radioactive iodine treatment
1502,30180972,surgery
1502,30180972,thiamazole
1503,30017236,computed tomography
1503,30017236,retrosternal goiter
1503,30017236,sternotomy
1503,30017236,thyroidectomy
1504,30778906,fine arts
1504,30778906,goiter
1504,30778906,history
1504,30778906,moretto da brescia
1504,30778906,renaissance
1506,31614658,goiter
1506,31614658,iodine deficiency
1506,31614658,iodine prophylaxis
1506,31614658,urinary iodine concentration cois
1509,30055961,neck approach
1509,30055961,sternotomy
1509,30055961,substernal goiter
1509,30055961,tertiary center
1509,30055961,thyroidectomy
1511,31552848,goiter
1511,31552848,iodine
1511,31552848,reproductive age
1511,31552848,salt iodine
1511,31552848,urinary iodine
1511,31552848,women cois
1512,31691192,iodine
1512,31691192,nodular goiter
1512,31691192,selenium
1512,31691192,thyroid gland
1512,31691192,thyroid hormones
1515,30803411,*longterm
1515,30803411,*methimazole
1515,30803411,*radioiodine
1515,30803411,*toxic multinodular goiter
1516,31074402,cervico-mediastinal goiter
1516,31074402,sternotomy
1516,31074402,thyroidectomy
1516,31074402,thyroiditis cois
1518,30900322,microwave
1518,30900322,substernal goiter
1518,30900322,thermal ablation
1518,30900322,thyroid
1518,30900322,ultrasound
1520,31447477,coronary artery
1520,31447477,ectopic goiter
1520,31447477,intrapericardial tumor
1520,31447477,thyroid tissue
1522,31270773,*art
1522,31270773,*goiter
1522,31270773,*history of medicine
1522,31270773,*thyroid
1524,31376092,genetic interaction analysis
1524,31376092,goiter
1524,31376092,hif-1α
1524,31376092,multifactor dimensionality reduction methodology
1524,31376092,polymorphisms
1524,31376092,vegf
1524,31376092,vegfr-2
1525,31668873,*adipocyte complement factors
1525,31668873,*adipokines
1525,31668873,*brown fat commitment
1525,31668873,*brown fat differentiation
1525,31668873,*extracellular matrix proteins
1525,31668873,*human batokines
1525,31668873,*human brown adipocytes
1525,31668873,*human brown fat
1525,31668873,*mitochondria
1525,31668873,*secretomics
1530,28840845,*sternotomy
1530,28840845,*computerized tomography
1530,28840845,*retrosternal goiter substernal.
1530,28840845,*surgery
1530,28840845,*thyroid
1530,28840845,*thyroidectomy
1531,29897006,*copy-number variation
1531,29897006,*genome-wide linkage analysis
1531,29897006,*multinodular goiter
1531,29897006,*next-generation sequencing
1532,29315620,amyloid goiter
1532,29315620,subacute thyroiditis
1532,29315620,thyroid
1532,29315620,ultrasonography
1533,30146569,*fdg-pet
1533,30146569,*hashimoto's thyroiditis
1533,30146569,*malignant lymphoma cois
1535,30306416,advances
1535,30306416,decade
1535,30306416,thyroid cois
1540,30141079,artificial pneumothorax
1540,30141079,carina
1540,30141079,mediastinal goiter
1540,30141079,prone position
1540,30141079,two-lung ventilation
1542,29310524,*art
1542,29310524,*goiter
1542,29310524,*sculptures
1543,31030636,*french-canadian
1543,31030636,*airway compromise
1543,31030636,*congenital hypothyroidism
1543,31030636,*dyshormonogenesis
1544,31811573,colloid goiter
1544,31811573,metals
1544,31811573,oxidative stress
1544,31811573,papillary thyroid carcinoma
1545,31285663,*dicer1
1545,31285663,*sertoli–leydig
1545,31285663,*genetic mutation
1545,31285663,*microrna
1545,31285663,*multinodular goiter
1545,31285663,"*sex cord–stromal tumour cois policy on disclosing conflicts of interest, and we declare that we have none."
1546,29275168,*goiter
1546,29275168,*hypothyroidism
1546,29275168,*mutation
1546,29275168,*thyroglobulin gene
1546,29275168,*truncated thyroglobulin protein
1547,28602544,*sternotomy
1547,28602544,*substernal goiter
1547,28602544,*thyroidectomy
1548,29548512,developed world
1548,29548512,developing world
1548,29548512,iodine deficiency
1548,29548512,low-resource setting
1548,29548512,thyroid cancer
1548,29548512,thyroid disease
1548,29548512,thyroid surgery
1549,29242007,*ecmo
1549,29242007,*extracorporeal membrane oxygenation
1549,29242007,*airway management
1549,29242007,*airway obstruction
1549,29242007,*mediastinal goiter
1549,29242007,*thyroid surgery
1550,30989520,*thyroid nodule
1550,30989520,*benign adenoma
1550,30989520,*multinodular goiter
1550,30989520,*thyroid cancer
1551,30037617,goiter
1551,30037617,hypothyroidism
1551,30037617,iodine deficiency
1551,30037617,native americans
1551,30037617,paleopathology
1554,31740871,thyroid papillary cancer haemogram
1555,29406821,graves' disease
1555,29406821,traditional chinese medicine
1555,29406821,goiter dispersion formula
1555,29406821,hyperthyroidism
1555,29406821,neurologic manifestations
1557,29215302,traditional chinese medicine
1557,29215302,goiter
1557,29215302,herbal regimen
1558,30055100,children
1558,30055100,iodine supply
1558,30055100,thyroid diseases
1558,30055100,thyromegaly
1559,29452573,metformin
1559,29452573,diffuse/nodular goiter
1559,29452573,insulin resistance
1559,29452573,obesity
1559,29452573,thyroid
1560,30820869,acute external compression of the trachea
1560,30820869,basedow’s goiter
1560,30820869,death
1560,30820869,intra-thyroid hemorrhage
1562,30084100,*euthyroid nodular goiter
1562,30084100,*insulin resistance
1562,30084100,*pulse wave velocity
1562,30084100,*strain index
1567,30506185,intrathoracic goitres
1567,30506185,retrosternal goitres
1567,30506185,substernal goitres
1567,30506185,thyroidectomy
1572,30220410,diagnosis
1572,30220410,diagnostic
1572,30220410,graves’ disease
1572,30220410,hyperthyroidism
1572,30220410,hyperthyroïdie
1572,30220410,maladie de basedow
1573,30843179,graves’ disease
1573,30843179,n-glycosylation
1573,30843179,tshr
1573,30843179,sialylation
1573,30843179,thyroid
1575,29360235,*avoiding sternotomy
1575,29360235,*intracapsular thyroidectomy
1575,29360235,*microdebrider
1575,29360235,*retrosternal goiter
1575,29360235,*thyroidectomy
1577,29348117,*graves' disease
1577,29348117,*carbimazole
1577,29348117,*radioiodine
1577,29348117,*thyroid
1577,29348117,*thyrotoxicosis cois
1583,30583800,completion thyroidectomy
1583,30583800,complications
1583,30583800,hemithyroidectomy
1583,30583800,hormone replacement
1583,30583800,isthmolobectomie
1583,30583800,supplémentation hormonale
1583,30583800,thyroïdectomie totale
1583,30583800,total thyroidectomy
1583,30583800,totalisation
1585,31813786,*antigen-specific immunotherapy
1585,31813786,*autoimmune thyroid disorders
1585,31813786,*corticosteroids
1585,31813786,*rituximab
1585,31813786,*teprotumumab
1585,31813786,*tocilizumab cois
1588,31281088,*asymmetrical nodular goitre
1588,31281088,*benign thyroid disease
1588,31281088,*hemithyroidectomy
1588,31281088,*thyroid surgery
1590,30634005,fetal therapy
1590,30634005,fetal thyroid
1590,30634005,thyroid disorders
1591,30158361,bone mineral density
1591,30158361,multinodular goiter
1591,30158361,thyroxine
1595,30044192,goitre
1595,30044192,theodor kocher
1595,30044192,thyroidectomy
1602,30701789,graves’ disease
1602,30701789,hyperthyroidism
1602,30701789,thyroid
1602,30701789,thyrotoxicosis
1602,30701789,toxic multinodular goiter
1603,31512191,graves’ disease
1603,31512191,graves’s orbithopathy
1603,31512191,lenin
1603,31512191,theodor kocher
1604,30417713,autoimmune thyroid disease
1604,30417713,graves’ disease
1604,30417713,hashitoxicosis
1604,30417713,fetal and neonatal hyperthyroidism
1604,30417713,methimazole treatment
1604,30417713,pediatric age
1604,30417713,radioiodine therapy
1604,30417713,thyroidectomy
1606,30456548,goiter
1606,30456548,graves’ disease
1606,30456548,iodine
1606,30456548,thyroid function tests
1606,30456548,thyroid gland
1607,31250924,*endocrinology
1607,31250924,*head and neck surgery
1607,31250924,*thyroid diseases
1607,31250924,*thyroid hormones
1615,31533103,acne
1615,31533103,minocycline
1615,31533103,tetracycline
1615,31533103,thyroiditis
1616,31235068,acfa
1616,31235068,atrial fibrillation
1616,31235068,complication
1616,31235068,complications
1616,31235068,heart failure
1616,31235068,hyperthyroidism
1616,31235068,hyperthyroïdie
1616,31235068,insuffisance cardiaque
1618,30637676,*goiter
1618,30637676,*hypothyroidism
1618,30637676,*iodine deficiency disorders
1620,31127592,goiter
1620,31127592,medical diagnosis
1620,31127592,painting
1620,31127592,saints
1622,31757411,*graves disease
1622,31757411,*hyperthyroidism
1622,31757411,*nodular goiter
1622,31757411,*thyroid cancer
1625,31721133,antithyroid drugs
1625,31721133,dietary supplements
1625,31721133,graves’ disease
1625,31721133,graves’ orbitopathy
1625,31721133,hyperthyroidism
1625,31721133,selenium cois assessment and supplementation.
1626,30835061,euthyroid
1626,30835061,medical diagnosis
1626,30835061,portrait
1628,28879586,amyloid
1628,28879586,amyloid goiter
1628,28879586,frozen section
1628,28879586,medullary thyroid carcinoma
1628,28879586,parathyroid cois interest to disclose. ethical approval: this article does not contain any studies with human participants or animals performed by any of the authors.
1630,29374396,adenolipoma
1630,29374396,thyroid
1630,29374396,ultrasound cois informed consent: written informed consent was obtained from the patient for the publication of this case report and accompanying images. ethical approval: all procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 helsinki declaration and its later amendments or comparable ethical standards.
1632,30196262,emergency medicine
1632,30196262,haematology (incl blood transfusion)
1632,30196262,radiology (diagnostics)
1632,30196262,thyroid disease cois
1634,30989613,endocrinology
1634,30989613,frederic bazille
1634,30989613,painting cois conflict of interest.
1639,31651072,*graves' disease
1639,31651072,*hashimoto's thyroiditis
1639,31651072,*difficulty
1639,31651072,*outcomes
1639,31651072,*thyroidectomy
1641,31182347,hipocalcemia
1641,31182347,hipoparatiroidismo
1641,31182347,hormona paratiroidea
1641,31182347,hypocalcemia
1641,31182347,hypoparathyroidism
1641,31182347,parathyroid hormone
1641,31182347,thyroidectomy
1641,31182347,tiroidectomía
1642,29911397,hyperthyroidism
1642,29911397,thyroiditis
1642,29911397,thyrotoxicosis
1642,29911397,ultrasonography
1642,29911397,ultrasonography/adverse effects
1645,31007819,hyperthyroidism
1645,31007819,senegal
1645,31007819,jaundice cois
1647,28887209,*biomarkers
1647,28887209,*gas-phase fractionation (gpf)
1647,28887209,*proteomics
1647,28887209,*tandem mass tag™ (tmt)
1647,28887209,*tears
1647,28887209,*thyroid-associated orbitopathy
1648,29319139,99mtc-dtpa
1648,29319139,go
1648,29319139,hyperthyroidism
1649,31691668,balanced orbital decompression
1649,31691668,bony orbital decompression
1649,31691668,lateral orbital wall
1649,31691668,medial orbital wall
1649,31691668,optic neuropathy
1649,31691668,strabismus
1651,30918569,hyperthyroidism
1651,30918569,surgery
1651,30918569,thyroidectomy cois
1653,29395824,*airway obstruction
1653,29395824,*cardiopulmonary bypass
1653,29395824,*morbid
1653,29395824,*obese
1653,29395824,*retrosternal goiter
1653,29395824,*thyroid disease
1653,29395824,*tracheal compression
1654,30333321,*endocrinology
1654,30333321,*genetics
1654,30333321,*molecular genetics
1654,30333321,*monogenic diseases
1654,30333321,*thyroid disease cois exists
1655,30375286,* gene
1655,30375286,*congenital hypothyroidism
1655,30375286,*oligogenic mutations cois
1656,29461666,*ligament of berry
1656,29461666,*laryngeal
1656,29461666,*nerve
1656,29461666,*recurrent
1656,29461666,*thyroidectomy
1658,29729448,graves' disease
1658,29729448,graves' orbitopathy
1658,29729448,neuropsychiatric disorders
1658,29729448,quality of life
1664,31400860,ambulatoire
1664,31400860,chirurgie
1664,31400860,facteurs de risque
1664,31400860,outpatient
1664,31400860,risk factors
1664,31400860,surgery
1664,31400860,thyroid
1664,31400860,thyroïde
1665,30843109,*children
1665,30843109,*graves’ disease
1665,30843109,*proteinuria
1666,30213303,epigenetics
1666,30213303,genetics
1666,30213303,graves’disease
1666,30213303,génétique
1666,30213303,maladie de basedow
1666,30213303,prediction score
1666,30213303,score de prédiction
1666,30213303,épigénétique
1669,31562615,multinodular goiter
1669,31562615,nativity
1669,31562615,wooden little shepherds
1670,31143336,graves´ disease
1670,31143336,onycholysis
1670,31143336,hyperthyroidism
1670,31143336,hypothyroidism
1670,31143336,plummer´s nails
1670,31143336,thyroid disease cois
1672,29452583,drugs
1672,29452583,eye lids
1672,29452583,inflammation
1672,29452583,orbit
1672,29452583,vision cois publication: not applicable. competing interests: the authors state that there is no competing interests regarding the publication of this paper. publisher’s note: springer nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
1673,29325833,antithyroid drugs
1673,29325833,encuesta
1673,29325833,enfermedad de graves
1673,29325833,fármaco antitiroideo
1673,29325833,graves’ disease
1673,29325833,hipertiroidismo
1673,29325833,hyperthyroidism
1673,29325833,pediatric
1673,29325833,pediátrico
1673,29325833,survey
1676,30918165,antithyroid drug
1676,30918165,graves’ disease
1676,30918165,hyperthyroidism
1676,30918165,tsh receptor antibody
1676,30918165,thyroid
1681,29353393,autoimmunity
1681,29353393,graves’ disease
1681,29353393,hyperthyroidism
1681,29353393,iodine induced
1681,29353393,trab
1681,29353393,toxic goitre
1683,29909393,general practice / family medicine
1683,29909393,hyperthyroidism
1683,29909393,liver disease
1683,29909393,thyroid disease
1683,29909393,thyroiditis cois
1684,32461007,evaluation of results of therapeutic interventions
1684,32461007,myxedema
1684,32461007,steroids
1684,32461007,therapeutics
1685,29525760,malignant and benign haematology
1685,29525760,thyroid disease cois
1686,29721730,goitre
1686,29721730,medical diagnosis
1686,29721730,painting
1686,29721730,raphael
1687,28450378,*decompression
1687,28450378,*diplopia
1687,28450378,*graves ophthalmopathy
1687,28450378,*orbital fat
1687,28450378,*proptosis cois
1689,30949910,*biomarker
1689,30949910,*graves’ disease
1689,30949910,*microrna
1689,30949910,*plasma
1690,31424978,etiopathogenesis
1690,31424978,graves’ disease
1690,31424978,genetic factors
1690,31424978,thyroid-associated orbitopathy
1690,31424978,vitamin d receptor
1692,31132076,igf-1
1692,31132076,igf-1r
1692,31132076,thyroid cancer
1693,31637658,*differentiated thyroid carcinoma
1693,31637658,*graves’ disease
1693,31637658,*mortality
1693,31637658,*recurrence
1694,31268129,*goiter
1694,31268129,*iodine deficiency
1694,31268129,*iodine status
1694,31268129,*thyroid-stimulating hormone concentration
1694,31268129,*urinary iodine concentration
1695,30996065,respiratory medicine
1695,30996065,thyroid disease cois
1698,31292360,graves disease
1698,31292360,marine-lenhart syndrome
1698,31292360,plummer disease
1699,31144509,thyroid
1699,31144509,graves
1699,31144509,orbitopathy
1700,30504400,graves' disease
1700,30504400,ki-67
1700,30504400,metallothionein
1700,30504400,nodular goiter
1700,30504400,thyroid
1701,31496266,graves’ ophthalmopathy
1701,31496266,quantitative analysis
1701,31496266,radiation therapy
1701,31496266,thyroid eye disease
1701,31496266,volumetric analysis
1706,29027675,airway management
1706,29027675,anesthesia
1706,29027675,head and neck
1706,29027675,neck neoplasm
1706,29027675,tracheostomy
1706,29027675,ultrasound
1708,32180887,anicteric cholestasis
1708,32180887,graves’ disease
1708,32180887,hyperthyroidism cois
1709,29108474,*oncogene testing
1709,29108474,*pediatric thyroid cancer cois of the other authors have any conflicts of interest to declare.
1710,29728450,pre-tibial myxoedema
1710,29728450,thyroid acropachy
1710,29728450,thyroid associated ophthalmopathy
1710,29728450,vitiligo cois
1711,31713721,antithyroid drugs
1711,31713721,children
1711,31713721,graves’ disease
1711,31713721,hyperthyroidism
1711,31713721,“block-and-replace” method
1712,29962351,graves` associated ophthalmopathy
1712,29962351,il-6
1712,29962351,thyroid-associated ophthalmopathy
1712,29962351,extrathyroidal manifestation
1712,29962351,infiltrating cytokines
1712,29962351,tocilizumab.
1713,30935806,internal carotid artery thrombosis
1713,30935806,thromboembolic stroke
1713,30935806,thyroid goitre
1714,30257972,anaesthesia
1714,30257972,cardiovascular medicine
1714,30257972,"ear, nose and throat/otolaryngology"
1714,30257972,resuscitation
1714,30257972,thyroid disease cois
1715,32476968,graves’ disease
1715,32476968,eosinophil
1715,32476968,sarcoidosis
1716,30307028,graves’ disease
1716,30307028,depressive symptoms
1716,30307028,hyperthyroidism
1716,30307028,sexual functioning
1716,30307028,thyroid nodules
1717,29574428,emergency medicine
1717,29574428,endocrinology
1717,29574428,paediatrics
1717,29574428,thyroid disease cois
1718,29791909,fetal goiter
1718,29791909,fetal hypothyroidism
1718,29791909,intra-amniotic treatment
1718,29791909,iodine
1718,29791909,wolff-chaikoff effect
1720,30351170,fam167a-blk
1720,30351170,graves' disease (gd)
1720,30351170,hashimoto's thyroiditis (ht)
1720,30351170,autoimmune thyroid disease (aitd)
1720,30351170,polymorphism
1723,30311856,*pakistan
1723,30311856,*goiter prevalence
1723,30311856,*iodine deficiency disorder
1723,30311856,*iodized salt
1723,30311856,*pregnancy
1724,31383679,asthma
1724,31383679,"ear, nose and throat"
1724,31383679,pregnancy
1724,31383679,thyroid disease cois
1725,30509783,anestesia general
1725,30509783,general anaesthesia
1725,30509783,glucogenosis
1725,30509783,glycogenosis
1725,30509783,hipertermia maligna
1725,30509783,hipoglucemia
1725,30509783,hypoglycaemia
1725,30509783,malignant hyperthermia
1725,30509783,mcardle's syndrome
1725,30509783,mioglobinuria
1725,30509783,miopatía
1725,30509783,myoglobinuria
1725,30509783,myopathy
1725,30509783,síndrome de mcardle
1726,31450040,*graves' disease
1726,31450040,*hyperthyroidism
1726,31450040,*toxic multinodular goiter
1726,31450040,*toxic solitary nodule
1727,30455812,graves
1727,30455812,child
1727,30455812,treatment
1728,30541519,graves’ disease
1728,30541519,graves’ disease treatment.
1728,30541519,i131.
1728,30541519,radioiodine. cois metro south human research ethics committee (reference number: lnr/qms/43580). all necessary permissions to access medical records from the princess alexandra hospital were obtained. consent to participate was not a requirement. competing interests: the authors declare they have no competing interests. publisher’s note: springer nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
1729,30626069,*graves’ orbitopathy
1729,30626069,*corticosteroids
1729,30626069,*hyperthyroidism
1729,30626069,*ophthalmopathy
1729,30626069,*prednisone cois
1732,31869260,* tnfsf15
1732,31869260,*graves’ disease
1732,31869260,*graves’ ophthalmopathy
1732,31869260,*tl1a
1732,31869260,*single nucleotide polymorphism
1733,31827052,aequorin
1733,31827052,graves’ ophthalmopathy
1733,31827052,thyroid-stimulating antibody
1733,31827052,thyrotropin receptor antibody
1734,31408196,*dicer1 syndrome
1734,31408196,*childhood
1734,31408196,*genetic counselling
1734,31408196,*multinodular goitre
1734,31408196,*thyroid pathologies
1740,31155292,*crispr/cas9
1740,31155292,*hearing loss
1740,31155292,*mouse model
1740,31155292,*pendred syndrome
1740,31155292,*slc26a4
1740,31155292,*vestibular dysfunction
1741,30537006,*graves' disease
1741,30537006,*rln injury
1741,30537006,*complications
1741,30537006,*hypoparathyroidism
1741,30537006,*thyroidectomy
1744,31377715,"ear, nose and throat/otolaryngology"
1744,31377715,hyperthyroidism
1744,31377715,otolaryngology/ent
1744,31377715,thyroid disease
1744,31377715,thyrotoxicosis cois
1747,31252621,ebv
1747,31252621,graves’ disease
1747,31252621,autoimmune thyroid disease
1747,31252621,hyperthyroidism
1747,31252621,viruses cois as prejudicing the impartiality of the research.
1748,31762351,receptive language outcomes
1748,31762351,non-syndromic enlarged vestibular aqueduct
1748,31762351,peabody picture vocabulary test
1748,31762351,pediatric cohort
1748,31762351,pendred syndrome
1750,30654201,depression
1750,30654201,hyperthyroidism
1750,30654201,thyroid disease
1750,30654201,women’s health
1751,31633822,*dfnb4
1751,31633822,*eva
1751,31633822,*pendred syndrome
1751,31633822,*slc26a4
1751,31633822,*genotype vs. phenotype
1751,31633822,*inner ear morphology
1751,31633822,*nonsyndromic enlarged vestibular aqueduct
1755,31749116,*antithyroid drug
1755,31749116,*graves’ disease
1755,31749116,*lymphocyte
1755,31749116,*neutrophil
1755,31749116,*relapse
1757,30955175,*fine-needle aspiration
1757,30955175,*goiter
1757,30955175,*hyperthyroidism
1757,30955175,*hypothyroidism
1757,30955175,*thyroid cancer
1757,30955175,*thyroid nodule
1757,30955175,*thyroid ultrasound
1758,29053044,graves’ ophthalmopathy
1758,29053044,graves’ orbitopathy
1758,29053044,thyroid eye disease
1758,29053044,superior ophthalmic vein thrombosis
1760,31372509,*cell biology
1760,31372509,*endocrinology
1760,31372509,*genetics
1760,31372509,*pathogenesis cois
1761,31290382,fluorescence microscopy
1761,31290382,thyroid nodule
1764,31187663,*hearing loss
1764,31187663,*iran
1764,31187663,*missense variant
1764,31187663,*next-generation sequencing
1767,27773627,bocio multinodular
1767,27773627,horner
1767,27773627,multinodular goiter
1767,27773627,oculosympathetic pathway
1767,27773627,thyroid
1767,27773627,tiroides
1767,27773627,vía oculosimpática
1768,31407208,autoimmune poliglandular syndromes
1768,31407208,graves’ disease
1768,31407208,hyperthyroidism
1768,31407208,thyroid
1769,30513035,dyshormonogenesis
1769,30513035,graves disease
1769,30513035,trab
1769,30513035,fetal goiter
1769,30513035,hyperthyroidism
1769,30513035,hypothyroidism
1770,31222404,corvis st
1770,31222404,goldmann applanation tonometry
1770,31222404,intraocular pressure
1770,31222404,ora
1770,31222404,thyroid-associated orbitopathy
1770,31222404,icare
1771,30862149,*graves’ disease
1771,30862149,*hyperthyroidism
1771,30862149,*antithyroid drugs cois
1772,31217394,adenovirus
1772,31217394,graves disease
1772,31217394,model
1774,30173328,*cognitive function
1774,30173328,*graves’ disease
1774,30173328,*graves’ ophthalmopathy
1774,30173328,*hyperthyroidism
1774,30173328,*quality of life
1775,30688164,*graves' disease
1775,30688164,*graves' ophthalmopathy
1775,30688164,*graves' orbitopathy
1775,30688164,*patient knowledge
1775,30688164,*thyroid eye disease
1776,30924917,*cancer
1776,30924917,*inflammation
1776,30924917,*neutrophil to lymphocyte ratio
1776,30924917,*thyroid nodule
1777,30263008,*dgge
1777,30263008,*gd
1777,30263008,*gut microbiota
1777,30263008,*high-throughput sequencing
1777,30263008,*hyperthyroidism
1777,30263008,*ophthalmopathy cois
1778,29281760,*complications
1778,29281760,*epidemiology biochemistry
1778,29281760,*hypoparathyroidism
1778,29281760,*mortality
1779,30955162,*graves’ disease
1779,30955162,*hyperthyroidism
1779,30955162,*leg tremor
1779,30955162,*postural tremor
1780,29923059,cholesterol
1780,29923059,graves
1780,29923059,ophthalmopathy
1780,29923059,orbitopathy
1780,29923059,statins
1781,29043478,goiter
1781,29043478,growth
1781,29043478,mri
1781,29043478,observer agreement
1781,29043478,quality of life
1781,29043478,thyroid function
1781,29043478,thyroidectomy
1782,30057393,graves orbitopathy
1782,30057393,deppression
1782,30057393,quality of life
1784,31184263,*external branch of the superior laryngeal nerve
1784,31184263,*goiter
1784,31184263,*quality of life
1784,31184263,*recurrent laryngeal nerve
1784,31184263,*thyroidectomy
1784,31184263,*voice
1785,31849168,graves' disease
1785,31849168,antithyroid drug
1785,31849168,children
1785,31849168,remission
1785,31849168,thyroid-stimulating hormone receptor antibodies
1786,30390961,benign/goiter
1786,30390961,preoperative workup
1786,30390961,thyroid
1786,30390961,thyroid surgery
1786,30390961,ultrasound/imaging
1787,30409157,gitelman syndrome
1787,30409157,graves’ disease
1787,30409157,"hypokalemia cois ethics approval and consent to participate: this study was performed according to the helsinki declaration. written informed consent to participate in the study was obtained from the patient and his mother. the patient’s son was 17 years old, and written informed consent was obtained from him and his parents as legal guardians. consent for publication: written informed consent was obtained from the patient and his mother for publication of the details of the case report. the patient’s son was 17 years old, and written informed consent was obtained from him and his parents as legal guardians. publisher’s note: springer nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations."
1788,31758881,*hashimoto’s thyroiditis
1788,31758881,*hypothyroidism
1788,31758881,*precocious puberty
1788,31758881,*stature cois
1789,30457413,biotherapies
1789,30457413,eugogo
1789,30457413,graves’ ophthalmopathy
1789,30457413,proptosis
1789,30457413,tocilizumab
1790,30339291,*cornea
1790,30339291,*dysthyroid optic neuropathy
1790,30339291,*orbital decompression
1790,30339291,*sight-threatening graves’ orbitopathy
1792,31655515,*lymphocyte
1792,31655515,*monocyte
1792,31655515,*neutrophil
1792,31655515,*platelet
1792,31655515,*ratio
1792,31655515,*thyrotoxicosis cois
1793,30760283,*myotonic dystrophy
1793,30760283,*papillary thyroid carcinoma
1793,30760283,*thyroid goiter
1793,30760283,*thyroid nodule
1793,30760283,"*ultrasound scan cois person (cpp), iorg 0009553 – institutional review board for the university hospital of lille. ethical committee under number: hp 1821 (benhamou_ethics_ojrd.pdf). consent for publication: na competing interests: the authors declare that they have no competing interests. publisher’s note: springer nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations."
1794,31323889,goiter
1794,31323889,hypothyroidism
1794,31323889,iodine deficiency
1794,31323889,iodine deficiency disorders
1794,31323889,iodine prophylaxis
1794,31323889,pregnancy
1794,31323889,schoolchildren cois as prejudicing the impartiality of the research reported.
1796,30880636,*graves' disease
1796,30880636,*autoimmune disease
1796,30880636,*balance
1796,30880636,*muscle strength
1796,30880636,*thyroid
1797,31715677,clinical protocols
1797,31715677,glaucoma
1797,31715677,graves ophthalmopathy
1797,31715677,ocular hypertension
1798,29306930,adolescents
1798,29306930,antithyroid drugs
1798,29306930,children
1798,29306930,hyperthyroidism
1798,29306930,management
1798,29306930,radioiodine
1798,29306930,thyrotoxicosis
1801,28569050,graves’ disease
1801,28569050,mir-146a
1801,28569050,mir-155
1801,28569050,mir-210
1801,28569050,regulatory t cells
1803,30302663,nodular recurrence
1803,30302663,thyroid lobectomy
1803,30302663,thyroid nodules
1804,32397019,disease attribute
1804,32397019,"lymphoma, non-hodgkin"
1804,32397019,prognosis
1804,32397019,thyroid neoplasms
1805,29595868,*goitre
1805,29595868,*hypocalcaemia
1805,29595868,*hypoparathyroidism
1805,29595868,*retrosternal goitre
1805,29595868,*thyroid gland
1805,29595868,*thyroidectomy
1806,29450866,diplopia
1806,29450866,graves’ orbitopathy
1806,29450866,orbital decompression
1806,29450866,proptosis
1806,29450866,quality of life
1807,29771881,endocrine ophthalmopathy
1807,29771881,multidimensional linear regression modeling
1807,29771881,prognostication
1807,29771881,risk factors
1807,29771881,toxic diffuse goiter
1809,30485487,*graves’ disease treatment
1809,30485487,*thyrotrophin receptor antibodies
1813,30540214,pulsed ivmp
1813,30540214,active ted
1813,30540214,efficacy and safety
1813,30540214,medical management
1813,30540214,steroid sparing agents
1815,31586293,*endogenous thyrotropin
1815,31586293,*methimazole
1815,31586293,*multinodular goitre
1815,31586293,*radioiodine cois
1816,31646433,*exophthalmos
1816,31646433,*graves’ disease
1816,31646433,*orbital decompression
1816,31646433,*orbital radiotherapy
1816,31646433,*orbitopathy
1817,30334140,*+49a/g polymorphism of the ctla4 gene
1817,30334140,*graves’ hyperthyroidism
1817,30334140,*graves’ orbitopathy
1817,30334140,*methimazole
1817,30334140,*predictors of remission
1819,31849350,cervical oesophageal perforation
1819,31849350,oesophageal injury
1819,31849350,oesophagogastroscopy
1819,31849350,oesophagus dilation
1819,31849350,thyroidectomy
1823,30369298,*ecological momentary assessments
1823,30369298,*patient-reported outcomes
1823,30369298,*thyroid diseases
1823,30369298,*thyroid-related quality of life
1825,30194634,graves’ ophthalmopathy
1825,30194634,tbii
1825,30194634,trab
1825,30194634,tsab
1826,31536167,afirma
1826,31536167,cytology
1826,31536167,fine-needle aspiration (fna)
1826,31536167,gene expression classifier (gec)
1826,31536167,genomic sequencing classifier (gsc)
1826,31536167,molecular
1826,31536167,thyroid
1830,29759035,*nis
1830,29759035,*slc5a5
1830,29759035,*congenital hypothyroidism
1830,29759035,*goiter
1830,29759035,*novel mutation
1830,29759035,*sodium–iodide symporter cois
1831,29332250,dysfunctional tear syndrome
1831,29332250,hyperthyroidism
1831,29332250,ocular surface inflammation
1831,29332250,tear cytokines
1831,29332250,thyroid-associated orbitopathy
1832,30135996,graves’ disease
1832,30135996,lipidomic analysis
1832,30135996,ophthalmopathy
1832,30135996,plasma
1832,30135996,urine
1832,30135996,nuplc-esi-ms/ms
1837,30696398,*acute airway obstruction
1837,30696398,*goitre
1837,30696398,*pregnancy
1837,30696398,*respiratory arrest cois publication: written informed consent for publication of the clinical details and clinical images was obtained from the patient. written informed consent for publication of the clinical details and clinical images was obtained from patient. competing interests: the authors declare that they have no competing interests. publisher’s note: springer nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
1838,31727496,children
1838,31727496,iodized salt
1838,31727496,thyroid abnormalities
1838,31727496,urinary iodine
1838,31727496,water iodine
1838,31727496,water replacement
1839,28766837,dicer1
1839,28766837,cystic nephroma
1839,28766837,multinodular goiter
1839,28766837,mutation
1839,28766837,neuroblastoma
1839,28766837,syndrome
1842,30387079,benign thyroid disease
1842,30387079,meta-analysis
1842,30387079,prospective study
1842,30387079,thyroid cancer
1844,31201593,extraocular muscle
1844,31201593,graves’ ophthalmopathy
1844,31201593,magnetic resonance imaging
1844,31201593,radiation therapy
1844,31201593,steroids
1845,31237847,intraocular pressure
1845,31237847,thyroid-associated orbitopathy
1848,30217613,basedow
1848,30217613,graves
1848,30217613,quality of life
1848,30217613,qualité de vie
1848,30217613,questionnaire
1848,30217613,strabisme
1848,30217613,strabismus
1848,30217613,thyroid
1848,30217613,thyroïde
1849,30217607,chirurgie de strabisme
1849,30217607,diplopia
1849,30217607,diplopie
1849,30217607,dysthyroid orbitopathy
1849,30217607,graves’ disease
1849,30217607,maladie de basedow
1849,30217607,orbitopathie dysthyroïdienne
1849,30217607,strabismus surgery
1852,31023276,bioassay
1852,31023276,graves’ disease
1852,31023276,trab
1852,31023276,"thyroid cois involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 helsinki declaration and its later amendments or comparable ethical standards. the study protocol was approved by the local ethics committee (ethikkommission nordwest und zentralschweiz (eknz) project no. 2015/227). need for informed consent was waived by the local ethics committee due retrospective nature of analysis with no impact on health outcome. consent for publication: not applicable. competing interests: bm and ps received research support by thermo fisher scientific, roche diagnostics, abbott and siemens unrelated to this study. all authors confirm that they do not have a conflict of interest associated with this manuscript. publisher’s note: springer nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations."
1853,30132285,autoimmune thyroiditis
1853,30132285,graves’ disease
1853,30132285,graves’ ophthalmopathy
1853,30132285,graves’ orbitopathy
1853,30132285,insulin-like growth factor-1 receptor
1853,30132285,thyroid
1853,30132285,thyroid autoimmunity
1853,30132285,thyroid eye disease
1854,31641884,computed tomography
1854,31641884,deep lateral orbital wall decompression
1854,31641884,fat removal
1854,31641884,graves’ orbitopathy
1854,31641884,prediction
1854,31641884,the greater wing of the sphenoid
1855,30862763,graves’ disease
1855,30862763,children
1855,30862763,long-term outcome
1855,30862763,methimazole treatment
1855,30862763,remission
1856,31340806,bleeding
1856,31340806,hematoma
1856,31340806,risk factor
1856,31340806,thyroid surgery
1856,31340806,thyroidectomy cois
1857,30049435,*graves' disease
1857,30049435,*thyroid cancer
1857,30049435,*thyroid nodules
1858,30696370,*children
1858,30696370,*goiter
1858,30696370,*sufficient iodine intake
1858,30696370,*thyroid volume
1859,31622299,"thyroidectomy, complications, hypocalcaemia, recurrent laryngeal nerve injury,  haemorrhage. (jpma 69: 1470; 2019).doi:10.5455/jpma.301233"
1862,30767621,*graves' disease
1862,30767621,*ciliogenesis
1862,30767621,*nodular hyperplasia
1862,30767621,*primary cilia
1862,30767621,*thyrocytes
1863,29649988,lipid layer thickness
1863,29649988,meibomian gland dysfunction
1863,29649988,"thyroid eye diseases cois (irb)/ethics committee approval was obtained from the committee of medical ethics and human experiments of chang gung memorial hospital (cgmh), taiwan. informed consent was obtained from each subject in the cgmh. consent for publication: not applicable. competing interests: the authors declare that they have no competing interests. publisher’s note: springer nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations."
1866,31309667,fukushima
1866,31309667,japanese black
1866,31309667,cattle
1866,31309667,goiter
1866,31309667,thyroid gland
1869,31094460,hormones
1869,31094460,immunological
1869,31094460,liquidators of the chernobyl accident
1869,31094460,non-hospital pneumonia
1870,30197184,*autoimmune disease
1870,30197184,*celiac disease
1870,30197184,*graves’ disease
1870,30197184,*myotonic dystrophy type 2
1871,29183262,*sds
1871,29183262,*globus symptoms
1871,29183262,*quality of life
1871,29183262,*thyroid surgery
1872,30719623,cyclosporine
1872,30719623,graves’ orbitopathy
1872,30719623,intravenous glucocorticoids
1872,30719623,methotrexate
1873,30737677,*hashimoto’s thyroiditis
1873,30737677,*iodothyronine deiodinase
1873,30737677,*thyroid gland
1873,30737677,*thyroid hormone metabolism
1874,31170960,destructive thyrotoxicosis
1874,31170960,diagnostic meta-analysis
1874,31170960,differential diagnosis
1874,31170960,graves’ disease
1874,31170960,peak systolic velocity of superior thyroid artery
1874,31170960,thyrotoxicosis cois
1875,31933295,focus harmonic scalpel
1875,31933295,hypocalcaemia
1875,31933295,hypoparathyroidism
1875,31933295,thyroidectomy
1876,31514388,diagnosis
1876,31514388,exosomes
1876,31514388,goiter
1876,31514388,heat shock proteins (hsp)
1876,31514388,molecular chaperones
1876,31514388,papillary carcinoma
1876,31514388,thyroid gland cois
1877,30110704,congenital hypothyroidism
1877,30110704,duoxa2
1877,30110704,fetal goiter
1877,30110704,mutation
1877,30110704,polyhydramnios
1878,29354016,*computed tomography
1878,29354016,*euthyroidism
1878,29354016,*graves' disease
1878,29354016,*methimazole
1878,29354016,*single-photon emission computed tomography
1879,29943563,graves disease
1879,29943563,hepatitis a virus
1879,29943563,triggering factor
1882,30092670,*go-qol
1882,30092670,*graves’ ophthalmopathy (go)
1882,30092670,*thyroid eye disease (ted)
1882,30092670,*adults
1882,30092670,*psychometrics
1882,30092670,*reliability
1882,30092670,*validity
1883,30690623,*endemic
1883,30690623,*goitre
1883,30690623,*iodine
1883,30690623,*urinary iodine excretion
1884,27659020,goiter
1884,27659020,subtotal resection
1884,27659020,thyroidectomy
1886,29032778,*iodine-deficiency disorders
1886,29032778,*iodized salt
1886,29032778,*iran
1886,29032778,*school-aged children
1887,31411490,arhi
1887,31411490,fine-needle aspiration cytology
1887,31411490,imprinted gene
1887,31411490,thyroid nodule cois
1888,31028051,"ear, nose and throat"
1888,31028051,respiratory system
1888,31028051,venous thromboembolism cois
1890,30621642,hashimoto’s thyroiditis
1890,30621642,magnetic resonance
1890,30621642,ophthalmopathy
1890,30621642,"orbitopathy cois accordance with the ethical standards of the institutional and/or national research committee and with the 1964 helsinki declaration and its later amendments or comparable ethical standards. this is a case report, retrospectively describing the course of the diagnostics and therapy, thus does not require the local bioethical committee approval. consent for publication: written informed consent was obtained from the patient for the publication of this report and any accompanying images. competing interests: the authors declare that they have no competing interests. publisher’s note: springer nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations."
1892,31347001,euthyroid
1892,31347001,in vitro fertilization
1892,31347001,intra-cytoplasmic sperm injection
1892,31347001,pregnancy outcomes
1893,31696306,*epoprostenol
1893,31696306,*hyperthyroidism
1893,31696306,*prostanoids
1893,31696306,*pulmonary hypertension
1893,31696306,*selexipag
1895,30369343,*pps method
1895,30369343,*thyroid volume
1895,30369343,*urinary iodine concentration
1896,30710486,goiter
1896,30710486,iodine deficiency disorders
1896,30710486,urinary iodine
1896,30710486,urinary thiocyanate
1900,30431723,graves’ disease
1900,30431723,graves’ ophthalmopathy
1900,30431723,optic nerve diseases
1900,30431723,optic nerve injuries
1900,30431723,"ultrasonography, doppler, color"
1901,31420436,materno-fetal medicine
1901,31420436,pregnancy
1901,31420436,thyroid disease cois
1902,30515705,bihar
1902,30515705,intelligence quotient (iq)
1902,30515705,iodized salt consumption
1902,30515705,total goitre rate
1904,30484383,*cochlear implantation
1904,30484383,*enlarged endolymphatic sacs
1904,30484383,*enlarged vestibular aqueduct
1904,30484383,*pendred syndrome
1904,30484383,*slc26a4
1904,30484383,*temporal bone
1906,31565879,*autoantibodies
1906,31565879,*graves disease
1906,31565879,*recurrence
1906,31565879,*thyroid peroxidase antibody cois
1908,30667296,*graves' disease
1908,30667296,*qol
1908,30667296,*sf-36
1908,30667296,*thypro
1908,30667296,*long-term
1908,30667296,*radioiodine
1909,30392997,hipocalcemia
1909,30392997,hipoparatiroidismo
1909,30392997,hypocalcemia
1909,30392997,hypoparathyroidism
1909,30392997,parathormone
1909,30392997,paratohormona
1909,30392997,thyroidectomy
1909,30392997,tiroidectomía
1911,31677639,*goiter
1911,31677639,*salt iodine concentration
1911,31677639,*shanghai
1911,31677639,*thyroid volume
1911,31677639,*urinary iodine concentration cois
1912,31860407,*graves'
1912,31860407,"*disease, graves'"
1912,31860407,"*orbitopathy, radioiodine, glucocorticoids, tsh receptor antibodies"
1913,30814438,graves’ disease
1913,30814438,hashimoto’s thyroiditis
1913,30814438,interleukin-17
1913,30814438,interleukin-1β
1913,30814438,interleukin-23
1916,29198022,*glaucoma
1916,29198022,*graves' disease
1916,29198022,*register study
1916,29198022,*toxic nodular goiter
1917,30890403,fna
1917,30890403,ptc
1917,30890403,mir-137
1917,30890403,mir-181b
1917,30890403,mir-214
1917,30890403,mir-222
1920,31691654,mechanical high-speed bone removal
1920,31691654,orbital bone decompression
1920,31691654,osteodestruction
1920,31691654,scanning electron microscopy
1920,31691654,thyroid eye disease
1920,31691654,ultrasonic bone removal
1921,30593716,blinking
1921,30593716,dry eye
1921,30593716,meibomian gland dysfunction
1921,30593716,thyroid eye disease
1922,30577987,thyroid surgery
1922,30577987,transcutaneous laryngeal ultrasound
1922,30577987,vocal cord mobility
1925,30701793,graves’ disease
1925,30701793,endocrine ophthalmopathy
1925,30701793,polymorphic genetic markers
1926,29446011,iodine
1926,29446011,iodine deficiency
1926,29446011,iodized salt
1926,29446011,iran
1926,29446011,uic cois ethical approval: the local ethics committee approved the study protocol. informed consent: informed consent was obtained from all individual participants included in the study.
1929,29946800,antithyroid drugs
1929,29946800,goiter
1929,29946800,graves’ disease
1929,29946800,graves’ orbitopathy
1929,29946800,hyperthyroidism
1929,29946800,predictive models
1929,29946800,recurrence
1929,29946800,tsh-receptor antibody
1930,31841476,accident at chnpp
1930,31841476,breast cancer
1930,31841476,functional parameters
1930,31841476,malignant tumors
1930,31841476,mammary gland
1930,31841476,structural parameters
1930,31841476,thyroid gland
1931,29937466,dysthyroid eye disease
1931,29937466,glucocortoid-resistant
1931,29937466,graves’ orbitopathy
1931,29937466,rituximab
1932,29940879,goiter
1932,29940879,iodine deficiency
1932,29940879,iodized salt
1932,29940879,pregnant women
1932,29940879,urinary iodine cois the institutional review board of hawassa university (irb 065-06). the local authorities were informed about the study objectives. after the study purpose was explained to the pregnant women informed written consent was obtained. confidentiality of the data obtained from participants was strictly secured and maintained. consent for publication: not applicable. competing interests: the authors declare that they have no competing interests. publisher’s note: springer nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
1933,29334119,elastography
1933,29334119,nodular goitre
1933,29334119,thyroid
1933,29334119,thyroid imaging reporting and data system
1933,29334119,ultrasound
1935,31660895,hmga2
1935,31660895,thyroid carcinoma
1935,31660895,microrna
1935,31660895,molecular markers
1935,31660895,preoperative diagnosis cois
1936,31810448,goitre
1936,31810448,iodine
1936,31810448,thyroid
1936,31810448,uic
1936,31810448,wic
1936,31810448,water cois
1937,29556769,ablation techniques
1937,29556769,high-intensity focused ultrasound ablation
1937,29556769,interventional ultrasonography
1937,29556769,nodular goitre
1937,29556769,ultrasound imaging
1939,30219088,antithyroid drugs
1939,30219088,cascore
1939,30219088,graves’ disease
1939,30219088,graves’ ophthalmopathy
1939,30219088,hyperthyroidism
1939,30219088,muscle index
1939,30219088,nospecs
1939,30219088,superonasal index
1939,30219088,"thyroidectomy cois medical university vienna gave a positive vote on the protocol and consent to participate. (protocol record 1839/2015). the trial was registered at the european clinical trials database (eudra-ct: 2015–003515-38). consent for publication: in consenting to participate in the clinical trial, all patients also consent to publication, as is stated in their consent form. competing interests: the author(s) declare that they have no competing interests. publisher’s note: springer nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations."
1941,31171533,acute renal failure
1941,31171533,liver disease
1941,31171533,thyroid disease cois
1942,31312298,graves´ disease
1942,31312298,hashimoto´s thyroiditis
1942,31312298,south africa
1942,31312298,autoimmune thyroid disease
1942,31312298,hyperthyroidism
1942,31312298,hypothyroidism cois
1943,30885146,cyclin d1
1943,30885146,cytology
1943,30885146,diagnosis
1943,30885146,ngs
1943,30885146,"thyroid nodule cois the patients, and the ethical committee of the national cancer center hospital, tokyo, japan, approved the procedures (approval #2010–077). the informed consent will be written or verbal from participants. the research poses no more than minimal risk to patients and includes appropriate safeguards to protect the patients’ rights, safety and privacy. consent for publication: not applicable. competing interests: the authors declare that they have no competing interests. publisher’s note: springer nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations."
1944,28656526,antioxidant
1944,28656526,fibroblast
1944,28656526,graves’
1944,28656526,melatonin
1944,28656526,n-acetyl-l-cysteine
1944,28656526,ophthalmopathy
1944,28656526,orbitopathy
1944,28656526,vitamin c
1945,29983514,goitre
1945,29983514,difficult intubation
1945,29983514,modified intubation difficulty score
1945,29983514,predictive factors
1945,29983514,thyroidectomy
1946,29026936,*eyelid retraction
1946,29026936,*graves’ orbitopathy
1946,29026936,*lid surgery
1946,29026936,*upper eyelid retraction
1947,30572375,cohort study
1947,30572375,school-aged children
1947,30572375,thyroid
1947,30572375,volume
1948,28832090,*aortic grafting
1948,28832090,*goitre
1948,28832090,*retrotracheal
1948,28832090,*thoracotomy
1948,28832090,*thyroidectomy
1949,29787340,cd8+ t cells
1949,29787340,cd8+ t-regulatory cells
1949,29787340,graves’ ophthalmopathy
1949,29787340,thyroid autoimmunity
1950,29764405,excessive iodine intake
1950,29764405,goitre
1950,29764405,iodine deficiency
1950,29764405,pregnant women
1950,29764405,"thyroid volume cois approved by the committee on human research, publications and ethics, knust, school of medical sciences and komfo anokye teaching hospital. the ethical approval reference number is chrpe/rc/058/16. permission to undertake the study at the hospitals was also sought from the hospital management. written informed consent was obtained from all participants recruited into the study. competing interests: the authors declare that they have no competing interests. publisher’s note: springer nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations."
1951,29319381,dwi
1951,29319381,grave’s orbitopathy
1951,29319381,mri
1951,29319381,head and neck
1951,29319381,orbit
1951,29319381,thyroid eye disease
1956,29708883,graves’ disease
1956,29708883,allogenic hematopoietic stem cell transplantation
1956,29708883,hyperthyroidism; severe aplastic anemia
1958,30458118,*rthβ
1958,30458118,*thrb gene
1958,30458118,*novel mutation
1959,28992728,intrapartum treatment
1959,28992728,cesarean section
1959,28992728,congenital high airway obstruction
1959,28992728,fetal neck tumors
1959,28992728,trachea
1961,30224619,graves’ disease
1961,30224619,glucose intolerance
1961,30224619,glycosuria
1961,30224619,hyperthyroidism
1961,30224619,urine glucose screening program
1962,29409479,dysthyroid optic neuropathy
1962,29409479,orbital radiotherapy
1962,29409479,three-wall decompression
1962,29409479,thyroid eye disease cois this case report was approved by the ethics committee of shanghai ninth people’s hospital (no. [2016]-29). the report was in compliance with the tenets of the declaration of helsinki for clinical research. consent for publication: written informed consent was obtained from the patient for publication of this case report and any accompanying images. a copy of the consent is available for review by the editor of this journal. competing interests: the authors declare that they have no competing interests. publisher’s note: springer nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
1963,29307098,hybrid procedure
1963,29307098,lung tumor
1963,29307098,mediastinal tumor
1963,29307098,robotic surgery
1963,29307098,single incision
1963,29307098,thyroid tumor
1965,29786585,pesticides
1965,29786585,morbidity
1965,29786585,thyroid gland
1965,29786585,application rate
1969,30413358,(99m)tc-pertechnetate uptake
1969,30413358,calculated-dose
1969,30413358,captación de (99m)tc-pertecnetato
1969,30413358,clinical outcomes
1969,30413358,cálculo de dosis
1969,30413358,enfermedad de graves
1969,30413358,graves’ disease
1969,30413358,radioiodine
1969,30413358,resultados clínicos
1969,30413358,yodo radiactivo
1971,31670633,postoperativehypocalcemia
1971,31670633,recurrentlaryngealnervepalsy
1971,31670633,totalthyroidectomy
1971,31670633,tubercleofzuckekandl
1975,30610492,antithyroid antibodies
1975,30610492,antithyroid drugs
1975,30610492,graves’ disease
1975,30610492,hyperthyroidism
1975,30610492,type 2 deiodinase
1976,29096966,*calcificaciones
1976,29096966,*calcifications
1976,29096966,*carcinoma tiroideo
1976,29096966,*doppler
1976,29096966,*ecografía
1976,29096966,*elastografía
1976,29096966,*elastography
1976,29096966,*malignancy
1976,29096966,*malignidad
1976,29096966,*nódulo tiroideo
1976,29096966,*thyroid carcinoma
1976,29096966,*thyroid nodule
1976,29096966,*ultrasound
1977,30426886,*graves' disease
1977,30426886,*tsh receptor antibody
1977,30426886,*incidence
1977,30426886,*neonatal hyperthyroidism
1977,30426886,*radioiodine therapy
1978,29633307,*graves’ disease
1978,29633307,*thypro
1978,29633307,*thyrotoxicosis
1978,29633307,*treatment choice
1978,29633307,*treatment satisfaction
1979,29023978,body mass index
1979,29023978,levothyroxine
1979,29023978,radioactive iodine ablation
1980,31369161,*grave's
1980,31369161,*cancer
1980,31369161,*nodules
1980,31369161,*thyroid
1981,31124148,*immunology
1981,31124148,*immunosuppression
1981,31124148,*thyroid diseases
1981,31124148,*vasculitis
1982,31079052,*cosmesis
1982,31079052,*eye lids
1982,31079052,*orbit cois
1983,30658624,99mtc-dtpa
1983,30658624,graves’ orbitopathy
1983,30658624,mri
1983,30658624,"spect/ct cois involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964. helsinki declaration and its later amendments or comparable ethical standards. the study was approved by the bioethical commission of medical university of bialystok, poland. all participants provided written informed consent to participate. competing interests: the authors declare that they have no competing interests. publisher’s note: springer nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations."
1984,30628510,clinical activity score
1984,30628510,color doppler imaging
1984,30628510,thyroid eye disease
1985,30616573,*diagnosis
1985,30616573,*graves’ disease
1985,30616573,*hashimoto’s thyroiditis
1985,30616573,*model
1986,29959506,computed tomography
1986,29959506,eyelid retraction
1986,29959506,graves’ orbitopathy
1986,29959506,inferior rectus muscle
1986,29959506,levator palpebrae superioris muscle
1986,29959506,margin reflex distance
1986,29959506,superior rectus muscle
1988,28738723,*thyroid eye disease
1988,28738723,*patient expectations
1988,28738723,*psychosocial adjustment
1988,28738723,*reconstructive surgery
1988,28738723,*treatment satisfaction
1991,29469200,*dicer1
1991,29469200,*cryptic exon
1991,29469200,*deep intronic mutation
1991,29469200,*lung cyst
1991,29469200,*multinodular goiter
1991,29469200,*ovarian sertoli-leydig cell tumor
1992,30761931,graves’ disease
1992,30761931,movement disorders
1992,30761931,autoimmune
1992,30761931,chorea
1992,30761931,hyperthyroidism
1992,30761931,myoclonus
1992,30761931,tremor
1993,30721670,*bone morphogenic protein 4
1993,30721670,*orbit
1993,30721670,*pathology
1993,30721670,*site-specific adipogenesis
1997,31784912,embryopathy
1997,31784912,graves’ diseases
1997,31784912,methimazole
1997,31784912,pancreatitis
1997,31784912,pregnancy
1997,31784912,propylthiouracil
1999,28568286,gpr174
1999,28568286,ptpn22
1999,28568286,rnaset2
1999,28568286,gene polymorphism
1999,28568286,liver damage
2000,30783963,*diabetes
2000,30783963,*graves’ disease
2000,30783963,*islet autoantibodies
2000,30783963,*thyroid autoantibodies cois ethical approval: all procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 helsinki declaration and its later amendments or comparable ethical standards. informed consent: informed consent was obtained from all individual participants included in the study.
2001,29521049,graves’ disease
2001,29521049,matrix metalloproteinases
2001,29521049,orbithopathy
2001,29521049,tissue inhibitors of metalloproteinases
2004,30151919,*3d
2004,30151919,*thyroid-associated orbitopathy
2004,30151919,*eye-tracking
2004,30151919,*facial deformity
2004,30151919,*scanpath
2005,29739340,*brazil
2005,29739340,*hereditary deafness
2005,29739340,*pendrin gene
2005,29739340,"*slc26a4 cois written informed consent was obtained from all individuals or their legal guardians (if patients were under 18). the project was approved by the ethics committee, instituto de biociências, universidade de são paulo (protocol n(o) 109/2010). consent for publication: all subjects have approved the submission of the manuscript by written informed consent. competing interests: the authors declare that they have no competing interests. publisher’s note: springer nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations."
2010,30167837,graves’ orbitopathy
2010,30167837,nasal airflow
2010,30167837,olfactory performance
2010,30167837,orbital decompression
2010,30167837,surgical outcome
2014,29096933,graves’ orbitopathy
2014,29096933,balanced decompression
2014,29096933,deep lateral decompression
2014,29096933,intact rim
2014,29096933,proptosis
2014,29096933,rim removal
2015,32202741,*igg4-associated disease
2015,32202741,*autoimmune thyroiditis
2015,32202741,*case report
2015,32202741,*inflammatory orbital disease
2015,32202741,*orbital involvement
2015,32202741,*thyroid eye disease
2020,30442552,graves’ orbitopathy
2020,30442552,deep lateral decompression
2020,30442552,proptosis
2020,30442552,rim-sparing
2021,32476690,"cholesterol, hdl"
2021,32476690,"igf1 protein, human"
2021,32476690,"igf2 protein, human"
2021,32476690,insulin
2021,32476690,insulin-like growth factor i
2021,32476690,insulin-like growth factor ii
2021,32476690,iodine
2021,32476690,"obesity, abdominal"
2021,32476690,thyroid nodule
2021,32476690,case-control studies
2021,32476690,insulin resistance
2021,32476690,metabolic syndrome
2022,30223781,*cd40
2022,30223781,*ctla-4
2022,30223781,*genetic polymorphism
2022,30223781,*graves’ disease cois the medical ethics committee of the affiliated hospital of guangdong medical university. the approval number was: pj2012029. all the above enrolled patients signed an informed consent document. consent for publication: not applicable. competing interests: the authors declare that they have no competing interests. publisher’s note: springer nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
2023,31188037,*bézier curves
2023,31188037,*graves orbitopathy
2023,31188037,*contour analysis
2023,31188037,*lower eyelid
2023,31188037,*lower eyelid retraction
2026,29627743,chronic autoimmune thyroiditis
2026,29627743,diffuse thyroid disease
2026,29627743,swe
2026,29627743,ft3/ft4 ratio
2027,30543152,*mapk/erk pathway
2027,30543152,*pi3k/akt pathway
2027,30543152,*tbx1
2027,30543152,*epithelial–mesenchymal transition
2027,30543152,*thyroid cancer
2028,31474503,graves’ orbitopathy
2028,31474503,endocrine ophthalmopathy
2028,31474503,fat removal
2028,31474503,orbital decompression
2029,30954956,endocrine system
2029,30954956,thyroid disease cois
2030,30084099,*craniosynostosis
2030,30084099,*graves’ orbitopathy
2031,31056988,extraocular muscle
2031,31056988,graves’ eye disease
2031,31056988,superior recuts
2031,31056988,thyroid eye disease
2032,31831041,graves disease
2032,31831041,thrombotic thrombocytopenic purpura cois
2034,30142011,color doppler imaging
2034,30142011,orbital decompression
2034,30142011,thyroid eye disease
2035,29937157,extraocular muscles
2035,29937157,graves’ ophthalmopathy
2035,29937157,grosor muscular
2035,29937157,muscle thickness
2035,29937157,músculos extraoculares
2035,29937157,oftalmopatía de graves
2035,29937157,optical coherence tomography
2035,29937157,orbitopatía tiroidea
2035,29937157,thyroid orbitopathy
2035,29937157,tocilizumab
2035,29937157,tomografía de coherencia óptica
2036,30009641,*human extraocular muscle
2036,30009641,*human extraocular muscle myoblasts
2036,30009641,*myogenesis
2036,30009641,*thyroid-associated ophthalmopathy
2036,30009641,*thyroid-stimulating hormone receptor
2038,30941511,anterior blepharotomy
2038,30941511,esthetic outcome
2038,30941511,graves’ ophthalmopathy
2038,30941511,tarsal platform show
2038,30941511,upper eyelid retraction
2044,30535759,autoimmune thyroid diseases
2044,30535759,graves’ disease
2044,30535759,hashimoto’s thyroiditis
2044,30535759,magi2
2044,30535759,single-nucleotide polymorphisms
2045,30513237,graves’ orbitopathy
2045,30513237,orbital decompression
2045,30513237,diplopia
2045,30513237,piezosurgery
2045,30513237,proptosis reduction
2047,29190000,autoimmune
2047,29190000,dna methylation
2047,29190000,genome-wide
2047,29190000,graves’ orbitopathy
2049,31365979,graves orbitopathy
2049,31365979,graves orbitopathy guality of life questionnaire
2049,31365979,quality of life
2050,31059842,cxcl10
2050,31059842,cxcl8
2050,31059842,fibroblasts
2050,31059842,graves' disease
2050,31059842,graves' ophthalmopathy
2050,31059842,thyrocytes
2052,29319400,graves’
2052,29319400,orbital decompression
2052,29319400,strabismus
2053,29166180,*corvis-st
2053,29166180,*dynamic scheimpflug analyzer
2053,29166180,*biomechanics
2053,29166180,*thyroid orbitopathy
2053,29166180,*whole eye movement
2054,28177666,graves’ disease
2054,28177666,graves’ ophthalmopathy
2054,28177666,cytokine
2054,28177666,gene
2054,28177666,genetic polymorphism
2054,28177666,maladie de graves
2054,28177666,ophtalmopathie de graves
2054,28177666,poly (adp-ribose) polymerase-1
2054,28177666,poly (adp-ribose) polymérase-1
2054,28177666,polymorphism
2054,28177666,polymorphisme
2054,28177666,polymorphisme génétique
2056,30937820,hypoparathyroidism
2056,30937820,recurrent nerve injury
2056,30937820,reoperative thyroid surgery
2056,30937820,total thyroidectomy
2057,31604721,calcium and bone
2057,31604721,thyroid disease cois
2058,30801749,*calcium
2058,30801749,*hypoparathyroidism
2058,30801749,*dyspepsia
2058,30801749,*hospitalization
2058,30801749,*patient survey
2058,30801749,*vitamin d
2059,30176063,*chinese cohort
2059,30176063,*graves' disease
2059,30176063,*genome-wide association study
2059,30176063,*susceptibility loci
2060,29336220,*graves'
2060,29336220,*cholesterol
2060,29336220,*ophthalmopathy
2060,29336220,*orbitopathy
2060,29336220,*statins
2061,29273685,*igf receptor
2061,29273685,*immune system
2061,29273685,*signal transduction
2061,29273685,"*thyroid cois member at the ucla school of medicine covering the diagnostic methods for monitoring anti-igf-ir antibodies and the therapeutic targeting of igf-ir in graves’ disease and other autoimmune diseases. i have requested that my current employer, the university of michigan medical school, adjudicate any conflicts of interest."
2062,31271716,*graves’ disease
2062,31271716,*pretibial myxedema
2062,31271716,*thyroid dermopathy
2065,31884304,autoantibodies
2065,31884304,graves' disease
2065,31884304,smoking
2065,31884304,vitamin 25(oh)d3 cois
2067,30092570,childhood onset
2067,30092570,graves’ disease
2067,30092570,papillary thyroid carcinoma
2067,30092570,slc5a5
2067,30092570,tfg/ntrk1
2067,30092570,tshr
2069,31685507,*graves' disease
2069,31685507,*cognitive impairment
2069,31685507,*functional near-infrared spectroscopy
2069,31685507,*hippocampus
2069,31685507,*magnetic resonance volumetry
2069,31685507,*quality of life cois and bristol-myers squibb.
2070,31338585,dexamethasone
2070,31338585,interleukin 6
2070,31338585,interleukin 6 receptor
2070,31338585,thyroid eye disease
2070,31338585,tocilizumab
2073,31462328,aggressive carcinoma
2073,31462328,graves’ disease
2073,31462328,matched cohort
2073,31462328,outcomes
2073,31462328,papillary thyroid carcinoma cois
2074,31304517,graves’ disease
2074,31304517,mig
2075,30825882,champagne bottle neck sign
2075,30825882,graves’ disease
2075,30825882,moyamoya vasculopathy
2075,30825882,recurrence
2075,30825882,vasculitis cois publication: written informed consent was obtained from the patient for publication of this case report. a copy of the written consent is available for review by the editor of this journal. competing interests: the authors declare that they have no competing interests. publisher’s note: springer nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
2077,29742012,eyelid
2077,29742012,recession
2077,29742012,retraction
2077,29742012,spacer graft
2077,29742012,thyroid
2081,28822031,thyroid eye disease
2081,28822031,thyroid ophthalmopathy
2081,28822031,visa
2086,28944477,*endoscopy
2086,28944477,*graves disease
2086,28944477,*orbit
2086,28944477,*paranasal sinus
2086,28944477,*quality of life
2086,28944477,*surgical decompression
2088,31482765,*graves' disease
2088,31482765,*antithyroid drugs
2088,31482765,*hyperthyroidism
2088,31482765,*long-term follow-up
2088,31482765,*radioiodine
2088,31482765,*recurrence
2088,31482765,*remission
2088,31482765,*thyroidectomy
2089,31057005,compressive optic neuropathy
2089,31057005,dysthyroid optic neuropathy
2089,31057005,extra-ocular muscles
2089,31057005,orbital computed tomography
2089,31057005,thyroid eye disease
2089,31057005,visual field
2091,30803176,orbital fibroblast
2091,30803176,pirfenidone
2091,30803176,thyroid
2091,30803176,transforming growth factor
2094,29439614,*131i
2094,29439614,*graves' disease
2094,29439614,*thyroglobulin autoantibodies
2094,29439614,*thyroglobulin measurement
2094,29439614,*thyroglobulin metabolic clearance
2094,29439614,*thyroid cancer
2095,28776731,*+49a/g
2095,28776731,*131i
2095,28776731,*graves' disease
2095,28776731,*cytotoxic t lymphocyte antigen 4
2095,28776731,*polymorphism
2095,28776731,*radionuclide
2095,28776731,*−318c/t
2098,31152536,graves’ orbitopathy
2098,31152536,orbit decompression
2098,31152536,thyroid-associated orbitopathy
2099,31595798,*graves’ ophthalmopathy
2099,31595798,*retina
2099,31595798,*density
2099,31595798,*microvasculature
2099,31595798,*optical coherence tomography angiography
2101,29784035,american thyroid association guidelines
2101,29784035,graves’ disease
2101,29784035,hyperthyroid
2101,29784035,thyroid hormones
2101,29784035,thyroid storm
2101,29784035,thyroidectomy cois obtained through our review ethics board committee prior to the study. competing interests: the authors declare that they have no competing interests. publisher’s note: springer nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
2102,29648895,autoimmune thyroid disease
2102,29648895,d1
2102,29648895,d2
2102,29648895,severity
2102,29648895,single nucleotide polymorphism
2103,29421653,*fibroblast proliferation
2103,29421653,*hyaluronan
2103,29421653,*igf-1
2103,29421653,*membrane potential
2103,29421653,*molecular weight
2103,29421653,*ph20
2105,31025590,b cells
2105,31025590,graves’ disease
2105,31025590,graves’ orbitopathy
2105,31025590,rituximab
2105,31025590,thyroid eye disease
2105,31025590,anti-cd20
2105,31025590,proptosis
2107,30354697,*graves’ disease
2107,30354697,*thyroid stimulating hormone receptor antagonist
2107,30354697,*antithyroid drugs
2107,30354697,*hyperthyroidism
2107,30354697,*immunosuppressive treatment
2107,30354697,*radioiodine
2107,30354697,*thyroid receptor antagonists
2107,30354697,*thyroid stimulating hormone
2107,30354697,*thyrotoxicosis
2108,30229982,*intravenous methylprednisolone
2108,30229982,*thyroid-associated ophthalmopathy
2108,30229982,*triglycerides
2110,29448964,exophthalmos
2110,29448964,myxedema
2110,29448964,primary hyperthyroidism
2110,29448964,rituximab cois case to the institutional ethics committee. consent for publication: written informed consent was obtained from the patient for publication of this case report and any accompanying images. copies of the written consent are available for review by the editor-in-chief of this journal. competing interests: the authors declare that they have no competing interests. publisher’s note: springer nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
2113,30924084,*gene
2113,30924084,*graves’ disease
2113,30924084,*polymorphisms
2113,30924084,*vdr
2113,30924084,*vitamin d receptor
2114,30173330,*i-ionm
2114,30173330,*neuromonitoring
2114,30173330,*recurrent laryngeal nerve stimulation
2114,30173330,*staged thyroidectomy
2114,30173330,*thyroid
2116,31530446,*dunhill procedure
2116,31530446,*graves' disease
2116,31530446,*graves' ophthalmopathy
2116,31530446,*bilateral subtotal thyroidectomy
2116,31530446,*subtotal thyroidectomy
2116,31530446,*total thyroidectomy
2117,28388869,graves’ disease
2117,28388869,s-trabs
2117,28388869,hyperthyroidism
2118,29343299,graves’ disease
2118,29343299,hashimoto’s thyroiditis
2118,29343299,metamorphic autoimmunity
2118,29343299,natural history
2118,29343299,thyroid status cois publication: not applicable. competing interests: the authors declare that they have no competing interests. publisher’s note: springer nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
2119,30912336,*antithyroid agents
2119,30912336,*cure
2119,30912336,*graves hyperthyroidism
2119,30912336,*long term outcome
2119,30912336,*radioactive iodine
2119,30912336,*remission
2119,30912336,*thyroidectomy cois
2120,31169822,arteriovenous fistula
2120,31169822,false aneurysm
2120,31169822,goiter
2120,31169822,thyroidectomy
2121,31391354,graves’ disease
2121,31391354,hyperthyroidism
2121,31391354,iodine-131 radioactive iodine uptake
2121,31391354,radioiodine therapy
2122,31379878,*graves' disease
2122,31379878,*tshr
2122,31379878,*next-generation sequencing
2122,31379878,*splicing isoforms
2122,31379878,*thymus
2122,31379878,*thyroid
2122,31379878,*tolerance
2126,30256028,autografts
2126,30256028,dermis-fat graft
2126,30256028,eyelids – surgery
2126,30256028,graves ophthalmopathy – surgery
2126,30256028,reconstructive surgical procedures – methods
2126,30256028,skin transplantation
2127,31146635,*jordan
2127,31146635,*hyperthyroidism
2127,31146635,*hypothyroidism
2127,31146635,*prevalence
2127,31146635,*thyroid dysfunction
2129,30506346,gender
2129,30506346,graves’ disease (gd)
2129,30506346,hyperthyroidism
2129,30506346,hyperuricemia
2129,30506346,serum uric acid (sua)
2131,30170970,diplopia
2131,30170970,dysthyroid optic neuropathy
2131,30170970,exophthalmos
2131,30170970,grave's disease
2131,30170970,orbital decompression
2131,30170970,vision loss
2133,31665858,hypercholesterolemia
2133,31665858,thyroid associated ophthalmopathy
2135,29562915,extra-thyroidal autoimmunity
2135,29562915,graves’ disease
2135,29562915,hashimoto’s thyroiditis
2135,29562915,metamorphic autoimmunity
2135,29562915,thyroid status cois publication: not applicable. competing interests: the authors declare that they have no competing interests. publisher’s note: springer nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
2136,31636036,ent surgery
2136,31636036,endocrine surgery
2136,31636036,gbi
2136,31636036,glasgow benefit inventory
2136,31636036,graves' disease
2136,31636036,patient recorded outcome measure
2136,31636036,patient satisfaction score
2136,31636036,thyroid
2136,31636036,total thyroidectomy cois
2137,31021263,lower eyelid retraction
2137,31021263,orbital decompression
2137,31021263,proptosis
2137,31021263,surgical technique
2137,31021263,thyroid eye disease
2140,29367360,"ear, nose and throat/otolaryngology"
2140,29367360,head and neck surgery
2140,29367360,otolaryngology / ent
2140,29367360,thyroid disease cois
2144,29996609,"decompression, surgical"
2144,29996609,graves ophthalmopathy
2144,29996609,optic nerve diseases
2144,29996609,orbit
2146,31418705,*haemoglobin a2
2146,31418705,*hyperthyroidism
2146,31418705,*β-thalassemia trait
2148,30220185,choroid
2148,30220185,graves ophthalmopathy
2148,30220185,"tomography, optical coherence"
2149,29996608,"decompression, surgical"
2149,29996608,endoscopy
2149,29996608,graves ophthalmopathy
2149,29996608,orbit
2151,29027055,deficiency disorder
2151,29027055,iodine in soil and plants
2151,29027055,people’s perception
2151,29027055,socio-economic determinants
2151,29027055,wheat crop
2152,29890310,forkhead box p3 (foxp3)
2152,29890310,graves' disease
2152,29890310,regulatory t cells
2152,29890310,restriction fragment length polymorphism
2152,29890310,single nucleotide polymorphism
2155,31742747,*hyperthyroidism
2155,31742747,*thyroid scintigraphy
2155,31742747,*thyroid ultrasonography
2155,31742747,*thyroid-stimulating immunoglobulins (tsi)
2155,31742747,*thyrotropin receptor antibodies (trab)
2156,30244229,cardiovascular medicine
2156,30244229,thyroid disease cois
2159,30099999,*autoimmune disorders
2159,30099999,*crohn disease
2159,30099999,*graves disease
2159,30099999,*hashimoto thyroiditis
2159,30099999,*inflammatory bowel disease
2159,30099999,*multiple sclerosis
2159,30099999,*systemic lupus erythematosus
2159,30099999,*ulcerative colitis
2160,29406005,*fetal
2160,29406005,*graves disease
2160,29406005,*hyperthyroidism
2160,29406005,*neonatal
2160,29406005,*thyrotoxicosis
2161,30670519,*clinical trials
2161,30670519,*immunology
2161,30670519,*paediatric endocrinology
2161,30670519,*thyroid disease cois
2164,31460819,endocrine ophthalmopathy
2164,31460819,endoscopic sinus surgery
2164,31460819,orbital complication
2164,31460819,rhinosinusitis
2164,31460819,vision loss
2166,29510406,autoimmune thyroid disease (aitd)
2166,29510406,graves’ disease (gd)
2166,29510406,hashimoto’s thyroiditis (ht)
2166,29510406,ikaros family of zinc finger3 (ikzf3)
2166,29510406,single nucleotide polymorphism (snp)
2168,28598035,graves’ disease
2168,28598035,association analysis
2168,28598035,early-onset
2168,28598035,heterogeneity analysis
2168,28598035,single nucleotide polymorphisms
2170,30226207,graves’ disease
2170,30226207,membranoproliferative glomerulonephritis
2170,30226207,proteinuria
2171,29310665,*graves’ disease
2171,29310665,*hyperthyroidism
2171,29310665,*methimazole
2171,29310665,"*thyroid receptor antibodies cois analysis of de-identified data collected for another purpose. all data are retrospective and presented in an aggregated fashion. so, no irb approval was required. patient numbers used in the model validation section of the article are spreadsheet numbers from data, which can not be used to identify the patients name, family name or other specific details. consent for publication: not applicable. competing interests: the authors declare that they have no competing interests. publisher’s note: springer nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations."
2173,31899052,*igf-1
2173,31899052,*orbital fibroblasts
2173,31899052,*thyroid-associated ophthalmopathy
2173,31899052,*thyroid-stimulating hormone receptor cois conflicts of interest associated with this publication and there has been no significant financial support for this work that could have influenced its outcome.
2174,31827051,autoimmune thyroid diseases
2174,31827051,graves’ disease
2174,31827051,hashimoto’s thyroiditis
2174,31827051,meta-analysis
2174,31827051,regulatory t cells
2175,31617239,graves' disease
2175,31617239,autoantibody
2175,31617239,catalase
2175,31617239,hydrogen peroxide
2175,31617239,malondialdehyde
2175,31617239,oxidative stress
2177,29976201,*circulating mirnas
2177,29976201,*graves’ disease
2177,29976201,*let-7b
2177,29976201,*thyrotropin receptor antibody
2178,31280470,*arterial stiffness
2178,31280470,*blood pressure
2178,31280470,*graves’ disease
2178,31280470,*pulse wave analysis
2184,29549672,autoantibodies
2184,29549672,autoimmune thyroid diseases
2184,29549672,blood platelets
2184,29549672,chronic inflammation
2184,29549672,lymphocytes
2185,28343872,*balanced decompression
2185,28343872,*dysthyroid optic neuropathy
2185,28343872,*fat decompression
2185,28343872,*lateral decompression
2185,28343872,*medial decompression
2185,28343872,*orbital decompression
2185,28343872,*surgical technique
2185,28343872,*thyroid eye disease
2188,30369529,graves’ disease
2188,30369529,cerebral venous thrombosis
2188,30369529,factor viii procoagulant protein
2188,30369529,hyperthyroidism
2189,29319130,anaplastic thyroid carcinoma
2189,29319130,thyrotoxicosis
2191,31932147,*autoimmune thyroid diseases
2191,31932147,*chemokines
2191,31932147,*cytokines
2191,31932147,*dermatological autoimmune diseases
2191,31932147,*systemic autoimmune diseases cois
2192,30843111,*anti-pla2r
2192,30843111,*children
2192,30843111,*graves’ disease
2192,30843111,*membranous nephropathy
2192,30843111,*rituximab
2198,29266775,*bmpr2
2198,29266775,*epstein-barr virus
2198,29266775,*graves’ disease
2198,29266775,*tgf-β/bmp
2198,29266775,*expression assay
2198,29266775,*functional analysis
2198,29266775,*lymphoblastoid cell lines
2198,29266775,*pulmonary arterial hypertension
2200,31279175,*autoimmune thyroid disease
2200,31279175,*development
2200,31279175,*ifng
2200,31279175,*methylation
2200,31279175,*prognosis
2201,30880626,*graves'
2201,30880626,*bimatoprost
2201,30880626,*fat atrophy
2201,30880626,*orbitopathy
2201,30880626,*prostaglandin f
2201,30880626,*thyroid eye disease
2202,30565709,*graves ophthalmopathy
2202,30565709,*inactive phase
2202,30565709,*interleukin-15
2202,30565709,*interleukin-17
2203,30057255,anca
2203,30057255,antineutrophil cytoplasmic antibodies
2203,30057255,methimazole
2203,30057255,metimazol
2203,30057255,vasculite
2203,30057255,vasculitis
2204,29517388,blood vessel density
2204,29517388,graves’ orbitopathy
2204,29517388,oct angiography
2204,29517388,decompression
2204,29517388,dysthyroid optic neuropathy
2205,29325496,*graves' disease
2205,29325496,*trab
2205,29325496,*neonatal thyrotoxicosis
2205,29325496,*pregnancy
2205,29325496,*thyroid
2206,30452877,calprotectin
2206,30452877,graves’ orbitopathy
2206,30452877,inflammation
2206,30452877,orbital fibroblast
2206,30452877,thyroid eye disease
2207,29174550,decompression
2207,29174550,endocrine orbitopathy
2207,29174550,scleral show
2211,31792849,graves’ ophthalmopathy
2211,31792849,spect/ct
2211,31792849,triamcinolone
2214,30044728,*graves’ disease
2214,30044728,*autoimmune
2214,30044728,*monoclonal antibody
2214,30044728,"*signaling cois antibody-mediated inflammatory auto-immune disorders (us 6936426), the diagnosis and therapy of antibody-mediated inflammatory autoimmune disorders (us 7998681 and us 8153121), and diagnostic methods related to graves’ disease and other autoimmune disorders (us 8178304). he was previously a paid consultant for river vision."
2215,29601105,*graves' ophthalmopathy
2215,29601105,*graves' orbitopathy
2215,29601105,*glucocorticoids
2215,29601105,*rituximab
2215,29601105,*thyroid eye disease
2218,31223030,graves' disease
2218,31223030,inflammation
2218,31223030,neutrophils platelet count.
2220,30187962,corticosteroid
2220,30187962,endocrine disorders
2220,30187962,topical
2222,30358895,*graves' disease
2222,30358895,*hcp5
2222,30358895,*autoimmunity
2222,30358895,*children
2222,30358895,*genetics
2222,30358895,*single nucleotide polymorphism
2222,30358895,*thyroid
2225,30854863,iodine radioisotopes
2225,30854863,neck dissection
2225,30854863,thyroid neoplasms
2225,30854863,thyrotoxicosis
2226,30814442,anti-thyroid drugs
2226,30814442,autotaxin
2226,30814442,graves’ disease
2226,30814442,lysophosphatidic acids
2226,30814442,thyroid hormones
2227,30488266,asymmetric enlargement
2227,30488266,lacrimal gland
2227,30488266,malignancy
2227,30488266,thyroid eye disease
2228,30463536,8-ohdg
2228,30463536,graves’ orbitopathy
2228,30463536,mda
2228,30463536,oxidative stress
2228,30463536,"tear cois all patients, and the study was conducted with approval from the institutional review board at chonnam national university hospital. consent for publication: not applicable. competing interests: the authors declare that they have no competing interests. publisher’s note: springer nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations."
2229,30148416,graves disease
2229,30148416,lasik
2229,30148416,salzmann’s nodular degeneration
2229,30148416,thyroid eye disease
2231,29949121,coagulation
2231,29949121,graves’ orbitopathy
2231,29949121,methylprednisolone
2231,29949121,pulmonary embolism
2231,29949121,venous thromboembolic event cois ethical approval: all procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 helsinki declaration and its later amendments or comparable ethical standards. informed consent: informed consent was obtained from all individual participants included in the study.
2233,29507013,adrenal disorders
2233,29507013,endocrine system
2233,29507013,thyroid disease cois
2235,30568070,graves’ disease
2235,30568070,surgical complications
2235,30568070,total thyroidectomy
2236,29482520,case report
2236,29482520,graves’ ophthalmopathy
2236,29482520,graves’ disease
2236,29482520,loss of vision
2236,29482520,orbital decompression
2236,29482520,strabismus cois publication: written informed consent was obtained from the patient for publication of this case report and any accompanying images. a copy of the written consent is available for review by the editor of this journal. competing interests: the authors declare that they have no competing interests. publisher’s note: springer nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
2237,30325581,99mtc-anti-tnf
2237,30325581,graves disease
2237,30325581,graves ophthalmopathy
2237,30325581,diagnosis
2237,30325581,nuclear medicine
2238,30188609,*aggregation
2238,30188609,*autoimmune thyroid diseases
2238,30188609,*blood platelets
2238,30188609,*platelet-derived microparticles
2240,31257166,*graves’ disease
2240,31257166,*hashimoto’s thyroiditis
2240,31257166,*autoimmune disease
2240,31257166,*dysbiosis
2240,31257166,*enterohepatic cycling of thyroid hormones
2240,31257166,*probiotics
2241,30302684,*hyperthyreodism
2241,30302684,*antithyroid drug
2241,30302684,*radioiodine therapy
2241,30302684,*thermoablation
2241,30302684,*thyroid surgery
2243,31240859,slco1b1
2243,31240859,grave's disease
2243,31240859,drug-induced liver injury
2243,31240859,methimazole
2243,31240859,polymorphisms
2246,28856610,ablation
2246,28856610,autoimmunity
2246,28856610,graves’ disease
2246,28856610,graves’ orbitopathy
2246,28856610,radioiodine
2246,28856610,thyroid
2247,31715678,acellular dermis
2247,31715678,eyelids
2247,31715678,graves ophthalmopathy
2247,31715678,reconstructive surgical procedures
2247,31715678,"transplantation, heterologous"
2249,29440561,*graves’ disease
2249,29440561,*polymorphism
2249,29440561,*tumor necrosis factor-α cois manuscript.
2251,31691261,graves’ disease
2251,31691261,graves’ orbitopathy
2251,31691261,idiopathic orbital inflammation
2251,31691261,orbital lymphoma
2251,31691261,pseudotumor
2252,31453725,graves’ disease
2252,31453725,thyrotropin
2252,31453725,hyperthyroidism
2252,31453725,immunoassay
2252,31453725,thyroid-stimulating antibody
2255,29571699,apparent diffusion coefficient
2255,29571699,diffusion-weighted imaging
2255,29571699,graves’ disease
2255,29571699,orbit
2255,29571699,thyroid associated ophthalmopathy
2256,29147850,*active
2256,29147850,*cytokines
2256,29147850,*eye
2256,29147850,*graves’
2256,29147850,*specificity
2256,29147850,*tears
2257,31834613,adverse events
2257,31834613,graves’ orbitopathy
2257,31834613,mycophenolate
2257,31834613,safety
2258,31782290,*thyroid hormone
2258,31782290,*thyroid volume
2258,31782290,*graves’ disease
2258,31782290,*soluble cd40 ligand (scd40l)
2259,31705858,graves' orbitopathy
2259,31705858,nrf2
2259,31705858,oxidative stress
2259,31705858,polydatin cois competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
2260,31612195,cxcr3
2260,31612195,graves’ophthalmoapthy
2260,31612195,mig
2260,31612195,thyroid eye disease
2262,31316787,*aih
2262,31316787,*graves' ophthalmopathy
2262,31316787,*methylprednisolone-induced liver injury
2262,31316787,*multiple sclerosis
2262,31316787,*steroid pulses
2263,30261581,graves’ disease
2263,30261581,nt-probnp
2263,30261581,ambulatory blood pressure monitoring
2263,30261581,blood pressure
2263,30261581,glucocorticoids
2263,30261581,graves’ orbitopathy
2263,30261581,hypertension
2263,30261581,methylprednisolone
2263,30261581,pulse therapy cois
2264,30222206,graves’ disease
2264,30222206,hashimoto thyroiditis
2264,30222206,alopecia areata
2264,30222206,autoimmune disease
2264,30222206,autoimmune thyroid disease
2265,29457989,"*aav, anti-neutrophil cytoplasmic antibody-associated vasculitis"
2265,29457989,"*anca, anti-neutrophil cytoplasmic antibody"
2265,29457989,"*dress, drug reaction with eosinophilia and systemic symptoms"
2265,29457989,"*ivig, intravenous ɤ-globulin"
2265,29457989,"*kd, kawasaki disease"
2265,29457989,*kawasaki disease
2265,29457989,"*mmi, methimazole"
2265,29457989,"*mpo, myeloperoxidase"
2265,29457989,"*ptu, propylthiouracil"
2265,29457989,*propylthiouracil
2265,29457989,*anti-neutrophil cytoplasmic antibody
2265,29457989,*general paediatrics
2265,29457989,*immunology
2265,29457989,*intravenous ɤ-globulin
2266,31393984,*basedow disease
2266,31393984,*dysthyroid optic neuropathy
2266,31393984,*endoscopic endonasal surgery
2266,31393984,*graves disease
2266,31393984,*optic nerve decompression
2266,31393984,*orbital apex
2266,31393984,*thyroid eye disease
2267,31296093,extraocular muscle
2267,31296093,graves’ ophthalmopathy
2267,31296093,real-time ultrasound elastography
2268,31236779,*antithyroid drug
2268,31236779,*graves’ disease
2268,31236779,*relapse
2268,31236779,*remission
2270,30179522,graves' disease
2270,30179522,autopsy
2270,30179522,high-altitude cerebral edema
2270,30179522,high-altitude pulmonary edema
2270,30179522,hyperthyroidism
2270,30179522,sudden death
2273,31672295,cytology
2273,31672295,false-negative diagnoses
2273,31672295,false-positive diagnoses
2273,31672295,fine-needle aspiration
2273,31672295,thyroid cancer
2273,31672295,thyroid nodule cois this work did not receive any specific grant funding.
2274,31587179,adverse events
2274,31587179,graves’ disease
2274,31587179,graves’ orbitopathy
2274,31587179,oral prednisone
2274,31587179,radioiodine
2274,31587179,steroid prophylaxis
2275,31207925,graves’ disease
2275,31207925,oxidative stress
2275,31207925,thiol/disulphide homeostasis cois
2276,31091045,*graves’ disease
2276,31091045,*alpha-2-macroglobulin
2276,31091045,*cytokines
2276,31091045,*lactoferrin
2277,30618332,*graves' disease
2277,30618332,*autoimmunity
2277,30618332,*peptides
2277,30618332,*thyroid
2280,29383806,*hla
2280,29383806,*association study
2280,29383806,*autoimmunity
2280,29383806,*haplotype
2280,29383806,*type 1 diabetes
2281,31255731,*autoimmune thyroid disease (aitd)
2281,31255731,*fas
2281,31255731,*hla-dr
2281,31255731,*hypothyroidism
2281,31255731,*il-1β
2281,31255731,*uterus globulin associated protein 1 (ugrp1)
2282,31176495,estrabismo
2282,31176495,fistula
2282,31176495,fístula
2282,31176495,hipertiroidismo
2282,31176495,hyperthyroidism
2282,31176495,orbit
2282,31176495,orbitopatía tiroidea
2282,31176495,strabismus
2282,31176495,thyroid orbitopathy
2282,31176495,órbita
2284,29866676,stroke
2284,29866676,thyroid disease cois
2285,29371709,"grave's disease, pcr-rflp, snps, cd 28, cd 40."
2286,31301652,mutation
2286,31301652,polymorphism
2286,31301652,thyroid digenesis
2286,31301652,thyroid gland
2286,31301652,thyroid hormones
2288,30474825,acute pancreatitis
2288,30474825,drug-induced pancreatitis
2288,30474825,methimazole
2291,29566435,*graves’ disease
2291,29566435,*anaemia
2291,29566435,*haemoglobin
2291,29566435,*hyperthyroidism
2291,29566435,*thyroid function tests
2291,29566435,*thyroid hormones
2291,29566435,*thyrotoxicosis
2292,29412482,*3d reconstruction
2292,29412482,*orbital soft tissue volume
2292,29412482,*thyroid associated ophthalmopathy
2293,31612654,decompression
2293,31612654,extraocular muscles
2293,31612654,graves ophthalmopathy
2293,31612654,optic nerve
2293,31612654,optical coherence tomogrphy cois
2294,31538314,cytokine
2294,31538314,graves’ orbitopathy
2294,31538314,human leukocyte antigen
2294,31538314,immunohistochemistry
2294,31538314,orbital tissue
2294,31538314,tsh receptor
2295,31202168,drug-induced liver injury
2295,31202168,human leukocyte antigens
2295,31202168,methimazole
2295,31202168,molecular docking
2299,30086864,*graves' disease
2299,30086864,*childhood
2299,30086864,*fetus
2299,30086864,*hyperthyroidism
2299,30086864,*neonates
2301,30414981,*biomarkers
2301,30414981,*fibrosis
2301,30414981,*graves' disease
2301,30414981,*inflammatory cytokines
2301,30414981,*orbitopathy
2301,30414981,*pai-1
2301,30414981,*plasmin cascade
2301,30414981,*serpins
2301,30414981,*tgf-β
2301,30414981,*tissue remodeling cois
2302,31023005,*graves’ disease
2302,31023005,*methimazole
2302,31023005,*selenium
2302,31023005,*trab
2302,31023005,*tpoab
2302,31023005,*tgab cois
2304,29256262,*ago
2304,29256262,*autoimmune thyroid disease
2304,29256262,*intractability
2304,29256262,*polymorphism
2304,29256262,*severity
2305,31446546,131i therapy
2305,31446546,hyperthyroidism
2305,31446546,hypothyroidism
2305,31446546,ku-70
2305,31446546,radiosensitivity
2306,29101123,*experimental laboratory cois
2308,29300515,b-cell lymphoma
2308,29300515,graves’ orbitopathy
2308,29300515,r-chop
2308,29300515,rituximab
2308,29300515,immunochemotherapy
2308,29300515,thyroid orbitopathy
2312,29308951,alexis retractor
2312,29308951,retractor
2312,29308951,lateral orbit
2312,29308951,thyroid eye disease
2313,31162982,eyelid retraction
2313,31162982,hering’s phenomenon
2313,31162982,mueller’s muscle-conjunctiva resection
2313,31162982,marginal reflex distance
2313,31162982,phenylephrine test
2313,31162982,thyroid eye disease
2314,30012381,anemarrhena bunge
2314,30012381,case report
2314,30012381,graves’ disease
2314,30012381,herbal decoction
2314,30012381,tsh binding inhibitory immunoglobulins
2314,30012381,thyroid stimulating hormone
2323,31740989,*grave’s disease
2323,31740989,*hepatotoxicity
2323,31740989,*mao-a
2323,31740989,*metabolomics
2323,31740989,*methimazole
2323,31740989,*ugt1a1*6
2326,30913888,adjustable sutures
2326,30913888,congenital fibrosis of the extraocular muscles
2326,30913888,double elevator palsy
2326,30913888,thyroid eye disease
2326,30913888,transposition procedure sec. knapp
2326,30913888,vertical strabismus
2327,30103255,*graves’ orbitopathy
2327,30103255,*methotrexate
2327,30103255,*methylprednisolone
2327,30103255,*steroid-sparing agents
2327,30103255,*thyroid eye disease
2328,29652204,corticoresistant
2328,29652204,graves’ orbitopathy
2328,29652204,low-dose
2328,29652204,rituximab
2328,29652204,treatment
2329,29491282,graves' disease
2329,29491282,central diabetes insipidus
2329,29491282,hyperthyroidism
2329,29491282,lymphocytic infundibulo-neurohypophysitis and thyroid crisis
2332,29397435,aldehyde dehydrogenase 2
2332,29397435,autoantigen
2332,29397435,graves’ orbitopathy
2332,29397435,orbital fat
2332,29397435,proteomic analysis
2333,31194638,*graves' disease
2333,31194638,*autoimmune thyroid disease
2333,31194638,*desensitization
2333,31194638,*immunomodulation
2333,31194638,*peptide immunotherapy
2333,31194638,"*thyroid stimulating hormone receptor cois attending study meetings and for ad hoc advice. s.h.s.p. has received speaker fees from sanofi, quidel, and berlin-chemie. c.d. has consulted for apitope, has received speaker fees, and has consulted for sanofi-genzyme. d.c.w. serves as chief scientific officer for apitope technology (bristol) ltd. and apitope international nv on a consultative basis; is on the scientific advisory board for apitope international nv and has sat on scientific advisory boards for actelion pharma and zealand pharma; received travel funding from apitope international nv; is a senior editor for immunotherapy; holds patents for peptides, tolerization-inducing composition, fviii peptides, and their use in tolerizing hemophiliacs, composition, disease markers, tolerogenic peptides from mbp, peptide selection method, and improvements relating to influenza vaccine; has consulted for peptide therapeutics ltd., teva, gsk bio, hoffmann-la roche, novartis, dti, and the food standards agency; received research support within the past three years from apitope international nv, ucb celltech, mrc, the immune tolerance network, and the wellcome trust; holds stock and stock options with apitope international nv; and was an expert witness for geron. k.b. is employed by apitope technology (bristol) ltd. n.o. was a contractor to apitope technology (bristol) ltd., a subsidiary of apitope international nv. l.j. is an employee of apitope international nv. t.w.-s. was an employee of apitope technology (bristol) ltd., a subsidiary of apitope international nv. c.c. serves as chief medical officer for apitope technology (bristol) ltd. and apitope international nv on a consultative basis. k.f.m. was an executive director of apitope international nv and its subsidiary, apitope technology (bristol) ltd. he was an employee of apitope technology (bristol) ltd. he is currently a non-executive director of and shareholder in apitope international nv. p.p. consults for ibsa. b.v. has received speaker fees from berlin-chemie. s.r. has received speaker fees from merck plc and abbott india ltd. g.j.k. consults for apitope and quidel and has received speaker fees from merck and berlin-chemie. k.b., j.g., c.e.h., i.m., r.d.m., and f.w. report no disclosures."
2335,30562606,ampk/mtor signaling pathway
2335,30562606,orbital preadipocyte
2335,30562606,sf1
2335,30562606,thyroid-associated ophthalmopathy
2337,29037117,*graves'
2337,29037117,"*disease, relapse, predictive biomarker, siglec1, ifn signature"
2338,31271712,*graves’ disease
2338,31271712,*acromegaly
2338,31271712,*case report
2338,31271712,*panhypopituitarism
2338,31271712,*radiosurgical treatment
2338,31271712,*secondary hypothyroidism
2338,31271712,*thyrotoxicosis
2341,30674011,16s rrna gene
2341,30674011,graves’ orbitopathy (go)
2341,30674011,gut microbiota
2341,30674011,thyrotropin receptor antibody (trab)
2343,30269213,graves’ disease
2343,30269213,hyperthyroidism
2343,30269213,robotic-assisted surgery
2343,30269213,surgical outcomes
2344,29848886,th2
2344,29848886,autoimmune thyroid disease
2344,29848886,intractability
2344,29848886,polymorphism
2344,29848886,severity
2346,30938833,cd4+p35+ebi3+t cell
2346,30938833,graves’ disease
2346,30938833,immunology
2346,30938833,interleukin 35
2352,29058517,thyroid eye disease
2352,29058517,abducens nerve
2352,29058517,orbital decompression
2353,31705696,graves disease
2353,31705696,hashimoto thyroiditis
2353,31705696,superb microvascular imaging
2353,31705696,chronic autoimmune thyroiditis
2353,31705696,color doppler
2353,31705696,vascularity index
2354,31310160,*graves' disease
2354,31310160,*long-term
2354,31310160,*methimazole
2354,31310160,*remission rates
2356,30384566,*shear wave elastography
2356,30384566,*virtual touch tissue imaging quantification
2356,30384566,*thyroid
2356,30384566,*hashimoto’s thyroiditis
2356,30384566,*graves’ disease
2357,30281845,*b-lymphocytes
2357,30281845,*b-cell activating factor
2357,30281845,*graves
2357,30281845,*autoimmune
2357,30281845,*disease
2357,30281845,*genotyping
2357,30281845,*polymorphism
2357,30281845,*thyroid
2358,29478847,breast cancer
2358,29478847,cancer du sein
2358,29478847,graves’ disease
2358,29478847,hyperthyroidism
2358,29478847,hyperthyroïdie
2358,29478847,maladie de basedow
2358,29478847,thyroxine
2358,29478847,triiodothyronine
2359,30777066,corneal dynamic scheimpflug analyser
2359,30777066,corvis st
2359,30777066,graves ophthalmopathy
2359,30777066,orbital soft tissue
2359,30777066,whole eye movement cois the tenets of the declaration of helsinki and received institutional review board (irb) approval from seoul st. mary’s hospital for the analysis of their medical records. the need for consent was waived by irb (name of irb: cmc irb). consent for publication: not applicable. competing interests: hhs is a member of the editorial board (associate editor) of bmc ophthalmology. the other authors declare that they have no competing interests. the authors declare that they have no financial competing interests. publisher’s note: springer nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
2360,30470210,intraoperative relaxed muscle positioning
2360,30470210,restrictive strabismus
2360,30470210,thyroid orbitopathy cois approval from the local ethical committee (cerrahpasa ethics committee) was received. informed consent was obtained from the patients for the participation in the study. consent for publication: additional consent was obtained from the patients whose preoperative and postoperative photos were used in the manuscript. competing interests: the authors declare that they have no competing interests. publisher’s note: springer nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
2361,30297028,*dry eye disease
2361,30297028,*graves' ophthalmopathy
2361,30297028,*tear break up time
2361,30297028,*tear osmolarity
2361,30297028,*thyroid eye disease
2362,30232923,*graves' disease
2362,30232923,*x chromosome
2362,30232923,*association analysis
2362,30232923,*dosage compensation
2362,30232923,*genetic model
2363,29875930,graves´ disease
2363,29875930,hyperthyroidism
2363,29875930,nuclear medicine
2363,29875930,thyroid neoplasms
2364,29377729,*ct
2364,29377729,*thyroid eye disease
2364,29377729,*exophthalmometer
2364,29377729,*exophthalmos
2365,31690110,graves’ orbitopathy
2365,31690110,endoscopic orbital decompression
2365,31690110,feasibility
2365,31690110,robotic endoscope guiding system
2365,31690110,robotic surgery
2366,31209622,ablation techniques
2366,31209622,graves’ disease
2366,31209622,high-intensity focused ultrasound ablation
2366,31209622,interventional ultrasonography
2366,31209622,thyrotoxicosis
2367,31203506,cosmesis
2367,31203506,endoscopic surgery
2367,31203506,graves’ ophthalmopathy
2367,31203506,optic nerve
2367,31203506,orbital decompression
2370,28181061,amsterdam declaration
2370,28181061,graves’ disease
2370,28181061,joint thyroid eye clinic
2370,28181061,ophthalmopathy
2370,28181061,thyroid
2371,31552761,*il-6
2371,31552761,*autoimmune thyroid disease
2371,31552761,*intractability
2371,31552761,*methylation
2371,31552761,*severity
2372,31308303,abo
2372,31308303,blood groups
2372,31308303,hashimoto
2372,31308303,thyroid
2373,31184281,*graves' disease
2373,31184281,*thyroglobulin antibody
2373,31184281,*thyroid peroxidase antibody
2373,31184281,*thyroiditis
2373,31184281,*thyrotropin receptor
2373,31184281,*transgenics cois
2374,31111437,pd-1 inhibitor
2374,31111437,pdl-1 inhibitor
2374,31111437,pembrolizumab
2374,31111437,small cell carcinoma of ovary
2374,31111437,thyroid
2374,31111437,thyroiditis
2374,31111437,thyrotoxicosis
2376,29319128,graves’ disease
2376,29319128,hif-1α
2376,29319128,pdgf-bb
2376,29319128,immunology
2376,29319128,macrophages
2377,31473202,biotin
2377,31473202,biotin interference
2377,31473202,biotin supplements
2377,31473202,immunoassay
2381,28548552,biomarker
2381,28548552,ccn1
2381,28548552,cyr61
2381,28548552,inflammation
2381,28548552,thyroid ophthalmopathy
2382,31554206,b lymphocytes
2382,31554206,graves’ disease
2382,31554206,t lymphocytes
2382,31554206,toll-like receptor 2
2382,31554206,toll-like receptor 4
2382,31554206,cytokines cois
2383,31134819,*graves’ disease
2383,31134819,*treg-th17-related immunosuppressive cytokines
2383,31134819,*dihydrotestosterone
2383,31134819,*mice
2383,31134819,*oxidative stress
2385,29372654,*functional tsh receptor antibodies
2385,29372654,*autoimmune thyroid diseases
2385,29372654,*bioassays
2385,29372654,*children
2385,29372654,*drug delivery
2385,29372654,*thyroid associated orbitopathy
2385,29372654,*thyroid blocking antibodies
2385,29372654,*thyroid stimulating antibodies
2386,29199443,inferior laryngeal nerve
2386,29199443,nonrecurrent laryngeal nerve
2386,29199443,thyroid surgery
2387,29336230,*dnmt
2387,29336230,*graves' disease
2387,29336230,*autoimmune thyroid disease
2387,29336230,*global dna methylation
2387,29336230,*lymphocyte
2388,31387688,hipocalcemia
2388,31387688,hipoparatiroidismo
2388,31387688,hormona paratiroidea
2388,31387688,hypocalcemia
2388,31387688,hypoparathyroidism
2388,31387688,parathyroid hormone
2388,31387688,thyroidectomy
2388,31387688,tiroidectomía
2389,31407938,*graves’ orbitopathy
2389,31407938,*thyroid eye disease
2389,31407938,*ocular ductions
2389,31407938,*recession
2389,31407938,*resection
2389,31407938,*squint surgery
2391,30927115,autoimmune thyroid disease
2391,30927115,chronic widespread pain
2391,30927115,fibromyalgia
2391,30927115,hashimoto thyroiditis
2391,30927115,osteoarthritis
2391,30927115,spinal degenerative disc disease
2393,29960265,ct
2393,29960265,graves' orbitopathy
2393,29960265,iterative model reconstruction
2394,29420104,decompression
2394,29420104,graves’ orbitopathy
2394,29420104,dysthyroid optic neuropathy
2394,29420104,steroids
2394,29420104,tocilizumab
2396,29098964,biotin
2396,29098964,graves’ hyperthyroidism
2396,29098964,tsh receptor antibodies
2396,29098964,false laboratory results
2396,29098964,immunoassay
2399,31505972,cd58
2399,31505972,autoimmune thyroid disease
2399,31505972,severity
2399,31505972,single nucleotide polymorphism
2400,31034694,choroid
2400,31034694,optical coherence tomography
2400,31034694,thickness
2400,31034694,thyroid-associated orbitopathy
2401,30270655,diplopia
2401,30270655,graves ophthalmopathy
2401,30270655,inferior oblique muscle
2401,30270655,orbital decompression
2403,29614339,*co-expression modules
2403,29614339,*functional pathways
2403,29614339,*graves' disease
2403,29614339,*pathogenesis
2403,29614339,*weighted gene co-expression network analysis
2404,29463244,duration of eye symptoms
2404,29463244,intravenous glucocorticoid therapy
2404,29463244,pretreatment clinical activity score
2404,29463244,restoration of euthyroidism
2404,29463244,thyroid-associated ophthalmopathy cois by the ethics committee of shanghai ninth people’s hospital. the written informed consents were obtained from all participants. this study was in compliance with the tenets of the declaration of helsinki for clinical research. consent for publication: not applicable competing interests: the authors declare that they have no competing interests. publisher’s note: springer nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
2405,29360077,graves' disease
2405,29360077,hyperthyroidism
2405,29360077,struma ovarii
2407,30646996,decompression
2407,30646996,graves ophthalmopathy
2407,30646996,strabismus
2407,30646996,surgical
2408,31674156,cytology
2408,31674156,fine-needle aspiration biopsy
2408,31674156,histopathology
2408,31674156,hyperthyroidism
2408,31674156,radioactive iodine
2409,30850507,*graves’ disease
2409,30850507,*hemoglobin
2409,30850507,*multispectral optoacoustic tomography (msot)
2409,30850507,*thyroid nodule
2410,30257816,graves’ disease
2410,30257816,hashimoto thyroiditis
2410,30257816,mrc 65/93
2410,30257816,antithyroglobulin antibodies
2410,30257816,immunoassays
2410,30257816,thyroglobulin
2411,30204589,*graves’ disease
2411,30204589,*biotin
2411,30204589,*multiple sclerosis
2411,30204589,*thyroid
2413,31055979,graves’ disease
2413,31055979,il-21
2413,31055979,th17 cells
2413,31055979,treg cells
2413,31055979,immune
2414,31755324,cd80
2414,31755324,cd86
2414,31755324,intractability
2414,31755324,polymorphism
2414,31755324,severity
2415,31657648,adipogenesis
2415,31657648,graves’ orbitopathy
2415,31657648,fibroblast growth factor receptors
2415,31657648,fibroblast growth factors
2415,31657648,myofibroblast
2416,31494956,*graves' disease
2416,31494956,*hashimoto's thyroiditis
2416,31494956,*autoimmune thyroid disease
2416,31494956,*interferon regulatory factor 3
2416,31494956,*interferon regulatory factor 7
2417,31488432,*graves’ orbitopathy
2417,31488432,*orbital adipose tissue
2417,31488432,*orbital fibroblast cois
2418,29361886,*antiretroviral therapy
2418,29361886,*graves’ disease
2418,29361886,*hiv
2418,29361886,*iris
2418,29361886,*immune thrombocytopenic purpura
2419,31707189,*3d anatomical modeling
2419,31707189,*biomechanical simulation
2419,31707189,*computer-assisted surgery planning
2419,31707189,*endocrine orbitopathy
2419,31707189,*fibrosis
2419,31707189,*retrospective cohort study
2421,30351237,*graves’
2421,30351237,*antagonist
2421,30351237,*disease
2421,30351237,*hyperthyroidism
2421,30351237,*orbitopathy
2421,30351237,*small molecule
2421,30351237,*thyrotropin receptor
2424,29053038,igg4-related orbital disease
2424,29053038,thyroid eye disease
2424,29053038,rituximab
2425,29023175,orbital
2425,29023175,autologous
2425,29023175,cosmetic
2425,29023175,decompression
2425,29023175,fat
2425,29023175,graft
2426,30560705,graves’ ophthalmopathy
2426,30560705,oxidative stress
2426,30560705,thiol-disulfide homeostasis
2428,31366254,*cd4+cd8+
2428,31366254,*graves’ disease
2428,31366254,*rtes
2428,31366254,*trab
2428,31366254,*effector memory cd8
2428,31366254,*lymphocyte subpopulations
2430,31739945,*arteriovenous malformations
2430,31739945,*benign disease
2430,31739945,*desmoid tumor
2430,31739945,*dupuytren contracture
2430,31739945,*graves ophthalmopathy
2430,31739945,*gynecomastia
2430,31739945,*heterotopic ossification
2430,31739945,*histiocytosis
2430,31739945,*radiation therapy
2431,30814476,*antithyroid drug-induced agranulocytosis
2431,30814476,*antithyroid drug-induced neutropenia
2431,30814476,*association
2431,30814476,*flavin-containing monooxygenase 3
2431,30814476,*graves’ disease
2433,31036428,cigarette
2433,31036428,cigarro
2433,31036428,dejar de fumar
2433,31036428,graves orbitopathy
2433,31036428,orbitopatía de graves
2433,31036428,orbitopatía tiroidea
2433,31036428,smoke cessation
2433,31036428,tabaco
2433,31036428,thyroid orbitopathy
2433,31036428,tobacco
2434,30182361,cd-20
2434,30182361,graves’ disease
2434,30182361,graves’ ophthalmopathy
2434,30182361,graves’ orbitopathy
2434,30182361,lymphocytes
2434,30182361,thyroid
2434,30182361,thyroid eye disease
2435,29987165,*graves’ disease
2435,29987165,*hla
2435,29987165,*mhc
2435,29987165,*amino acid position
2435,29987165,*genome-wide association studies cois
2437,29103088,diastolic function
2437,29103088,echocardiography
2437,29103088,graves’ disease
2437,29103088,left ventricular function
2437,29103088,left ventricular mass index
2437,29103088,myocardial performance index
2437,29103088,tissue doppler imaging
2440,30335539,ocular pulse amplitude
2440,30335539,choroidal perfusion in thyroid eye disease
2440,30335539,choroidal thickness in thyroid eye disease
2440,30335539,dynamic contour tonometry
2440,30335539,thyroid eye disease
2443,29973096,*children
2443,29973096,*graves’ disease
2443,29973096,*hashimoto’s disease
2443,29973096,*ifih1 gene
2443,29973096,*ptpn gene
2443,29973096,*tshr gene
2443,29973096,*single nucleotide polymorphisms
2444,29058307,*graves' disease
2444,29058307,*graves' orbitopathy
2444,29058307,*autoimmunity
2444,29058307,*self-antigen mouse model
2444,29058307,*thyroid disease
2446,31266487,*dfnb4
2446,31266487,*deafness
2446,31266487,*haplotype
2446,31266487,*hearing
2446,31266487,*noncoding
2446,31266487,*pendred syndrome
2446,31266487,*slc26a4 cois
2447,31327128,graves’ disease
2447,31327128,graves’ orbitopathy
2447,31327128,outcome
2447,31327128,radioiodine
2447,31327128,tsh-receptor antibody
2447,31327128,thyroid carcinoma
2447,31327128,thyroidectomy
2448,31267667,hyperthyroidism
2448,31267667,obesity
2448,31267667,treatment
2448,31267667,weight changes
2450,31669312,autoimmune hypothyroidism
2450,31669312,cribado neonatal tiroideo
2450,31669312,enfermedad de graves
2450,31669312,graves disease
2450,31669312,hipertirotropinemia
2450,31669312,hipotiroidismo autoinmune
2450,31669312,hyperthyrotropinemia
2450,31669312,neonatal thyroid screening
2450,31669312,thyroiditis
2450,31669312,tiroiditis
2451,31108563,*agranulocytosis
2451,31108563,*antithyroid drug
2451,31108563,*human leucocyte antigen
2451,31108563,*meta-analysis cois
2452,30528501,national health insurance research database
2452,30528501,cohort study
2452,30528501,hyperthyroidism
2452,30528501,hypothyroidism
2452,30528501,psoriasis
2452,30528501,psoriatic arthritis
2452,30528501,thyroid diseases
2453,29485308,*diplopia
2453,29485308,*resection
2453,29485308,*thyroid eye disease
2453,29485308,*vertical strabismus
2454,31444554,macular vasculature
2454,31444554,peripapillary vasculature
2454,31444554,thyroid eye disease
2455,30372544,*graves’ disease
2455,30372544,*trab
2455,30372544,*tshr
2455,30372544,*hyperthyroidism
2455,30372544,*thyroid scintigraphy
2456,30197231,*adderall
2456,30197231,*attention deficit hyperactivity disorder
2456,30197231,*etomidate
2456,30197231,*fentanyl
2456,30197231,*graves disease
2456,30197231,*hyperthyroidism
2456,30197231,*midazalom
2456,30197231,*moderate sedation
2456,30197231,*procedural sedation
2456,30197231,*propofol
2456,30197231,*rapid sequence intubation
2456,30197231,*rocuronium
2456,30197231,*thyroid storm
2458,29329570,case report
2458,29329570,graves’ disease
2458,29329570,graves’ orbitopathy
2458,29329570,igg4-related disease
2458,29329570,igg4-related orbitopathy cois of the declaration of helsinki. approval by the institutional ethics comittee was not required as this was a single case report. consent for publication: written informed consent was obtained from the patient for publication of this case report and any accompanying images. a copy of written consent is available for review by the editor of this journal. competing interests: the authors declare that they have no competing interests. publisher’s note: springer nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
2460,29288501,*graves’ disease
2460,29288501,*iodine
2460,29288501,*iodine restricted
2460,29288501,*iodine supplemented
2460,29288501,*recurrence rate
2461,30900216,angptl8
2461,30900216,graves’ disease cois
2462,30673921,*autoantigen
2462,30673921,*autoimmune
2462,30673921,*flow cytometry
2462,30673921,*immune
2462,30673921,*interleukin 2
2462,30673921,*lupus
2462,30673921,*metformin
2462,30673921,*multiple sclerosis
2462,30673921,*orbitopathy
2462,30673921,*pcsk9
2462,30673921,*rheumatoid arthritis
2462,30673921,*somatostatin
2462,30673921,*statin
2462,30673921,*testosterone
2462,30673921,*thyroid
2463,30291728,*graves’ disease
2463,30291728,*graves’ ophthalmopathy
2463,30291728,*hypothyroidism
2463,30291728,*iodine radioisotopes
2463,30291728,*thyroid function tests
2463,30291728,*thyrotoxicosis
2463,30291728,*treatment failure
2463,30291728,*weight gain
2465,31580214,*epstein-barr virus
2465,31580214,*graves' disease
2465,31580214,*asymptomatic infection
2465,31580214,*autoantibody
2465,31580214,*thyrotropin receptor autoantibody (trab)
2465,31580214,*viral reactivation cois
2466,30911279,biomarker
2466,30911279,diagnostics
2466,30911279,genetic signature
2466,30911279,molecular alteration
2466,30911279,papillary thyroid cancer cois
2467,31708111,*ctla4
2467,31708111,*graves’ disease
2467,31708111,*restriction fragment length polymorphism
2467,31708111,*single nucleotide polymorphism
2468,31033004,cd32b
2468,31033004,fcγr
2468,31033004,fcγrii
2468,31033004,graves' disease
2468,31033004,autoimmunity
2470,29974826,*cd4+ helper t cells
2470,29974826,*graves’ disease
2470,29974826,*t cell immunoglobulin domain and mucin domain 3
2470,29974826,*thyroid-associated ophthalmopathy
2470,29974826,*autoimmune thyroid disease
2470,29974826,*immune tolerance.
2471,31733941,*graves’ disease
2471,31733941,*ifih1 gene
2471,31733941,*lada diabetes
2471,31733941,*multiple sclerosis
2471,31733941,*polymorphism cois
2472,31557136,graves’ ophthalmopathy
2472,31557136,graves’ orbitopathy
2472,31557136,calcium
2472,31557136,methylprednisolone
2472,31557136,phosphate
2474,31272958,*graves’ ophthalmopathy
2474,31272958,*glucocorticoid
2474,31272958,*network meta-analysis cois
2475,30549306,*graves' orbitopathy
2475,30549306,*immunosuppression
2475,30549306,*methotrexate
2475,30549306,*methylprednsolone
2475,30549306,*rituximab
2478,30979639,dysthyroid optic neuropathy
2478,30979639,medial orbital wall decompression
2478,30979639,transcaruncular approach
2478,30979639,transnasal endoscopic approach
2478,30979639,vision
2480,30111225,graves' disease
2480,30111225,acute kidney injury
2480,30111225,hyperthyroidism
2480,30111225,methimazole
2480,30111225,nephrotoxicity
2482,30771152,*autoimmune thyroid disease
2482,30771152,*ctla-4
2482,30771152,*foxp3
2482,30771152,*graves’ disease
2482,30771152,*hashimoto’s thyroiditis
2482,30771152,*polymorphism
2484,29589999,*graves'
2484,29589999,*adipogenesis
2484,29589999,*extracellular-regulated kinase (erk)
2484,29589999,*hyaluronan production
2484,29589999,"*orbitopathy, biguanides, amp-activated protein kinase"
2485,29526990,false-positive
2485,29526990,lithium-heparin plasma
2485,29526990,tsh receptor antibody (trab)
2485,29526990,third-generation
2487,31833078,graves' disease
2487,31833078,hyperthyroidism
2487,31833078,tissue doppler imaging
2487,31833078,two-dimensional speckle tracking echocardiography
2488,30616690,*graves disease
2488,30616690,*hashimoto thyroiditis
2488,30616690,*macrophage-nk cells cross talk
2488,30616690,*thyroid cancer
2488,30616690,*tumor immunity cois competing interests: the authors declare that they have no conflict of interest. publisher’s note: springer nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
2489,29631510,*graves' ophthalmopathy immunoglobulins
2489,29631510,*igf-1 receptor
2489,29631510,*tsh receptor
2489,29631510,*pakt
2489,29631510,*perk1/2 cois
2490,30335556,graves’ disease
2490,30335556,orbital decompression
2490,30335556,infraorbital anaesthesia
2490,30335556,piezoelectric surgery
2490,30335556,thyroid eye disease
2491,30246383,*t follicular helper cells (tfh)
2491,30246383,*t helper 17 (th17)
2491,30246383,*t helper 22 (th22)
2491,30246383,*autoimmune thyroid diseases (aitds)
2491,30246383,*cytokines
2491,30246383,*immune tolerance
2491,30246383,*interleukin 17 (il-17)
2491,30246383,*interleukin 21 (il-21)
2492,29941778,autoimmune thyroid disease
2492,29941778,celiac disease
2492,29941778,glandular autoimmunity
2492,29941778,polyglandular autoimmune syndrome
2492,29941778,type 1 diabetes cois
2498,30973094,*graves' orbitopathy
2498,30973094,*toll-like receptor 2
2498,30973094,*high mobility group box 1
2498,30973094,*inflammation
2498,30973094,*receptor for advanced glycation end products
2499,30391932,*foxp3 acetylation
2499,30391932,*graves’ disease (gd)
2499,30391932,*treg function defect
2499,30391932,*mir-23a-3p
2502,30519958,bone mineral density
2502,30519958,bone turnover markers
2502,30519958,glucocorticoid
2503,29174716,autoimmune thyroid disease
2503,29174716,ctla4
2503,29174716,drb1*
2503,29174716,graves' disease
2503,29174716,hashimoto's thyroiditis
2503,29174716,human leukocyte antigen
2504,29021480,continuous glucose monitoring
2504,29021480,methylprednisolone pulse therapy
2504,29021480,mitiglinide
2504,29021480,rapid-acting insulin secretagogue
2504,29021480,repaglinide
2504,29021480,steroid-induced diabetes
2505,30284412,donor sclera
2505,30284412,ocular deviations
2505,30284412,strabismus
2505,30284412,surgical technique
2506,29256181,antioxidant
2506,29256181,fibroblast
2506,29256181,graves’
2506,29256181,ophthalmopathy
2506,29256181,orbitopathy
2506,29256181,retinol
2506,29256181,vitamin e
2506,29256181,β-carotene
2507,30515677,*continuous glucose monitoring
2507,30515677,*glycemic variation
2507,30515677,*graves’ disease
2507,30515677,*mean amplitude of glycemic excursions cois
2508,29804271,*durvalumab
2508,29804271,*graves’ orbitopathy
2508,29804271,*tremelimumab
2513,29549956,*graves' disease
2513,29549956,*autoantibodies
2513,29549956,*breast milk
2513,29549956,*methimazole
2513,29549956,*propylthiouracil
2513,29549956,*thyroid hormones
2514,30196781,*ophthalmoplegia
2514,30196781,*carotid-cavernous sinus fistula
2514,30196781,*cranial neuropathy
2514,30196781,*diplopia
2514,30196781,*hypoglobus
2514,30196781,*proptosis
2515,29482415,inter-ethnic
2515,29482415,orbit
2515,29482415,orbital decompression
2515,29482415,trigone
2516,31062662,*graves’ disease
2516,31062662,*autoantibody
2516,31062662,*decoy effect
2516,31062662,*exosome
2516,31062662,*thyrotropin receptor
2517,31809586,*b10 cells
2517,31809586,*graves’ disease
2517,31809586,*ilc2s
2517,31809586,*autoantibodies
2518,29656212,autoimmune thyroid disease
2518,29656212,calgranulins
2518,29656212,mrp14
2518,29656212,mrp6
2518,29656212,mrp8
2518,29656212,oxidative stress
2520,30222515,*epstein–barr virus
2520,30222515,*epstein–barr virus reactivation
2520,30222515,*epstein–barr virus-encoded small rna1
2520,30222515,*graves' disease
2520,30222515,*igg4-related disease cois
2521,29141453,*nodular thyroid diseases
2521,29141453,*goitre
2521,29141453,*insulin resistance
2521,29141453,*metabolic syndrome
2521,29141453,*thyroid volume
2523,30503299,*coronary artery vasospasm
2523,30503299,*graves’ disease
2523,30503299,*interleukin-6
2523,30503299,*silent myocardial infarction
2524,29557700,*decompression
2524,29557700,*graves’ orbitopathy
2524,29557700,*dose-effect
2524,29557700,*eye muscle surgery
2524,29557700,*tendon elongation of medial rectus muscle
2525,29233566,*anergy
2525,29233566,*autoimmune thyroid disease
2525,29233566,*b lymphocytes
2525,29233566,*flow cytometry
2528,30938100,*graves' disease
2528,30938100,*ptpn22 gene
2528,30938100,*gene polymorphism cois
2530,30724135,*graves' orbitopathy
2530,30724135,*pdgf-bb
2530,30724135,*adipogenesis
2530,30724135,*basic-fgf
2530,30724135,*tyrosine kinase inhibitor
2532,29780146,anca-related vasculitis
2532,29780146,mpo-anca
2532,29780146,omaav
2532,29780146,propylthiouracil
2534,30679116,autologous fat
2534,30679116,esthetic
2534,30679116,hyaluronic acid
2534,30679116,lateral orbital wall decompression
2534,30679116,temporal hollowing
2534,30679116,thyroid eye disease
2536,29800560,*graves' opthalmopathy
2536,29800560,*lfa-1/icam-1/gsk-3β pathway
2536,29800560,*logistic regression
2536,29800560,*mdr model
2536,29800560,*single nucleotide polymorphism
2536,29800560,*smoking
2537,29454070,graves’ disease
2537,29454070,interleukin-1 receptor antagonist
2537,29454070,interleukin-1-β
2537,29454070,restriction fragment length polymorphism
2537,29454070,single nucleotide polymorphism
2539,31328557,*circadian rhythm
2539,31328557,*graves’ disease
2539,31328557,*hashimoto’s thyroiditis
2539,31328557,*polymorphism
2540,31264142,anti-gastric parietal cell antibodies
2540,31264142,autoimmune gastritis
2540,31264142,autoimmune thyroid disease
2540,31264142,children
2540,31264142,screening
2541,29970608,endocrine system
2541,29970608,thyroid disease cois
2542,29269558,*endocrinology
2542,29269558,*pharmacology cois
2543,31411123,*graves' disease
2543,31411123,*levothyroxine
2543,31411123,*radioiodine treatment
2543,31411123,*thyrotropin
2543,31411123,*triiodothyronine cois
2544,31088643,abhormone
2544,31088643,colloid antigen 2
2544,31088643,graves’ disease
2544,31088643,thyroid blocking antibody
2544,31088643,thyroid stimulating antibody
2545,29666119,*experimental – laboratory
2545,29666119,*inflammation
2545,29666119,*orbit
2545,29666119,*pathology
2545,29666119,*stem cells cois
2546,29729713,autoimmune diseases
2546,29729713,meta-analysis.
2546,29729713,ptpn22
2547,28960748,hashimoto's
2547,28960748,autoimmune
2547,28960748,goiter
2547,28960748,hypothyroidism
2547,28960748,iodine
2547,28960748,vitiligo
2548,31399042,*adipogenesis
2548,31399042,*go animal model
2548,31399042,*graves’ disease
2548,31399042,*graves’ ophthalmopathy
2548,31399042,*thyroid disease
2548,31399042,*hpmscs cois
2549,31034586,b cell-activating factor
2549,31034586,graves' disease
2549,31034586,hashimoto's thyroiditis
2549,31034586,autoimmune thyroid disease
2549,31034586,osteopontin
2550,30208979,* aitd autoimmune thyroid disease
2550,30208979,* dio deiodinases
2550,30208979,* gd graves’ disease
2550,30208979,* gpx glutathione peroxidases
2550,30208979,* ht hashimoto's thyroiditis
2550,30208979,* id iron deficiency
2550,30208979,* l-t4 levothyroxine
2550,30208979,* rct randomised controlled trial
2550,30208979,* t3 tri-iodothyronine; t4
2550,30208979,* tpo thyroid peroxidase
2550,30208979,* tsh thyroid-stimulating hormone
2550,30208979,* tg thyroglobulin
2550,30208979,* thyroxine
2550,30208979,*autoimmune thyroid disease
2550,30208979,*autoimmune thyroiditis
2550,30208979,*iodine
2550,30208979,*iron
2550,30208979,*nutrition
2550,30208979,*selenium
2553,31091046,*graves’ ophthalmopathy
2553,31091046,*fibrosis
2553,31091046,*glycosaminoglycans
2553,31091046,*matrix metalloproteinases
2553,31091046,*pathogenesis
2553,31091046,*tissue inhibitor of metalloproteinases
2554,30684216,*autoantibodies
2554,30684216,*graves’ disease
2554,30684216,*hashimoto’s thyroiditis
2554,30684216,*tsh receptor
2554,30684216,*thyroid
2555,31439560,dermatology
2555,31439560,meningitis
2555,31439560,paediatrics cois
2556,31384956,fibroblast growth factor 23
2556,31384956,graves’ disease
2556,31384956,osteoporosis
2556,31384956,phosphorus
2557,30725486,*graves’ disease
2557,30725486,*hashimoto’ s thyroiditis
2557,30725486,*autoimmune thyroid disease
2557,30725486,*metabolomics
2557,30725486,*polyamine metabolites
2557,30725486,*serum
2557,30725486,*spermine
2558,29709954,carcinoembryonic antigen
2558,29709954,hypothyroidism
2559,31527321,denosumab
2559,31527321,fibroblast growth factor 23 (fgf-23)
2559,31527321,hypercalcemia
2559,31527321,hyperthyroidism
2559,31527321,zoledronic acid
2560,30506426,*bone mineral density
2560,30506426,*graves’ ophthalmopathy
2560,30506426,*graves’ orbitopathy
2560,30506426,*gucocorticoid-induced osteoporosis
2560,30506426,*methylprednisolone
2560,30506426,*trabecular bone score cois
2561,29526119,*graves’ disease
2561,29526119,*hashimoto’s disease
2561,29526119,*tnf-α
2561,29526119,*methylation
2561,29526119,*polymorphism
2563,31750736,4q21.1
2563,31750736,cxcl9
2563,31750736,hashimoto's thyroiditis
2563,31750736,naaa
2563,31750736,single nucleotide polymorphisms
2565,29864750,*autoimmunity
2565,29864750,*rheumatic diseases
2565,29864750,*thyroiditis
2566,31359380,autoimmune thyroid diseases
2566,31359380,dna methylation
2566,31359380,graves’ disease
2566,31359380,hashimoto thyroiditis
2566,31359380,icam-1
2568,30133352,*ebv reactivation
2568,30133352,*graves’ disease
2568,30133352,*ig production
2568,30133352,*estradiol cois
2569,30589937,b lymphocyte kinase
2569,30589937,graves' disease
2569,30589937,hashimoto’s thyroiditis
2569,30589937,autoimmune thyroid disease
2569,30589937,secreted phosphoprotein 1
2570,29791034,cd10
2570,29791034,adenomatous goitre
2570,29791034,anaplastic thyroid carcinoma
2570,29791034,immunohistochemistry
2570,29791034,thyroid tumour
2572,28725932,alzheimer’s disease
2572,28725932,chronological age
2572,28725932,dna methylation
2572,28725932,graves’ disease
2572,28725932,neural networks
2572,28725932,prediction accuracy
2573,30067105,antibody
2573,30067105,antithyroid drugs
2573,30067105,autoimmunity
2573,30067105,cutaneous reactions
2573,30067105,hepatotoxicity
2574,31573408,*antithyroid drugs
2574,31573408,*drug-induced hepatotoxicity
2574,31573408,*drug-induced liver injury
2574,31573408,*metimazole
2574,31573408,*propylthiouracil
2576,30417843,goitre
2576,30417843,incidence
2576,30417843,pyramidal lobe
2576,30417843,thyroidectomy cois
2578,31793246,highly differentiated follicular carcinoma of ovary
2578,31793246,imprint cytology
2578,31793246,monodermal teratoma
2578,31793246,struma ovarii
2579,31105122,gitelman syndrome
2579,31105122,slc12a3 gene
2579,31105122,eplerenone
2579,31105122,hypokalemia
2579,31105122,thyrotoxic hypokalemic periodic paralysis
2580,30201436,*autoimmunity
2580,30201436,*immune regulation
2580,30201436,*t cells
2580,30201436,*microrna-183
2580,30201436,*microrna-96
2581,31434818,graves’ disease
2581,31434818,hashimoto’s thyroiditis
2581,31434818,immune-checkpoint inhibitors
2581,31434818,immunoglobulin g4
2581,31434818,riedel’s thyroiditis
2582,30599051,*benign thyroid disease
2582,30599051,*radioiodine therapy
2582,30599051,*radioiodine uptake test
2582,30599051,*thyroid
2582,30599051,*thyroid stunning
2583,31301659,autopsy
2583,31301659,goiter
2583,31301659,malignancy
2583,31301659,metastatic disease
2583,31301659,thyroid
2583,31301659,thyroid nodule
2584,29956299,l-thyroxine in utero treatment
2584,29956299,dyshormonogenesis
2584,29956299,foetal goitre
2585,30936024,*biological therapy
2585,30936024,*disease progression
2585,30936024,*prognosis
2585,30936024,*treatment
2586,31387553,diagnostic criteria
2586,31387553,metastasis
2586,31387553,painful goiter
2586,31387553,subacute thyroiditis
2586,31387553,thyroid cancer cois
2587,29398296,*goitre
2587,29398296,*myasthenia gravis
2587,29398296,*ophthalmoplgia
2587,29398296,*thyrotoxicosis
2588,29923170,ancient greece
2588,29923170,endocrinology
2588,29923170,galen
2588,29923170,goitre
2588,29923170,hippocrates
2588,29923170,history
2588,29923170,thyroid
2589,30589040,nodular goiters
2589,30589040,ultrasound grayscale ratio (usgr)
2589,30589040,papillary carcinoma
2589,30589040,thyroid nodules cois
2590,28693960,backdoor
2590,28693960,lateral approach
2590,28693960,open throidectomy
2590,28693960,sternomastoid
2591,29396842,age-related changes
2591,29396842,chemical elements
2591,29396842,inductively coupled plasma mass spectrometry
2591,29396842,neutron activation analysis
2591,29396842,thyroid
2592,30175973,casc2
2592,30175973,long non-coding rna
2592,30175973,lymph node metastasis
2592,30175973,papillary thyroid cancer
2593,29724875,diabetes
2593,29724875,thyroid disease cois
2596,30860079,*endoscopic thyroidectomy using vestibular approach
2596,30860079,*scar.free thyroidectomy
2596,30860079,*transoral endoscopic thyroidectomy cois
2597,30939883,* thyroid nodules
2597,30939883,*fnab of thyroid gland
2597,30939883,*the bethesda 2017 revised classification of thyroid fnab
2597,30939883,*the bethesda system for reporting thyroid cytology 2010
2597,30939883,*goitre
2597,30939883,*thyroid cancer
2598,31691509,*echogenicity
2598,31691509,*nodular goiters
2598,31691509,*papillary thyroid carcinoma
2598,31691509,*ultrasonic diagnosis
2598,31691509,*ultrasound gray scale ratio cois
2601,31155540,deiodinase
2601,31155540,ft3/ft4 ratio
2601,31155540,hashimoto thyroiditis
2601,31155540,thyroid hormone
2601,31155540,thyroid volume
2602,29197093,*fndc5 gene
2602,29197093,*hyperthyroidism
2602,29197093,*hypothyroidism
2602,29197093,*irisin
2603,29996756,*thyroid diseases
2604,28627279,graves’ disease
2604,28627279,maternal autoantibodies
2604,28627279,anti-ro and anti-la antibodies
2604,28627279,athrogryposis multiplex congenital
2604,28627279,autoimmune thrombocytopenia
2604,28627279,fetal brain hemorrhage
2604,28627279,fetal heart block
2604,28627279,fetal thyroid goiter
2604,28627279,myasthenia gravis
2605,31670631,calciumsupliments
2605,31670631,calciumvalue
2605,31670631,thyroidectomy
2606,29626393,fnac
2606,29626393,children
2606,29626393,thyroid
2607,29409458,*breast cancer
2607,29409458,*goitre
2607,29409458,*lobular breast cancer
2607,29409458,*metastases to thyroid cois publication: written informed consent was obtained from the patient for the publication of this case report and any accompanying images. a copy of the written consent is available for review by the editor-in-chief of this journal. competing interests: the authors declare that they have no competing interests. publisher’s note: springer nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
2608,31580203,neuromonitoring
2608,31580203,goiter
2608,31580203,recurrent laryngeal nerve palsy
2608,31580203,thyroid
2608,31580203,vocal cords
2609,31178475,congenital hypothyroidism
2609,31178475,gene mutation
2609,31178475,goiter
2609,31178475,thyroglobulin cois
2610,31292912,c cell hyperplasia
2610,31292912,c cells
2610,31292912,papillary carcinoma
2610,31292912,thyroid
2610,31292912,thyroidectomy
2611,31127647,*dnmt1
2611,31127647,*mgmt
2611,31127647,*ms-hrm
2611,31127647,*ctdna
2611,31127647,*methylation
2611,31127647,*papillary thyroid cancer
2612,31255196,autoimmune thyroiditis
2612,31255196,graves’ disease
2612,31255196,hashimoto's thyroiditis
2612,31255196,surgical management
2613,29724805,spect/ct
2613,29724805,parallax error
2613,29724805,parathyroid scintigraphy
2613,29724805,pinhole collimator
2613,29724805,thyroid scintigraphy
2614,30927996,history of thymectomy
2614,30927996,myasthenia gravis
2614,30927996,myasthenic
2614,30927996,surgical management of myasthenia gravis
2614,30927996,thymoma
2614,30927996,thymus
2614,30927996,transcervical
2615,30884127,cep78
2615,30884127,wdr62
2615,30884127,lateral lymph node metastasis
2615,30884127,thyroid cancer
2616,30739612,*deficiency
2616,30739612,*excess
2616,30739612,*iodine
2616,30739612,*sub-saharan africa
2617,29459090,cancer thyroïdien
2617,29459090,goitre ovarien
2617,29459090,ovarian teratoma
2617,29459090,struma ovarii
2617,29459090,thyroid carcinoma
2617,29459090,tératome ovarien
2618,31430255,tpo gene
2618,31430255,congenital goiter
2618,31430255,congenital hypothyroidism
2618,31430255,thyroid carcinoma
2618,31430255,thyroid dyshormonogenesis
2619,29313120,ablation techniques
2619,29313120,high-intensity focused ultrasound ablation
2619,29313120,induced hyperthermia
2619,29313120,interventional ultrasonography
2619,29313120,nodular goitre
2620,29503241,atrial fibrillation
2620,29503241,congestive heart failure
2620,29503241,graves’ disease
2620,29503241,hyperthyroidism
2620,29503241,toxic multinodular goitre
2623,29845469,*family health
2623,29845469,*health promotion
2623,29845469,*screening cois
2624,31267862,*nrf2
2624,31267862,*personalized nutrition
2624,31267862,*flavonoid
2624,31267862,*goiter
2624,31267862,*hyperthyroidism
2624,31267862,*hypothyroidism
2624,31267862,*phytochemical
2624,31267862,*thyroid.
2625,29676344,histopathology
2625,29676344,retrospective
2625,29676344,thyroid diseases cois
2626,31297898,*bipolar disorders
2626,31297898,*lithium
2626,31297898,*thyroid hormones
2626,31297898,*thyroid structure
2628,30665612,*hypocalcemia
2628,30665612,*indocyanine green
2628,30665612,*multinodular goiter
2628,30665612,*parathyroid
2628,30665612,*parathyroid hormone
2628,30665612,*thyroidectomy
2630,29354015,*benign thyroid nodule
2630,29354015,*laser
2630,29354015,*laser ablation
2630,29354015,*quality of life
2630,29354015,*thyroid
2630,29354015,*thyroid nodule
2631,29330630,ablation techniques
2631,29330630,high-intensity focused ultrasound ablation
2631,29330630,interventional ultrasonography
2631,29330630,nodular goitre
2631,29330630,pain management
2632,30009365,galen
2632,30009365,thomas wharton
2632,30009365,botium
2632,30009365,thyroid foramen
2633,30949714,autonomous thyroid function
2633,30949714,hyperthyroidism
2633,30949714,hypothyroidism
2633,30949714,iodine exposure
2633,30949714,nodular goiter
2636,30717458,diet
2636,30717458,gestational diabetes mellitus
2636,30717458,microbiota
2636,30717458,"pregnancy cois design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript, or in the decision to publish the results."
2637,30903785,children
2637,30903785,morbidity
2637,30903785,pesticides
2637,30903785,thyroid gland
2638,31670642,crp
2638,31670642,anaplastic
2638,31670642,cancer
2638,31670642,ferritin
2638,31670642,inflammatorymarkers
2638,31670642,thyroid
2639,30732901,congenital hypothyroidism
2639,30732901,goiter
2639,30732901,idd
2639,30732901,iran
2639,30732901,salt iodisation
2641,30358496,*goiter
2641,30358496,*iodine deficiency
2641,30358496,*iodine in salt
2641,30358496,*thyroid volume
2641,30358496,*urinary iodine
2642,30378716,*foxq1
2642,30378716,*papillary thyroid carcinoma
2642,30378716,*poor prognosis
2643,30568076,infertility
2643,30568076,negative thyroid antibody
2643,30568076,nongoitrous
2643,30568076,subclinical hypothyroidism
2643,30568076,thyroid autoimmunity
2644,28952819,ebsln
2644,28952819,ionm
2644,28952819,rln
2644,28952819,goiter
2644,28952819,surgery
2644,28952819,thyroid
2645,28940588,ectopic thyroid
2645,28940588,endobronchial ultrasonography
2645,28940588,transbrochial needle aspiration
2646,29770856,benign thyroid disease
2646,29770856,mixed follicular-papillary variant
2646,29770856,multifocality
2646,29770856,papillary thyroid microcarcinoma
2646,29770856,risk factors
2646,29770856,thyroid weight
2646,29770856,tumour size
2647,31237859,vegf-a
2647,31237859,angiogenic factor
2647,31237859,histopathological factors
2647,31237859,immunohistochemistry
2647,31237859,papillary thyroid carcinoma
2647,31237859,thyroid carcinoma
2649,28224254,eastern mediterranean region (emr)
2649,28224254,goiter
2649,28224254,iodine
2649,28224254,iodine deficiency disorders (idds)
2649,28224254,who
2650,31445060,environmental chemicals
2650,31445060,pesticides
2650,31445060,thyroid diseases
2650,31445060,case–control study
2651,30521675,*goiter
2651,30521675,*health insurance
2651,30521675,*socioeconomic disparities
2651,30521675,*thyroid disease
2651,30521675,*thyroid volume
2653,30773379,*fusion imaging
2653,30773379,*hybrid imaging
2653,30773379,*single-photon emission computed tomography/ultrasound
2653,30773379,*thyroid
2653,30773379,*ultrasound
2655,31074384,follicular proliferation
2655,31074384,lobectomy
2655,31074384,malignancy
2655,31074384,surgery
2655,31074384,tir3b
2655,31074384,thyroid cancer
2655,31074384,total thyroidectomy cois
2656,30734891,dysgenesis
2656,30734891,dyshormonogenesis
2656,30734891,hashimoto thyroiditis
2656,30734891,hypothyroidism
2656,30734891,iodine deficiency
2656,30734891,levothyroxine
2656,30734891,mental retardation
2656,30734891,stunted growth
2659,32312925,benign thyroidectomy
2659,32312925,cervical thyroid remnant
2659,32312925,papillary thyroid carcinoma
2664,31142293,hashimoto’s thyroiditis
2664,31142293,papillary thyroid carcinoma cois
2665,29544745,adults
2665,29544745,influences
2665,29544745,prevalence
2665,29544745,thyroid nodules
2668,30371103,neuromonitoring
2668,30371103,nonrecurrent laryngeal nerve
2668,30371103,palsy
2668,30371103,recurrent laryngeal nerve
2668,30371103,thyroidectomy
2669,29573939,*shear wave
2669,29573939,*cancer
2669,29573939,*elastography
2669,29573939,*thyroid nodules
2669,29573939,"*ultrasound cois device or technology referenced in this paper. ag, mb, vk, bhk, jw, ddm, mr, jmk, mf, and aa have no competing financial interests in the technology described in this study. the content is solely the responsibility of the authors and does not necessarily represent the official views of the national institutes of health."
2670,30829140,*benign/goiter
2670,30829140,*endocrine
2670,30829140,*thyroid
2670,30829140,*thyroid cancer
2670,30829140,*thyroid/parathyroid
2670,30829140,*thyroidectomy
2671,30086865,*complication prevention
2671,30086865,*congenital hypothyroidism
2671,30086865,*goiter
2671,30086865,*next generation sequencing
2671,30086865,*systemic disease complications
2671,30086865,*thyroid
2672,30637454,hypocalcemia
2672,30637454,postoperative hypoparathyroidism
2672,30637454,thyroid surgery
2672,30637454,thyroidectomy
2672,30637454,vitamin d deficiency
2673,29695560,*bad
2673,29695560,*bax
2673,29695560,*bcl-2
2673,29695560,*benign thyroid nodules
2673,29695560,*apoptosis
2673,29695560,*gene expression
2674,29720101,*congenital hypothyroidism
2674,29720101,*goiter
2674,29720101,*novel mutations
2674,29720101,*tg
2674,29720101,"*thyroglobulin cois performed in miami has been approved by the human subject research office of the university of miami (irb number: 20140632). written informed consent for participating in the study has been obtained from all study participants and in the case of subjects under the age of 18 assent was obtained from the child and consent from their parents. consent for publication: written informed consent for publishing all data of the study, such as medical data, images and genetic results has been obtained from all study participants or in the case of subjects under the age of 18 assent was obtained from the child and consent from their parent. competing interests: the authors declare that they have no competing interests. publisher’s note: springer nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations."
2675,31326901,genetics
2675,31326901,pituitary disorders
2675,31326901,thyroid disease cois
2677,30666977,iccidd
2677,30666977,iodine deficiency disorder
2677,30666977,iodized salt
2677,30666977,last mile
2677,30666977,public health nutrition
2677,30666977,success story
2677,30666977,way forward cois
2678,31169246,anaplastic thyroid carcinoma
2678,31169246,giant cells
2678,31169246,osteoclasts cois
2681,30610567,collision
2681,30610567,double tumor
2681,30610567,pit-1
2681,30610567,pituitary tumor
2681,30610567,plurihormonal
2681,30610567,sf-1
2681,30610567,stem cell
2682,29717097,*complication
2682,29717097,*elderly
2682,29717097,*morbidity
2682,29717097,*mortality
2682,29717097,*tracheostomy cois
2683,30707410,early diagnosis of rth β
2683,30707410,rth β management
2683,30707410,resistance to thyroid hormones
2683,30707410,spanish cohort
2683,30707410,thrb gene
2686,31250039,billing diagnosis
2686,31250039,coding quality
2686,31250039,prevalence of thyroid disorders
2686,31250039,primary data
2686,31250039,validation
2687,30700956,cardiovascular disease
2687,30700956,hyperthyroidism
2687,30700956,pattern
2687,30700956,presentation
2687,30700956,thyro-cardiac disease
2688,31489070,sarcoidosis
2688,31489070,endoscopy
2688,31489070,hypothalamus
2688,31489070,neurosarcoidosis
2688,31489070,pituitary gland
2688,31489070,sella turcica cois
2689,30450534,congenital hypothyroidism
2689,30450534,screening
2689,30450534,thyroid dysgenesis
2689,30450534,thyroid scintigraphy
2690,29409365,*percutaneous laser ablation
2690,29409365,*hyperthyroidism
2690,29409365,*toxic nodules
2691,31243250,igg4
2691,31243250,hypertrophic pachymeningitis
2691,31243250,non-caseating granuloma
2691,31243250,sarcoidosis
2693,30236136,conventional
2693,30236136,hypocalcemia
2693,30236136,ligasure® small jaw
2693,30236136,recurrent laryngeal nerve
2693,30236136,"thyroidectomy cois chancellor of research and development, tabriz university of medical sciences (committee reference number: 92170), and registered in iranian registry of clinical trials (www.irct.com), trial registration: irct2014010516077n1, registered: 23 may 2014). all patients provided written consent form in order to participate in the study and the procedures followed were in accordance with the ethical standards of the ethics committee of the tabriz university of medical sciences. consent for publication: not applicable. competing interests: the authors declare that they have no competing interests. publisher’s note: springer nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations."
2694,29039144,*endoscopic thyroidectomy
2694,29039144,*natural orifice transluminal endoscopic surgery
2694,29039144,*robotic thyroidectomy
2694,29039144,*transoral thyroidectomy
2695,30919068,ablation techniques
2695,30919068,high-intensity focused ultrasound ablation
2695,30919068,interventional ultrasonography
2695,30919068,nodular goiter
2695,30919068,pain management
2696,30778718,ablation techniques
2696,30778718,high-intensity focused ultrasound ablation
2696,30778718,interventional ultrasonography
2696,30778718,nodular goiter
2696,30778718,ultrasound imaging
2697,32202723,*cancer
2697,32202723,*cytology
2697,32202723,*nodular goiter
2697,32202723,*stratification
2697,32202723,*thyroid gland
2697,32202723,*ultrasonography
2698,30105949,*tirads
2698,30105949,*imaging
2698,30105949,*multinodular goiter
2698,30105949,*scoring system
2698,30105949,*ultrasonography
2699,30039748,*graves' disease
2699,30039748,*hashimoto's thyroiditis
2699,30039748,*quality of life
2699,30039748,*sexual dysfunction
2699,30039748,*thyroid autoimmunity
2700,31741093,adolescent
2700,31741093,child
2700,31741093,thyroid neoplasm
2700,31741093,thyroid nodule
2700,31741093,ultrasonography
2702,30833205,e-learning
2702,30833205,personalized learning environment
2702,30833205,practice-based learning and improvement
2702,30833205,professionalism
2702,30833205,systems-based practice
2702,30833205,vodcast vs. lecture
2703,30666981,anaemia
2703,30666981,diagnosis
2703,30666981,hypertension
2703,30666981,interventions
2703,30666981,recovery
2703,30666981,status fluorosis
2703,30666981,stillbirth cois
2704,29239041,familial adenomatous polyposis
2704,29239041,familial medullary thyroid carcinoma
2704,29239041,familial non-medullary thyroid carcinoma
2704,29239041,familial thyroid carcinoma
2704,29239041,multiple endocrine neoplasia
2705,29683529,*braf mutation
2705,29683529,*immunocytochemistry
2705,29683529,*molecular testing
2705,29683529,*plump cells
2705,29683529,*thyroid malignancies
2705,29683529,*thyroid nodules
2706,29529424,*goiter
2706,29529424,*iodine deficiency disorders
2706,29529424,*iodine supplementation
2706,29529424,*pregnancy
2706,29529424,*thyroid hormones
2707,31752761,bilateral cataract
2707,31752761,hypocalcemia
2707,31752761,hypoparathyroidism
2707,31752761,serum calcium and ethiopia
2707,31752761,tetany
2707,31752761,total thyroidectomy cois authors have any proprietary interests or conflicts of interest related to this submission.
2708,30595314,autopsy
2708,30595314,hypothyroidism
2708,30595314,ischemic heart disease
2708,30595314,thyroid
2709,31074392,cancer
2709,31074392,fine needle aspiration citology
2709,31074392,follicular
2709,31074392,goiter
2709,31074392,kidney transplantation
2709,31074392,papillary
2709,31074392,thyroid
2709,31074392,thyroid nodule cois
2711,31396854,ezh2
2711,31396854,h3k27me3
2711,31396854,immunohistochemistry
2711,31396854,thyroid cancer
2712,30197365,carcinoma thyroid
2712,30197365,poorly differentiated
2712,30197365,thyroglobulin cois
2713,31254103,"chronic hypocalcaemia, permanent hypoparathyroidism, operative volume"
2713,31254103,endocrine surgery
2713,31254103,surgeon volume
2713,31254103,thyroidectomy
2713,31254103,volume-outcome
2714,29637242,notes
2714,29637242,parathyroid gland
2714,29637242,toetva
2714,29637242,thyroid gland
2715,30252648,adolescent
2715,30252648,anthropometry
2715,30252648,blood pressure
2715,30252648,child
2715,30252648,glucose metabolism
2715,30252648,lipid metabolism
2715,30252648,subclinical hypothyroidism
2716,29885011,*biobanking
2716,29885011,*fine needle aspiration cytology
2716,29885011,*preanalytical procedures
2716,29885011,*thyroid
2717,28771678,sjögren syndrome
2717,28771678,annular erythema
2717,28771678,eccrine gland
2717,28771678,hidradenitis
2717,28771678,lymphocyte
2721,31565844,*intraoperative neuromonitoring
2721,31565844,*nerves at risk
2721,31565844,*phonosurgical therapy
2721,31565844,*recurrent laryngeal nerve
2721,31565844,*vocal fold paralysis
2721,31565844,*vocal function
2722,31133065,children
2722,31133065,deficiency
2722,31133065,excess
2722,31133065,nepal
2722,31133065,salt iodine
2722,31133065,thyroid
2722,31133065,urinary iodine cois
2723,31502218,acromegaly
2723,31502218,complications
2723,31502218,doppler
2723,31502218,ultrasound
2723,31502218,visceromegaly
2725,29319359,hyperthyroidism
2725,29319359,hypothyroidism
2725,29319359,pregnancy and thyroid
2725,29319359,prevention
2725,29319359,screening
2725,29319359,thyroid cancer
2725,29319359,thyroid disease
2726,31820353,iodine
2726,31820353,kombu
2726,31820353,risk assessment
2726,31820353,seaweeds
2726,31820353,toxic risk
2726,31820353,wakame
2727,31671395,choriocarcinoma
2727,31671395,germ cell tumors
2727,31671395,human chorionic gonadotropin
2727,31671395,hyperthyroidism
2729,29886838,anaplastic thyroid carcinoma
2729,29886838,aetiology
2729,29886838,new approaches
2729,29886838,prognostic factors
2729,29886838,risk factors
2729,29886838,treatment.
2730,31409088,dicer1
2730,31409088,cystic nephroma
2730,31409088,genetic testing
2730,31409088,hereditary cancer syndromes
2730,31409088,pleuropulmonary blastoma
2731,31238185,carotid body tumor
2731,31238185,ectopic thyroid
2731,31238185,in-111 pentetreotide
2731,31238185,paraganglioma
2732,30259504,calcifediol
2732,30259504,sunlight
2732,30259504,thyroid disease
2732,30259504,ultraviolet rays
2732,30259504,vitamin d deficiency
2733,29444549,body weight
2733,29444549,endocrine surgery
2733,29444549,general surgery
2733,29444549,thyroidectomy
2734,31400012,*epidemiology
2734,31400012,*hyperthyroidism
2734,31400012,*hypothyroidism
2734,31400012,*incidence
2734,31400012,*iodine
2734,31400012,*myxoedema
2734,31400012,*thyrotoxicosis
2735,29851122,*epidemiology
2735,29851122,*hyperthyroidism
2735,29851122,*incidence
2735,29851122,*iodine
2735,29851122,*thyrotoxicosis
2737,30681972,hashimoto’s thyroiditis
2737,30681972,thrβ gene mutation
2737,30681972,resistance to thyroid hormone
2738,29798143,collagen triple helix repeat containing 1
2738,29798143,epithelial-mesenchymal transition
2738,29798143,immunohistochemistry
2738,29798143,thyroid neoplasms cois relevant financial relationships with commercial interests to disclose.
2739,29333819,autoimmune thyroiditis
2739,29333819,child
2739,29333819,hashimoto's disease
2739,29333819,hypothyroidism
2740,31468286,anaplastic thyroid carcinoma
2740,31468286,ham-1
2740,31468286,in situ hybridization
2740,31468286,long non-coding rna
2740,31468286,pca3
2740,31468286,pcr array
2740,31468286,papillary thyroid carcinoma
2740,31468286,rt-pcr
2740,31468286,thyroid carcinoma
2741,30413933,aggressiveness
2741,30413933,id genes
2741,30413933,thyroid cancer
2741,30413933,bhlh
2745,31610911,children
2745,31610911,conseil génétique
2745,31610911,dicer1
2745,31610911,dépistage
2745,31610911,enfant
2745,31610911,genetic counseling
2745,31610911,ovarian sertoli-leydig tumor
2745,31610911,pleuropneumoblastoma
2745,31610911,pleuropneumoblastomes
2745,31610911,rare tumors
2745,31610911,screening
2745,31610911,surveillance
2745,31610911,tumeur ovarienne de sertoli-leydig
2745,31610911,tumeurs rares
2746,31375535,cancer
2746,31375535,cytopathology
2746,31375535,endocrine pathology
2746,31375535,thyroid cancer cois
2747,30074074,benign thyroid surgery
2747,30074074,head and neck surgery
2747,30074074,postoperative complications
2747,30074074,thyroid surgery
2747,30074074,vocal fold palsy
2749,30387163,*rct
2749,30387163,*cholecalciferol
2749,30387163,*hypocalcaemia
2749,30387163,*thyroidectomy
2749,30387163,*vitamin d
2750,30306604,adolescents
2750,30306604,autoimmune thyroiditis
2750,30306604,children
2750,30306604,l-selenomethionine
2750,30306604,organic selenium
2752,30902382,*carcinoma de células renales
2752,30902382,*neoplasia metastásica
2752,30902382,*neoplasm metástasis
2752,30902382,*renal cell carcinoma
2752,30902382,*thyroid
2752,30902382,*tiroides
2753,29466241,graves’ disease
2753,29466241,amiodarone-induced thyrotoxicosis
2753,29466241,hyperthyroidism
2755,32372175,c cell
2755,32372175,cancer
2755,32372175,diagnosis
2755,32372175,foxa1
2755,32372175,thyroid
2757,30891786,*iodine
2757,30891786,*iodine excess
2757,30891786,*iodized salt
2757,30891786,*thyroglobulin
2757,30891786,*thyroid autoimmunity
2759,29459556,autoimmune polyglandular syndrome
2759,29459556,hashimoto’s thyroiditis
2759,29459556,pulmonary hypertension
2759,29459556,type 1 diabetes
2760,31835129,copper
2760,31835129,iodine
2760,31835129,selenium
2760,31835129,thyroiditis
2760,31835129,zinc
2762,31770674,iodine
2762,31770674,adolescents
2762,31770674,children
2762,31770674,deficiency
2762,31770674,dietary intake
2762,31770674,pre-schoolers
2765,28717869,endoscopic thyroidectomy
2765,28717869,toetva
2765,28717869,thyroidectomy
2765,28717869,transoral
2765,28717869,transoral endoscopic thyroidectomy
2765,28717869,transoral neck surgery
2766,30953492,epidemiology
2766,30953492,hepatitis c infection
2766,30953492,interferon
2766,30953492,morbidity
2766,30953492,ribavirin
2766,30953492,"thyroid dysfunction cois database. according to the regulation of ministry of health and welfare, taiwan, all of the nhir datasets are only available from the information center, ministry of health and welfare, taiwan. the study was approved by the institute review board of the show chwan memorial hospital, taiwan (no. 1051201). informed consent from the subjects was not obtained because there was no personal contact between the patients and the data collectors. consent for publication: not applicable. competing interests: the authors declare that they have no competing interests. publisher’s note: springer nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations."
2767,30168266,inguinal hernia
2767,30168266,uroflowmetry
2767,30168266,visual analog scale
2767,30168266,voiding dysfunction
2769,31881874,acdf
2769,31881874,anterior cervical discectomy and fusion
2769,31881874,c7/t1 anterior discectomy
2769,31881874,cervicothoracic junction
2769,31881874,hemithyroidectomy cois
2770,30955264,"carcinoma, papillary"
2770,30955264,prognosis
2770,30955264,thyroid neoplasms
2771,29079441,graves’ disease
2771,29079441,ompf porin
2771,29079441,serological cross-reactivity
2771,29079441,thyroid-stimulating hormone receptor
2771,29079441,yersinia pseudotuberculosis
2772,29993215,color doppler
2772,29993215,neoplasms
2772,29993215,thyroid nodule
2772,29993215,ultrasonography
2775,30784009,acoustic respiratory rate monitoring
2775,30784009,airway obstruction
2775,30784009,postoperative hemorrhage
2775,30784009,tachypnea
2775,30784009,thyroidectomy
2776,30272298,*co-morbidities
2776,30272298,*endometriosis
2776,30272298,*whole exome sequencing
2776,30272298,*autoimmune diseases
2776,30272298,*family history
2777,30298217,cross-sectional studies
2777,30298217,epidemiology
2777,30298217,general practice
2777,30298217,health services research
2777,30298217,otolaryngologists
2777,30298217,thyroid gland
2778,29730784,*neuromonitoring
2778,29730784,*quality of life
2778,29730784,*surgery
2778,29730784,*thyroid
2778,29730784,*voice cois ethical approval: all procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 helsinki declaration and its later amendments or comparable ethical standards. informed consent: informed consent was obtained from all individual participants included in the study.
2779,31248397,3d printing
2779,31248397,airway pathology
2779,31248397,bronchial tree
2779,31248397,bronchoscopy
2779,31248397,multi-material
2779,31248397,simulation cois
2781,30264384,choline
2781,30264384,parathyroid adenoma
2781,30264384,positron emission tomography computed tomography
2781,30264384,primary hyperparathyroidism
2782,29380231,*diagnose
2782,29380231,*glucocorticoid treatment
2782,29380231,*igg4
2782,29380231,*inflammation
2782,29380231,*riedel cois ethical approval: for this type of retrospective study formal consent was not required.
2784,31821747,*braf mutation
2784,31821747,*fine-needle aspiration cytology
2784,31821747,*personalized medicine
2784,31821747,*programmed death-ligand 1 (pd-l1)
2784,31821747,*thyroid cancer
2785,31751626,*congenital hypothyroidism
2785,31751626,*erad
2785,31751626,*protein folding
2785,31751626,*thyroid genes
2787,30260174,gh
2787,30260174,igf-1
2787,30260174,acromegaly
2787,30260174,cancer
2787,30260174,neoplasms
2787,30260174,registry
2788,29504626,rdw
2788,29504626,heart failure
2788,29504626,hypothyroidism
2788,29504626,radioiodine therapy
2789,29317181,extramedullary hematopoiesis
2789,29317181,fine needle aspiration
2789,29317181,thyroid
2790,31914295,lymphatic metastasis
2790,31914295,melatonin
2790,31914295,melatonin receptor
2790,31914295,papillary thyroid cancer cois relevant financial relationships with commercial interests to disclose.
2793,30691690,"abordaje biaxilo-biareolar, ba-ba"
2793,30691690,abordaje extracervical
2793,30691690,baba endoscopic thyroidectomy
2793,30691690,bilateral axillo-breast approach
2793,30691690,endoscopic thyroidectomy
2793,30691690,scarless thyroidectomy
2793,30691690,tiroidectomía endoscópica
2793,30691690,tiroidectomía sin cicatriz cervical
2794,30406929,autoimmune
2794,30406929,empty sella
2794,30406929,pituitary adenoma
2794,30406929,prolactin
2794,30406929,thyroid
2795,30218312,iodine
2795,30218312,iodine deficiency disorder
2795,30218312,pregnancy
2795,30218312,thyroid
2796,29582344,hypothyroidism
2796,29582344,levothyroxine formulation
2796,29582344,liquid levothyroxine
2796,29582344,tsh
2797,29022276,central hyperthyroidism
2797,29022276,hyperthyroidism
2797,29022276,pituitary tumors
2797,29022276,tsh-secreting pituitary adenoma
2797,29022276,thyrotropinoma
2798,30740757,*18f-fdg pet/ct
2798,30740757,*eu-tirads
2798,30740757,*diagnosis
2798,30740757,*thyroid cancer
2798,30740757,*ultrasound
2799,31703968,*contrast-enhanced ultrasonography
2799,31703968,*papillary thyroid microcarcinoma
2799,31703968,*tumor size stratification
2800,31918249,braf(v600e)
2800,31918249,hbme-1
2800,31918249,lymph node metastasis
2800,31918249,papillary thyroid carcinoma
2800,31918249,ultrasound
2801,30443896,difficulty scale
2801,30443896,operative time
2801,30443896,total thyroidectomy
2802,30267376,autoimmune thyroid disease
2802,30267376,greece
2802,30267376,iodine
2802,30267376,thyroid
2802,30267376,thyroiditis
2803,30182360,incidence
2803,30182360,recurrence
2803,30182360,risk factors
2803,30182360,thyroid lobectomy
2803,30182360,thyroid nodules
2804,29774590,*anatomy handbook
2804,29774590,*pathogenesis and classification of neoplasms
2804,29774590,*prostatic hyperplasia
2805,30058426,electrophoresis
2805,30058426,mass spectrometry
2805,30058426,proteomics
2805,30058426,serum
2805,30058426,thyroid cancer
2806,29698806,14q32 deletion
2806,29698806,cancer
2806,29698806,dicer1 syndrome
2807,29536247,indocyanine green
2807,29536247,mivat
2807,29536247,near-infrared fluorescence
2807,29536247,parathyroid
2807,29536247,video-assisted thyroidectomy
2808,29164514,iodine
2808,29164514,microcarcinoma
2808,29164514,papillary thyroid cancer
2808,29164514,risk factors
2808,29164514,thyroid thyroglobulin antibody
2808,29164514,thyroid-stimulating hormone
2810,29438906,*fgf19
2810,29438906,*fgfr4
2810,29438906,*serum concentration
2810,29438906,*thyroid cancer
2810,29438906,*βklotho
2811,29273943,children
2811,29273943,pten hamartoma tumor syndrome (phts)
2811,29273943,screening
2811,29273943,thyroid cancer
2811,29273943,thyroid disease
2812,31841457,131і
2812,31841457,chornobyl disaster
2812,31841457,late endocrine and neuropsychiatric effects
2812,31841457,pathogenesis
2812,31841457,prenatal irradiation
2813,29968224,*apheresis
2813,29968224,*therapeutic plasma exchange
2813,29968224,*thyroid hormones
2813,29968224,*thyrotoxicosis
2814,29340973,age
2814,29340973,iodine status
2814,29340973,reference intervals
2814,29340973,thyroid dysfunction
2814,29340973,thyrotropin
2815,31190472,cold nodule
2815,31190472,cytology
2815,31190472,histopathology
2815,31190472,hot nodule
2815,31190472,warm nodule
2817,30639646,autoimmune thyroid diseases
2817,30639646,autoimmune thyroiditis
2817,30639646,celiac disease
2817,30639646,chronic autoimmune gastritis
2817,30639646,graves' diseases
2817,30639646,graves' ophthalmopathy
2817,30639646,multiple sclerosis
2817,30639646,polymyalgia rheumatica
2817,30639646,rheumatoid arthritis
2817,30639646,sarcoidosis
2817,30639646,sjogren disease
2817,30639646,systemic lupus erythematosus
2817,30639646,type 1 diabetes (type 1)
2817,30639646,vitiligo
2818,29949024,cytology
2818,29949024,diagnosis
2818,29949024,fine-needle aspiration
2818,29949024,niftp
2818,29949024,negative
2818,29949024,thyroid
2820,31383578,hypocalcemia
2820,31383578,hypoparathyroidism
2820,31383578,pediatric population
2820,31383578,total thyroidectomy
2821,31365889,etiology
2821,31365889,thyroid disease
2821,31365889,thyroid tissue
2821,31365889,toxic/essential trace metals
2822,30953130,*brain tumor
2822,30953130,*cns sarcoma
2822,30953130,*ciliary body medulloepithelioma
2822,30953130,*dicer1
2822,30953130,*dicer1-associated cns sarcoma
2822,30953130,*etmr
2822,30953130,*pineoblastoma
2822,30953130,*pituitary blastoma
2824,29703200,classification and regression tree method (cart)
2824,29703200,low transmission
2824,29703200,malaria exposure
2824,29703200,plasmodium falciparum
2824,29703200,plasmodium vivax
2824,29703200,reservoir of infection
2824,29703200,sero-epidemiology
2824,29703200,vietnam
2825,30410095,*diagnostic evaluation
2825,30410095,*etiology
2825,30410095,*genetic
2825,30410095,*hydrops fetalis
2825,30410095,"*nonimmune cois through the ucsf center for maternal-fetal precision medicine. m.e.n. is a consultant to invitae and has received research funding from natera, but this funding was not applied to this study. the other authors declare no conflicts of interest."
2826,31699952,congenital
2826,31699952,hypothyroidism
2826,31699952,young adult
2828,31621051,autoregulation
2828,31621051,cognition
2828,31621051,primary hyperparathyroidism
2828,31621051,vascular stiffness
2828,31621051,vasomotor reactivity cois
2829,30997493,*developing countries
2829,30997493,*effectiveness
2829,30997493,*folic acid
2829,30997493,*fortification
2829,30997493,*functional outcomes
2829,30997493,*iodine
2829,30997493,*iron
2829,30997493,*micronutrient status
2829,30997493,*systematic review
2829,30997493,*vitamin a
2831,31323353,hypocalcemia
2831,31323353,intact parathyroid hormone (pth)
2831,31323353,pediatric thyroidectomy
2832,30973063,*tbab
2832,30973063,*trab
2832,30973063,*tsab
2832,30973063,*fetal hyperthyroidism
2832,30973063,*fetal malformation
2832,30973063,*maternal hashimoto's disease
2833,30772970,tyumen region
2833,30772970,iodine deficiency
2833,30772970,iodized salt
2833,30772970,nutrition
2833,30772970,prevention cois publication of this article.
2834,30963819,*s1pr1
2834,30963819,*sphingosine 1 phosphate
2834,30963819,*sphingosine kinase 1
2834,30963819,*thyroiditis
2835,29650436,concentración urinaria de yodo
2835,29650436,epidemiological survey
2835,29650436,escolares
2835,29650436,estudio epidemiológico
2835,29650436,schoolchildren
2835,29650436,tsh en sangre capilar
2835,29650436,tsh in capillary blood
2835,29650436,urinary iodine concentration
2836,29030129,acoustic analysis
2836,29030129,análise acústica
2836,29030129,disfonia
2836,29030129,dysphonia
2836,29030129,hoarseness
2836,29030129,laryngeal paralysis
2836,29030129,paralisia laríngea
2836,29030129,rouquidão
2836,29030129,thyroidectomy
2836,29030129,tireoidectomia
2837,30891966,*classification
2837,30891966,*convolutional neural network
2837,30891966,*deep learning
2837,30891966,*head and neck cancer
2837,30891966,*hyperspectral imaging
2837,30891966,*optical biopsy
2837,30891966,*squamous cell carcinoma
2838,30472362,carbon nanoparticles
2838,30472362,parathyroid glands
2838,30472362,recurrent laryngeal nerve
2838,30472362,total thyroidectomy
2839,30443770,foxp3
2839,30443770,garp
2839,30443770,papillary thyroid carcinoma
2839,30443770,thyroid cancer
2840,29848235,*central neck
2840,29848235,*hypocalcemia
2840,29848235,*hypoparathyroidism
2840,29848235,*parathyroid hormone
2840,29848235,*paresthesia
2840,29848235,*thyroidectomy
2841,28875268,hashimoto’s thyroiditis
2841,28875268,papillary thyroid carcinoma
2841,28875268,tsh
2841,28875268,thyroid cytology
2841,28875268,thyroid nodules
2842,29170092,*adaptive redox homeostasis
2842,29170092,*antioxidant defense
2842,29170092,*argpyrimidine-modified heat-shock proteins
2842,29170092,*ccm1/krit1
2842,29170092,*cerebral cavernous malformations
2842,29170092,*cerebrovascular disease
2842,29170092,*glyoxalase 1 (glo1)
2842,29170092,*heme oxygenase-1 (ho-1)
2842,29170092,*nuclear factor erythroid 2-related factor 2 (nrf2)
2842,29170092,*oxidative dna damage and apoptosis
2842,29170092,*oxidative stress
2842,29170092,*redox signaling
2842,29170092,*c-jun
2844,31619220,calcitonin
2844,31619220,carcinoembryogenic antigen
2844,31619220,medullary thyroid carcinoma
2844,31619220,thyroid cancer cois
2845,31135104,*braf mutation
2845,31135104,*hyalinizing trabecular tumor
2845,31135104,*immunocytochemistry
2845,31135104,*molecular testing
2845,31135104,*personalized medicine
2845,31135104,*thyroid malignancy
2845,31135104,*thyroid nodule
2846,29043574,autoimmunity
2846,29043574,ctla4
2846,29043574,immune checkpoint inhibitors
2846,29043574,melanoma
2846,29043574,pd1
2846,29043574,thyroid diseases
2848,30684524,diagnostic marker
2848,30684524,ptc
2848,30684524,plasma microrna
2848,30684524,qrt-pcr
2849,30509240,braf v600e
2849,30509240,matrix metalloproteinase-9
2849,30509240,"papillary thyroid cancer cois institutional review board and ethics committee of the research institute for endocrine sciences, shahid beheshti university of medical sciences, tehran, iran (25ecries93/10/23); and was conducted in accordance with the declaration of helsinki guidelines a written informed consent was obtained from all participants. consent for publication: not applicable. competing interests: the authors do not report any relevant conflict of interest. publisher’s note: springer nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations."
2850,31784815,comparison between germany and switzerland
2850,31784815,degs1
2850,31784815,iodine
2850,31784815,iodine-containing foods
2850,31784815,iodized salt
2850,31784815,salt
2852,30909759,*statement
2852,30909759,*minimally invasive treatments
2852,30909759,*percutaneous thermal ablation
2852,30909759,*thyroid gland
2852,30909759,*thyroid nodule
2852,30909759,*ultrasonography
2853,31182340,*autoimmunity
2853,31182340,*graves' disease
2853,31182340,*ifnγ
2853,31182340,*immune checkpoints
2853,31182340,*pd-1
2853,31182340,*pd-l1
2853,31182340,*pd-l2
2853,31182340,*t-lymphocytes
2853,31182340,*tolerances
2855,35288841,anaplastic thyroid carcinoma
2855,35288841,cribriform-morular thyroid carcinoma
2855,35288841,follicular nodular disease
2855,35288841,follicular thyroid carcinoma
2855,35288841,high-grade thyroid carcinoma
2855,35288841,hyalinizing trabecular tumor
2855,35288841,medullary thyroid carcinoma
2855,35288841,papillary thyroid carcinoma
2855,35288841,poorly differentiated thyroid carcinoma
2855,35288841,thyroblastoma
2855,35288841,who classification of thyroid tumors
2857,34506000,compression syndrome
2857,34506000,goiter
2857,34506000,ischemic stroke
2857,34506000,thrombosis
2858,34417736,autoimmune
2858,34417736,fibrocyte
2858,34417736,graves’ ophthalmopathy
2858,34417736,insulin-like growth factor receptor
2858,34417736,orbit
2859,35685217,*massive goiter
2859,35685217,*multinodular goiter
2859,35685217,*retrosternal extension
2859,35685217,*sternotomy
2859,35685217,*thyroidectomy cois commercial or financial relationships that could be construed as a potential conflict of interest.
2861,35657195,basedow
2861,35657195,hashimoto
2861,35657195,inflammation
2861,35657195,thyroiditis
2861,35657195,auto
2861,35657195,immunity
2862,34792795,autoimmune/inflammatory syndrome induced by adjuvants (asia)
2862,34792795,covid-19
2862,34792795,graves’ disease
2862,34792795,sars-cov2 vaccination
2862,34792795,thyroiditis cois
2863,34670889,hyperthyroidism
2863,34670889,multinodular goiter
2863,34670889,thyroglobulin
2863,34670889,tracheal compression
2863,34670889,tracheal deviation cois
2864,35538703,giant goiter
2864,35538703,hashimoto’s thyroiditis
2864,35538703,case report
2864,35538703,en bloc excision
2864,35538703,hyperthyroidism
2864,35538703,thyroid
2865,34342859,covid
2865,34342859,graves’ disease
2865,34342859,sars-cov-2 rna vaccination
2865,34342859,thyroid cois employment by an organization that may gain or lose financially from publication of the article. there are also no other competing interests regarding the manuscript.
2867,34915750,*adaptor protein
2867,34915750,*aging
2867,34915750,*cytoskeleton
2867,34915750,*hypothyroidism
2867,34915750,*iodide organification cois
2869,34272677,fine arts
2869,34272677,giovanni martino spanzotti
2869,34272677,goiter
2869,34272677,history
2869,34272677,renaissance
2870,34688699,*long-term
2870,34688699,*proptosis
2870,34688699,*re-treatment
2870,34688699,*teprotumumab
2870,34688699,*thyroid eye disease
2873,34476761,fermo stella
2873,34476761,fine arts
2873,34476761,goiter
2873,34476761,history
2873,34476761,renaissance
2874,35567330,complication
2874,35567330,large intrathoracic goiter
2874,35567330,minimally invasive surgery
2874,35567330,robot-assisted thoracoscopic surgery
2874,35567330,tracheal stenosis cois
2877,35221176,*airway stenosis
2877,35221176,*ecmo
2877,35221176,*nodular goiter cois authors were disclosed.
2879,35469855,bkmr analysis
2879,35469855,ng
2879,35469855,pbdes
2879,35469855,risk factor
2881,35186140,alt – alanine aminotransferase
2881,35186140,ap – alkaline phosphatase
2881,35186140,ast – aspartate aminotransferase
2881,35186140,arttg – antibodies to thyroid-stimulating hormone receptors
2881,35186140,cdld – chronic diffuse liver diseases
2881,35186140,dtg – diffuse toxic goiter
2881,35186140,swv – shear wave velocity
2881,35186140,t3f – free triiodothyronine
2881,35186140,t4f – thyroxine free
2881,35186140,tg – thyroid gland
2881,35186140,tsh – thyroid-stimulating hormone
2881,35186140,diffuse toxic goiter
2881,35186140,shear wave elastography
2881,35186140,ultrasound examination
2882,35331216,micronodular goiter
2882,35331216,papillary thyroid microcarcinoma
2882,35331216,ultrasound grayscale ratio cois
2883,34980104,*iodine
2883,34980104,*nodular goiter
2883,34980104,*perchlorate
2883,34980104,*thyroid cancer
2883,34980104,*thyroid function cois
2884,35436270,diffuse non-toxic goiter
2884,35436270,mathematical model
2884,35436270,risk
2884,35436270,type 2 diabetes mellitus
2885,35390148,benign multinodular goiter
2885,35390148,postoperative morbidity
2885,35390148,total thyroidectomy
2885,35390148,vocal cord palsy
2885,35390148,weight of specimen
2887,34405392,autonomous multinodular goiter
2887,34405392,gene expression
2887,34405392,thyroid nodule cois
2889,33218789,extra-adrenal paraganglioma
2889,33218789,paraganglioma
2889,33218789,subclavian paraganglia
2889,33218789,superior mediastinum
2893,34874796,graves’ ophthalmopathy
2893,34874796,thyroid-associated orbitopathy
2893,34874796,thyroid eye disease
2893,34874796,thyroid ophthalmopathy
2897,34928376,*graves’ disease
2897,34928376,*adolescents
2897,34928376,*children
2897,34928376,*rituximab
2897,34928376,*thionamide
2897,34928376,*thyrotoxicosis
2899,35037871,hypercalcemia
2899,35037871,lithium
2899,35037871,nephrogenic diabetes insipidus
2899,35037871,thyroid disorders
2900,34787691,environment
2900,34787691,genetic codes
2900,34787691,graves’ ophthalmopathy
2900,34787691,human organism
2900,34787691,risk factor
2901,33832185,*congenital goiter
2901,33832185,*hypothyroidism
2901,33832185,*thyroglobulin
2901,33832185,*novel mutation
2901,33832185,*case report
2905,33226264,bactericide
2905,33226264,intestinal microbiota
2905,33226264,iodine
2905,33226264,nutrition
2905,33226264,thyroid diseases
2905,33226264,thyroid hormones
2908,35264385,immunology
2908,35264385,materno-fetal medicine
2908,35264385,neonatal intensive care
2908,35264385,thyrotoxicosis cois
2909,35574000,epidemiology
2909,35574000,evaluation
2909,35574000,graves orbitopathy
2909,35574000,novel therapeutic approach
2909,35574000,pathogenesis cois commercial or financial relationships that could be construed as a potential conflict of interest.
2910,35307540,*covid-19
2910,35307540,*graves' disease
2910,35307540,*hashimoto's thyroiditis
2910,35307540,*thyroid cois
2911,35226548,coronavirus disease 2019
2911,35226548,hyperthyroidism
2911,35226548,hypothyroidism
2911,35226548,non-thyroidal illness
2911,35226548,thyroid
2911,35226548,thyroid cancer
2911,35226548,thyroiditis cois conflict of interest.
2912,35334525,cervicotomy
2912,35334525,intrathoracic goitre
2912,35334525,morbidity
2912,35334525,sternotomy
2912,35334525,thyroid surgery cois
2913,32975863,graves ophthalmopathy
2913,32975863,thyroid eye disease
2915,35167950,*dry eye
2915,35167950,*exposure keratopathy
2915,35167950,*ocular surface disease
2915,35167950,*thyroid eye disease
2918,35226748,*graves disease
2918,35226748,*autoimmune addison disease
2918,35226748,*autoimmune hypothyroidism
2918,35226748,*autoimmune polyendocrine syndromes
2919,33525898,teprotumumab
2919,33525898,compressive optic neuropathy
2919,33525898,dysthyroid optic neuropathy
2919,33525898,graves’ ophthalmopathy
2919,33525898,thyroid eye disease
2920,34334562,emo syndrome
2920,34334562,graves' disease
2920,34334562,musculoskeletal ultrasound
2920,34334562,osteoarthropathy cois
2921,35684009,cancer
2921,35684009,iodine
2921,35684009,iodine deficiency
2921,35684009,iodine supplementation
2921,35684009,prevalence
2921,35684009,thyroid dysfunction cois
2923,35614620,"graves, orbital fibroblasts, autoimmunity."
2924,35230257,graves‘ disease
2924,35230257,iceland
2924,35230257,pediatric
2924,35230257,treatment
2925,35422184,autoimmune eye diseases
2925,35422184,graves’ orbitopathy
2925,35422184,anti-il6-receptor antibodies
2925,35422184,neuromyelitis optica spectrum disorders
2925,35422184,noninfectious uveitis
2925,35422184,optic neuropathy
2925,35422184,peripheral ulcerative keratitis
2925,35422184,tocilizumab
2927,33908335,graves disease
2927,33908335,antithyroid agents
2927,33908335,hemodynamics
2927,33908335,hyperthyroidism
2927,33908335,thyroidectomy
2927,33908335,thyrotropin
2928,35287535,*graves’ disease
2928,35287535,*graves’ orbitopathy
2928,35287535,*k1-70
2928,35287535,*antithyroid drugs
2928,35287535,*hyperthyroidism
2928,35287535,*iscalimab
2928,35287535,*methimazole
2928,35287535,*propylthiouracil
2928,35287535,*radioactive iodine
2928,35287535,*rituximab
2928,35287535,*thyroidectomy
2928,35287535,*thyrotropin receptor
2929,34487995,diplopia
2929,34487995,endoscopic
2929,34487995,eye
2929,34487995,graves'
2929,34487995,oculoplastic
2929,34487995,orbital decompression
2929,34487995,proptosis
2929,34487995,revision
2929,34487995,rhinology
2929,34487995,sinus
2929,34487995,thyroid
2930,33775197,entropion
2930,33775197,eyelid retraction
2930,33775197,orbital decompression
2930,33775197,thyroid eye disease
2930,33775197,ultrasound biomicroscopy
2931,34954838,graves' disease
2931,34954838,head and neck
2931,34954838,hyperthyroidism
2931,34954838,surgery
2933,34663089,*graves'
2933,34663089,*disease
2933,34663089,*patient-reported outcomes
2933,34663089,*quality of life
2933,34663089,*thyroidectomy cois
2934,35534869,*autoimmune thyroid disease
2934,35534869,*human leucocyte antigen
2934,35534869,*relapsing polychondritis cois
2935,35315985,graves' ophthalmopathy
2935,35315985,proptosis
2935,35315985,thiol-disulfide
2936,35658138,parathyroidectomy
2936,35658138,prevention of damage
2936,35658138,recurrent laryngeal nerve
2936,35658138,thyroidectomy
2937,34291428,*art
2937,34291428,*exophthalmos
2937,34291428,*graves’ disease
2937,34291428,*history
2938,33579690,*eye (globe)
2938,33579690,*eye lids
2938,33579690,*immunology
2938,33579690,*orbit
2938,33579690,*pathology cois medical centre has received research-associated funding from horizon therapeutics.
2939,34687316,*graves disease
2939,34687316,*adolescents
2939,34687316,*children
2939,34687316,*rituximab
2939,34687316,*thionamide
2939,34687316,*thyrotoxicosis
2940,35600602,graves’ disease
2940,35600602,central hypothyroidism
2940,35600602,maternal trab
2940,35600602,neonatal hyperthyroidism
2940,35600602,neonates cois commercial or financial relationships that could be construed as a potential conflict of interest.
2942,35379490,hypoparathyroidism
2942,35379490,paediatrics
2942,35379490,postoperative complications
2942,35379490,thyroidectomy
2942,35379490,"vocal cord palsy cois hy chung, and kenneth ky wong have no conflicts of interest or financial ties to disclose."
2945,35015288,adjuvants
2945,35015288,autoimmune syndrome
2945,35015288,graves’ disease
2945,35015288,sars-cov-2 vaccination
2945,35015288,subacute painful thyroiditis
2945,35015288,thyrotoxicosis cois
2946,35381100,graves’ disease
2946,35381100,antithyroid agents
2946,35381100,pericarditis
2946,35381100,pleurisy
2948,35303084,graves’ orbitopathy
2948,35303084,cystine deprivation
2948,35303084,ferroptosis
2948,35303084,glycolysis
2948,35303084,orbital fibroblast
2949,35504153,multinodular goiter
2949,35504153,neck hematoma
2949,35504153,recurrent laryngeal nerve injury
2949,35504153,substernal thyroid goiter
2949,35504153,thyroidectomy
2950,35100622,*covid-19
2950,35100622,*graves’ disease
2950,35100622,*sars-cov-2
2950,35100622,*revaccination
2950,35100622,*subacute thyroiditis
2950,35100622,*vaccine
2951,34996091,*addison disease
2951,34996091,*autoantibodies
2951,34996091,*graves
2951,34996091,*hashimoto thyroiditis
2951,34996091,*disease
2951,34996091,*insulin-dependent diabetes mellitus
2952,35580958,gynecological cancer
2952,35580958,obstetrics and gynaecology cois
2953,32912014,myositis
2953,32912014,whipple’s disease
2953,32912014,orbitopathy
2953,32912014,tropheryma whipplei
2955,35662442,antithyroid drugs
2955,35662442,graves disease
2955,35662442,hyperthyroidism
2955,35662442,radioiodine therapy
2955,35662442,thyroid eye disease
2955,35662442,thyroidectomy cois
2956,35069441,*dna methylation
2956,35069441,*graves’ ophthalmopathy
2956,35069441,*epigenetics
2956,35069441,*gut microbiome
2956,35069441,*histone modification
2956,35069441,*noncoding rnas cois commercial or financial relationships that could be construed as a potential conflict of interest.
2959,35039921,central neck tumour
2959,35039921,hypercalcaemia
2959,35039921,hyperparathyroidism
2959,35039921,parathyroid adenoma
2959,35039921,parathyroid cancer
2959,35039921,parathyroid neoplasms
2960,34515780,graves’ disease
2960,34515780,juvenile dermatomyositis
2960,34515780,anti-melanoma differentiation antigen 5
2960,34515780,soluble interleukin-2 receptor
2961,34250837,choroidal vascularity
2961,34250837,graves’ disease
2961,34250837,binarization
2961,34250837,choroidal thickness
2961,34250837,thyroid
2962,33884704,graves' disease
2962,33884704,tsh receptor antibody
2962,33884704,antithyroid drug
2962,33884704,remission
2963,34642808,dysthyroid optic neuropathy
2963,34642808,graves orbitopathy
2963,34642808,magnetic resonance imaging
2963,34642808,muscle index
2963,34642808,optic neuropathy
2964,35413468,covid-19
2964,35413468,graves' disease
2964,35413468,graves' ophthalmopathy
2964,35413468,sars-cov-2
2964,35413468,vaccine cois personal relationships that could have appeared to influence the work reported in this paper.
2965,35418378,contraindications and precautions
2965,35418378,"ear, nose and throat/otolaryngology"
2965,35418378,eye
2965,35418378,ophthalmology
2965,35418378,thyroid disease cois
2967,35562686,multinodular goitre
2967,35562686,rln trifurcations
2967,35562686,recurrent laryngeal nerve variations
2967,35562686,thyroidectomy cois
2969,35504602,*graves disease
2969,35504602,*hashimoto disease
2969,35504602,*immunoglobulin g4
2969,35504602,*riedel thyroiditis
2969,35504602,*thyroid diseases cois was reported.
2971,35168232,benign intracranial hypertension
2971,35168232,child
2971,35168232,graves’ disease
2971,35168232,idiopathic intracranial hypertension
2971,35168232,pseudotumor cerebri
2972,34365588,asthenia
2972,34365588,parathyroidectomy
2972,34365588,quality of life
2972,34365588,thyroidectomy
2975,34895729,*graves hyperthyroidism
2975,34895729,*endocrine ophthalmopathy
2975,34895729,*orbital irradiation
2975,34895729,*radiotherapy
2975,34895729,*thyroid eye disease
2975,34895729,*thyroid-associated orbitopathy
2976,35119087,18f-fch pet/ct
2976,35119087,fluorocholine
2976,35119087,hyperparathyroidism
2976,35119087,parathyroid imaging
2977,35651979,*graves’ disease (gd)
2977,35651979,*autoimmune disease (aid)
2977,35651979,*autoimmune thyroid disease (aitd)
2977,35651979,*inactivated sars-cov-2 vaccine
2977,35651979,*thyrotropin receptor antibody (trab) cois commercial or financial relationships that could be construed as a potential conflict of interest.
2978,35627231,graves’ disease
2978,35627231,x chromosome
2978,35627231,covariates
2978,35627231,logistic regression
2978,35627231,robust cois
2979,35403994,*amyloid encephalopathy
2979,35403994,*graves’ orbitopathy
2979,35403994,*hearing loss
2979,35403994,*inflammatory bowel disease
2979,35403994,*teprotumumab
2979,35403994,*thyroid-eye disease
2981,35734176,*graves’ disease
2981,35734176,*auto-immune thyroiditis
2981,35734176,*kidney biopsy
2981,35734176,*membranous nephropathy
2981,35734176,*renal pathology cois commercial or financial relationships that could be construed as a potential conflict of interest.
2982,35320248,"graves, thyroid associated orbitopathy, immunomodulation"
2983,35112273,*atrial fibrillation
2983,35112273,*hypothyroidism
2983,35112273,*subclinical thyroid disease
2983,35112273,*thyroid disease
2984,35548945,graves disease
2984,35548945,hyperthyroidism
2984,35548945,newborn
2984,35548945,pregnancy
2984,35548945,thyroid-stimulating hormone receptor antibodies
2985,35615845,clinical activity score; intraocular pressure; orbitopathy; thyroid dysfunction.
2986,35707463,graves orbitopathy
2986,35707463,adipogenesis
2986,35707463,fibroblasts
2986,35707463,fibrosis
2986,35707463,inflammation
2986,35707463,periostin cois commercial or financial relationships that could be construed as a potential conflict of interest.
2987,35331947,decompression
2987,35331947,endonasal
2987,35331947,endoscopic
2987,35331947,nonthyroid
2987,35331947,orbital
2992,34752624,*graves disease
2992,34752624,*amygdala
2992,34752624,*cognition
2992,34752624,*depression
2992,34752624,*hippocampus
2992,34752624,*longitudinal
2993,35022743,*graves disease
2993,35022743,*pittsburgh sleep quality index
2993,35022743,*hyperthyroidism
2993,35022743,*subjective sleep disorders
2993,35022743,*sympathetic tone
2994,35606042,endocrine cancer
2994,35606042,hyperthyroidism
2994,35606042,thyroid disease
2994,35606042,thyrotoxicosis cois
2995,32017356,*iodine deficiency
2995,32017356,*nepal
2995,32017356,*micronutrients
2995,32017356,"*salt iodization cois unicef, support the government of nepal's effort toward universal salt iodization but have no conflict of interest in developing this summary. the opinions and statements in this article are those of the authors and may not reflect official unicef policies. kedar parajuli, in his capacity working for government of nepal to prevent and control iodine deficiency in nepal, has no conflict of interest in developing this summary. robin houston, chandra pandav, macha raja maharjan, and jonathan gorstein have all both undertaken consultancies with various agencies working in nepal on nutrition issues, including in support of the usi program, but have no conflict of interest related to this paper."
2997,35614367,compressive optic neuropathy (con)
2997,35614367,diplopia
2997,35614367,dysthyroid optic neuropathy (don)
2997,35614367,graves ophthalmopathy (go)
2997,35614367,teprotumumab
2997,35614367,thyroid eye disease (ted)
2998,33865565,graves’ disease
2998,33865565,iodine therapy
2998,33865565,meta-analysis
2998,33865565,radioactive iodine
2998,33865565,thyroid diseases
2999,35182078,c-reactive protein
2999,35182078,graves' disease
2999,35182078,hashimoto's thyroiditis
2999,35182078,interleukin-39
2999,35182078,white blood cell cois
3000,34347269,*antiquity
3000,34347269,*endocrinology
3000,34347269,*etruscan
3000,34347269,*goitre
3000,34347269,*palaeopathology
3000,34347269,*thyroid
3001,33910662,*copper deficiency
3001,33910662,*hematological disease
3001,33910662,*mri
3001,33910662,*myeloneuropathy
3002,34487739,*graves’ orbitopathy
3002,34487739,*thyroid eye disease
3002,34487739,*fibroblast
3002,34487739,*insulin-like growth factor 1 receptor
3002,34487739,*microrna
3002,34487739,*orbital fibroblast
3002,34487739,*teprotumumab
3002,34487739,"*therapeutics, targeted therapy cois"
3003,33059514,epiblepharon
3003,33059514,singapore
3003,33059514,graves’ ophthalmopathy
3003,33059514,pediatric
3003,33059514,thyroid eye disease
3004,35432203,*22q11.2 deletion syndrome
3004,35432203,*digeorge syndrome
3004,35432203,*growth disorders
3004,35432203,*hypoparathyroidism
3004,35432203,*thyroid disorders cois commercial or financial relationships that could be construed as a potential conflict of interest.
3006,35628410,smad
3006,35628410,tgfβ
3006,35628410,adipogenesis
3006,35628410,hpmscs
3006,35628410,thyroid disease
3006,35628410,thyroid-associated ophthalmopathy cois
3007,35528009,hashimoto thyroiditis
3007,35528009,anti-parietal cell antibodies
3007,35528009,gastric malignancies
3007,35528009,organ-specific autoimmunity
3007,35528009,systemic autoimmunity cois commercial or financial relationships that could be construed as a potential conflict of interest.
3009,33172865,*anatomy
3009,33172865,*orbit
3009,33172865,"*treatment medical cois ak—employer, horizon therapeutics."
3010,34970859,*graves' disease
3010,34970859,*metabolomics
3010,34970859,*myopathy
3010,34970859,*senescence
3010,34970859,*t cells cois
3011,34920294,cyclind1
3011,34920294,d2–40
3011,34920294,follicular neoplasm
3011,34920294,multinodular goiter with dominant nodules
3011,34920294,oncocytic cell tumors
3011,34920294,poorly differentiated thyroid carcinoma
3013,35489725,gapdh
3013,35489725,papillary thyroid carcinoma
3013,35489725,cfdna integrity index
3013,35489725,circulating cell-free dna
3013,35489725,β-actin
3015,35675824,graves’ disease
3015,35675824,hashimoto’s thyroiditis
3015,35675824,autoimmune thyroid disease
3015,35675824,gut microbiota
3016,34374618,graves’ hyperthyroidism
3016,34374618,anti-ttg
3016,34374618,celiac disease
3016,34374618,false-positivity
3019,32965148,graves’s orbitopathy
3019,32965148,tocilizumab
3019,32965148,outcome
3019,32965148,rituximab
3021,34782167,*nodular goiter
3021,34782167,*operated recurrent goiter
3021,34782167,*shear-wave velocity
3021,34782167,*thyroid sonoelastography cois
3023,35108585,"*botox-a (btx-a, botulinum toxin type a)"
3023,35108585,*orbital fibroblast
3023,35108585,*tgf-β/smad signaling
3023,35108585,*thyroid-associated ophthalmopathy (tao)
3024,35672057,"ear, nose and throat/otolaryngology"
3024,35672057,oncology
3024,35672057,thyroid disease cois
3025,35459655,cardiothoracic surgery
3025,35459655,surgical oncology
3025,35459655,thyroid disease cois
3027,35338690,*childhood cancer survivors
3027,35338690,*head and neck radiation
3027,35338690,*hypoparathyroidism
3027,35338690,*pediatric thyroidectomy
3027,35338690,*recurrent laryngeal nerve paralysis
3028,34193409,experimental and laboratory
3028,34193409,orbit cois
3029,34799942,c-reactive protein
3029,34799942,graves’ disease
3029,34799942,hashimoto's thyroiditis
3029,34799942,autoimmune thyroid disease
3029,34799942,interleukin-38 cois
3030,34933777,b cell subsets
3030,34933777,cd32b
3030,34933777,graves’ disease
3030,34933777,inhibitory receptors cois competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
3031,34291345,diplopia
3031,34291345,exophthalmos
3031,34291345,graves’ orbitopathy
3031,34291345,orbital decompression
3031,34291345,surgical outcome cois paper and did not receive any financial support toward the completion of this work.
3032,35018816,*italy
3032,35018816,*age-standardized rates
3032,35018816,*thyroid surgery
3032,35018816,*thyroidectomies
3032,35018816,*time trends
3033,35522861,autoimmune thyroiditis
3033,35522861,ctla
3033,35522861,graves’ disease
3033,35522861,hashimoto’s thyroiditis (ht)
3033,35522861,il-17
3033,35522861,il-23
3035,35235663,*graves’ disease
3035,35235663,*sars-cov-2 vaccine
3035,35235663,*hyperthyroidism
3036,35145479,*b lymphocytes
3036,35145479,*graves’ disease
3036,35145479,*graves’ orbitopathy
3036,35145479,*rituximab
3036,35145479,*tsh-receptor antibodies cois commercial or financial relationships that could be construed as a potential conflict of interest.
3037,35135806,general surgery
3037,35135806,head and neck surgery
3037,35135806,otolaryngology / ent
3037,35135806,thyroid disease
3037,35135806,thyrotoxicosis cois
3038,35024887,computed tomography
3038,35024887,correlations
3038,35024887,itmig classification
3038,35024887,lymphadenopathy
3038,35024887,thoracic radiography
3040,35381687,*antithyroid agents
3040,35381687,*epidemiology
3040,35381687,*graves disease
3040,35381687,"*kidney failure, chronic cois was reported."
3041,32878536,ct imaging
3041,32878536,extraocular muscle
3041,32878536,fatty infiltration
3041,32878536,thyroid eye disease
3042,35624535,graves’ disease
3042,35624535,hyperthyroidism
3042,35624535,hypercalcemia
3042,35624535,liver damage
3042,35624535,palpitation
3042,35624535,vomiting cois non-financial interests to disclose.
3043,35273577,*il-11
3043,35273577,*clinical activity score
3043,35273577,*fibrosis
3043,35273577,*orbital fibroblast
3043,35273577,*thyroid-associated ophthalmopathy cois commercial or financial relationships that could be construed as a potential conflict of interest.
3044,34788857,*m22 (a monoclonal tsab)
3044,34788857,*tsh receptor (tshr)
3044,34788857,*tshr stimulating antibody (tsab)
3044,34788857,*crosstalk
3044,34788857,*insulin-like growth factor receptor 1 (igf1r)
3044,34788857,*teprotumumab
3044,34788857,*thyroid eye disease (ted)
3045,34324163,autoimmune thyroid diseases
3045,34324163,bioassay
3045,34324163,disease
3045,34324163,functional thyrotropin receptor antibodies
3045,34324163,graves
3045,34324163,orbitopathy
3045,34324163,stimulatory antibodies
3046,35429598,autoimmune thyroid diseases
3046,35429598,high-throughput sequencing
3046,35429598,immune repertoires
3046,35429598,t cells receptor
3048,35663306,erk
3048,35663306,graves’ ophthalmopathy
3048,35663306,stat3
3048,35663306,dihydroartemisinin
3048,35663306,fibrosis
3048,35663306,inflammation
3048,35663306,orbital fibroblast cois commercial or financial relationships that could be construed as a potential conflict of interest.
3049,35018442,*individual participant data
3049,35018442,*meta-analysis
3049,35018442,*muscle strength
3049,35018442,*quality of life
3049,35018442,*vitamin d
3050,35119800,drug reaction with eosinophilia and systemic symptoms (dress)
3050,35119800,severe cutaneous adverse drug reactions (scars)
3050,35119800,thyroid dysfunction
3050,35119800,thyroiditis
3051,35610583,bayesian method
3051,35610583,graves’ disease data
3051,35610583,minnesota center for twin and family research data
3051,35610583,penalized fieller’s method
3051,35610583,skewed x chromosome inactivation cois
3052,35184917,*decompression surgery
3052,35184917,*endocrine orbitopathy
3052,35184917,*fully digital analysis
3052,35184917,*navigated surgery
3053,35244288,99mtechnetium uptake
3053,35244288,grave's disease
3053,35244288,trab
3053,35244288,nonuniform uptake
3054,35066781,*blood markers
3054,35066781,*clinical biomarkers
3054,35066781,*graves’ ophthalmopathy
3054,35066781,*orbital imaging
3054,35066781,*tear cytokines
3055,35220164,*autoimmune thyroid diseases
3055,35220164,*graves' disease
3055,35220164,*hyperthyroidism
3055,35220164,*inactivated covid-19 vaccine
3055,35220164,*sars-cov-2
3055,35220164,*mrna vaccine cois
3056,35563653,graves’ orbitopathy
3056,35563653,disulfiram
3056,35563653,fibrosis
3056,35563653,myofibroblasts
3056,35563653,perimysial orbital fibroblasts cois
3057,35307774,dicer1
3057,35307774,multinodular goiter
3057,35307774,pediatric poorly differentiated thyroid carcinoma
3057,35307774,thyroblastoma cois
3058,35088381,antithyroid drug
3058,35088381,graves’ disease
3058,35088381,long-term
3058,35088381,methimazole
3058,35088381,remission
3058,35088381,thionamides
3059,35295987,*cancer diagnosis
3059,35295987,*cancer risk
3059,35295987,*familial non-medullary thyroid carcinoma
3059,35295987,*familial thyroid cancer
3059,35295987,*papillary thyroid carcinoma
3059,35295987,*susceptibility genes cois commercial or financial relationships that could be construed as a potential conflict of interest.
3060,35398834,dysthyroid optic neuropathy
3060,35398834,fat decompression
3060,35398834,grave’s disease
3060,35398834,orbital decompression
3060,35398834,thyroid eye disease
3061,34861792,*graves' disease
3061,34861792,*mica
3061,34861792,*mendelian randomization
3061,34861792,*nkg2d
3061,34861792,*community-based cohort
3061,34861792,*phenome-wide association
3062,35189399,*cd4(+) t cells
3062,35189399,*graves’ disease (gd)
3062,35189399,*immune
3062,35189399,*regulatory t cells
3062,35189399,*t helper cells 17
3063,35241008,*adpkd
3063,35241008,*polycystic kidney disease
3063,35241008,*thyroid nodules
3063,35241008,*ultrasonography cois commercial or financial relationships that could be construed as a potential conflict of interest.
3064,35615718,graves’ disease
3064,35615718,graves’ orbitopathy
3064,35615718,antithymocyte globulin
3064,35615718,proptosis
3064,35615718,thyroid eye disease cois commercial or financial relationships that could be construed as a potential conflict of interest.
3065,35300630,intraocular pressure
3065,35300630,strabismus
3065,35300630,surgery
3065,35300630,thyroid eye disease cois
3066,34549377,extra-cellular volume fraction
3066,34549377,extraocular muscle
3066,34549377,fibrosis
3066,34549377,t1 mapping
3066,34549377,thyroid-associated ophthalmopathy
3068,34532987,graves’ eye disease
3068,34532987,graves’ ophthalmopathy
3068,34532987,graves’ orbitopathy
3068,34532987,diplopia
3068,34532987,outcomes
3068,34532987,strabismus surgery
3068,34532987,thyroid eye disease
3068,34532987,topical anaesthesia
3069,35565939,graves’ disease
3069,35565939,antithyroid drugs
3069,35565939,neonate
3069,35565939,thyroid volume
3069,35565939,ultrasound cois
3070,34988642,benign goitre
3070,34988642,quality of life
3070,34988642,thypro 39 questionnaire
3070,34988642,thyroidectomy
3071,35508893,graves' disease
3071,35508893,dosimetry
3071,35508893,hyperthyroidism
3071,35508893,multinodular goitre
3071,35508893,radioiodine
3071,35508893,theranostics
3071,35508893,toxic adenoma
3072,33103521,graves’ disease
3072,33103521,hashimoto’s thyroiditis
3072,33103521,autoimmune thyroid diseases
3072,33103521,polymorphism
3072,33103521,protein tyrosine phosphatase nonreceptor 22
3073,34850456,autoimmune thyroid disease
3073,34850456,interference
3073,34850456,nonthyroid autoimmune diseases
3073,34850456,thyroid hormone autoantibody
3075,34347224,blepharoptosis
3075,34347224,graves' disease
3075,34347224,myasthenic ptosis
3075,34347224,myogenic ptosis
3075,34347224,thyroid eye disease
3076,33390059,exophthalmos
3076,33390059,eyelid retraction
3076,33390059,orbital decompression
3076,33390059,thyroid-associated orbitopathy
3076,33390059,vertical diplopia
3077,34871593,*autoimmune thyroid disease
3077,34871593,*homogeneous camp biosensor
3077,34871593,*thyroid blocking immunoglobulins or antibodies
3077,34871593,*thyroid stimulating immunoglobulins or antibodies
3077,34871593,*thyroid-stimulating hormone receptor
3078,35386700,*cd11c+ b cells
3078,35386700,*cxcr3-cxcl10
3078,35386700,*graves’ disease
3078,35386700,*trab
3078,35386700,*cytokines cois commercial or financial relationships that could be construed as a potential conflict of interest.
3080,34605662,*graves'
3080,34605662,*adipogenesis
3080,34605662,*antifibrotic
3080,34605662,*disulfiram
3080,34605662,*orbital fibroblast
3080,34605662,*orbitopathy
3082,34773561,clinical features
3082,34773561,cytokines
3082,34773561,graves’ disease
3082,34773561,igg4-related diseases
3082,34773561,serum igg4
3084,34928110,pediatric age.
3084,34928110,thyroid cancer
3084,34928110,grave's disease
3085,34877883,*go-qol
3085,34877883,*graves' orbitopathy
3085,34877883,*decompression
3085,34877883,*lid
3085,34877883,*quality of life
3085,34877883,*strabismus surgery
3085,34877883,*systematic review
3086,35458147,sarawak
3086,35458147,usi
3086,35458147,goitre
3086,35458147,school children
3086,35458147,urinary iodine concentration cois
3090,35405683,inflammatory myofibroblastic tumor
3090,35405683,surgery
3090,35405683,thyroid cancer
3090,35405683,ultrasonic examination
3091,35459658,endocrine system
3091,35459658,hyperthyroidism
3091,35459658,thyroid disease cois
3094,35402292,*16 rrna gene sequencing
3094,35402292,*graves’ disease
3094,35402292,*th17 & treg axis
3094,35402292,*intestinal flora
3094,35402292,*short chain fatty acids cois commercial or financial relationships that could be construed as a potential conflict of interest.
3096,35187713,elisa
3096,35187713,graves’ disease
3096,35187713,tsh-receptor antibody
3096,35187713,diagnostic performance
3096,35187713,dot blot assay cois
3097,34778997,*hirata disease
3097,34778997,*human leukocyte antigen
3097,34778997,*hyperinsulinaemic hypoglycaemia
3097,34778997,*insulin autoantibody
3097,34778997,*insulin autoimmune syndrome
3097,34778997,*sulfhydryl group
3098,35713042,"multinodular goitre, complications of total thyroidectomy, surgeons' experience  in thyroid surgery."
3100,35220890,graves’ disease
3100,35220890,nrcam
3100,35220890,th1 cells
3100,35220890,lncrna runx1-it1 cois
3101,34489313,*cardiomyopathies
3101,34489313,*diastolic
3101,34489313,*heart failure
3101,34489313,*systolic cois
3102,34060342,graves’ disease
3102,34060342,hematoma
3102,34060342,hypocalcemia
3102,34060342,recurrent laryngeal nerve injury
3102,34060342,"thyroidectomy cois conflicts of interest with respect to the research, authorship, and/or publication of this article."
3103,35064543,bone mineral density
3103,35064543,graves’ disease
3103,35064543,muscle mass
3103,35064543,thyroid hormone
3104,33637620,experimental – laboratory
3104,33637620,inflammation
3104,33637620,"orbit cois coinvestigator on a study funded by genentech to evaluate the use of rituximab for orbital inflammatory diseases. jtr, rad, bsk, dok, and gjh are consultants to horizon pharmaceuticals which manufactures teprotumumab. jtr receives research support from horizon pharmaceuticals."
3105,35569928,graves' disease
3105,35569928,coronavirus disease 2019
3105,35569928,type 1 diabetes
3105,35569928,vaccination
3107,35568525,*puberty
3107,35568525,*fetal programming
3107,35568525,*goiter
3107,35568525,*hyperthyroidism
3107,35568525,*hypothyroidism
3110,34545512,collagen1
3110,34545512,fibrocytes
3110,34545512,graves orbitopathy
3110,34545512,tshr
3110,34545512,peripheral blood mononuclear cells
3111,34671950,b cells
3111,34671950,graves' ophthalmopathy
3111,34671950,graves' orbitopathy
3111,34671950,lymphocytes
3111,34671950,plasmacells
3111,34671950,t-cells
3111,34671950,thyroid eye disease
3113,35439657,dysthyroid optic neuropathy
3113,35439657,graves' disease
3113,35439657,orbital decompression surgery
3113,35439657,orbital surgery
3113,35439657,visual acuity
3115,34613563,graves’ orbitopathy
3115,34613563,immunoassay
3115,34613563,thyroid stimulating immunoglobulin
3115,34613563,thyroid-associated orbitopathy
3116,34714163,*graves' disease
3116,34714163,*trab assay
3116,34714163,*thyroid autoimmunity-clinical
3116,34714163,*thyroid eye disease
3116,34714163,*thyroid stimulating immunoglobulins
3117,34927457,*graves' orbitopathy
3117,34927457,*igf-1r
3117,34927457,*tshr antibody
3117,34927457,*teprotumumab cois
3118,35320246,"sub acute thyroiditis, nuclear scan, pyrexia of unknown origin, thyroid  antibodies."
3121,34544941,graves’ disease
3121,34544941,graves’ ophthalmopathy
3121,34544941,hyperthyroidism
3121,34544941,internal ophthalmoplegia
3121,34544941,tonic pupil
3123,34781042,graves ophthalmopathy
3123,34781042,diabetes
3123,34781042,extraocular muscles
3123,34781042,optic neuropathy
3123,34781042,severity
3123,34781042,thyroid eye disease
3124,35278055,abuja
3124,35278055,goitres
3124,35278055,management outcome
3124,35278055,pattern cois
3125,35555881,fat-suppression
3125,35555881,intravenous glucocorticoid therapy
3125,35555881,magnetic resonance imaging
3125,35555881,t2 mapping
3125,35555881,thyroid-associated ophthalmopathy
3125,35555881,treatment response cois
3126,34241830,autoimmunity
3126,34241830,goiter
3126,34241830,lupus
3126,34241830,malar
3126,34241830,pregnancy
3126,34241830,rash
3126,34241830,sle
3126,34241830,thyroid cois
3128,35698219,case report
3128,35698219,graves' disease
3128,35698219,guillain-barré syndrome
3128,35698219,hashimoto's disease
3128,35698219,transition cois
3130,35082799,*graves’ disease
3130,35082799,*berberine
3130,35082799,*methimazole
3130,35082799,*microbiome
3130,35082799,*prebiotics cois commercial or financial relationships that could be construed as a potential conflict of interest.
3131,35396078,ethanol
3131,35396078,radiofrequency
3131,35396078,thermal ablation
3131,35396078,thyroid cancer
3131,35396078,thyroid nodule
3133,34714162,*graves' disease
3133,34714162,*graves' orbitopathy
3133,34714162,*orbital cell stimulation
3133,34714162,*thyroid stimulation
3133,34714162,"*thyrotropin receptor stimulatory autoantibodies cois germany, has received research-associated funding from the jgu medical faculty, advancecor (germany), apitope (united kingdom), berlin-chemie (germany), byondis (the netherlands), horizon therapeutics (usa), immunovant (usa), isar (germany), mediomics (usa), merck (germany), novartis (usa), quidel (usa), river vision (usa), and roche (switzerland). g.j.k. consults for glycoera (switzerland), immunovant, mediomics, merck, novartis, roivant (usa), quidel, and vasaragen (usa)."
3135,34743487,*eyelids
3135,34743487,*inflammation
3135,34743487,*orbit
3135,34743487,*selenium cois was reported.
3136,35592782,*diffusion tensor imaging
3136,35592782,*dysthyroid optic neuropathy
3136,35592782,*magnetic resonance imaging
3136,35592782,*optic nerve
3136,35592782,*thyroid-associated ophthalmopathy cois commercial or financial relationships that could be construed as a potential conflict of interest.
3137,35413779,*blood flow velocity
3137,35413779,*graves disease
3137,35413779,"*receptors, thyrotropin"
3137,35413779,*thyroiditis
3137,35413779,*thyrotoxicosis
3137,35413779,"*ultrasonography, doppler, color cois samsung medison co., ltd. (seoul, korea). the sponsor had no role in the writing of the manuscript or in the decision to submit the manuscript for publication."
3138,35144579,extraocular muscles
3138,35144579,graves’ disease
3138,35144579,lacrimal gland
3138,35144579,magnetic resonance imaging
3138,35144579,prolapse
3138,35144579,proptosis
3138,35144579,thyroid-associated ophthalmopathy cois
3139,34330200,dry eye
3139,34330200,graves’ ophthalmopathy
3139,34330200,meibography
3139,34330200,meibomian glands
3139,34330200,ocular surface
3140,34774300,*drinking water
3140,34774300,*goiter
3140,34774300,*nitrate
3140,34774300,*perchlorate
3140,34774300,*sodium iodide symporter
3140,34774300,*thiocyanate
3141,34637060,dysthyroid optic neuropathy
3141,34637060,octa
3141,34637060,peripapillary vessel density
3141,34637060,retinal nerve fiber layer thickness
3141,34637060,thyroid-associated ophthalmopathy cois
3142,35405579,clinical activity score prediction
3142,35405579,disease activity differentiation
3142,35405579,magnetic resonance imaging
3142,35405579,magnetization transfer
3142,35405579,thyroid-associated ophthalmopathy
3143,35235144,angptl3
3143,35235144,graves’ disease
3143,35235144,hdl subfractions
3143,35235144,hyperthyroidsim
3143,35235144,hypothyroidism
3143,35235144,pre-β1 hdl
3144,34979862,central choroidal thickness
3144,34979862,choroidal vascularity index
3144,34979862,clinical activity score
3144,34979862,non-inflammatory active ted
3144,34979862,thyroid eye disease
3145,35370997,*graves’ disease (gd)
3145,35370997,*hashimoto’s thyroiditis (ht)
3145,35370997,*n-glycosylation
3145,35370997,*immunoglobulin g (igg)
3145,35370997,*immunosuppressive therapy
3145,35370997,*ultraperformance liquid chromatography  cois commercial or financial relationships that could be construed as a potential conflict of interest.
3150,34645767,autoimmune polyglandular syndrome
3150,34645767,superior mesenteric artery syndrome
3150,34645767,type 1 diabetes
3151,35094312,*antithyroid drugs
3151,35094312,*efficacy
3151,35094312,*graves
3151,35094312,*hyperthyroidism
3151,35094312,*therapeutic plasma exchange
3153,34536118,medial orbital wall decompression
3153,34536118,medial rectus muscle expansion
3153,34536118,medial rectus muscle misalignment
3153,34536118,periosteal flap
3153,34536118,thyroid eye disease
3155,34822305,atf4
3155,34822305,pct
3155,34822305,ret mutation
3155,34822305,cancer médullaire de la thyroïde
3155,34822305,medullary thyroid carcinoma
3155,34822305,mutation de ret
3155,34822305,recurrence
3155,34822305,récidive
3155,34822305,survie
3155,34822305,survival
3157,35069439,*graves’ disease
3157,35069439,*autoimmune thyroid disease
3157,35069439,*hyperthyroidism
3157,35069439,*pulmonary hypertension
3157,35069439,*thyroid hormone cois commercial or financial relationships that could be construed as a potential conflict of interest.
3158,35061094,mibi
3158,35061094,parathyroidectomy
3158,35061094,primary hyperparathyroidism
3158,35061094,surgery
3158,35061094,thyroid nodule cois
3159,35429846,graves' disease
3159,35429846,incidentally discovered
3159,35429846,medullary thyroid carcinoma
3159,35429846,thyroid
3160,35619700,*cd40
3160,35619700,*pd-l1
3160,35619700,*t cell
3160,35619700,*orbital fibroblast
3160,35619700,*thyroid associated ophthalmopathy cois commercial or financial relationships that could be construed as a potential conflict of interest.
3161,34779257,*graves'
3161,34779257,*autoimmunity
3161,34779257,*disease
3161,34779257,*orbitopathy
3161,34779257,*preclinical mouse model
3162,35265076,*akt/nfκb signaling pathway
3162,35265076,*graves ophthalmopathy
3162,35265076,*glucocorticoid sensitivity
3162,35265076,*mir-885-3p
3162,35265076,*plasma exosomes cois commercial or financial relationships that could be construed as a potential conflict of interest.
3163,35321340,*graves’ disease (gd)
3163,35321340,*electronic medical record (emr)
3163,35321340,*genome-wide association study (gwas)
3163,35321340,*human leukocyte antigen (hla)
3163,35321340,*phenome-wide association studies (phewas) cois commercial or financial relationships that could be construed as a potential conflict of interest.
3166,35667695,"*ear, nose and throat"
3166,35667695,*genetics
3166,35667695,*thyroid disease cois
3169,33198545,octa
3169,33198545,ted
3169,33198545,thyroid eye disease
3169,33198545,optical coherence tomography angiography
3169,33198545,retinal vascularity
3170,34859391,anti-tg
3170,34859391,anti-tpo
3170,34859391,ctla-4
3170,34859391,graves´ disease
3170,34859391,radioiodine
3170,34859391,trab cois
3171,35489145,biomedical informatics
3171,35489145,computer-aided diagnosis (cad)
3171,35489145,convolutional neural network (cnn)
3171,35489145,deep learning
3171,35489145,multi-class classification
3171,35489145,thyroid disease diagnosis
3173,34477926,computed tomography
3173,34477926,extraocular muscles
3173,34477926,graves’ orbitopathy
3173,34477926,quantitative analysis
3173,34477926,thyroid eye disease
3177,34544076,16s ribosomal rna
3177,34544076,25(oh)d
3177,34544076,graves’ disease
3177,34544076,il-17
3177,34544076,intestinal flora
3178,34851466,bell’s phenomenon
3178,34851466,graves
3178,34851466,ophthalmopathy
3178,34851466,orbital wall decompression
3178,34851466,thyroid-associated ophthalmopathy
3179,35720300,graves’ disease
3179,35720300,hashimoto’s thyroiditis
3179,35720300,cell communication
3179,35720300,immune dysregulation
3179,35720300,thyroid tissue cois commercial or financial relationships that could be construed as a potential conflict of interest.
3181,35721705,*graves’ disease
3181,35721705,*biomedical modeling
3181,35721705,*computer-aided treatment
3181,35721705,*hyperthyroidism
3181,35721705,*mathematical thyroid model cois commercial or financial relationships that could be construed as a potential conflict of interest.
3183,35698208,biomechanical simulation
3183,35698208,computer tomography data
3183,35698208,decompression surgery
3183,35698208,endocrine orbitopathy cois
3184,35413827,antithyroid drug
3184,35413827,maternal subtotal thyroidectomy
3184,35413827,neonatal hyperthyroidism
3184,35413827,thyroid function
3184,35413827,thyroid-stimulating hormone receptor antibody cois
3185,35088429,graves' disease
3185,35088429,graves' ophthalmopathy
3185,35088429,autoimmune diseases
3185,35088429,hyperthyroidism
3185,35088429,thyroid diseases
3187,35229626,*graves' disease
3187,35229626,*autoimmune thyroid disease
3187,35229626,*primary thyroid lymphoma
3188,34468829,octa
3188,34468829,pulse therapy
3188,34468829,thyroid-associated orbitopathy cois
3191,35566351,graves orbitopathy (go)
3191,35566351,alternative tobacco products
3191,35566351,cigarette smoke extract
3191,35566351,real time cell electronic sensing (rt ces)
3191,35566351,retrobulbar fibroblast cois
3192,33913798,graves’ disease
3192,33913798,medullary thyroid carcinoma
3192,33913798,carcinogenesis
3192,33913798,endothelin
3193,34580763,dicer1
3193,34580763,papillary thyroid carcinoma
3193,34580763,poorly differentiated thyroid carcinoma
3193,34580763,thyroid carcinoma
3194,35370990,*graves’ disease
3194,35370990,*iodine radioisotopes
3194,35370990,*radiopharmaceuticals
3194,35370990,*subclinical thyrotoxicosis
3194,35370990,*toxic multinodular goitre
3194,35370990,*toxic nodule
3194,35370990,*treatment outcome cois commercial or financial relationships that could be construed as a potential conflict of interest.
3196,35145480,*lymph node metastasis
3196,35145480,*papillary thyroid carcinoma
3196,35145480,*postoperative radioactive iodine
3196,35145480,*treatment strategy
3196,35145480,*tumor location cois commercial or financial relationships that could be construed as a potential conflict of interest.
3197,35465762,*goiter
3197,35465762,*thyroid
3197,35465762,*thyroid nodule
3197,35465762,*thyroiditis
3197,35465762,"*ultrasound cois conflicts of interest with respect to the research, authorship, and/or publication of this article."
3199,35538553,intraocular pressure
3199,35538553,lateral gaze
3199,35538553,primary gaze
3199,35538553,teprotumumab
3199,35538553,thyroid eye disease
3199,35538553,upgaze cois
3200,35144533,case report
3200,35144533,glucocorticoids
3200,35144533,graves’ disease
3200,35144533,hepatitis b virus
3200,35144533,methimazole cois
3201,33443352,*activating variant of tshr gene
3201,33443352,*non-autoimmune hyperthyroidism
3201,33443352,*neonatal hyperthyroidism
3203,35441746,benign thyroid nodule
3203,35441746,papillary thyroid carcinoma
3203,35441746,platelet count
3203,35441746,platelet distribution width
3203,35441746,thyroglobulin cois
3204,34854944,*fibrous dysplasia
3204,34854944,*gnas
3204,34854944,*intramuscular myxoma
3204,34854944,*mazabraud’s syndrome
3204,34854944,*mccune-albright syndrome
3205,35579208,aneurysmal bone cyst
3205,35579208,graves’ disease
3205,35579208,moyamoya disease
3205,35579208,case report
3205,35579208,ischemic cerebral infarction
3205,35579208,proximal femur cois conflict of interest.
3206,35443720,case report
3206,35443720,germ cell tumor
3206,35443720,human chorionic gonadotropin
3206,35443720,hyperthyroidism
3206,35443720,paraneoplastic syndrome cois
3207,35091101,graves' disease
3207,35091101,trab
3207,35091101,bioassay
3207,35091101,diagnosis
3207,35091101,thyroid-stimulating immunoglobulin
3207,35091101,thyrotoxicosis
3208,35090420,acute transient thyroid swelling
3208,35090420,adenomatous goiter
3208,35090420,airway obstruction
3208,35090420,aortic regurgitation
3208,35090420,fine-needle aspiration
3208,35090420,nodular goiter
3208,35090420,thyroid gland
3208,35090420,tracheal intubation cois
3211,35562642,machine learning
3211,35562642,mass spectrometry imaging
3211,35562642,papillary thyroid carcinoma
3211,35562642,probe electrospray ionization mass
3211,35562642,rapid diagnosis
3212,35659565,acute inflammation
3212,35659565,fucoidan
3212,35659565,neutrophil adhesion
3212,35659565,p-selectin
3212,35659565,sargassum fusiforme
3213,35734334,compressive goitre
3213,35734334,case report
3213,35734334,dyspnea
3213,35734334,thyroidectomy cois
3214,34751793,laser therapy
3214,34751793,nodular goiter
3214,34751793,radiofrequency ablation
3214,34751793,thyroid nodule
3215,35039349,immunological products and vaccines
3215,35039349,lung cancer (oncology)
3215,35039349,safety
3215,35039349,therapeutic indications
3215,35039349,thyroid disease cois
3217,34050454,dental fluorosis
3217,34050454,ptpn22
3217,34050454,polymorphisms
3217,34050454,tshr
3217,34050454,thyroid
3218,34780050,congenital hypothyroidism
3218,34780050,goiter
3218,34780050,next-generation sequencing
3218,34780050,tpo
3218,34780050,thyroid dyshormonogenesis
3219,34755283,autoimmune thyroiditis
3219,34755283,hypothyroidism
3219,34755283,survey
3219,34755283,thyroid
3219,34755283,thyroid hormones
3220,34861221,euthyroidism
3220,34861221,euthyroïdie
3220,34861221,french endocrine society
3220,34861221,hypothyroidism
3220,34861221,hypothyroïdie
3220,34861221,levothyroxine
3220,34861221,liothyronine
3220,34861221,lévothyroxine
3220,34861221,société française d’endocrinologie
3220,34861221,survey
3220,34861221,sondage
3221,35593680,l-thyroxine
3221,35593680,active follow-up
3221,35593680,active surveillance
3221,35593680,fine-needle aspiration biopsy
3221,35593680,indications for hemithyroidectomy
3221,35593680,nodular goiter
3221,35593680,papillary thyroid microcarcinoma
3221,35593680,radioiodine treatment
3221,35593680, thyroid cancer
3223,34416585,france
3223,34416585,goiter cause
3223,34416585,hair analysis
3223,34416585,historical samples
3223,34416585,lead contamination
3223,34416585,savoy
3224,35382047,graves’ disease
3224,35382047,case report
3224,35382047,type 1 diabetes mellitus
3225,35728893,oculoplastics
3225,35728893,orbital and lacrimal disorders
3225,35728893,thyroid disease cois
3227,35734310,bahirdar
3227,35734310,ethiopia
3227,35734310,salt iodization
3227,35734310,households
3227,35734310,iodine deficiency cois
3232,28668317,goiter
3232,28668317,retrograde dissection of the inferior laryngeal nerve
3232,28668317,sternotomy
3233,27701774,graves’ ophthalmopathy
3233,27701774,graves’ orbitopathy
3233,27701774,thyroid eye disease
3235,28648509,*pendred syndrome
3235,28648509,*congenital hypothyroidism
3235,28648509,*goiter
3235,28648509,*iodide
3235,28648509,*sensorineural deafness
3235,28648509,*thyroid hormone
3236,27221572,*substernal goiter
3236,27221572,*thyroid disease
3236,27221572,*thyroid neoplasm
3236,27221572,*thyroid nodule
3236,27221572,*thyroidectomy
3237,28572231,grave’s disease
3237,28572231,radioiodine
3237,28572231,thionamides
3237,28572231,thyroidectomy
3237,28572231,thyrotoxicosis
3242,26392367,clinical evaluation
3242,26392367,multinodular goiter
3242,26392367,physiopathology
3242,26392367,treatment
3243,27480576,*goiter
3243,27480576,*rhtsh
3244,26708850,benign multinodular goiter
3244,26708850,dunhill procedure
3244,26708850,goiter recurrence
3244,26708850,post-operative complications
3244,26708850,subtotal thyroidectomy
3244,26708850,total thyroidectomy
3245,26433162,arrhythmias
3245,26433162,carlos chagas
3245,26433162,goiter
3245,26433162,history
3245,26433162,myxedema
3245,26433162,thyroid
3246,28516755,dietary iodine intake
3246,28516755,goiter
3246,28516755,iodine
3246,28516755,japanese
3246,28516755,kombu
3246,28516755,seaweed
3246,28516755,thyroid function
3250,26520480,ct
3250,26520480,fiberoptic endoscopy
3250,26520480,goiter
3250,26520480,substernal
3250,26520480,surgery
3251,27687679,anatomy
3251,27687679,intrathoracic goiter
3251,27687679,multinodular goiter
3251,27687679,thoracic inlet
3251,27687679,thyroid gland
3251,27687679,thyroidectomy
3252,28749783,children
3252,28749783,goiter
3252,28749783,l thyroxine
3252,28749783,nodular
3252,28749783,recurrence
3252,28749783,thyroidectomy
3255,29172409,ethiopia
3255,29172409,goiter
3255,29172409,prevalence
3255,29172409,risk factors cois
3256,28331628,*china
3256,28331628,*iodine deficiency disorders (idd)
3256,28331628,*iodized salt
3257,27173499,*clinical images
3257,27173499,*endocrinology
3257,27173499,*surgery cois
3262,28271464,goiter
3262,28271464,medical diagnosis
3262,28271464,painting
3262,28271464,rubens
3264,27059986,graves’ disease
3264,27059986,graves’ orbitopathy
3264,27059986,immunmodulatory therapy
3264,27059986,reconstructive surgical procedures
3264,27059986,thyroid-stimulating hormone receptor
3265,28551882,acid sulfate soils
3265,28551882,iodide
3265,28551882,laterite
3265,28551882,salt iodization
3265,28551882,selenium
3265,28551882,soil organic matter
3267,28395497,"goiter, substernal"
3267,28395497,harmonic scalpel
3267,28395497,"surgical procedures, operative"
3268,26995097,cervical approach
3268,26995097,ectopic goiter
3268,26995097,ectopic thyroid
3268,26995097,intrathoracic goiter
3268,26995097,substernal goiter
3268,26995097,thyroidectomy
3270,26472934,asthma
3270,26472934,goiter
3270,26472934,mediastinum
3270,26472934,sternotomy
3270,26472934,thyroidectomy
3270,26472934,substernal
3271,28258641,amyloid goiter
3271,28258641,familial mediterranean fever
3271,28258641,head and neck ultrasound
3271,28258641,thyroid
3278,26742784,*creutzfeldt-jacob disease
3278,26742784,*heidenhain variant
3278,26742784,*compressive optic neuropathy
3278,26742784,*higher visual processing
3278,26742784,*proptosis
3278,26742784,*spongiform encephalopathy
3278,26742784,*thyroid eye disease
3278,26742784,*visual fields
3284,28612896,*complications
3284,28612896,*recurrent goiter
3284,28612896,*surgery
3284,28612896,*thyroidectomy
3291,28648505,*digeorge syndrome
3291,28648505,*hypoparathyroidism
3291,28648505,*parathyroid
3291,28648505,*pseudohypoparathyroidism
3291,28648505,*thyroid
3294,27005286,*areola approach
3294,27005286,*laparoscope
3294,27005286,*silk thread
3294,27005286,*strategies
3294,27005286,*substernal goiter
3294,27005286,*thyroidectomy
3295,26403613,body surface area
3295,26403613,drinking water
3295,26403613,goiter
3295,26403613,iodized salt
3295,26403613,prevalence
3296,28606271,"antigens, cd40"
3296,28606271,bone marrow cells
3296,28606271,fibroblasts
3296,28606271,graves ophthalmopathy
3296,28606271,insulin-like growth factor ⅰ
3296,28606271,"receptors, thyrotropin"
3298,28535654,clinicopathological characteristics
3298,28535654,nuclear factor erythroid 2-related factor 2
3298,28535654,thyroid neoplasms
3299,26708863,cervical approach
3299,26708863,mediastinal goiter
3299,26708863,sternotomy
3299,26708863,thoracotomy
3299,26708863,thyroidectomy
3300,26721191,cervico-mediastinal goiter
3300,26721191,cervicosternotomy
3300,26721191,cervicotomy
3300,26721191,goiter
3300,26721191,intrathoracic thyroid mass
3300,26721191,total thyroidectomy
3304,28471268,*graves' disease
3304,28471268,*cardiovascular risk
3304,28471268,*hyperthyroidism
3304,28471268,*morbidity
3304,28471268,*mortality
3304,28471268,*toxic nodular goiter
3305,28190186,iodine
3305,28190186,nis
3305,28190186,nodular goiter
3305,28190186,tshr
3307,28292346,*endemic goiter
3307,28292346,*high iodine
3307,28292346,*iodine deficiency
3310,27779276,adolescents
3310,27779276,children
3310,27779276,overt hypothyroidism
3310,27779276,pregnancy
3310,27779276,subclinical hypothyroidism
3312,28805773,diffuse toxic goiter
3312,28805773,long-term results
3312,28805773,subtotal resection of the thyroid gland
3312,28805773,surgical treatment
3312,28805773,thyroidectomy
3313,29265071,angiogenesis
3313,29265071,apoptosis
3313,29265071,diffuse toxic goiter
3313,29265071,thyroid cell proliferation
3315,28835334,fine needle aspiration and biopsy
3315,28835334,nodules
3315,28835334,thyroid
3315,28835334,ultrasound
3316,26900630,*autoimmune thyroiditis
3316,26900630,*cxcl10
3316,26900630,*cxcr3
3316,26900630,*graves ophthalmopathy
3316,26900630,*graves disease
3316,26900630,*chemokines
3316,26900630,*corticosteroids
3316,26900630,*rituximab
3316,26900630,*teprotumumab
3316,26900630,*tocilizumab
3317,28215480,goiter prevalence
3317,28215480,iodine deficiency disorder
3317,28215480,iodine nutritional status
3317,28215480,pakistan
3317,28215480,salt iodization
3320,27106540,boron
3320,27106540,goiter
3320,27106540,iodine
3320,27106540,schoolchildren
3320,27106540,silicon
3320,27106540,thyroid
3321,28841887,intravascular lymphoma
3321,28841887,large b-cell
3321,28841887,nodular goiter
3321,28841887,"thyroid cois waived by the institutional ethics committee of the central hospital of wuhan, china. consent for publication: written informed consent for the publication of clinical details and clinical images of the patient was obtained from a relative of the patient. a copy of the consent form is available for review by the editor of this journal. competing interests: the authors declare that they have no competing interests. publisher’s note: springer nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations."
3325,28061776,*ethiopia
3325,28061776,*goiter
3325,28061776,*salt iodine content
3325,28061776,*school children
3327,28011236,dicer
3327,28011236,iodine metabolism-related genes
3327,28011236,microrna
3327,28011236,thyroid
3327,28011236,thyroid cell differentiation
3327,28011236,thyroid tumor
3329,28127991,*autoimmunity
3329,28127991,*graves’ disease
3329,28127991,*ophthalmopathy
3329,28127991,*tyrosine kinase
3330,26966785,*graves’ disease
3330,26966785,*graves’ ophthalmopathy
3330,26966785,*graves’ orbitopathy
3330,26966785,*antithyroid drugs
3330,26966785,*glucocorticoids
3330,26966785,*hyperthyroidism
3330,26966785,*radiotherapy
3330,26966785,*rituximab
3330,26966785,*selenium
3331,28872214,*thyroid-related quality-of-life patient-reported outcome (thypro)
3331,28872214,*goiter
3331,28872214,*quality of life
3331,28872214,*surgery
3331,28872214,*thyroid
3332,28580573,*ex-utero intrapartum treatment
3332,28580573,*airways obstruction
3332,28580573,*fetus
3332,28580573,*neck tumors
3332,28580573,*ultrasound
3335,27460951,congenital goiter
3335,27460951,endemic goiter
3335,27460951,fifteenth century
3335,27460951,fine arts
3335,27460951,hyperthyroidism
3336,28703113,intraoperative neuromonitoring
3336,28703113,recurrent goiter
3336,28703113,recurrent laryngeal nerve
3337,26750728,benign thyroid diseases
3337,26750728,changes of radioiodine therapy
3337,26750728,jóindulatú pajzsmirigybetegségek
3337,26750728,pajzsmirigyrák
3337,26750728,radiojódterápia változásai
3337,26750728,thyroid cancer
3340,27927635,*children
3340,27927635,*thyroid volume
3340,27927635,*total goiter rate
3340,27927635,*urine iodine concentration
3340,27927635,*urine iodine excretion
3341,26884295,doppler
3341,26884295,elasticity imaging techniques
3341,26884295,goiter
3341,26884295,nodular
3341,26884295,thyroid
3341,26884295,ultrasonography
3342,27153850,*hepatotoxicity
3342,27153850,*hyperthyroidism
3342,27153850,*methimazole
3342,27153850,*propylthiouracil
3342,27153850,*radioactive iodine
3342,27153850,*thyroid
3342,27153850,*thyroidectomy
3345,26298554,autoimmune thyroiditis
3345,26298554,child
3345,26298554,doppler
3345,26298554,goiter
3345,26298554,thyroid gland
3345,26298554,ultrasound
3346,28891673,lead
3346,28891673,nodular goiter
3346,28891673,papillary thyroid carcinoma
3346,28891673,thyroid adenoma
3346,28891673,thyroid hormones
3350,27673426,*goiter
3350,27673426,*hypothyroidism
3350,27673426,*respiratory function
3350,27673426,*sleep apnea syndrome
3350,27673426,*thyroid disease
3350,27673426,*upper airway obstruction
3355,27552913,bmn
3355,27552913,egipcios
3355,27552913,egyptian
3355,27552913,mng
3355,27552913,tsh
3355,27552913,vitamin d
3355,27552913,vitamina d
3357,28025831,*goiter
3357,28025831,*headache attributed to hypothyroidism
3357,28025831,*hyperthyroidism
3357,28025831,*migraine
3357,28025831,*new daily persistent headache
3359,28178662,han chinese
3359,28178662,snps
3359,28178662,vegfa
3359,28178662,nodular goiter
3359,28178662,papillary thyroid carcinoma cois
3363,27862717,*congenital hypothyroidism
3363,27862717,*fetal therapy
3363,27862717,*goiter
3364,28506088,leukocytes
3364,28506088,papillary thyroid carcinoma
3364,28506088,platelets
3364,28506088,thyroid cancer
3364,28506088,white blood cells
3365,28728986,benign multi-nodular goitre
3365,28728986,thyroidectomy
3366,26841373,i-131
3366,26841373,large goiter
3366,26841373,multinodular goiter
3366,26841373,radioiodine therapy
3366,26841373,radioiodine uptake
3366,26841373,rhtsh
3367,27931874,follicular thyroid cancer
3367,27931874,goiter
3367,27931874,papillary thyroid cancer
3367,27931874,raman spectroscopy
3367,27931874,thyroid
3370,29183897,paediatrics
3370,29183897,thyroid disease cois
3372,27828690,*graves disease
3372,27828690,*hashimoto’s thyroiditis
3372,27828690,*igg4 related disease
3372,27828690,*riedel’s thyroiditis
3372,27828690,*immunoglobulin
3377,26260217,antonello da messina
3377,26260217,goiter in holy images
3377,26260217,italian renaissance
3379,27029843,graves’ disease
3379,27029843,hyperthyroidism
3379,27029843,mediastinal mass
3379,27029843,thyroid remnant
3379,27029843,total thyroidectomy
3380,28578595,*graves’ disease
3380,28578595,*autoimmune
3380,28578595,*hyperplasia
3380,28578595,*thymic
3380,28578595,*thymic lymphoid hyperplasia
3380,28578595,*true thymic hyperplasia
3381,26850414,*goiter
3381,26850414,*medical diagnosis
3381,26850414,*painting
3381,26850414,*titian
3382,27385363,disparity
3382,27385363,graves’ ophthalmopathy
3382,27385363,orbitopathy
3382,27385363,socioeconomic status
3385,28533884,graves’ disease
3385,28533884,thyroid gland
3385,28533884,tuberculosis
3387,28606272,autoimmunity
3387,28606272,genetic predisposition to disease
3387,28606272,graves ophthalmopathy
3387,28606272,oxidative stress
3387,28606272,smoking
3393,27565137,*cretinism
3393,27565137,*goiter
3393,27565137,*iodine
3393,27565137,*thyroid
3397,28899873,endocrine system
3397,28899873,paediatrics (drugs and medicines)
3397,28899873,thyroid disease cois
3399,29075974,adjuvant treatment
3399,29075974,escape
3399,29075974,hyperthyroidism
3399,29075974,iodide
3399,29075974,thyroidectomy cois ethical approval: this article does not contain any studies with human participants or animals performed by any of the authors.
3400,28942732,*etiology
3400,28942732,*graves’ disease
3400,28942732,*pathophysiology
3400,28942732,*primary immunodeficiency
3400,28942732,*review cois publication: not applicable competing interests: all authors declare they have no competing interest.
3401,28770897,"thyroid associated orbitopathy, graves ophthalmopathy, hypothyroidism."
3418,27169853,dietary
3418,27169853,goitrogens
3418,27169853,nitrate
3418,27169853,perchlorate
3418,27169853,risk assessment
3418,27169853,thiocyanate
3421,27795799,*toxic goiter
3421,27795799,*thyroid abscess
3421,27795799,*thyroiditis cois
3423,27819113,ata
3423,27819113,graves’ disease
3423,27819113,igg4
3423,27819113,ophthalmopathy
3423,27819113,tpoab
3426,28493593,*recurrent laryngeal nerve
3426,28493593,*superior parathyroid
3426,28493593,*thyroid
3426,28493593,*thyroidectomy
3430,27481173,*thyroidectomy
3430,27481173,*graves
3430,27481173,*hematoma
3430,27481173,*malignancy
3430,27481173,*toxic nodular goitre
3432,27470116,drainage
3432,27470116,hematoma
3432,27470116,surgical outcomes
3432,27470116,thyroid surgery
3435,29138656,hyperthyroidism
3435,29138656,senegal
3435,29138656,child
3435,29138656,profile
3437,26994869,*graves' ophthalmopathy
3437,26994869,*chronic lymphocytic leukemia (cll)
3437,26994869,*lymphoproliferative disorder
3437,26994869,*orbital inflammation
3437,26994869,*orbital lymphoma
3437,26994869,*proptosis
3437,26994869,*small lymphocytic lymphoma (sll)
3437,26994869,*thyroid eye disease
3439,28450994,graves-basedow's disease
3439,28450994,child
3439,28450994,student abuse cois
3441,27933384,autoimmune thyroid disease
3441,27933384,papillary thyroid cancer
3441,27933384,thyroglobulin antibodies
3441,27933384,thyroid peroxidase antibodies
3443,29422752,goiter
3443,29422752,graves' disease
3443,29422752,ophthalmopathy
3443,29422752,thyroid
3443,29422752,thyroid-associated orbitopathy cois
3445,26477042,goiter
3445,26477042,iodine deficiency disorders
3445,26477042,salt iodization
3445,26477042,urinary iodine concentration
3447,28533836,thyroid
3447,28533836,pathology
3447,28533836,sarcoma
3447,28533836,treatment cois
3449,28363119,ct
3449,28363119,grave's disease
3449,28363119,pulmonary hypertension
3450,28278511,graves ophthalmopathy
3450,28278511,il-6
3450,28278511,microrna-146a
3450,28278511,notch2
3450,28278511,orbital fibroblast reporter gene
3450,28278511,qrt-pcr
3451,27609530,diplopia
3451,27609530,intraocular pressure
3451,27609530,orbital decompression
3451,27609530,proptosis
3451,27609530,visual acuity
3451,27609530,visual field
3452,28755510,graves' disease
3452,28755510,graves' hyperthyroidism
3452,28755510,graves' orbitopathy
3452,28755510,thyroid eye disease
3453,28606263,"decompression, surgical"
3453,28606263,graves ophthalmopathy
3453,28606263,"imaging, three-dimensional"
3453,28606263,orbit
3454,29890100,*thyroidectomy
3454,29890100,*thyroid nodule
3454,29890100,*recurrent laryngeal nerve palsy
3454,29890100,*hypoparathyroidism
3454,29890100,*postoperative pain
3460,28635216,"carcinoma, papillary"
3460,28635216,multifocal tumor
3460,28635216,ret/ ptcrearrangement
3460,28635216,thyroid neoplasms
3462,26927707,*graves' disease
3462,26927707,*thyroid surgery
3462,26927707,*hyperthyroidism
3462,26927707,*thyroid storm
3462,26927707,*thyroidectomy
3462,26927707,*thyrotoxicosis
3463,27375108,antithyroïdien de synthèse
3463,27375108,graves’ disease
3463,27375108,grossesse
3463,27375108,hyperthyroidism
3463,27375108,hyperthyroïdie
3463,27375108,maladie de basedow
3463,27375108,pregnancy
3463,27375108,synthetic antithyroid drug
3466,26466836,*graves’ disease
3466,26466836,*ophthalmopathy
3466,26466836,*radiotherapy
3468,27494076,*biomarkers
3468,27494076,*graves’ disease
3468,27494076,*hashimoto thyroiditis
3468,27494076,*vegf
3468,27494076,*splicing isoforms
3471,27555041,calcium oxalate
3471,27555041,colloid
3471,27555041,crystals
3471,27555041,cytology
3471,27555041,thyroid
3472,27402179,bocio endémico
3472,27402179,cirugía general
3472,27402179,cooperación sanitaria
3472,27402179,endemic goiter
3472,27402179,equipamiento quirúrgico
3472,27402179,general surgery
3472,27402179,nódulo tiroideo
3472,27402179,surgical aid program
3472,27402179,surgical equipment
3472,27402179,thyroid gland
3472,27402179,thyroid nodule
3472,27402179,thyroidectomy
3472,27402179,tiroidectomía
3472,27402179,tiroides
3473,28456099,goiter
3473,28456099,hashimoto thyroiditis
3473,28456099,hyperthyroidism
3473,28456099,hypothyroidisms
3473,28456099,mammographic density
3473,28456099,thyroid
3476,29871201,e-cadherin
3476,29871201,papillary thyroid carcinoma
3476,29871201,serum cois relevant financial relationships with commercial interests to disclose.
3485,26932403,hashimoto thyroiditis
3485,26932403,igg4-related disease
3485,26932403,immunoglobulin g cois
3488,26813846,disparity
3488,26813846,substernal goiter
3488,26813846,thyroidectomy
3489,27083552,art
3489,27083552,goitre
3489,27083552,renaissance
3492,28329777,graves’ disease
3492,28329777,children
3492,28329777,thyreostatics
3493,28606260,clinical protocols
3493,28606260,graves ophthalmopathy
3493,28606260,practice guidelines as topic
3494,27619197,*airflow
3494,27619197,*cfd
3494,27619197,*energy loss
3494,27619197,*goiters
3494,27619197,*trachea
3498,28420409,adolescent students
3498,28420409,ethiopia
3498,28420409,iodine deficiency
3498,28420409,wolaita and dawuro zone
3506,27222685,nodular goiter
3506,27222685,malignancy
3506,27222685,ultrasound
3509,29798067,hornor's symptoms
3509,29798067,lymph node dissection
3509,29798067,thyroid gland operation cois relevant financial relationships with commercial interests to disclose.
3510,26315305,goitrous children
3510,26315305,iodine
3510,26315305,selenium
3510,26315305,trace elements
3510,26315305,zinc
3513,25261415,*life cycle
3513,25261415,*minerals/trace elements
3513,25261415,*nutrition
3513,25261415,*parenteral nutrition
3513,25261415,*pediatrics
3516,28606261,clinical protocols
3516,28606261,glucocorticoids
3516,28606261,graves ophthalmopathy
3516,28606261,radiotherapy
3519,27383156,e-cadherin
3519,27383156,thyroid cancer
3519,27383156,β-catenin
3520,26669779,autoimmune thyroiditis
3520,26669779,fibrosing variant of hashimoto’s thyroiditis
3520,26669779,igg4-related disease
3520,26669779,riedel’s thyroiditis
3521,29541314,intubation
3521,29541314,cervical spine surgery
3521,29541314,thyroidectomy
3527,27809623,*hyperthyroidism
3527,27809623,*hypothyroidism
3527,27809623,*pregnancy
3529,28537560,tsh
3529,28537560,calcium
3529,28537560,hypocalcemia
3529,28537560,multinodular goiter
3529,28537560,thyroidectomy
3530,27687458,difficult airway
3530,27687458,difficult ventilation
3530,27687458,fiberoptic intubation
3530,27687458,general anesthesia
3533,28457178,*complications
3533,28457178,*hematoma
3533,28457178,*hypocalcemia
3533,28457178,*outcomes
3533,28457178,*safety
3533,28457178,*thyroidectomy
3534,28389359,aitd
3534,28389359,ps
3534,28389359,slc26a4
3534,28389359,splicing minigene assay
3535,28389809,computer-assisted
3535,28389809,diagnosis
3535,28389809,thyroid neoplasms
3535,28389809,ultrasonography
3537,27426718,cáncer de tiroides
3537,27426718,cáncer tiroideo incidental
3537,27426718,incidental thyroid cancer
3537,27426718,prognosis
3537,27426718,pronóstico
3537,27426718,thyroid cancer
3542,28699427,*t3
3542,28699427,*t4
3542,28699427,*hyperthyroidism
3542,28699427,*metabolomics
3544,27601286,methimazole
3544,27601286,mild graves' disease
3544,27601286,thyroid function
3544,27601286,thyroid volume
3545,29084476,*graves' disease
3545,29084476,*graves' orbitopathy
3545,29084476,*mortality
3545,29084476,*suicide
3545,29084476,*unnatural death
3553,26438397,autophagy
3553,26438397,graves’ orbitopathy
3553,26438397,statins
3554,28806880,*goiter
3554,28806880,*neck ultrasound
3554,28806880,*nodular goiter
3554,28806880,*thyroid gland
3554,28806880,*volume
3559,27882431,cervico-mediastinal goiters
3559,27882431,chest x-rays
3559,27882431,intrathoracic goiters
3559,27882431,mediastinal nodules
3559,27882431,thyroid surgery
3560,28255974,*acromegaly
3560,28255974,*meta-analysis
3560,28255974,*pituitary
3560,28255974,*thyroid
3560,28255974,*thyroid cancer
3562,26925783,*are
3562,26925783,*auf1
3562,26925783,*ftc.
3562,26925783,*hur
3562,26925783,*follicular adenoma
3562,26925783,*thyroid carcinoma
3564,28974848,i131 therapy
3564,28974848,hyperthyreoidism treatment
3564,28974848,"incidence of hypotihyeoidism cois sabrina licina participate in study design and acquisition, analysis and interpretation of data. authors equally participate in drafting the article and give final approval for the version which is submitted."
3565,27716078,*asystole
3565,27716078,*hyperextension
3565,27716078,*position
3565,27716078,*thyroidectomy
3567,29120123,*graves ophthalmopathy – diagnostic imaging
3567,29120123,*orbit – diagnostic imaging
3567,29120123,*multidetector computed tomography
3567,29120123,*exophthalmos – diagnosis
3567,29120123,*cross-sectional studies
3570,26337375,multinodular goiter
3570,26337375,thyroid autotransplantation
3570,26337375,thyroidectomy
3573,27438852,slovenia
3573,27438852,food supply
3573,27438852,iodine
3573,27438852,sales
3573,27438852,salt
3573,27438852,sodium
3576,26270564,gpx
3576,26270564,gsh
3576,26270564,hashimoto’s thyroiditis
3576,26270564,lpo
3576,26270564,oxidative stress
3576,26270564,catalase
3576,26270564,thyroid cancer
3576,26270564,thyroid goitre
3578,28619420,(131)i treatment
3578,28619420,bocio nodular
3578,28619420,fracaso de tratamiento
3578,28619420,hipertiroidismo
3578,28619420,hipotiroidismo
3578,28619420,hyperthyroidism
3578,28619420,hypothyroidism
3578,28619420,nodular goitre
3578,28619420,tratamiento (131)i
3578,28619420,treatment failure
3579,26969710,*imaging
3579,26969710,*muscles
3579,26969710,*orbit
3579,26969710,*treatment surgery
3580,29197845,materno-fetal medicine
3580,29197845,neonatal and paediatric intensive care
3580,29197845,neonatal health cois
3585,27693824,harmonic scalpel
3585,27693824,ligasure vessel sealing system
3585,27693824,substernal goitre
3585,27693824,thyroid surgery
3585,27693824,total thyroidectomy
3588,28025026,graves
3588,28025026,pulmonary hypertension
3588,28025026,right heart function
3588,28025026,strain
3588,28025026,tapse
3588,28025026,thyroid
3590,26936928,*dyshormonogenesis
3590,26936928,*goiter
3590,26936928,*hypothyroidism
3590,26936928,*pendred syndrome
3595,28771438,fetal goiter
3595,28771438,intra-amniotic levothyroxine administration
3595,28771438,maternal graves’ disease
3602,26272351,taiwan
3602,26272351,iodine
3602,26272351,iodized salt
3602,26272351,nutrition survey
3602,26272351,thyroid gland
3608,28737965,m22
3608,28737965,trab
3608,28737965,diagnosis
3608,28737965,hyperthyroidism
3612,26603660,graves' disease
3612,26603660,radioiodine therapy
3612,26603660,thyroid
3612,26603660,ultrasound
3613,26886211,autoimmune thyroid disease
3613,26886211,breast neoplasms
3613,26886211,trastuzumab cois
3614,28576912,endocrine cancer
3614,28576912,head and neck cancer
3614,28576912,head and neck surgery
3614,28576912,pathology
3614,28576912,thyroid disease cois
3616,28781316,graves' disease
3616,28781316,autoimmune hepatitis
3616,28781316,interface hepatitis
3616,28781316,liver histology
3616,28781316,pediatric case
3618,27586672,robotics
3618,27586672,thymectomy
3618,27586672,thymus
3618,27586672,thyroid
3618,27586672,transaxillary thyroidectomy
3623,26708845,fine needle cytology
3623,26708845,hurthle cells
3623,26708845,rapid on-site evaluation
3623,26708845,ultrasound
3626,26321232,case-control study
3626,26321232,disease
3626,26321232,fcrl3
3626,26321232,graves’
3626,26321232,single nucleotide polymorphisms
3627,26062519,graves’ orbitopathy
3627,26062519,hepatocyte growth factor
3627,26062519,interleukin-8
3627,26062519,methylprednisolone treatment
3628,26796368,recurrent laryngeal nerve injury
3628,26796368,substernal goitres
3628,26796368,surgical management
3629,28444621,criminal offense
3629,28444621,goiter
3629,28444621,major part
3629,28444621,metabolic disease
3629,28444621,public health
3630,28427469,*eugogo
3630,28427469,*epidemiology
3630,28427469,*graves’ orbitopathy
3630,28427469,*incidence
3630,28427469,*ophthalmopathy
3630,28427469,*prevalence
3630,28427469,*rare disease
3632,27206523,antiviral
3632,27206523,extrahepatic manifestation
3632,27206523,graves’ hyperthyroidism
3632,27206523,hbv infection
3634,27465670,*antithyroid drugs
3634,27465670,*goiter
3634,27465670,*graves’ disease
3634,27465670,*graves’ orbitopathy
3634,27465670,*hyperthyroidism
3634,27465670,*thyrotropin receptor antibody
3636,27422154,bocio multinodular
3636,27422154,bocio multinodular tóxico
3636,27422154,hipertiroidismo
3636,27422154,hyperthyroidism
3636,27422154,multinodular goitre
3636,27422154,radioiodine
3636,27422154,radioyodo
3636,27422154,toxic multinodular goitre
3636,27422154,rhtsh
3637,28215490,ectopic goitre
3637,28215490,horner's syndrome
3637,28215490,parapharyngeal space
3641,26626435,coagulación
3641,26626435,coagulation
3641,26626435,thyroid
3641,26626435,tiroides
3644,28389487,*surgery
3644,28389487,*cancer
3644,28389487,*overdiagnosis cois
3645,28124062,papillon initiative
3645,28124062,diffuse goitre
3645,28124062,geriatric medicine
3645,28124062,nodular goitre
3645,28124062,thyroid dysfunction
3646,27531964,surgery
3647,27358549,*coronary artery bypass grafting
3647,27358549,*subtotal thyroidectomy
3647,27358549,*surgery
3650,27241825,cochlear implantation
3650,27241825,pendred syndrome
3650,27241825,enlarged vestibular aqueduct
3650,27241825,gusher
3650,27241825,malformations
3650,27241825,surgical complications
3656,28458607,*computed tomography
3656,28458607,*euthyroidism
3656,28458607,*graves' disease
3656,28458607,*methimazole
3656,28458607,*single-photon emission computed tomography
3660,26066526,children
3660,26066526,endemic goitre
3660,26066526,iodine-deficiency goitre
3660,26066526,salt iodine
3661,28812921,dacryoadenitis
3661,28812921,idiopathic orbital inflammatory syndrome
3661,28812921,silent sinus syndrome
3661,28812921,thyroid eye disease
3662,26975391,autoimmunity
3662,26975391,hormone secretion
3662,26975391,nodular goiter
3662,26975391,thyroid
3663,27553050,graves’ disease
3663,27553050,marinelli’s formula
3663,27553050,thyroid iodine uptake
3663,27553050,thyroid technetium uptake cois
3665,28874217,hypocalcemia
3665,28874217,hypoparathyroidism
3665,28874217,parathyroid hormone
3665,28874217,thyroidectomy
3665,28874217,vitamin d
3668,27927064,*graves’ disease
3668,27927064,*cytokines
3668,27927064,*traditional chinese medicine
3669,27051255,computed tomography
3669,27051255,exophthalmos reduction
3669,27051255,graves ophthalmopathy
3669,27051255,orbital decompression cois was reported.
3670,26897110,iodine deficiency
3670,26897110,iodine prophylaxis
3670,26897110,iodized salt
3670,26897110,thyroid volume
3670,26897110,urinary iodine concentration
3674,28540810,*thyroid nodules
3674,28540810,*combined therapy
3674,28540810,*radiofrequency ablation (rfa)
3674,28540810,*radioiodine therapy (rit)
3677,26726836,hashimoto’s thyroiditis
3677,26726836,nodular goiter
3677,26726836,hepatocyte growth factor
3677,26726836,hypothyroidism
3679,28154699,*autoimmunity
3679,28154699,*dakar
3679,28154699,*hyperthyroidism cois
3680,27214836,berkeley drosophila genome project (bdgp)
3680,27214836,computerised tomography (ct)
3680,27214836,enlarged vestibular aqueduct (eva)
3680,27214836,hearing loss (hl)
3680,27214836,magnetic resonance imaging (mri)
3680,27214836,pendred syndrome (ps)
3680,27214836,videonystagmography (vng)
3681,27465319,*graves’ disease
3681,27465319,*graves’ ophthalmopathy
3681,27465319,*genetic polymorphism
3681,27465319,*meta-analysis
3684,28052261,*pendred syndrome
3684,28052261,*disease-specific ips cells
3684,28052261,*inner ear
3684,28052261,*outer sulcus cells
3690,27510038,*developmental delay
3690,27510038,*failure to thrive
3690,27510038,*spontaneous transient graves’ thyrotoxicosis
3700,28458304,basedow's disease
3700,28458304,igg4
3700,28458304,igg4 thyroiditis
3700,28458304,igg4-related disease
3701,27941044,*diagnostic tests/investigation
3701,27941044,*eye (globe)
3701,27941044,*imaging
3701,27941044,*orbit cois
3705,27906671,bethesda category iii
3705,27906671,acoustic radiation force impulse elastography
3705,27906671,fine-needle aspiration cytology
3705,27906671,thyroid nodules
3705,27906671,ultrasound cois
3707,26567024,immunology
3707,26567024,inflammation
3707,26567024,orbit
3707,26567024,treatment medical
3712,27157450,*hashimoto thyroiditis
3712,27157450,*autoimmune disease
3712,27157450,*autoimmune thyroid disease
3712,27157450,*hyperthyroidism
3712,27157450,*hypothyroidism
3712,27157450,*type 1 diabetes
3715,28688760,hypothyroidism
3715,28688760,hypothyroïdie
3715,28688760,l-thyroxine
3715,28688760,non adherence
3715,28688760,non-observance
3718,26801325,depression
3718,26801325,exophthalmos
3718,26801325,graves’ disease
3718,26801325,psychotherapy
3718,26801325,stress
3719,28074218,graves disease
3719,28074218,hashimoto disease
3719,28074218,hyperthyroidism
3719,28074218,hypothyroidism
3719,28074218,levothyroxine
3720,28050807,alternative first-line therapy
3720,28050807,graves ophthalmopathy
3720,28050807,orbital radiotherapy
3720,28050807,thyroid eye disease
3721,28001456,*graves’ ophthalmopathy
3721,28001456,*rasch analysis
3721,28001456,*quality of life
3721,28001456,*questionnaires
3721,28001456,*reliability
3721,28001456,*validation study
3721,28001456,*validity
3723,27106887,down's syndrome
3723,27106887,graves’ disease
3723,27106887,adolescent
3723,27106887,hemodialysis
3723,27106887,renal transplantation
3726,27350133,carcinoma
3726,27350133,diagnostic discrepancies
3726,27350133,histology
3726,27350133,sources of error
3726,27350133,thyroid cytology
3730,28861686,bell’s phenomenon
3730,28861686,inferior rectus muscle recession
3730,28861686,nasal transposition of the inferior rectus muscle
3730,28861686,thyroid-associated inferior rectus myopathy
3732,28296512,amsterdam declaration
3732,28296512,thyroid eye disease
3732,28296512,radioiodine
3732,28296512,smoking
3732,28296512,thyroid function
3733,26996584,thymus hyperplasia
3733,26996584,graves disease
3733,26996584,"immunoglobulins, thyroid-stimulating"
3733,26996584,receptors thyrotropin cois
3735,27651496,graves
3735,27651496,hyperthyroidism
3735,27651496,radioiodine
3735,27651496,thyroidectomy
3738,28755140,biomarker
3738,28755140,enzyme-linked immunosorbent assay
3738,28755140,klln protein
3738,28755140,pten protein
3738,28755140,papillary thyroid carcinoma
3743,28870952,*metallothioneins
3743,28870952,*papillary thyroid carcinoma
3743,28870952,*thyroid gland
3746,28882932,muscle disease
3746,28882932,thyroid disease cois
3747,28805160,*graves' disease
3747,28805160,*graves' ophthalmopathy
3747,28805160,*clinical activity score
3747,28805160,*immunoglobulin g4
3747,28805160,*thyroid autoantibody
3748,28675712,graves’ disease
3748,28675712,hashimoto’s disease
3748,28675712,thyroglobulin
3748,28675712,polymorphism
3748,28675712,severity
3749,28162094,graves’ disease
3749,28162094,human leukocyte antigen
3749,28162094,hyperthyroidism
3749,28162094,thiamazole
3749,28162094,thyroid scintigraphy
3749,28162094,thyroid-stimulating hormone-binding inhibitory immunoglobulin
3750,27664101,graves’ disease
3750,27664101,graves’ orbitopathy
3750,27664101,natural course
3751,26100786,cd69
3751,26100786,graves’ disease
3751,26100786,hashimoto thyroiditis
3751,26100786,il-10
3751,26100786,nkg2d
3751,26100786,treg cells
3754,28319410,*mean platelet volume
3754,28319410,*papillary thyroid cancer
3754,28319410,*platelet distribution width plateletcrit.
3757,28379055,diffusion
3757,28379055,graves
3757,28379055,magnetic resonance imaging
3757,28379055,orbit
3759,27804243,*graves’ disease
3759,27804243,*hyperthyroidism
3759,27804243,*pulmonary hypertension
3759,27804243,*pulmonary hypertensive crisis
3759,27804243,*thyroid storm
3760,27486810,dysthyroid optic neuropathy
3760,27486810,graves’ orbitopathy
3760,27486810,thyroid eye disease
3765,28478488,anti-thyroid drugs
3765,28478488,graves’ disease
3765,28478488,hyperthyroidism
3765,28478488,radio-iodine
3765,28478488,surgery
3765,28478488,"thyroid cois currently in uk for observational studies. conflict of interest: the authors declare that they have no competing interests. ethical approval: no specific approval was obtained from an ethics committee. as this is an observational study of a current clinical pathway and no intervention was involved, permission was only obtained from the audit and service evaluation office of the sheffield teaching hospitals nhs foundation trust. as the data was anonymised and individual patients cannot be identified from the report, individual patient consent was not deemed to be necessary and was not obtained."
3768,28500433,dysthyroid optic neuropathy
3768,28500433,orbital radiation therapy
3768,28500433,thyroid-associated orbitopathy
3769,28130596,angle kappa
3769,28130596,interpupillary distance
3769,28130596,orbital decompression
3769,28130596,thyroid-associated orbitopathy
3773,27638651,*graves’ disease
3773,27638651,*hyperthyroidism
3773,27638651,*mathematical modeling
3773,27638651,*relapse
3780,27319009,agranulocytosis
3780,27319009,alemtuzumab
3780,27319009,childhood
3780,27319009,graves’ disease
3780,27319009,graves’ orbitopathy
3780,27319009,hyperthyroidism
3780,27319009,methimazole
3780,27319009,pregnancy
3780,27319009,propylthiouracil
3780,27319009,radioiodine
3780,27319009,thionamides
3780,27319009,thyroidectomy
3783,26951052,autoimmunity
3783,26951052,graves’ disease
3783,26951052,hla
3783,26951052,stress
3784,28835054,graves′ disease
3784,28835054,hashimoto disease
3784,28835054,thyroid neoplasms
3785,27838267,*graves’ disease
3785,27838267,*coronary vasospasm
3785,27838267,*hyperthyroidism
3785,27838267,*methimazole
3785,27838267,*nitroglycerin
3785,27838267,*thyroid peroxidase antibody
3785,27838267,*thyroid-stimulating immunoglobulin
3786,28811719,cirrhosis
3786,28811719,cognitive impairment
3786,28811719,hepatic encephalopathy
3786,28811719,hypothyroidism
3786,28811719,magnetic resonance spectroscopy
3786,28811719,portosystemic shunt cois regarding funding or conflict of interest with respect to this manuscript.
3789,27560939,thyroid eye disease
3789,27560939,ptosis
3789,27560939,upper eyelid retraction
3792,26787873,cell engineering
3792,26787873,designer cells
3792,26787873,gene switch
3792,26787873,prosthetic networks
3792,26787873,synthetic biology cois
3795,27599688,graves ophthalmopathy
3795,27599688,quality of life
3795,27599688,thyroid eye disease
3796,27159575,graves’ ophthalmopathy
3796,27159575,long-term follow-up
3796,27159575,orbital decompression
3796,27159575,quality of life
3796,27159575,thyroid associated ophthalmopathy
3798,28070771,*graves disease
3798,28070771,*clinical reasoning
3798,28070771,*dual process theory
3798,28070771,*framing cois interest. funding: none.
3799,27169807,compressive optic neuropathy
3799,27169807,dysthyroid optic neuropathy
3799,27169807,dysthyroid orbitopathy
3799,27169807,graves’ orbitopathy
3799,27169807,optical coherence tomography
3799,27169807,peripapillary retinal nerve fiber layer thickness
3802,28222800,*autosomal recessive inheritance
3802,28222800,*childhood deafness
3802,28222800,*exome sequencing
3802,28222800,*pendred syndrome
3802,28222800,*syndromic hearing loss
3803,28347567,*art
3803,28347567,*exophthalmos
3803,28347567,*graves disease
3804,27086918,benign nodule
3804,27086918,programmed death-ligand 1
3804,27086918,protein biomarkers
3804,27086918,subcellular localization
3804,27086918,"thyroid cancer cois (sc, jv, fj, op, aa and cm) have nothing to disclose."
3805,27914141,children
3805,27914141,hashimoto disease
3805,27914141,hypothyroidism
3805,27914141,thyroid disease cois
3808,27220843,*antithyroid drugs
3808,27220843,*graves’ disease
3808,27220843,*graves’ ophthalmopathy
3808,27220843,*radioactive iodine
3808,27220843,*thyroidectomy
3812,28273705,congenital hypothyroidism
3812,28273705,gene
3812,28273705,mutation
3814,28715111,* hla-b*40:238
3814,28715111,*new allele
3814,28715111,*sequencing-based typing
3815,27715404,african descent
3815,27715404,graves orbitopathy
3815,27715404,pediatric
3815,27715404,optic neuropathy
3816,27709471,age
3816,27709471,glucocorticoids
3816,27709471,graves’ disease
3816,27709471,graves’ orbitopathy
3816,27709471,natural history
3816,27709471,radiotherapy
3817,27680576,echocardiography
3817,27680576,graves’ disease
3817,27680576,tissue doppler
3818,27170049,*graves’ ophthalmopathy
3818,27170049,*histamine
3818,27170049,*histamine receptor type-1
3818,27170049,*loratadine
3818,27170049,*mast cell
3818,27170049,*nf-κb controlled cytokine
3818,27170049,*nf-κb inhibitor
3818,27170049,*orbital fibroblast
3820,29270757,graves’ ophthalmopathy
3820,29270757,magnetic resonance
3820,29270757,methylprednisolone
3828,28941661,*anion transporters
3828,28941661,*homology modeling
3828,28941661,*membrane proteins
3828,28941661,*pathogenic mutations
3828,28941661,*slc26
3828,28941661,*solute carriers
3828,28941661,*trafficking
3828,28941661,*transport
3830,28063079,autoimmunity
3830,28063079,graves’ disease
3830,28063079,graves’ orbitopathy
3830,28063079,microbiota and dysbiosis
3831,26864507,*graves disease
3831,26864507,*hypothyroidism
3831,26864507,*radioiodine therapy
3831,26864507,*thyroid hormones
3831,26864507,*treatment outcome
3835,26686233,lateral rim repositioning
3835,26686233,orbital decompression
3835,26686233,proptosis
3835,26686233,thyroid eye disease
3835,26686233,thyroid related orbitopathy
3837,27762730,*tshr
3837,27762730,*autoimmune thyroid disease
3837,27762730,*intractability
3837,27762730,*polymorphism
3837,27762730,*severity
3838,27245701,col13a1
3838,27245701,thyroid-associated ophthalmopathy
3838,27245701,collagen xiii
3838,27245701,extraocular fat
3838,27245701,thyroid eye disease
3845,28463526,*overcorrection
3845,28463526,*strabismus surgery
3845,28463526,*thyroid eye disease
3845,28463526,*vertical strabismus
3846,26799350,breastfeeding
3846,26799350,endocrinology
3846,26799350,pharmacology
3846,26799350,pregnancy
3846,26799350,thyroid
3846,26799350,women's health
3848,29262478,genetic testing
3848,29262478,"receptors, thyroid hormone"
3848,29262478,thyroid hormone resistance syndrome
3849,27376649,ectopic (parasitic) goiter
3849,27376649,hashimoto’s autoimmune thyroiditis
3849,27376649,high plasma cell content
3849,27376649,hürthle cell
3849,27376649,lymph node metastasis
3850,28684549,*bisphenol a
3850,28684549,*endocrine disrupting chemical
3850,28684549,*iodine excess intake
3850,28684549,*nodular goiter
3850,28684549,*papillary thyroid carcinoma cois manuscript.
3858,27371612,histopathology
3858,27371612,molecular pathology
3858,27371612,thyroid cancer
3859,26876240,*graves’ orbitopathy
3859,26876240,*orbital radiation
3859,26876240,*systemic steroids
3859,26876240,*thyroid-associated orbitopathy
3862,29085976,grave’s orbitopathy
3862,29085976,increase of intraorbital pressure
3862,29085976,orbital diseases
3862,29085976,postoperative complications
3862,29085976,postoperative intraorbital hemorrhage
3864,26540014,intraoperative neuromonitoring (ionm)
3864,26540014,recurrent laryngeal nerve (rln)
3864,26540014,robotic thyroid surgery
3864,26540014,transaxillary robotic surgery
3864,26540014,vagal automatic periodic stimulation (aps)
3866,27848228,dna polymerase
3866,27848228,graves’ disease
3866,27848228,iodide peroxidase and mrnas
3868,27729751,*age group
3868,27729751,*computed tomography
3868,27729751,*computer communication network
3868,27729751,*lacrimal gland
3868,27729751,*thyroid-associated ophthalmopathy cois
3870,28392335,(131)i
3870,28392335,agranulocitosis
3870,28392335,agranulocytosis
3870,28392335,anti-thyroid drugs
3870,28392335,enfermedad de graves
3870,28392335,fármacos antitiroideos
3870,28392335,graves’ disease
3874,27792295,*graves' disease
3874,27792295,*hashimoto's thyroiditis
3874,27792295,*lymphocytic thyroiditis
3874,27792295,*papillary carcinoma
3874,27792295,*thyroid cancer
3875,29047240,exophthalmos
3875,29047240,korea
3875,29047240,sialyltransferases
3875,29047240,single nucleotide polymorphism
3875,29047240,thyroid-associated ophthalmopathy cois
3877,28195542,autoimmune thyroid diseases
3877,28195542,intractability
3877,28195542,intraindividual variation
3877,28195542,microrna
3877,28195542,severity
3879,27844093,diffusion tensor imaging
3879,27844093,extraocular muscle
3879,27844093,mri
3879,27844093,thyroid associated orbitopathy
3882,26860528,botulinum toxin
3882,26860528,restrictive strabismus
3882,26860528,strabismus surgery
3882,26860528,thyroid eye disease
3883,27449491,alternating diplopia
3883,27449491,alternating orthotropia
3883,27449491,cyclic vertical deviation
3883,27449491,dysthyroid ophthalmopathy
3885,27272160,*graves’ disease
3885,27272160,*adverse drug reactions
3885,27272160,*cutaneous figurate erythema
3885,27272160,"*methimazole cois conflicts of interest with respect to the research, authorship, and/or publication of this article."
3886,29030215,cost-effectiveness
3886,29030215,ionm
3886,29030215,nerve injury
3886,29030215,neural monitoring
3886,29030215,thyroid surgery
3889,27919794,*graves disease
3889,27919794,*ischemic stroke
3889,27919794,*magnetic resonance imaging
3889,27919794,*vasculitis
3889,27919794,*vessel wall imaging
3891,28845025,anti-thyroid peroxidase antibody
3891,28845025,graves’ disease
3891,28845025,hashimoto’s disease
3891,28845025,polymorphism
3891,28845025,severity
3898,27734978,complications
3898,27734978,different approaches
3898,27734978,graves’ orbitopathy
3898,27734978,orbital decompression
3900,29152991,esophageal carcinoma
3900,29152991,gastrointestinal stromal tumors
3900,29152991,non-small cell lung cancer
3900,29152991,thyroid papillary carcinoma
3900,29152991,multi-organ primary carcinoma
3902,25835075,dythyroid optic neuropathy
3902,25835075,endoscopic transethomoid medial orbital wall decompression
3902,25835075,endoscopic transethomoid orbital fat decompression
3902,25835075,proptosis reduction
3903,25835051,dysthyroid optic neuropathy
3903,25835051,mean deviation
3903,25835051,pattern standard deviation
3903,25835051,three-wall orbital decompression
3903,25835051,two-wall orbital decompression
3904,28284988,*cd279
3904,28284988,*graves' disease
3904,28284988,*hyperthyroidism
3904,28284988,*lymphocytes
3904,28284988,*pd-1
3906,26699948,brow fat hypertrophy
3906,26699948,premalar fat hypertrophy
3906,26699948,thyroid eye disease
3908,28606259,"decompression, surgical"
3908,28606259,graves ophthalmopathy
3908,28606259,orbit
3912,28768936,hashimoto’s thyroiditis
3912,28768936,thyroglobulin antibodies
3912,28768936,thyroid peroxidase antibodies
3914,27245255,*graves’ disease
3914,27245255,*hashimoto’s disease
3914,27245255,*sirt1
3914,27245255,*snp
3914,27245255,*intractability
3914,27245255,*severity
3915,28547036,atrial fibrillation
3915,28547036,graves’ disease
3915,28547036,microrna
3915,28547036,thyroid hormone
3916,27808570,*dicer
3916,27808570,*drosha
3916,27808570,*autoimmune thyroid disease
3916,27808570,*severity
3916,27808570,*single nucleotide polymorphism
3917,27387241,graves’ orbitiopathy
3917,27387241,anti-cel
3917,27387241,anti-cml
3917,27387241,methylprednisolone treatment
3918,28669056,autoimmune thyroiditis
3918,28669056,graves’ disease
3918,28669056,hashimoto’s thyroiditis
3918,28669056,th17 cells
3918,28669056,th22 cells
3919,25567342,laryngopharyngeal reflux
3919,25567342,local neck symptoms
3919,25567342,nodular goiter
3919,25567342,thyroidectomy
3923,26567020,*cosmesis
3923,26567020,*orbit
3923,26567020,*treatment surgery
3924,27422248,*gas inflation
3924,27422248,*single-incision endoscopic thyroidectomy
3924,27422248,*trans-axillary endoscopic thyroidectomy
3931,26666958,*cancer
3931,26666958,*coupling
3931,26666958,*metabolism
3931,26666958,*papillary
3931,26666958,*thyroid
3932,28742402,graves’ disease
3932,28742402,hashimoto’s disease
3932,28742402,il-10
3932,28742402,mirna
3932,28742402,polymorphism
3933,28243072,graves ophthalmopathy
3933,28243072,age-related
3933,28243072,autoimmune thyroidopathy
3933,28243072,elderly
3933,28243072,subconjunctival orbital fat prolapse
3933,28243072,thyroid associated orbitopathy cois
3935,26744121,pendred syndrome
3935,26744121,tp53
3935,26744121,thyroid carcinoma
3936,26683653,capsular dissection
3936,26683653,guidelines
3936,26683653,intraoperative
3936,26683653,neurophysiological monitoring
3936,26683653,nodular goiter
3937,27877085,*autophagy
3937,27877085,*age-related macular degeneration
3937,27877085,*cataracts
3937,27877085,*diabetic retinopathy
3937,27877085,*ocular tumours.
3937,27877085,*thyroid-associated ophthalmopathy cois
3939,28413173,autoimmune thyroid diseases
3939,28413173,graves’ disease
3939,28413173,hashimoto’s thyroiditis
3939,28413173,serum 25-hydroxyvitamin d
3939,28413173,vitamin d deficiency
3942,28219358,*graves’ disease
3942,28219358,*innate immunity
3942,28219358,*tlrs
3945,28883260,graves’ disease
3945,28883260,metastasis
3945,28883260,thyroid carcinoma
3946,28473357,arrhythmias
3946,28473357,paediatrics (drugs and medicines)
3946,28473357,thyroid disease cois
3949,28078992,*tobacco smoking
3949,28078992,*adults
3949,28078992,*children
3949,28078992,*ocular inflammation
3949,28078992,*optic neuropathy
3949,28078992,*orbitopathy
3949,28078992,*retinopathy
3953,27769543,*grave's disease
3953,27769543,*potassium iodide
3953,27769543,*thyroidectomy
3960,26884288,graves’ disease
3960,26884288,graves’ orbitopathy
3960,26884288,dysthyroid optic neuropathy
3960,26884288,endoscopic intranasal orbital decompression
3960,26884288,methylprednisolone
3960,26884288,orbital decompression
3961,28741406,thyroid eye disease
3961,28741406,compressive optic neuropathy
3961,28741406,decompression
3961,28741406,diplopia
3961,28741406,orbit
3961,28741406,proptosis
3962,28699478,*graves' disease
3962,28699478,*antithyroid drugs
3962,28699478,*continuous therapy
3962,28699478,*long-term therapy
3962,28699478,*meta-analysis
3962,28699478,*methimazole
3962,28699478,*propylthiouracil
3964,27692684,*endocrine orbitopathy
3964,27692684,*navigated surgery
3964,27692684,*piezosurgery
3970,28851197,graves ophthalmopathy
3970,28851197,psychometrics
3970,28851197,quality of life
3970,28851197,root cause analysis
3975,28341401,*hearing loss
3975,28341401,*localization
3975,28341401,*misfolding
3975,28341401,*molecular chaperone
3975,28341401,*morphological analysis
3975,28341401,*p123s mutant
3975,28341401,*pendrin
3977,26979769,*graves’ orbitopathy
3977,26979769,*pai-1
3977,26979769,*tgf-β
3977,26979769,*cell density
3977,26979769,*hyaluronan
3977,26979769,*orbital fibroblasts
3980,26701678,antithyroid drugs
3980,26701678,graves’ disease
3980,26701678,natural killer t cells
3980,26701678,radioactive iodine
3980,26701678,regulatory t cells
3981,28235670,*comparative study
3981,28235670,*conventional open
3981,28235670,*endoscopy
3981,28235670,*graves' disease
3981,28235670,*meta-analysis
3981,28235670,*thyroidectomy
3982,27615550,*graves’ disease
3982,27615550,*hyperthyroidism
3982,27615550,*antithyroid drugs
3982,27615550,*carbimazole
3982,27615550,*methimazole
3982,27615550,*propylthiouracil
3984,28859864,decision making
3984,28859864,game of dice task
3984,28859864,graves’ disease
3984,28859864,hyperthyroidism
3984,28859864,thyroid hormones
3985,28259878,cytopathology
3985,28259878,fine needle aspiration
3985,28259878,graves disease
3985,28259878,thyroid
3989,27771369,homology modeling
3989,27771369,mutation mapping
3989,27771369,non-syndromic hearing loss with enlarged vestibular aqueduct (ns-eva)
3989,27771369,pendred syndrome
3989,27771369,pendrin
3989,27771369,slc26a4
3989,27771369,transmembrane protein
3993,28515387,aitd
3993,28515387,il-12
3993,28515387,il-18
3993,28515387,polymorphism
3993,28515387,socs1
4001,27160433,*diabetes mellitus
4001,27160433,*endocrine tumor
4001,27160433,*granulomatous insulitis
4001,27160433,*pancreas
4005,27612658,*graves' disease
4005,27612658,*autoimmunity
4005,27612658,*fibrocyte
4005,27612658,*interleukin-12
4005,27612658,*thyroid-associated ophthalmopathy cois interest in any material discussed in this article.
4007,27543288,*biochemistry
4007,27543288,*experimental &#8211 laboratory
4007,27543288,*inflammation
4007,27543288,*orbit
4009,27580012,col13a1
4009,27580012,collagen xiii
4009,27580012,thyroid eye disease
4009,27580012,thyroid-associated ophthalmopathy
4011,28500376,graves’ disease
4011,28500376,ptpn22
4011,28500376,rheumatoid arthritis
4011,28500376,systemic lupus erythematosus
4012,27369733,convergence spasm
4012,27369733,cranial nerve palsy
4012,27369733,double vision
4012,27369733,graves’ disease
4012,27369733,strabismus
4017,26675405,adipocyte
4017,26675405,cytokine
4017,26675405,fibrocyte
4017,26675405,fibrosis
4017,26675405,graves' ophthalmopathy
4017,26675405,growth factor
4017,26675405,hyaluronan
4017,26675405,inflammation
4017,26675405,orbital fibroblast
4019,29093229,ctla-4 gene exon 1
4019,29093229,ctla-4 gene with promotor-318
4019,29093229,regulatory t cells
4019,29093229,tshr gene rs2268458 intron 1
4019,29093229,thyroid receptor antibody (trab)
4019,29093229,graves’ disease
4019,29093229,relapse
4022,27987077,epstein–barr virus
4022,27987077,graves’ disease
4022,27987077,graves’ orbitopathy
4022,27987077,idiopathic inflammatory pseudotumor
4022,27987077,thyroid
4023,27637079,graves’ disease
4023,27637079,t3
4023,27637079,neutrophils
4023,27637079,resistin
4025,27113266,pediatric graves' disease
4025,27113266,pediatric hyperthyroidism
4025,27113266,shared decision making
4025,27113266,thyroidectomy
4026,27793633,(177)lu-dotatate
4026,27793633,cáncer de tiroides
4026,27793633,peptide receptor radionuclide therapy
4026,27793633,radioactive iodine refractory
4026,27793633,refractario al yodo radiactivo
4026,27793633,thyroid neoplasms
4026,27793633,tratamiento con análogos de la somatostatina radiomarcados
4031,27130144,ck5/6
4031,27130144,cytokeratin
4031,27130144,lymphoepithelial complex
4031,27130144,p63
4031,27130144,squamous cell metaplasia
4031,27130144,thyroid
4031,27130144,thyroiditis
4034,28201927,graves’ disease
4034,28201927,cytological alteration
4034,28201927,histologic changes
4034,28201927,radioactive iodine treatment
4034,28201927,thyroid
4037,27700191,parathyroid autotransplantation
4037,27700191,hypocalcemia
4037,27700191,inadvertent parathyroidectomy
4037,27700191,parathormone
4037,27700191,thyroidectomy
4042,28336282,botulinum toxin type a
4042,28336282,dysthyroid orbitopathy
4042,28336282,grave's disease
4042,28336282,maladie de basedow
4042,28336282,ophtalmopathie dysthyroïdienne
4042,28336282,orbital inflammatory disease
4042,28336282,orbitopathie inflammatoire
4042,28336282,rétraction palpébrale supérieure
4042,28336282,toxine botulique a
4042,28336282,upper eyelid retraction
4043,27638540,cd28/ctla-4/icos
4043,27638540,gene polymorphism
4043,27638540,graves’ disease
4043,27638540,graves’ orbitopathy
4043,27638540,haplotype cois
4044,28895066,131i therapy
4044,28895066,graves’ hyperthyroidism
4044,28895066,lithium carbonate
4044,28895066,thyroid
4046,28185649,*anti-cd20
4046,28185649,*graves ophthalmopathy
4046,28185649,*neuropathie optique
4046,28185649,*optic neuropathy
4046,28185649,*orbitopathie basedowienne
4046,28185649,*rituximab
4049,28825582,*immunosuppressive agents
4049,28825582,*multiple organ failure
4049,28825582,*plasmapheresis
4049,28825582,*thyroid crisis
4049,28825582,*thyroidectomy
4052,28001121,*graves' disease
4052,28001121,*antithyroid agents
4052,28001121,*long-term prognosis
4053,27734319,autoimmunity
4053,27734319,graves’ disease
4053,27734319,hyperthyroidism
4053,27734319,selenium
4053,27734319,thyroid
4055,28705701,graves disease
4055,28705701,orbital decompression surgery
4055,28705701,piezosurgery
4055,28705701,thyroid-associated orbitopathy
4057,28176220,clinical activity score
4057,28176220,cyclosporine
4057,28176220,graves’ orbitopathy or ophthalmopathy
4057,28176220,intravenous glucocorticoids
4057,28176220,orbital radiotherapy
4057,28176220,shared decision-making
4058,26626367,graves' disease
4058,26626367,hyperthyroidism
4058,26626367,surgery
4058,26626367,thyroid carcinoma
4058,26626367,thyroid nodules
4061,27266815,aire
4061,27266815,apeced
4061,27266815,autoimmunity
4061,27266815,graves’ disease
4061,27266815,mutation
4061,27266815,polymorphism
4062,25855160,autoimmune thyroid disease
4062,25855160,instrumentation
4062,25855160,thyroid
4062,25855160,tissue characterization
4062,25855160,ultrasound
4067,29307154,graves
4067,29307154,interleukin-6
4067,29307154,meta-analysis
4067,29307154,polymorphism
4068,28223014,decompression
4068,28223014,endocrine orbitopathy
4068,28223014,navigated surgery
4071,27863461,*genome-wide association study
4071,27863461,*graves’ disease
4071,27863461,*pooled blood
4073,27618833,graves’ disease
4073,27618833,iodine radioisotopes
4073,27618833,pregnancy outcome
4074,27566407,calreticulin(calr)
4074,27566407,endoplasmic reticulum (er) stress
4074,27566407,graves' disease(gd)
4074,27566407,heat shock 70kda protein 5(hspa5)
4074,27566407,proteomics
4075,27419847,*choroidal thickness
4075,27419847,*graves’ disease
4075,27419847,*graves’ ophthalmopathy
4075,27419847,*clinical activity score
4075,27419847,*optical coherence tomography
4076,27163552,graves disease
4076,27163552,moyamoya
4076,27163552,stroke
4076,27163552,vasculopathy
4077,26932949,*graves’ disease
4077,26932949,*balanced decompression
4077,26932949,*endoscopic orbital decompression
4077,26932949,*orbital decompression
4077,26932949,*orbital sling
4077,26932949,*orbital strut
4078,28042648,*graves’ orbitopathy
4078,28042648,*intravenous steroids
4078,28042648,*orbital irradiation
4078,28042648,*radioiodine therapy
4080,26886940,graves’ orbitopathy
4080,26886940,ich guideline
4080,26886940,medical dictionary for regulatory activities (meddra)
4080,26886940,mycophenolate
4080,26886940,safety
4081,27206624,*graves’ disease
4081,27206624,*hashimoto’s thyroiditis
4081,27206624,*th17
4081,27206624,*tregs
4081,27206624,*anti-thyroid antibodies
4083,28506419,99m tc-mibi scintigraphy
4083,28506419,mibi uptake
4083,28506419,radioguided surgery
4083,28506419,thyroid cancer
4083,28506419,thyroid follicular neoplasm
4083,28506419,thyroidectomy
4088,27107937,*coexpression
4088,27107937,*graves' disease
4088,27107937,*ox40/ox40l
4088,27107937,*t cell activation
4090,27762178,endoscopic surgical procedure
4090,27762178,mri
4090,27762178,skull base
4091,29246597,*autoantibody
4091,29246597,*encephalitis
4091,29246597,*hashimoto's encephalopathy
4091,29246597,*intravenous immunoglobulin
4097,27143020,intraoperative neuromonitoring
4097,27143020,prognostic value
4097,27143020,recurrent laryngeal nerve
4097,27143020,staged thyroidectomy
4097,27143020,thyroid surgery cois interest: author małgorzata stopa declares that she has no conflict of interest. author marcin barczyński declares that he has no conflict of interest. ethical approval: all procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 helsinki declaration and its later amendments or comparable ethical standards. informed consent: informed consent was obtained from all individual participants included in the study.
4104,28119492,*antibody
4104,28119492,*gene polymorphism
4104,28119492,*hla-dq
4104,28119492,*ocular myasthenia gravis
4104,28119492,*tnf-α
4104,28119492,*thyroid associated ophthalmopathy cois manuscript.
4108,28236218,agranulocytosis
4108,28236218,antithyroid drug
4108,28236218,graves’ disease
4108,28236218,hyperthyroidism
4109,26850223,autoimmune thyroid diseases
4109,26850223,cytokines
4109,26850223,graves' disease
4109,26850223,hashimoto's disease
4109,26850223,single nucleotide polymorphisms
4109,26850223,thyroid-associated ophthalmopathy
4111,28606262,"decompression, surgical"
4111,28606262,graves ophthalmopathy
4111,28606262,optic nerve diseases
4111,28606262,orbit
4111,28606262,treatment outcome
4115,26735162,*in vivo confocal microscopy
4115,26735162,*langerhans cells
4115,26735162,*inflammation
4115,26735162,*ocular surface
4115,26735162,*thyroid-associated ophthalmopathy
4116,26559967,strabismus
4116,26559967,surgical outcomes
4116,26559967,thyroid eye disease
4117,28453366,thyroid eye disease
4117,28453366,compressive optic neuropathy
4117,28453366,visual field
4120,26775634,adjustable sutures
4120,26775634,endocrine orbitopathy
4120,26775634,orbital decompression
4120,26775634,restrictive strabismus
4120,26775634,strabismus surgery
4120,26775634,thyroid associated ophthalmopathy
4121,26635355,slc26
4121,26635355,stas domain
4121,26635355,anion transporters
4121,26635355,inherited diseases
4121,26635355,membrane protein folding
4122,28061802,endoscopy
4122,28061802,graves’ disease
4122,28061802,neurosurgery
4122,28061802,pituitary neoplasms
4122,28061802,tsh-producing tumor
4122,28061802,tshoma
4122,28061802,thyrotropin
4123,28502931,22q11.2 deletion syndrome
4123,28502931,graves' disease
4123,28502931,hla
4123,28502931,regulatory t-cell
4127,27824294,*graves'
4127,27824294,*fibroblast
4127,27824294,*ophthalmopathy
4127,27824294,*orbitopathy
4127,27824294,*selenium
4129,26795296,arylesterase
4129,26795296,autoimmune thyroid disease
4129,26795296,oxidative status
4129,26795296,paraoxonase cois that could be perceived as prejudicing the impartiality of the research reported.
4132,27838736,activity
4132,27838736,computed tomography
4132,27838736,hounsfield unit
4132,27838736,orbital volume
4132,27838736,thyroid-associated orbitopathy
4134,28070798,*addison’s disease
4134,28070798,*autoimmune polyendocrine syndromes
4134,28070798,*autoimmunity
4134,28070798,*environment
4134,28070798,*graves’ disease
4134,28070798,*hashimoto’s thyroiditis
4134,28070798,*lifestyle
4134,28070798,*type 1 diabetes mellitus
4134,28070798,*vitamin d
4137,27465669,*glucocorticoid
4137,27465669,*graves’ ophthalmopathy
4137,27465669,*hepatitis
4137,27465669,*statins
4138,29187926,basedow-graves ophthalmopathy
4138,29187926,corticosteroids
4138,29187926,exophthalmos decompression
4138,29187926,neuropathy
4140,28742400,autoimmune thyroid diseases
4140,28742400,cd40
4140,28742400,single nucleotide polymorphism
4145,26935935,autoimmunity
4145,26935935,graves’ disease
4145,26935935,primary biliary cirrhosis
4146,26864865,autoimmune thyroid diseases
4146,26864865,graves’ disease
4146,26864865,hashimoto thyroiditis
4146,26864865,cytokine
4146,26864865,interleukin-1β
4147,28209438,graves’ disease
4147,28209438,hypocretin
4147,28209438,myasthenia gravis
4147,28209438,myotonic dystrophy
4148,28081504,hashimoto's thyroiditis
4148,28081504,igg
4148,28081504,neonatal fc receptor
4148,28081504,tgab
4148,28081504,th1/th2 cytokines
4149,28630226,disturbances
4149,28630226,endocrinology
4149,28630226,fluid electrolyte and acid-base
4149,28630226,muscle
4149,28630226,thyroid disease cois
4150,27810496,alopecia areata
4150,27810496,graves’ disease
4150,27810496,non-hla genes
4150,27810496,trab
4150,27810496,type 1 diabetes
4151,26876268,graves’ orbitopathy
4151,26876268,igg4-asszociált betegség
4151,26876268,igg4-related disease
4151,26876268,endokrin orbitopathia
4151,26876268,idiopathic inflammatory orbitopathy
4151,26876268,idiopathiás inflammatorikus orbitopathia
4151,26876268,myasthenia gravis
4151,26876268,occularis lymphoma
4151,26876268,ocular lymphoma
4152,29196352,deaf awareness
4152,29196352,hearing impaired
4152,29196352,young people
4153,28238453,graves disease
4153,28238453,hashimoto thyroiditis
4153,28238453,autoimmune thyroiditis
4153,28238453,hyperthyroidism
4153,28238453,hypothyroidism
4153,28238453,thyroid cancer
4153,28238453,vitiligo
4158,27116895,igg4-related disease
4158,27116895,lymphocyte/plasma cell infiltrations
4158,27116895,malt lymphomas
4158,27116895,orbital pseudotumors
4160,26965896,endoscopic thyroidectomy
4160,26965896,graves’ disease
4160,26965896,hypocalcemia
4160,26965896,parathyroid preservation
4161,26204988,berke incision approach
4161,26204988,chemosis
4161,26204988,deep lateral orbital wall decompression
4161,26204988,swinging eyelid approach
4162,27273008,oscillopsia
4162,27273008,proptosis
4162,27273008,temporal hollowing
4162,27273008,thyroid eye disease
4162,27273008,visual acuity
4163,27259978,clpp
4163,27259978,slc26a4
4163,27259978,tbc1d24
4163,27259978,pendred syndrome
4163,27259978,perrault syndrome
4163,27259978,enlarged vestibular aqueduct
4163,27259978,hereditary deafness cois
4164,28665696,14q32.2
4164,28665696,ciqtnf6
4164,28665696,graves' disease
4164,28665696,rac2
4164,28665696,snp
4164,28665696,association
4165,28660988,graves' orbitopathy
4165,28660988,clinical activity score
4165,28660988,dysthyroid optic neuropathy
4165,28660988,rituximab
4165,28660988,thyroid gland
4167,28364200,graves’ orbitopathy
4167,28364200,inflammation
4167,28364200,orbital fibroblasts
4167,28364200,s1p receptor antagonist
4167,28364200,sphingosine-1-phosphate
4168,26955881,*genetics
4168,26955881,*graves’ disease
4168,26955881,*hashimoto thyroiditis
4168,26955881,*vegf
4168,26955881,*polymorphisms
4169,28689782,*bacteria
4169,28689782,*graves' disease
4169,28689782,*hashimotos's thyroiditis
4170,29180171,*graves' disease
4170,29180171,*hyperthyroidism
4170,29180171,*recurrence
4170,29180171,*subtotal thyroidectomy
4171,29088997,*graves' disease
4171,29088997,*antineutrophil cytoplasmic antibody
4171,29088997,*propylthiouracil
4171,29088997,*vasculitis
4172,29050489,*graves' ophthalmopathy
4172,29050489,*inflammation biomarker.
4172,29050489,*neutrophil-to-lymphocyte ratio
4172,29050489,*thyroid ophthalmopathy
4174,27247969,*grave’s disease
4174,27247969,*ted
4174,27247969,*ted treatment options
4174,27247969,*thyroid eye disease
4176,28260364,"decompression, surgical"
4176,28260364,graves ophthalmopathy
4176,28260364,orbit
4176,28260364,"surgical procedures, minimally invasive"
4176,28260364,treatment outcome
4177,26865797,diplopia
4177,26865797,exophthalmos
4177,26865797,eyelid retraction
4177,26865797,graves ophthalmopathy
4177,26865797,orbital decompression cois was reported.
4179,28606264,graves ophthalmopathy
4179,28606264,magnetic resonance imaging
4179,28606264,oculomotor muscles
4180,28388348,decompression
4180,28388348,graves’ disease
4180,28388348,geriatric
4180,28388348,strabismus
4180,28388348,thyroid eye disease cois alone are responsible for the content and writing of the paper.
4183,28439882,*graves' disease
4183,28439882,*hashimoto's thyroiditis
4183,28439882,*tsh-receptor blocking antibodies
4183,28439882,*tsh-receptor stimulating antibodies
4183,28439882,*bioassay
4184,28743746,*graves' disease
4184,28743746,*iodination
4184,28743746,*post-translational modification (ptm)
4184,28743746,*protein processing
4184,28743746,*protein secretion
4184,28743746,*thyroglobulin
4184,28743746,*thyroid
4184,28743746,*thyroid hormone cois this article
4186,27888002,*autoimmune thyroid diseases (aitd)
4186,27888002,*graves' disease (gd)
4186,27888002,*hashimoto's thyroiditis (ht)
4186,27888002,*micrornas
4186,27888002,*single nucleotide polymorphism (snp)
4189,26767650,graves’ disease
4189,26767650,graves’ ophthalmopathy
4189,26767650,graves’ orbitopathy
4189,26767650,nicotinamide phosphoribosyltransferase
4189,26767650,pre-b cell colony-enhancing factor
4189,26767650,visfatin
4191,29110673,clinical outcomes
4191,29110673,graves’ ophthalmopathy
4191,29110673,"imrt cois ethics committee of west china hospital, sichuan university. informed consent was obtained from all individual participants included in the study. consent for publication: the consent to publish the study and accompanying images was obtained. competing interests: the authors declare that they have no competing interests. publisher’s note: springer nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations."
4195,28895880,graves’ disease
4195,28895880,hashimoto’s thyroiditis
4195,28895880,autoimmune thyroid disease
4195,28895880,thyroid cancer
4195,28895880,vitamin d cois
4196,28833367,graves’ hyperthyroidism
4196,28833367,ferritin
4196,28833367,hepcidin
4196,28833367,iron metabolism
4198,28133945,graves' orbitopathy
4198,28133945,field of binocular single vision
4198,28133945,quality of life
4198,28133945,strabismus surgery
4200,28521825,"*graves’ disease, susceptibility, single nucleotide polymorphisms, 4p14, 6q27"
4202,27003434,acute liver damage
4202,27003434,graves’ ophthalmopathy
4202,27003434,hepatotoxicity
4202,27003434,intravenous glucocorticoid therapy
4202,27003434,methylprednisolone
4204,29130665,hyaluronic acid
4204,29130665,insulin-like growth factor-1 receptor
4204,29130665,signal pathway
4204,29130665,thyroid associated ophthalmopathy
4205,28781323,sitsh
4205,28781323,familial dysalbuminemic hyperthyroxinemia (fdh)
4205,28781323,thiamazole
4208,27160786,enlarged
4208,27160786,fluctuation
4208,27160786,hearing loss
4208,27160786,large
4208,27160786,risk factor
4208,27160786,vertigo
4208,27160786,vestibular aqueduct
4209,28756232,*akt/nf-κb
4209,28756232,*galectin-9
4209,28756232,*inflammation
4209,28756232,*thyroid-associated ophthalmopathy
4209,28756232,*tim3
4210,27558389,*auto-immune thyroid dysfunction
4210,27558389,*chordoma
4210,27558389,*tyrosine kinase inhibitors
4211,27718482,graves’ disease
4211,27718482,analytical interference
4211,27718482,biotin
4211,27718482,hyperestrogenism
4211,27718482,immunoassay
4214,27234136,células t reguladoras (tregs)
4214,27234136,enfermedad de graves
4214,27234136,graves’ disease
4214,27234136,hashimoto's thyroiditis
4214,27234136,t helper
4214,27234136,t regulatory cells (treg)
4214,27234136,th17
4214,27234136,thyroid autoimmunity
4214,27234136,tiroideas autoinmunitarias
4214,27234136,tiroiditis de hashimoto
4216,26459776,dna methylation
4216,26459776,epigenetics
4216,26459776,graves' disease
4216,26459776,t cell signaling
4216,26459776,tshr
4219,27267669,*fibroblast growth factor
4219,27267669,*graves’ ophthalmopathy
4219,27267669,*hyaluronan
4219,27267669,*orbital fibroblast
4219,27267669,*platelet-derived growth factor-bb
4219,27267669,*vascular endothelial growth factor
4220,28450690,*basedow’s disease
4220,28450690,*sjogren’s syndrome
4220,28450690,*autoimmune diseases
4220,28450690,*chronic myopathic type
4220,28450690,*sarcoid myopathy
4221,28333576,*epstein–barr virus
4221,28333576,*graves' disease
4221,28333576,*activation-induced cytidine deaminase
4221,28333576,*autoreactive b cells
4221,28333576,*polyclonal b cell activation
4221,28333576,*reactivation cois
4224,26854256,autoimmune diseases
4224,26854256,coeliac disease
4224,26854256,comorbidity
4226,28636775,autoimmune thyroid disease
4226,28636775,cd163
4226,28636775,fn14
4226,28636775,tweak
4227,27986127,*graves' disease
4227,27986127,*hyperthyroidism
4227,27986127,*irisin
4227,27986127,*myostatin
4230,27458112,apoptosis
4230,27458112,autoimmune thyroid disease
4230,27458112,intractability
4230,27458112,polymorphism
4230,27458112,severity
4231,28049375,*graves' disease
4231,28049375,*antithyroid drugs (atds)
4231,28049375,*comparative effectiveness
4231,28049375,*hyperthyroidism
4231,28049375,*radioactive iodine (rai)
4231,28049375,*thyroidectomy cois
4234,29102101,graves disease
4234,29102101,cardiogenic shock
4234,29102101,iodinated contrast
4234,29102101,thyroid storm
4235,29235358,glioblastoma multiforme
4235,29235358,learning curve brain neoplasm
4235,29235358,multi-disciplinary team
4236,28187375,8-ohdg
4236,28187375,graves's disease
4236,28187375,hashimoto thyroiditis
4236,28187375,papillary thyroid carcinoma
4238,26791860,acute graft-versus-host disease
4238,26791860,dna typing
4238,26791860,epistatic interaction
4238,26791860,genome diversity
4238,26791860,graft-versus-leukemia effect
4238,26791860,graves’ disease
4238,26791860,hla allele
4238,26791860,hla class i and class ii gene and molecule
4238,26791860,hla haplotype
4238,26791860,hashimoto thyroiditis
4238,26791860,linkage disequilibrium
4238,26791860,next-generation sequencing
4238,26791860,polymorphism
4238,26791860,regulatory t cell
4238,26791860,thyroglobulin antibody and serum level
4238,26791860,thyroid peroxidase antibody and serum level
4238,26791860,thyroid stimulating hormone receptor antibody and serum level
4238,26791860,unrelated hematopoietic stem cell transplantation
4239,26997461,goitre ovarien
4239,26997461,kyste ovaire
4239,26997461,ovarian cyst
4239,26997461,struma ovarii
4239,26997461,thyroid
4239,26997461,thyroïde
4240,28087387,*a proliferation-inducing ligand (april)
4240,28087387,*b-cell activating factor (baff)
4240,28087387,*graves' orbitopathy
4240,28087387,*orbital fibroblasts
4242,27729026,*goitre in pregnancy
4242,27729026,*iodine status in pregnancy
4242,27729026,*thyroid stimulating hormone
4242,27729026,*thyroid volume
4242,27729026,*urinary iodine
4244,28099999,*graves' disease
4244,28099999,*tshr autoantibodies
4244,28099999,*autoimmunity
4244,28099999,*intrathymic transcription
4244,28099999,*thyroid autoantigens
4244,28099999,*tolerance
4246,27345036,graves’ disease
4246,27345036,tgfbeta1
4246,27345036,nodular goiter
4246,27345036,papillary cancer
4246,27345036,thyroid
4246,27345036,transforming growth factor beta 1
4247,26518171,alopecia areata
4247,26518171,associations
4247,26518171,autoimmune disease
4247,26518171,comorbidities
4247,26518171,prevalence
4247,26518171,thyroid disease
4247,26518171,vitiligo
4248,28604944,graves’ orbitopathy
4248,28604944,adrenal insufficiency
4248,28604944,cortisol
4248,28604944,glucocorticoids
4248,28604944,methylprednisolone
4250,27245471,*autoimmune thyroid disease
4250,27245471,*chemokine
4250,27245471,*intractability
4250,27245471,*severity
4250,27245471,*single nucleotide polymorphism
4251,28595789,goitre prevalence
4251,28595789,iodine intake
4251,28595789,saharawi refugee camps
4251,28595789,urinary iodine concentration
4251,28595789,water iodine concentration
4252,27888493,goitre
4252,27888493,medical diagnosis
4252,27888493,painting
4252,27888493,de ribera
4255,28420934,"goitre, hyperthyroidism, hypothyroidism, thyroid nodules."
4256,29169383,multinodular goitre
4256,29169383,saudi arabia
4256,29169383,solitary nodule
4256,29169383,thyroid fine needle aspiration cytology
4257,26996162,airway obstruction
4257,26996162,goitre
4257,26996162,intratracheal
4257,26996162,intubation
4258,28521312,children
4258,28521312,goitre
4258,28521312,iodine prophylaxis
4258,28521312,thyroid volume
4258,28521312,ultrasound examination
4260,25880137,*iodine
4260,25880137,*cognition
4260,25880137,*development
4260,25880137,*goitre
4260,25880137,*thyroid hormones
4261,27364542,*esrd
4261,27364542,*tsh
4261,27364542,*nodular goiter
4261,27364542,*thyroid gland
4261,27364542,*urinary iodine excretion
4262,28474274,*endoscopic thyroidectomy
4262,28474274,*goiter
4262,28474274,*mediastinal emphysema
4262,28474274,*robotic thyroidectomy
4262,28474274,*subcutaneous emphysema
4263,26612322,advanced spectral imaging
4263,26612322,duel-energy computed tomography
4263,26612322,intranodular hemorrhage
4263,26612322,material decomposition
4263,26612322,thyroid nodule
4264,28098046,* ht-us hypoechoic pattern at thyroid ultrasound
4264,28098046,* iqr interquartile range
4264,28098046,* tpoab thyroperoxidase antibodies
4264,28098046,* tsh thyroid-stimulating hormone
4264,28098046,* tgab thyroglobulin
4264,28098046,* uie urinary i excretion
4264,28098046,*goitre
4264,28098046,*iodine intake
4264,28098046,*thyroid antibodies
4264,28098046,*thyroid diseases
4265,28858843,methimazole
4265,28858843,plasma exchange
4265,28858843,thrombotic thrombocytopenic purpura
4265,28858843,thyrotoxicosis
4265,28858843,toxic multinodular goiter
4269,27421794,epidemiology
4269,27421794,iodine
4269,27421794,iodine deficiency disorders
4269,27421794,iodine fortification
4269,27421794,prophylaxis
4269,27421794,risk of iodine fortification
4271,25994301,all-trans retinoic acid
4271,25994301,autoantibodies
4271,25994301,hashimoto’s thyroiditis
4271,25994301,γδ t cells
4274,27852654,*cardiomyopathies
4274,27852654,*cobalt
4274,27852654,*heart failure
4274,27852654,*hip prosthesis
4274,27852654,*polycythemia
4276,28613043,congenital hypothyroidism with defective dehalogenation of iodotyrosines
4276,28613043,cretinism
4276,28613043,endemic goiter
4276,28613043,iodine deficiency
4276,28613043,thyroid hormones and mental development
4277,27119700,thyroid nodule
4277,27119700,benign adenoma
4277,27119700,multinodular goiter
4277,27119700,thyroid cancer
4278,26527084,fish bone
4278,26527084,foreign body
4278,26527084,neck radiograph
4278,26527084,retropharyngeal abscess
4278,26527084,retropharyngeal goiter
4278,26527084,tonsillitis
4279,28585680,radioactive iodine
4279,28585680,thyroid cancer
4279,28585680,toxic multinodular goitre
4280,29589552,antithyroid medication
4280,29589552,graves' disease
4280,29589552,hashitoxicosis
4280,29589552,hyperthyroidism
4280,29589552,radioactive iodine
4280,29589552,subacute granulomatous thyroiditis
4280,29589552,thyroidectomy
4280,29589552,toxic adenoma
4280,29589552,toxic multinodular goiter.
4282,29871272,langerhans cell histiocytosis
4282,29871272,thyroid cois relevant financial relationships with commercial interests to disclose.
4284,28297755,interleukin-17
4284,28297755,micrornas
4284,28297755,thyroid neoplasms
4285,28712235,total thyroidectomy
4285,28712235,recurrent laryngeal nerve injury
4285,28712235,subtotal thyroidectomy
4286,28690737,struma ovarii
4286,28690737,malignant ovarian goiter
4286,28690737,thyroid cois
4287,28262255,cowden syndrome
4287,28262255,hamartomatous tumour
4287,28262255,multinodular goiter
4287,28262255,pten
4287,28262255,pten hamartoma tumour syndrome
4290,29415534,*pegylated interferon alpha
4290,29415534,*chronic hepatitis c
4290,29415534,*thyroid dysfunction
4293,29798345,cn0
4293,29798345,lymph node metastasis
4293,29798345,papillary thyroid carcinoma
4293,29798345,risk factors cois relevant financial relationships with commercial interests to disclose.
4294,27263038,calcifications
4294,27263038,doppler
4294,27263038,malignancy
4294,27263038,thyroid carcinoma
4294,27263038,thyroid nodule
4294,27263038,ultrasound
4296,26526666,dicer1 syndrome
4296,26526666,hodgkin lymphoma
4296,26526666,t cell type
4297,28569114,children
4297,28569114,goiter
4297,28569114,iodine deficiency disorders
4297,28569114,thyroid volume
4297,28569114,urinary iodine
4299,28476227,*congenital hypothyroidism
4299,28476227,*deiodinase
4299,28476227,*dysgenesis
4299,28476227,*dyshormonogenesis
4299,28476227,*goiter
4299,28476227,*resistance to thyroid hormone
4299,28476227,*thyroid hormone receptors
4302,27922153,*graves’ disease
4302,27922153,*guideline
4302,27922153,*hyperthyroidism
4302,27922153,*radioiodine therapy
4302,27922153,*thyrotoxicosis
4302,27922153,*toxic goiter
4307,26686396,*airflow
4307,26686396,*cfd
4307,26686396,*energy
4307,26686396,*power
4307,26686396,*trachea
4307,26686396,*work of breathing
4311,27913858,fnac
4311,27913858,frozen section
4311,27913858,multinodular goiter
4311,27913858,papillary carcinoma
4311,27913858,thyroid cancer
4311,27913858,thyroid nodule
4314,26876062,*goiter
4314,26876062,*medullary
4314,26876062,*multiple endocrine neoplasia (men)
4314,26876062,*parathyroid
4314,26876062,*thyroidectomy
4317,26511970,cyclooxygenase-2
4317,26511970,ep4 receptor
4317,26511970,microsomal prostaglandin e synthase-1
4317,26511970,papillary thyroid carcinoma
4317,26511970,prostaglandin e2
4320,28042647,*core-needle aspiration biopsy
4320,28042647,*cytokeratin 17
4320,28042647,*fine-needle aspiration biopsy
4320,28042647,*nodular goiter
4320,28042647,*thyroid
4322,28103777,iodine
4322,28103777,iodine deficiency.
4322,28103777,iodine prophylaxis
4322,28103777,metabolic pathway
4322,28103777,synthesis
4322,28103777,thyroid hormones
4323,28085013,il-23
4323,28085013,papillary thyroid carcinoma
4323,28085013,mir-15a
4323,28085013,mir-16
4323,28085013,mir-940
4326,28756521,anticholinesterase pesticide
4326,28756521,hypothyroidism
4326,28756521,poisoning
4327,28954336,"goiter, nodular"
4327,28954336,thyroid neoplasms
4327,28954336,"tomography, x-ray computed"
4328,27259353,diffuse goiter
4328,27259353,iodine intake
4328,27259353,subclinical hypothyroidism
4328,27259353,thyroid nodule
4328,27259353,universal salt iodization (usi)
4328,27259353,urinary iodine concentration (uic)
4329,28405949,endoscopic thyroidectomy
4329,28405949,minimally invasive thyroidectomy
4329,28405949,thyroid surgery
4334,26537235,atrial fibrillation
4334,26537235,elderly
4334,26537235,hyperthyroidism
4334,26537235,iodine
4334,26537235,thyreostatic therapy
4337,27152602,thyroid diseases
4337,27152602,autoimmunity
4337,27152602,iodization
4337,27152602,study
4345,28867693,congenital hypothyroidism
4345,28867693,genetics
4345,28867693,mutation
4345,28867693,newborn screening
4345,28867693,thyroid peroxidase (tpo)
4346,27510155,benign goiter
4346,27510155,complications
4346,27510155,routine data
4346,27510155,thyroid surgery
4346,27510155,volume outcome
4353,26708844,chylous fistula
4353,26708844,thoracic duct
4353,26708844,thyroid-surgery
4355,27405595,*thyroid
4355,27405595,*laser
4355,27405595,*nodule
4355,27405595,*thermal ablation
4355,27405595,*ultrasound
4357,27344303,classification
4357,27344303,juan rosai
4357,27344303,poorly differentiated carcinoma
4357,27344303,thyroid
4362,26708858,inferior thyroid artery
4362,26708858,multinodular goiter
4362,26708858,thyroidectomy
4363,28845837,*mazabraud syndrome
4363,28845837,*mccune-albright syndrome
4363,28845837,"*fibrous dysplasia, malignant transformation."
4363,28845837,*myxoma
4366,26443708,general surgery
4366,26443708,minimally invasive surgery
4366,26443708,robotics
4368,26886166,dicer1
4368,26886166,laser capture microdissection
4368,26886166,mutation
4368,26886166,well-differentiated fetal adenocarcinoma
4368,26886166,β-catenin
4369,26884118,*68ga
4369,26884118,*cck2 receptor
4369,26884118,*pet/ct
4369,26884118,*medullary thyroid carcinoma
4369,26884118,*somatostatin receptor
4370,28276222,*ataxia telengiectasia
4370,28276222,*papillary thyroid carcinoma
4371,27094775,hashimotos
4371,27094775,hypothyroidism
4371,27094775,thyroiditis
4373,29050166,lymphoma
4373,29050166,pathology
4373,29050166,thyroid
4373,29050166,ultrasonography
4375,27784321,*case report
4375,27784321,*cervical sympathetic chain damage
4375,27784321,*horner’s syndrome
4375,27784321,*thyroidectomy
4377,29038858,parathyroidectomy
4377,29038858,radiology
4377,29038858,synchronous thyroid pathology
4378,27025990,*children
4378,27025990,*congenital hypothyroidism
4378,27025990,*cáncer de tiroides
4378,27025990,*hipotiroidismo congénito
4378,27025990,*ionising radiation
4378,27025990,*niños
4378,27025990,*radiación ionizante
4378,27025990,*thyroid cancer
4379,27530498,intra-operative
4379,27530498,pth
4379,27530498,post operative hypocalcemia
4379,27530498,thyroidectomy
4380,27121690,hyperthyroidism
4380,27121690,lithium
4380,27121690,radioactive iodine ablation
4380,27121690,thyroxine
4381,26884115,biopsy
4381,26884115,fine-needle biopsy
4381,26884115,thyroid cancer
4381,26884115,thyroid nodule
4381,26884115,thyroiditis
4387,26577641,basal cell carcinoma
4387,26577641,basal cell nevus syndrome
4387,26577641,dicer1 syndrome
4387,26577641,familial adenomatous polyposis
4387,26577641,pilomatrixoma
4387,26577641,pleuropulmonary blastoma
4389,28694722,acute illness
4389,28694722,guidelines
4389,28694722,thyroid tests cois
4390,28387096,diagnosis
4390,28387096,fnmtc
4390,28387096,genetic
4390,28387096,hereditary
4390,28387096,familial thyroid cancer
4393,28648507,*pax8
4393,28648507,*tshr
4393,28648507,*congenital hypothyroidism
4393,28648507,*hormone resistance
4393,28648507,*mutations
4393,28648507,*subclinical hypothyroidism
4394,28490006,adenoid cystic carcinoma
4394,28490006,cytopathology
4394,28490006,fine needle aspiration
4394,28490006,larynx
4394,28490006,thyroid
4395,27756965,*chlorpheniramine
4395,27756965,*drug-induced torsades de pointes
4395,27756965,*propranolol
4397,28276223,*kocher-debre-semelaigne syndrome
4397,28276223,*atrophic autoimmune thyroiditis
4397,28276223,*pituitary expansion
4397,28276223,*rickets
4398,27387245,*hypocalcemia
4398,27387245,*postoperative hypoparathyroidism
4398,27387245,*teriparatide
4400,29275552,hyperthyroidism
4400,29275552,blood chemical analysis
4400,29275552,case analysis
4400,29275552,"death, sudden, cardiac"
4400,29275552,forensic pathology cois relevant financial relationships with commercial interests to disclose.
4403,28479907,diagnostic accuracy
4403,28479907,cytology
4403,28479907,fine needle aspiration
4403,28479907,tertiary hospital
4403,28479907,thyroidectomy
4404,27162199,fnab
4404,27162199,immunohistochemistry
4404,27162199,neuroendocrine tumors
4404,27162199,thyroid paraganglioma
4407,27041628,fluorescence
4407,27041628,fluorescence-guided surgery
4407,27041628,indocyanine green
4407,27041628,near-infrared imaging
4407,27041628,parathyroid
4407,27041628,thyroidectomy
4409,28291538,anca anti-protéinase 3 (pr3-anca)
4409,28291538,anti-neutrophil cytoplasmic antibody (anca)
4409,28291538,anticorps anti-cytoplasme des neutrophiles (anca)
4409,28291538,propylthiouracil
4409,28291538,propylthiouracile
4409,28291538,proteinase3-anca (pr3-anca)
4409,28291538,pyoderma gangrenosum
4410,27520400,*c-reactive protein
4410,27520400,*resveratrol
4410,27520400,*resveratrol (pubchem cid: 445154)
4410,27520400,*type 2 diabetes mellitus
4411,27091372,laryngeal nerves
4411,27091372,prospective study
4411,27091372,recurrent laryngeal nerve
4411,27091372,recurrent laryngeal nerve injuries
4411,27091372,thyroidectomy
4414,28952196,c-cell
4414,28952196,ret mutation
4414,28952196,minute medullary thyroid carcinoma
4414,28952196,solid cell nests
4415,28025468,t1-weighted imaging
4415,28025468,fetus
4415,28025468,magnetic resonance imaging
4415,28025468,thyroid cois interest.
4416,27233786,diabetes mellitus
4416,27233786,hormone replacement therapy
4416,27233786,hypercalcemia
4416,27233786,hypertension
4416,27233786,osteoporosis
4417,29798949,carcinoma
4417,29798949,papillary
4417,29798949,thyroid cois
4418,28389458,drug interaction
4418,28389458,levothyroxine
4418,28389458,ritonavir
4420,28756810,high iodine
4420,28756810,iodine deficiency
4420,28756810,thyroglobulin
4421,28294052,cognition
4421,28294052,iodine deficiency
4421,28294052,iodine excess
4421,28294052,neurodevelopment
4421,28294052,pregnancy
4421,28294052,prophylaxis.
4423,29871097,"carcinoma, papillary"
4423,29871097,lymph node metastasis
4423,29871097,thyroid neoplasms cois relevant financial relationships with commercial interests to disclose.
4428,28688118,dicer1
4428,28688118,acute transient hepatitis
4428,28688118,monozygotic twins
4428,28688118,pleuropulmonary blastoma
4429,27105534,gene expression profile
4429,27105534,hypoxia
4429,27105534,microenvironment
4429,27105534,oncogenes
4429,27105534,thyroid cancer cois
4430,26193980,fnab
4430,26193980,nodule depth
4430,26193980,pain
4430,26193980,thyroid nodule
4430,26193980,vas score
4431,28196954,*metformin
4431,28196954,*thyroid cancer
4431,28196954,*thyroid disease
4431,28196954,*thyroid nodule
4431,28196954,*thyrotropin
4432,28188700,afirma
4432,28188700,fna
4432,28188700,cytology
4432,28188700,thyroid nodules
4434,28317625,*autoimmunity
4434,28317625,*hyperthyroidism
4434,28317625,*hypothyroidism
4434,28317625,*pulmonary hypertension
4434,28317625,*trab
4435,28229359,calcitonin
4435,28229359,pregnancy
4435,28229359,thyroid volume
4437,27461263,hyperthyroidism
4437,27461263,papillary thyroid cancer
4437,27461263,thyroid cancer
4438,27245300,*biokinetics
4438,27245300,*hyperthyroidism
4438,27245300,*internal dosimetry
4438,27245300,*radioiodine therapy
4439,27013327,ablation
4439,27013327,nodule
4439,27013327,radiofrequency
4439,27013327,thyroid
4440,26931517,patient safety
4440,26931517,resident involvement
4440,26931517,resident participation
4440,26931517,surgical education
4440,26931517,thyroid
4441,26744989,drinking water
4441,26744989,ion chromatography
4441,26744989,method development
4441,26744989,nis inhibitors
4442,29102947,*cancer
4442,29102947,*cardiovascular disease
4442,29102947,*end-stage renal disease
4442,29102947,*hypothyroidism
4442,29102947,*thyroid abnormalities
4442,29102947,*thyroid nodules
4442,29102947,*waiting list for renal transplant
4443,28432675,mini-invasive thyroidectomy
4443,28432675,thyroid
4443,28432675,thyroidectomy
4443,28432675,transoral thyroidectomy
4446,28684081,adherence to diet
4446,28684081,attitude towards diet
4446,28684081,body mass index
4446,28684081,meal plan
4446,28684081,type 2 diabetes mellitus
4447,28034775,*intra-operative neuro-monitoring
4447,28034775,*re-operation
4447,28034775,*recurrent laryngeal nerve palsy
4447,28034775,*thyroid cancer
4447,28034775,*thyroidectomy
4448,28238190,*pentraxin 3
4448,28238190,*resveratrol
4448,28238190,*total antioxidant status
4448,28238190,*type 2 diabetes mellitus
4449,27071746,all-cause mortality
4449,27071746,cardiovascular mortality
4449,27071746,cardiovascular risk
4449,27071746,mediterranean diet
4450,28982849,*thyroid
4450,28982849,*immunohistochemistry
4450,28982849,*lymph node metastasis
4450,28982849,*papillary thyroid carcinoma
4450,28982849,*sphingosine kinase 1
4451,28791817,binder syndrome
4451,28791817,bone graft
4451,28791817,cartilage graft
4451,28791817,maxillary underdevelopment
4451,28791817,resorption
4452,26932954,*4d ct
4452,26932954,*parathyroid adenoma
4452,26932954,*parathyroid hyperplasia
4452,26932954,*sestamibi scintigraphy
4453,26246426,hypothyroidism
4453,26246426,end-stage renal disease
4453,26246426,hemodialysis
4453,26246426,thyroid nodule
4454,28626131,congenital hypothyroidism
4454,28626131,duoxa2
4454,28626131,genetics
4454,28626131,mutation
4454,28626131,newborn screening
4455,28387647,thyroid nodule
4455,28387647,frozen section fine-needle aspiration biopsy.
4455,28387647,papillary carcinoma
4455,28387647,thyroidectomy
4456,28250870,*congenital hypothyroidism
4456,28250870,*growth retardation
4456,28250870,*mental retardation cois
4457,27488391,breast and endometrial cancer
4457,27488391,cowden syndrome
4457,27488391,multiple meningiomas
4457,27488391,pten hamartoma
4457,27488391,radiology
4458,26786663,tc99m sestamibi scintigraphy
4458,26786663,primary hyperparathyroidism
4458,26786663,thyroid disorder
4458,26786663,thyroid pathology
4458,26786663,ultrasonography
4460,28703115,completion lymphadenectomy
4460,28703115,tall-cell variant
4460,28703115,thyroid carcinoma
4461,26780986,hypocalcemia
4461,26780986,hypoparathyroidism
4461,26780986,parathyroid hormone
4461,26780986,thyroidectomy
4461,26780986,vitamin d
4462,26711165,assays
4462,26711165,biomarker
4462,26711165,differentiated thyroid cancers
4462,26711165,thyroglobulin
4468,29059259,*bone metabolism markers
4468,29059259,*hyperthyroidism
4468,29059259,*sclerostin
4469,28109483,global health
4469,28109483,haiti
4469,28109483,head and neck surgery
4469,28109483,otolaryngology
4470,27744598,99mtc-mibi
4470,27744598,autonomously functioning thyroid nodules
4470,27744598,parathyroid carcinoma
4470,27744598,parathyroid scintigraphy
4474,28604619,cancer
4474,28604619,flavonoid
4474,28604619,invasiveness
4474,28604619,iodide uptake
4474,28604619,phytochemical
4474,28604619,proliferation
4474,28604619,radioiodine therapy
4474,28604619,sodium iodide symporter (nis)
4474,28604619,thyroid cois
4475,26983701,dicer-1
4475,26983701,pleuropulmonary blastoma
4475,26983701,sertoli-leydig cell tumor
4475,26983701,thyroid carcinoma
4475,26983701,familial neoplasia
4477,28506409,bethesda classification
4477,28506409,guidelines
4477,28506409,lobectomy
4477,28506409,thyroid
4477,28506409,thyroid carcinoma
4477,28506409,thyroidectomy
4478,27639841,abtpo
4478,27639841,autoimmune thyroid diseases
4478,27639841,autoimmune thyroiditis
4478,27639841,hypothyroidism
4478,27639841,organ specific autoimmune diseases
4478,27639841,systemic rheumatological disorders
4480,28189449,hyperthyroidism
4480,28189449,lymphadenectomy
4480,28189449,pediatric thyroidectomy
4480,28189449,total thyroidectomy
4480,28189449,transient hypocalcemia
4481,27208531,computer-aided diagnosis
4481,27208531,medical imaging
4481,27208531,morphometry
4485,27809694,*us elastography
4485,27809694,*fibronectin-1
4485,27809694,*fibrosis
4485,27809694,*galectin-3
4485,27809694,*indeterminate cytology
4485,27809694,*thyroid nodules
4486,27833458,*epidemiology
4486,27833458,*monitoring
4486,27833458,*prevalence trend
4486,27833458,*thyroid disorders
4487,27288566,elderly
4487,27288566,harmonic
4487,27288566,ligasure
4487,27288566,thyroidectomy
4487,27288566,vessel sealing
4490,26838584,growth hormone deficiency
4490,26838584,hypothyroidism
4490,26838584,pituitary hyperplasia
4492,28025932,*global health
4492,28025932,*humanitarian
4492,28025932,*quality of life
4492,28025932,*resource limited
4492,28025932,*thyroid
4492,28025932,*thyroidectomy
4494,28039060,*calcium prophylaxis
4494,28039060,*hypocalcemia
4494,28039060,*oral calcium
4494,28039060,*parathyroid hormone
4494,28039060,*thyroidectomy
4499,28870235,barley young leaf
4499,28870235,chronic lymphocytic thyroiditis
4499,28870235,hypothyroidism
4499,28870235,isoflavones
4499,28870235,soybean
4499,28870235,thin-layer chromatography
4499,28870235,kale cois from the patient for publication of this case report and any accompanying images. a copy of the written consent is available for review by the editor-in-chief of this journal. competing interests: the authors declare that they have no competing interests. publisher’s note: springer nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
4500,28222777,*dicer1 mutations
4500,28222777,*dicer1 syndrome
4501,26970173,*27 kd heat-shock protein
4501,26970173,*antioxidants
4501,26970173,*oxidants
4501,26970173,*thyroid tumors
4502,26370671,diagnostic
4502,26370671,foxe1
4502,26370671,follicular thyroid lesion
4502,26370671,pax8
4502,26370671,ttf-1
4502,26370671,thyroid nodules
4504,26796150,24-h urine
4504,26796150,adults
4504,26796150,benin
4504,26796150,icp-ms
4504,26796150,iodine
4505,26289771,dicer1
4505,26289771,mirna
4505,26289771,ovarian cancer
4505,26289771,sarcoma
4505,26289771,sertoli-leydig cell tumor cois interest to disclose.
4507,28964290,hearing loss
4507,28964290,slc26a4
4507,28964290,whole exome sequencing cois to report.
4512,26795600,cerebral cavernous malformation (ccm)
4512,26795600,cerebrovascular disease
4512,26795600,cytochrome p450 (cyp)
4512,26795600,disease severity
4512,26795600,familial cerebral cavernous malformation type 1
4512,26795600,free radicals
4512,26795600,genetic markers set association study
4512,26795600,inter-individual variability in disease susceptibility and outcome
4512,26795600,intracerebral hemorrhage
4512,26795600,krit1/ccm1
4512,26795600,matrix metalloproteinase (mmp)
4512,26795600,oxidative stress
4512,26795600,reactive oxygen species (ros)
4512,26795600,vascular brain lesions
6127,20463839,complications
6127,20463839,retrosternal goitre
6127,20463839,sternotomy
6127,20463839,surgical treatment
6127,20463839,thyroid
6247,19270831,graves' disease
6247,19270831,hantaan virus
6247,19270831,hemorrhagic fever with renal syndrome
6528,19759882,biometry
6528,19759882,eye abnormalities
6528,19759882,graves’
6528,19759882,graves’ disease
6528,19759882,ophthalmopathy
6528,19759882,photography
6601,19568361,drug-induced hypersensitivity
6601,19568361,graves' disease
6601,19568361,hyperthyroidism
6601,19568361,iodine therapy
6601,19568361,vogt-koyanagi-harada disease
6686,19547630,graves’ disease
6686,19547630,endocrine orbitopathy
6686,19547630,impaired earning capacity
6686,19547630,occupational disability
6686,19547630,quality of life
7145,20463832,stem cells
7145,20463832,thyroid
7145,20463832,thyroid cancer
7145,20463832,tissue repair
7337,19606248,calcitonin
7337,19606248,false-positive test
7337,19606248,ret mutation
7337,19606248,total thyroidectomy
7347,32548696,compression symptoms
7347,32548696,fine needle aspiration cytology
7347,32548696,operative indications
7347,32548696,thyroid gland
7347,32548696,thyroid imaging reporting and data system
7348,32780357,goiter
7348,32780357,goiters
7348,32780357,intrathoracic goiter
7348,32780357,intrathoracic
7348,32780357,substernal
7350,33445947,retrosternal goiter – sternotomy – thoracotomy − thyroid gland disease − vocal  cord paresis
7351,34941205,retrosternal goiter
7351,34941205,simultaneous surgery
7351,34941205,sternotomy
7352,32929476,*graves disease
7352,32929476,*tsh receptor antibodies
7352,32929476,*antithyroid drugs
7352,32929476,*diagnosis
7352,32929476,*management
7352,32929476,*radioactive iodine
7352,32929476,*thyroidectomy
7352,32929476,*treatment
7354,34151940,american medicine
7354,34151940,benjamin smith barton
7354,34151940,goiter
7354,34151940,medical geography
7355,33069387,*enfermedad de graves-basedow
7355,33069387,*glucocorticoides
7355,33069387,*glucocorticoids
7355,33069387,*graves-basedow disease
7355,33069387,*graves’ ophthalmopathy
7355,33069387,*inflamación orbitaria
7355,33069387,*orbitopathy
7355,33069387,*orbitopatía
7355,33069387,*rituximab
7355,33069387,*teprotumumab
7355,33069387,*tocilizumab
7356,33835415,art and medicine
7356,33835415,epifania benintendi
7356,33835415,florence
7356,33835415,nodal goitre
7358,34288592,aspiration cytology
7358,34288592,dyshormonogenetic goiter
7358,34288592,thyroid
7359,33895978,dante alighieri
7359,33895978,goiter
7359,33895978,history
7359,33895978,middle ages
7365,32059832,*cxcl10
7365,32059832,*cxcr3
7365,32059832,*graves' disease
7365,32059832,*graves' ophthalmopathy
7365,32059832,*th1 immune response
7365,32059832,*teprotumumab cois
7367,33878810,*congenital hypothyroidism
7367,33878810,*literacy
7367,33878810,*cognitive dysfunction
7367,33878810,*indigenous population
7367,33878810,*prenatal care
7367,33878810,*chronic malnutrition
7367,33878810,*social vulnerability cois
7368,32472406,art
7368,32472406,drawing
7368,32472406,endemic
7368,32472406,endocrinology
7368,32472406,goiter
7369,33995810,goiter
7369,33995810,follicular carcinoma
7369,33995810,lymphoma
7369,33995810,malignancy
7369,33995810,papillary carcinoma cois
7370,32970371,rose
7370,32970371,us-fna
7370,32970371,amyloid
7370,32970371,amyloid goiter
7370,32970371,interventional pathologist
7373,33507686,diet
7373,33507686,goiter
7373,33507686,helicobacter pylori
7373,33507686,gastric carcinoma
7373,33507686,stature
7374,33396042,endemic goiter
7374,33396042,hypo-and hyperthyroidism
7374,33396042,iodine nutrition
7374,33396042,thiocyanate
7374,33396042,thyroid echogenicity/cytomorphology
7377,33607721,cardiovascular diseases
7377,33607721,methylarginines
7377,33607721,multinodular goiter
7377,33607721,thyroid
7378,32500695,hypoparathyroidism
7378,32500695,laryngeal paresis
7378,32500695,polidocanol
7378,32500695,recurrent nodular goiter
7378,32500695,sclerotherapy
7380,32107168,*graves’ disease
7380,32107168,*th1 chemokines
7380,32107168,*epidemiology
7380,32107168,*hepatitis c virus
7380,32107168,*risk factors
7380,32107168,*viruses cois
7381,34149612,*graves’ disease
7381,34149612,*autoimmune
7381,34149612,*goiter
7381,34149612,*growth factor
7381,34149612,*hormone
7381,34149612,*ophthalmopathy
7381,34149612,*thyroid cois autoimmune disease and consultancy for horizon therapeutics consultant immunovant.
7382,32893229,cardiopulmonary arrest
7382,32893229,intrathoracic goiter
7382,32893229,phrenic nerve paralysis cois
7383,33409915,multinodular goiter
7383,33409915,thyroid adenoma
7383,33409915,thyroid cancer
7383,33409915,trace elements
7384,34245984,goiter
7384,34245984,risk factors
7384,34245984,trace elements
7385,34707013,maximum density of ct
7385,34707013,nodular goiter
7385,34707013,parathyroid lesions
7385,34707013,single-photon emission computed tomography/computed tomography
7387,33574798,*graves’ hyperthyroidism
7387,33574798,*graves’ orbitopathy
7387,33574798,*oxidative stress
7387,33574798,*reactive oxygen species
7387,33574798,*selenium
7387,33574798,*selenocysteine
7387,33574798,*selenoproteins cois commercial or financial relationships that could be construed as a potential conflict of interest.
7388,32493403,antithyroid drug
7388,32493403,block-replace therapy
7388,32493403,case report
7388,32493403,fetal goiter
7388,32493403,perinatal management
7388,32493403,triiodothyronine-predominant graves’ disease cois
7390,33804853,goiter
7390,33804853,sternotomy
7390,33804853,thyroidectomy cois
7392,33396135,association
7392,33396135,case-control study
7392,33396135,mineral elements
7392,33396135,thyroid function
7392,33396135,thyroid tumor and goiter
7393,34628753,acupoint indications
7393,34628753,acupoints at the upper arms
7393,34628753,goiter
7393,34628753,scrofula
7393,34628753,specific effect
7396,32078117,*congenital hypothyroidism
7396,32078117,*gene mutation
7396,32078117,*tpo deficiency
7396,32078117,*thyroid dyshormonogenesis
7397,31907822,endemic
7397,31907822,goiter
7397,31907822,iconography
7397,31907822,surgery
7398,32474859,b-cell lymphoma
7398,32474859,hashimoto’s thyroiditis
7398,32474859,core needle biopsy
7398,32474859,fine needle aspiration cytology
7398,32474859,primary thyroid lymphoma
7400,32824922,*nf-e2-related factor 2
7400,32824922,*goiter
7400,32824922,*micrornas
7400,32824922,*thyroid neoplasms
7400,32824922,*vascular endothelial growth factor a cois commercial or financial relationships that could be construed as a potential conflict of interest.
7401,34244226,endocrine
7401,34244226,instrumentation
7401,34244226,radioactive iodine therapy
7401,34244226,radioactive iodine uptake
7401,34244226,radionuclide therapy
7401,34244226,substernal goiter
7404,33468112,*excessive iodine
7404,33468112,*goiter
7404,33468112,*iodization
7404,33468112,*school children
7404,33468112,*southern ethiopia cois
7405,31994506,aortic window
7405,31994506,ectopia
7405,31994506,hyperparathyroidism
7405,31994506,parathyroid adenoma
7405,31994506,thoracoscopy
7406,34167409,*intrathoracic goiter
7406,34167409,*ablation technique
7406,34167409,*ultrasound
7407,33579801,*diffuse and nodular goiter
7407,33579801,*lab tests for benign thyroid disorders
7407,33579801,*primary autoimmune hypothyroidism
7407,33579801,*radionuclide imaging
7407,33579801,"*subacute, destructive thyroiditis"
7407,33579801,*ultrasound imaging
7412,32341696,children
7412,32341696,dental pathology
7412,32341696,diffuse nontoxic goiter
7412,32341696,local protective mechanisms
7415,33837650,*anatomy
7415,33837650,*development
7415,33837650,*embryology
7415,33837650,*retrosternal goiter
7415,33837650,*thyroidectomy
7422,33310200,nodular goiter
7422,33310200,papillary thyroid carcinoma
7422,33310200,polycyclic aromatic hydrocarbon
7422,33310200,risk assessment cois competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
7423,32320467,*15 mci
7423,32320467,*fixed activity
7423,32320467,*hyperthyroidism
7423,32320467,*radioiodine
7423,32320467,*toxic multinodular goiter
7423,32320467,*volume reduction
7425,33980774,graves disease
7425,33980774,hyperthyroidism
7425,33980774,large goiter
7425,33980774,radioiodine therapy
7429,34220711,*congenital hypothyroidism
7429,34220711,*fetal goiter
7429,34220711,*growth
7429,34220711,*mutations
7429,34220711,*neuropsychological evaluation
7429,34220711,*thyroid peroxidase cois commercial or financial relationships that could be construed as a potential conflict of interest.
7430,33878943,retrosternal goiter
7430,33878943,acromegaly
7430,33878943,airway management
7430,33878943,anesthesia
7430,33878943,case report
7430,33878943,multidisciplinary strategy
7430,33878943,tracheal compression cois conflict of interest.
7432,33391188,*graves’ disease
7432,33391188,*asymmetry
7432,33391188,*exophthalmos
7432,33391188,*hyperthyroidism
7432,33391188,*unilateral cois commercial or financial relationships that could be construed as a potential conflict of interest.
7435,32812038,*15 mci
7435,32812038,*fixed activity
7435,32812038,*hyperthyroidism
7435,32812038,*radioiodine
7435,32812038,*toxic multinodular goiter
7435,32812038,*volume reduction
7436,33252592,*grave’s disease
7436,33252592,*trab
7436,33252592,*ft3:ft4 ratio
7438,31984866,*graves' disease
7438,31984866,*dementia
7438,31984866,*epidemiology
7438,31984866,*hyperthyroidism
7438,31984866,*toxic nodular goiter
7441,32633627,*anaplastic thyroid cancer
7441,32633627,*gene mutation
7441,32633627,*thyroglobulin
7441,32633627,*thyroid dyshormonogenesis
7443,31950881,*graves' disease
7443,31950881,*chronic lymphocytic thyroiditis
7443,31950881,*incidental thyroid microcarcinomas
7443,31950881,*multinodular goiter
7443,31950881,*papillary thyroid cancer
7443,31950881,*papillary thyroid microcarcinomas
7444,32495658,thyroid surgery
7444,32495658,anesthesia
7444,32495658,gastrointestinal intubation
7444,32495658,goiter
7444,32495658,intratracheal intubation
7444,32495658,nasogastric tube
7452,33619720,graves’ disease
7452,33619720,coronary artery spasm
7452,33619720,myocardial infarction
7452,33619720,thyrotoxicosis
7453,33735381,*graves orbitopathy
7453,33735381,*cholesterol
7453,33735381,*statins
7454,32749654,graves’ orbitopathy
7454,32749654,pathogenesis
7454,32749654,thyrotropin receptor
7454,32749654,thyrotropin receptor antibodies cois
7455,33655885,graves' orbitopathy
7455,33655885,graves’ disease
7455,33655885,graves’ ophthalmopathy
7455,33655885,thyroid diseases
7456,32729049,compressive optic neuropathy
7456,32729049,dysthyroid optic neuropathy
7456,32729049,graves orbitopathy
7456,32729049,orbital decompression
7456,32729049,stretch optic neuropathy
7456,32729049,thyroid eye disease
7458,32826306,*oesophageal varices cois
7459,34112358,biomarkers
7459,34112358,dietary reference values
7459,34112358,estimated average requirement cut-point method
7459,34112358,goiter
7459,34112358,goitrogens
7459,34112358,iodine
7459,34112358,iodine deficiency disorders
7459,34112358,"thyroid hormones, salt iodization"
7459,34112358,urinary iodine concentration
7461,34867996,*graves’ disease
7461,34867996,*hashimoto’s thyroiditis
7461,34867996,*autoimmune thyroid diseases (aitd)
7461,34867996,*exosomes
7461,34867996,*immune regulation cois commercial or financial relationships that could be construed as a potential conflict of interest.
7462,33484076,orbital disease
7462,33484076,thyroid eye disease
7462,33484076,thyroid ophthalmopathy
7463,32326785,chorioretinal folds
7463,32326785,grave’s ophthalmopathy
7463,32326785,choroidal folds
7463,32326785,thyroid eye disease
7463,32326785,thyroid orbitopathy
7464,32663624,autoimmunity
7464,32663624,hashimoto's thyroiditis
7464,32663624,helicobacter pylori
7464,32663624,hepatitis c
7464,32663624,mimicry
7464,32663624,thyroid cois declare. the authors did not recieve any funding from any institution for this article.
7465,33387353,art
7465,33387353,graves' disease
7465,33387353,thyroid swelling
7468,34680964,*pendred syndrome
7468,34680964,*whole-exome sequencing
7468,34680964,*genotype-phenotype correlation cois
7470,34362755,covid-19
7470,34362755,thyroid disease cois
7474,33011882,*chemiluminescence
7474,33011882,*cytochrome p450 reductase
7474,33011882,*cytochrome b5-reductase
7474,33011882,*nontoxic nodular goiter
7474,33011882,*papillary thyroid cancer
7474,33011882,*toxic goiter
7478,32880074,anterior
7478,32880074,computed tomography
7478,32880074,magnetic resonance imaging
7478,32880074,mediastinum
7485,34029917,cochlear implant
7485,34029917,deafness
7485,34029917,enlarged vestibular aqueduct
7485,34029917,hearing aid
7485,34029917,hearing loss
7485,34029917,incomplete partition
7485,34029917,pendred syndrome
7486,33619715,graves’ orbitopathy
7486,33619715,exophthalmos
7486,33619715,meningioma
7491,34410066,graves’ disease
7491,34410066,graves’ ophthalmopathy
7491,34410066,ted
7491,34410066,monoclonal antibodies
7491,34410066,thyroid eye disease
7493,32571507,benign
7493,32571507,goiter
7493,32571507,graves’ disease
7493,32571507,pediatric
7493,32571507,thyroid
7495,34033289,*implications
7495,34033289,*iodine deficiency
7495,34033289,*pregnancy
7497,35004341,*graves’ disease
7497,35004341,*graves’ orbitopathy (go)
7497,35004341,*lactobacillus
7497,35004341,*prevotella
7497,35004341,*tshr (thyroid-stimulating hormone receptor)
7497,35004341,*th17 and treg cells
7497,35004341,*veillonella
7497,35004341,*gut microbiota cois commercial or financial relationships that could be construed as a potential conflict of interest.
7498,33449383,*graves' disease
7498,33449383,*hashimoto's thyroiditis
7498,33449383,*interferon lambda 1
7498,33449383,*interleukin-29
7498,33449383,*subacute thyroiditis
7499,34026662,*16s rrna
7499,34026662,*graves’ disease
7499,34026662,*clinical parameters
7499,34026662,*gut microbiota
7499,34026662,*next-generation sequencing cois commercial or financial relationships that could be construed as a potential conflict of interest.
7500,34182968,dilated cardiomyopathy
7500,34182968,ethiopia
7500,34182968,methimazole
7500,34182968,propylthiouracil
7500,34182968,thyrotoxicosis
7500,34182968,β-blocker cois
7501,34855196,graves’ disease (gd)
7501,34855196,antithyroid drugs (atds)
7501,34855196,radioactive iodine (rai)
7501,34855196,total thyroidectomy (tt)
7502,30927742,*graves’ disease
7502,30927742,*factitious disorders
7502,30927742,*thyroxine
7503,33445994,graves’ disease
7503,33445994,intelligent diagnosis
7503,33445994,deep learning
7503,33445994,diagnostic performance
7503,33445994,nuclear medicine residents
7503,33445994,subacute thyroiditis
7503,33445994,thyroid disease
7503,33445994,thyroid scintigraphy cois conflict of interest.
7505,33515213,graves’ disease
7505,33515213,graves’ ophthalmopathy
7505,33515213,graves’ orbitopathy
7505,33515213,thyroglobulin cois as prejudicing the impartiality of the research reported.
7506,31919775,corticosteroids
7506,31919775,graves’ disease
7506,31919775,tshr
7506,31919775,thyroid eye disease
7507,32893226,cushing's syndrome
7507,32893226,graves' disease
7507,32893226,central hypothyroidism
7507,32893226,syndrome of inappropriate secretion of thyroid-stimulating hormone cois
7510,33487459,adipose tissue
7510,33487459,glande thyroïde
7510,33487459,thyroid gland
7510,33487459,thyrolipoma
7510,33487459,thyrolipomatose
7510,33487459,thyrolipomatosis
7510,33487459,thyrolipome
7510,33487459,tissu adipeux
7511,34965078,*graves’ disease
7511,34965078,*radioiodine therapy
7511,34965078,*thyroid eye disease
7511,34965078,*thyroidectomy
7516,34969797,ear
7516,34969797,nose and throat/otolaryngology
7516,34969797,vascular surgery cois
7517,34118212,cancer de la thyroïde
7517,34118212,goitre multinodulaire
7517,34118212,multinodular goiter
7517,34118212,mutation du gène pds
7517,34118212,pds gene mutation
7517,34118212,pendred syndrome
7517,34118212,syndrome de pendred
7517,34118212,thyroid cancer
7518,34195868,hypocalcemia
7518,34195868,hypoparathyroidism
7518,34195868,indocyanine green (icg)
7518,34195868,near-infrared autofluorescence (nir-af)
7518,34195868,near-infrared fluorescence imaging (nifi)
7518,34195868,parathyroid glands (pgs)
7518,34195868,thyroid surgery
7518,34195868,total thyroidectomy
7519,33112798,*graves’ orbitopathy
7519,33112798,*binding immunoglobulin protein
7519,33112798,*endoplasmic reticulum stress
7519,33112798,*thyroid eye disease
7519,33112798,*unfolded protein response
7521,32638234,graves’ disease
7521,32638234,pancytopenia
7521,32638234,review
7524,33462034,calcium and bone
7524,33462034,hyperthyroidism cois
7525,33685911,pericardial disease
7525,33685911,thyroid disease cois
7533,32765422,*graves' disease
7533,32765422,*autoimmunity
7533,32765422,*hyperthyroidism
7533,32765422,*inflammation
7533,32765422,*natural killer cells
7534,33661574,antithyroid drugs
7534,33661574,hepatitis
7534,33661574,hyperthyroidism
7534,33661574,plasma exchange
7534,33661574,plasmapheresis
7535,33557156,*22q11.2 deletion syndrome
7535,33557156,*down syndrome
7535,33557156,*graves’ disease
7535,33557156,*hashimoto’s thyroiditis
7535,33557156,*klinefelter syndrome
7535,33557156,*prader–willi syndrome
7535,33557156,*rasopathies
7535,33557156,*turner syndrome
7535,33557156,*williams syndrome
7535,33557156,*genetic syndromes cois
7538,34303550,basedow
7538,34303550,dysthyroidism
7538,34303550,dysthyroïdie
7538,34303550,glaucoma
7538,34303550,glaucome
7538,34303550,graves’ disease
7538,34303550,hypertonie intra-oculaire
7538,34303550,ocular hypertension
7540,34725062,cardiothoracic surgery
7540,34725062,otolaryngology / ent
7540,34725062,thyroid disease cois
7541,34753719,hepatitis other
7541,34753719,thyrotoxicosis cois
7542,32441005,antithyroid drugs
7542,32441005,covid-19
7542,32441005,glucocorticoids
7542,32441005,graves’ disease
7542,32441005,graves’ orbitopathy cois
7544,33789121,alkaloid
7544,33789121,cyanogenic glucoside
7544,33789121,flavonoid
7544,33789121,phytochemical
7544,33789121,polyphenol
7544,33789121,thyroid
7545,32157663,art
7545,32157663,history
7545,32157663,thyroid swelling
7549,31948703,*epidemiology
7549,31948703,*goiter
7549,31948703,*national inpatient sample
7549,31948703,*predictive factors
7549,31948703,*thyroid disease
7549,31948703,*thyroidectomy cois conflicts of interest to disclose.
7550,33420947,*lingual thyroid
7550,33420947,*oropharynx
7550,33420947,*robotic thyroidectomy
7550,33420947,*thyroidectomy
7553,32910410,art
7553,32910410,graves’ disease
7553,32910410,history
7556,33569041,*graves’ disease
7556,33569041,*hyperthyroidism
7556,33569041,*review
7556,33569041,*thyroxine
7556,33569041,*treatment cois commercial or financial relationships that could be construed as a potential conflict of interest.
7557,32173798,*benign thyroid disease
7557,32173798,*chris
7557,32173798,*radioiodine therapy
7557,32173798,*stunning
7557,32173798,*thyroid
7558,33367675,*graves’ disease
7558,33367675,*slit2
7558,33367675,*thyroid-associated ophthalmopathy
7560,34227705,*graves' disease
7560,34227705,*goiter
7560,34227705,*hyperthyroidism
7560,34227705,*pediatric
7560,34227705,*scintigraphy
7561,34969799,covid-19
7561,34969799,thyroid disease
7561,34969799,thyrotoxicosis
7561,34969799,unwanted effects/adverse reactions cois
7565,32477269,*graves' disease
7565,32477269,*anti-thyroid drug
7565,32477269,*carbimazole
7565,32477269,*dose
7565,32477269,*hyperthyroidism
7566,32797478,amyloidosis
7566,32797478,goitre
7566,32797478,hypothyroidism
7567,33431523,neonatal and paediatric intensive care
7567,33431523,pregnancy
7567,33431523,thyroid disease
7567,33431523,thyrotoxicosis cois
7568,33988300,*lepr
7568,33988300,*graves' disease
7568,33988300,*immune-related genes
7568,33988300,*leptin receptor
7568,33988300,*thyroid-associated ophthalmopathy
7568,33988300,*weighted gene co-expression network analysis cois
7569,32199035,*hyperthyroidism
7569,32199035,*postoperative complications
7569,32199035,*surgery
7569,32199035,*thyroid diseases
7569,32199035,*thyroidectomy
7572,33597052,*goiter prevalence
7572,33597052,*iodine nutrition
7572,33597052,*thyroid cancer
7572,33597052,*urine iodine
7573,33367747,*graves’ disease
7573,33367747,*igf-1r
7573,33367747,*thsr
7573,33367747,*autoimmunity
7573,33367747,*exosomes
7574,33934566,*graves’ disease
7574,33934566,*myh11
7574,33934566,*itraq technique
7574,33934566,*inflammatory response
7574,33934566,*proteomics
7574,33934566,*thyroid-associated obitopathy cois
7575,33914707,*endocrinology
7575,33914707,*thyroid disease cois exists.
7578,34192497,complications
7578,34192497,goitre
7578,34192497,thyroidectomy
7578,34192497,tracheomalacia
7580,33509724,excisional biopsy
7580,33509724,foot
7580,33509724,radiation therapy
7580,33509724,thyroid dermopathy
7581,33579884,*dfnb4
7581,33579884,*menière
7581,33579884,*hydrops
7581,33579884,*mouse
7581,33579884,*pendred
7583,33283314,*graves' disease
7583,33283314,*rai
7583,33283314,*long-term atd
7583,33283314,*surgery
7583,33283314,*treatment
7584,34560868,*amhara region
7584,34560868,*dessie
7584,34560868,*ethiopia
7584,34560868,*iodine deficiency
7584,34560868,*urinary iodine concentration cois
7586,33863564,acuité visuelle
7586,33863564,antioxidant therapy
7586,33863564,cas score
7586,33863564,exophthalmos
7586,33863564,légère orbitopathie thyroïdienne
7586,33863564,mild graves’ orbitopathy
7586,33863564,ouverture palpébrale
7586,33863564,oxidative stress
7586,33863564,palpebral fissure
7586,33863564,placebo
7586,33863564,proptose
7586,33863564,selenium
7586,33863564,stress oxydatif
7586,33863564,sélenium
7586,33863564,traitement anti-oxydatif
7586,33863564,visual acuity
7587,32847459,dry eye disease
7587,32847459,grave’s disease
7587,32847459,grave’s eye disease
7587,32847459,ocular inflammation
7587,32847459,ocular surface
7587,32847459,thyroid eye disease
7588,33994519,graves' disease
7588,33994519,antithyroid drug
7588,33994519,fetal goiter
7588,33994519,fetal hyperthyroidism
7588,33994519,tachycardia
7590,32553518,*graves’ disease
7590,32553518,*nsqip
7590,32553518,*racial disparities
7590,32553518,*thyroidectomy cois conflicts of interest to disclose.
7591,33530368,*graves’ disease
7591,33530368,*autoimmunity
7591,33530368,*dendritic cells
7591,33530368,*methimazole cois
7592,32968816,*graves disease
7592,32968816,*cytokine
7592,32968816,*fibroblasts
7592,32968816,*hyaluronan
7592,32968816,*ophthalmopathy
7592,32968816,*orbit
7593,33532627,*graves' disease
7593,33532627,*trab
7593,33532627,*multivariable analysis
7593,33532627,*thyroid surgery cois
7594,32709792,*dysthyroid optic neuropathy
7594,32709792,*indian
7594,32709792,*thyroid eye disease cois
7595,33380646,immunohistochemistry
7595,33380646,molecular genetics
7595,33380646,thyroid paraganglioma
7595,33380646,thyroid tumor
7595,33380646,total thyroidectomy cois
7596,32130689,graves’ disease
7596,32130689,multiple sclerosis
7596,32130689,personalized medicine
7596,32130689,thyroidectomy
7596,32130689,thyroiditis
7598,32691849,*graves’ disease
7598,32691849,*graves’ ophthalmopathy
7598,32691849,*eye diseases
7598,32691849,*geographical locations
7598,32691849,*meta-analysis
7598,32691849,*prevalence
7598,32691849,*thyroid diseases
7599,33617351,dna methylation
7599,33617351,graves' disease
7599,33617351,bioinformatic analysis
7599,33617351,genome-wide
7600,34774035,extraocular muscle
7600,34774035,magnetic resonance imaging
7600,34774035,short-tau inversion recovery
7600,34774035,thyroid-associated ophthalmopathy cois
7601,33146848,application test
7601,33146848,artificial intelligence
7601,33146848,clinical trials
7601,33146848,thyroid-associated ophthalmopathy
7602,33658136,graves’ ophthalmopathy
7602,33658136,diffusion magnetic resonance imaging
7602,33658136,extraocular muscles
7602,33658136,magnetic resonance imaging
7603,33593429,*graves’ disease
7603,33593429,*graves’ orbitopathy
7603,33593429,*gut microbiota
7603,33593429,*human fecal microbiota transplant
7603,33593429,*microbiome modulation
7603,33593429,*murine model
7603,33593429,*probiotics
7603,33593429,*vancomycin cois other collaborative projects with cultech ltd. the other authors declare that they have no competing interests.
7604,33675208,graves’ disease
7604,33675208,antithyroid treatment
7604,33675208,pediatric thyroidology
7604,33675208,thyroidectomy
7604,33675208,thyrotoxicosis
7606,32034469,endocrine orbitopathy
7606,32034469,epidemiology
7606,32034469,graves’ disease
7606,32034469,healthcare research
7606,32034469,interdisciplinary orbit center
7607,34497059,endocrine system
7607,34497059,respiratory system
7607,34497059,thyroid disease cois
7608,32924380,graves’ disease
7608,32924380,graves’ orbitopathy
7608,32924380,children
7608,32924380,hepatic dysfunction
7608,32924380,lymphocyte subsets
7609,34647611,complications
7609,34647611,hypoparathyroidism
7609,34647611,nodular goitre
7609,34647611,surgical treatment
7609,34647611,thyroid cancer
7610,34518175,genetics
7610,34518175,hyperthyroidism
7610,34518175,thyroid disease cois
7611,34725068,general practice / family medicine
7611,34725068,otolaryngology / ent
7611,34725068,thyroid disease
7611,34725068,thyrotoxicosis cois
7614,34448404,airway obstruction
7614,34448404,asthma
7614,34448404,goitre
7614,34448404,pre-eclampsia
7614,34448404,pregnancy
7615,33779950,hypocalcemia
7615,33779950,intrathoracic goiter
7615,33779950,morbidity
7615,33779950,nerve paralysis
7615,33779950,sternotomy
7615,33779950,surgery
7615,33779950,thyroid cois
7616,32727336,graves’ disease
7616,32727336,thyrotoxicosis
7616,32727336,anti-thyroid therapy
7616,32727336,arrhythmia
7616,32727336,electrocardiogram
7616,32727336,hyperthyroidism
7617,32705333,alopecia areata
7617,32705333,cohort study
7617,32705333,epidemiology
7617,32705333,taiwan’s national health insurance research database
7617,32705333,thyroid disease
7620,33481211,graves’ disease
7620,33481211,gut microbiota
7620,33481211,lactobacillus
7620,33481211,ruminococcus
7620,33481211,trab
7621,33169897,goiter
7621,33169897,imaging mass spectrometry
7621,33169897,obesity
7621,33169897,thyroglobulin
7621,33169897,thyroid disease
7621,33169897,thyroid tissue
7622,33926416,baff
7622,33926416,br3
7622,33926416,graves’ disease
7622,33926416,hashimoto’s thyroiditis
7622,33926416,taci cois
7624,32203974,*antibodies
7624,32203974,*autoimmune diseases
7624,32203974,*drug therapy
7624,32203974,*hyperthyroidism
7624,32203974,*hypothyroidism
7624,32203974,*placenta
7624,32203974,*research laboratories
7624,32203974,*therapeutic drug monitoring
7624,32203974,*thyroid
7624,32203974,*thyroid-stimulating hormone
7626,33563685,anxiety disorders (including ocd and ptsd)
7626,33563685,endocrinology
7626,33563685,psychiatry
7626,33563685,psychotic disorders (incl schizophrenia)
7626,33563685,thyroid disease cois
7627,33966669,*endemic goitre
7627,33966669,*iodine deficiency disorders
7627,33966669,*salt iodine content
7627,33966669,*total goitre rate
7627,33966669,*ultrasonography
7627,33966669,*universal salt iodisation
7627,33966669,*urinary iodine concentration
7628,32875953,thyroid stimulating hormone
7628,32875953,hyperthyroidism
7628,32875953,thyroid uptake and scan
7631,32705522,glucocorticoids
7631,32705522,graves’ orbithopathy
7631,32705522,radiotherapy
7634,33106982,extracellular matrix
7634,33106982,fbln1 gene
7634,33106982,fibulin-1
7634,33106982,multinodular goiter
7634,33106982,papillary thyroid cancer
7636,34194397,*graves’ disease
7636,34194397,*antithyroid drugs
7636,34194397,*children
7636,34194397,*hyperthyroidism
7636,34194397,*remission cois commercial or financial relationships that could be construed as a potential conflict of interest.
7637,34689799,fine-needle aspiration
7637,34689799,midkine
7637,34689799,multinodular goiter
7637,34689799,thyroid cancer
7637,34689799,thyroid nodule cois
7638,34521015,epid dosimetry
7638,34521015,machine learning
7638,34521015,multifactorial error sources
7638,34521015,positioning error detection
7638,34521015,radiomics analysis
7639,34418335,graves’ disease
7639,34418335,hypothyroidism
7639,34418335,radioiodine therapy
7639,34418335,thyroid peroxidase antibody (tpoab)
7639,34418335,thyrotropin receptor antibody (trab)
7640,34448415,fine-needle cytology
7640,34448415,goitre
7640,34448415,thyroid cancer
7640,34448415,thyroid nodules
7640,34448415,thyroidectomy
7641,34893568,*endocrine
7641,34893568,*exophthalmos
7641,34893568,*goiter
7641,34893568,*selfie
7641,34893568,*thyroid
7641,34893568,*thyroidectomy cois
7642,33128357,*c cell hyperplasia
7642,33128357,*medullary thyroid cancer
7642,33128357,*calcitonin
7642,33128357,*pentagastrin
7642,33128357,*cut-off cois
7643,34019179,cd73
7643,34019179,immunohistochemistry
7643,34019179,papillary thyroid carcinoma
7643,34019179,thyroid adenoma
7643,34019179,thyroid carcinoma cois
7645,34782518,goitre
7645,34782518,intrathoracic
7645,34782518,retrosternal
7645,34782518,sternotomy cois
7647,33193994,grave’s disease
7647,33193994,hyperthyroidism
7647,33193994,radioactive iodine disease cois
7648,33619717,genetic
7648,33619717,mutation
7648,33619717,thyroid disease
7649,34560890,graves’ disease
7649,34560890,r282s
7649,34560890,resistance to thyroid hormone
7649,34560890,syndrome of inappropriate secretion of tsh
7649,34560890,thyroid hormone receptor β cois
7652,33474918,bony orbital decompression
7652,33474918,dysthyroid optic neuropathy
7652,33474918,endoscopic orbital decompression
7652,33474918,surgical treatment
7652,33474918,thyroid eye disease
7653,33345558,body composition
7653,33345558,hypocalcemia
7653,33345558,hypoparathyroidism
7653,33345558,thyroid
7653,33345558,total thyroidectomy
7655,34331946,diagnostic efficacy
7655,34331946,graves’ disease
7655,34331946,methimazole
7655,34331946,responsiveness
7655,34331946,thyroid-stimulating immunoglobulin
7656,32449092,16s rrna gene
7656,32449092,graves’ disease
7656,32449092,graves’ orbitopathy
7656,32449092,gut microbiota
7656,32449092,metabolic functions
7658,32057544,goiter size
7658,32057544,graves' disease
7658,32057544,outcome
7658,32057544,radioiodine therapy cois declare.
7659,34552563,*dicer1 mutation
7659,34552563,*dicer1 syndrome
7659,34552563,*goiter
7659,34552563,*goitre
7659,34552563,*hereditary cancer
7659,34552563,*thyroidectomy cois commercial or financial relationships that could be construed as a potential conflict of interest. the reviewer kt declared a past collaboration with one of the authors kw to the handling editor.
7660,33528651,european group on graves’ orbitopathy
7660,33528651,graves’ orbitopathy
7660,33528651,quality of life
7660,33528651,thyroid eye disease
7662,32847889,ophthalmology
7662,32847889,pathology cois
7663,33346898,autoimmunity
7663,33346898,goiter
7663,33346898,graves’ disease
7663,33346898,graves’ orbitopathy
7663,33346898,hyperthyroidism cois
7664,31980413,*adolescents
7664,31980413,*antithyroid drugs
7664,31980413,*children
7664,31980413,*graves disease cois
7668,34630829,ectopic thyroid tissue
7668,34630829,case report
7668,34630829,submandibular mass
7668,34630829,thyroid goiter cois
7669,33026541,hyperthyroidism
7669,33026541,hypothyroidism
7669,33026541,iodine
7669,33026541,spa
7669,33026541,thyroid gland
7671,31982255,auto-immunité
7671,31982255,autoimmunity
7671,31982255,chest pain
7671,31982255,douleur thoracique
7671,31982255,graves’ disease
7671,31982255,maladie de basedow
7671,31982255,myocardite
7671,31982255,myocarditis
7674,34823306,*aggression
7674,34823306,*graves disease
7674,34823306,*prevalence
7674,34823306,*prognosis
7674,34823306,*thyroid neoplasms cois was reported.
7675,34256242,graves' disease
7675,34256242,graves' orbitopathy
7675,34256242,interleukin 17
7675,34256242,interleukin 23
7675,34256242,thyrotropin receptor cois
7676,33728674,graves' disease
7676,33728674,catalytic activity
7676,33728674,thyroid proteomics
7676,33728674,thyrotoxicosis
7676,33728674,toxic multinodular goitre
7677,34164724,deep lateral orbital wall decompression
7677,34164724,extraocular muscle expansion
7677,34164724,greater wing of sphenoid bone
7677,34164724,orbital fat removal
7678,34090378,non-specific orbital inflammation
7678,34090378,comorbidity
7678,34090378,orbital mass
7678,34090378,prednisolone
7678,34090378,thyroid eye disease cois
7679,32527309,case report
7679,32527309,lipoma
7679,32527309,minor salivary gland
7679,32527309,parotid gland
7679,32527309,sialolipoma cois
7680,33317492,case report
7680,33317492,graves’ disease
7680,33317492,orbitopathy
7680,33317492,pregnancy
7680,33317492,smoking
7680,33317492,tao cois
7681,34300095,*saudi arabia
7681,34300095,*iodine deficiency disorders
7681,34300095,*stunting cois
7682,34938274,*swedish endocrine society
7682,34938274,*desiccated thyroid extract (dte)
7682,34938274,*euthyroidism
7682,34938274,*hypothyroidism
7682,34938274,*levothyroxine
7682,34938274,*liothyronine
7682,34938274,"*survey cois authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest. ibsa had no role in the design of the survey, data analysis, data presentation, data interpretation or writing the manuscript; the authors did not receive remuneration by ibsa."
7685,32279181,gender differences
7685,32279181,graves’ disease
7685,32279181,lymphocytic infiltration
7685,32279181,papillary thyroid cancer
7685,32279181,thyroidectomy
7685,32279181,thyroiditis and cancer
7686,34033290,*graves' disease
7686,34033290,*graves' orbitopathy
7686,34033290,*hyperthyroidism
7687,33544540,body surface area
7687,33544540,middle school students
7687,33544540,thyroid volume
7688,34252869,intravenous glucocorticoid
7688,34252869,t2 ideal
7688,34252869,t2 mapping
7688,34252869,therapeutic efficacy
7688,34252869,thyroid-associated ophthalmopathy
7689,32306294,*exophthalmos
7689,32306294,*graves’ disease
7689,32306294,*graves’ orbitopathy
7689,32306294,*igf-1 receptor
7689,32306294,*teprotumumab
7689,32306294,*thyroid eye disease
7690,32166667,diabetes
7690,32166667,euthyroid hormones
7690,32166667,free thyroxine
7690,32166667,free triiodothyronine
7690,32166667,islet beta-cell function
7691,32798996,*graves disease
7691,32798996,*outcomes
7691,32798996,*radioactive iodine ablation
7691,32798996,*thyroidectomy
7693,33860431,*antithyroid agents
7693,33860431,*grave’s disease
7693,33860431,*hyperthyroidism
7693,33860431,*recurrence
7693,33860431,*treatment outcome
7694,34381549,cameroon
7694,34381549,nodular goitre
7694,34381549,cancer
7694,34381549,thyroid cois
7695,32734611,*graves' disease
7695,32734611,*trabs
7695,32734611,*age
7695,32734611,*radioiodine
7695,32734611,*thyroid hormones cois
7696,34120661,complications
7696,34120661,recurrent laryngeal nerve
7696,34120661,surgery
7696,34120661,thyroid
7696,34120661,vagus nerve
7696,34120661,vocal fold palsy
7697,34806437,*iodine deficiency
7697,34806437,*iodine excess
7697,34806437,*iodized salt
7698,33993334,cerebrospinal fluid in the optic nerve sheath
7698,33993334,dysthyroid optic neuropathy
7698,33993334,magnetic resonance imaging
7698,33993334,optic nerve
7698,33993334,quantitative water-fat sequence
7699,32524368,antithyroid drugs
7699,32524368,graves’ disease treatment
7699,32524368,graves’ orbitopathy
7699,32524368,hyperthyroidism
7700,32461446,*diabetes mellitus
7700,32461446,*thyroid eye disease
7700,32461446,*thyroid-related orbitopathy
7700,32461446,*type-2 dm cois
7701,31910731,graves’
7701,31910731,timp-1
7701,31910731,strain
7701,31910731,thyroid
7702,33439464,*effective half-life
7702,33439464,*graves’ disease
7702,33439464,*radioiodine therapy
7702,33439464,*radioiodine uptake test
7702,33439464,*thyroid cois
7703,34659126,*n1b metastasis
7703,34659126,*nomogram
7703,34659126,*papillary thyroid cancer
7703,34659126,*predicting
7703,34659126,*skip metastasis cois commercial or financial relationships that could be construed as a potential conflict of interest.
7704,31927747,differentiated thyroid cancer
7704,31927747,pediatrics
7704,31927747,thyroid
7704,31927747,thyroid nodules
7705,32595602,*graves' hyperthyroidism
7705,32595602,*graves' ophthalmopathy
7705,32595602,*anti-thyroid drugs
7705,32595602,*corticosteroid pulse therapy
7705,32595602,*relapse of graves' hyperthyroidism
7706,34266819,head and neck surgery
7706,34266819,paediatric oncology
7706,34266819,radiotherapy
7706,34266819,thyroid disease cois
7709,32218623,point of care
7709,32218623,thyroid ultrasound cois
7710,33023116,endemic congenital hypothyroidism
7710,33023116,endemic goitre
7710,33023116,familial aggregation
7710,33023116,iodine deficiency
7710,33023116,thyroid metabolism cois
7711,32709788,*india
7711,32709788,*orbital decompression
7711,32709788,*survey
7711,32709788,*thyroid eye disease cois
7712,32527127,prolonged endotracheal intubation
7712,32527127,retrosternal goitre (rsg)
7712,32527127,tracheomalacia
7713,33947272,*graves'disease
7713,33947272,*radioactive iodine therapy
7713,33947272,*thyrotropin receptor antibody
7713,33947272,*thyrotropin-binding inhibitory immunoglobulins
7713,33947272,*total thyroidectomy cois
7714,32358735,choroidal thickness
7714,32358735,ganglion cell layer thickness
7714,32358735,graves’ disease
7714,32358735,graves’ orbitopathy
7714,32358735,optic nerve head
7714,32358735,optical coherence tomography
7714,32358735,retinal thickness
7715,32975031,*thypro
7715,32975031,*benign
7715,32975031,*quality of life
7715,32975031,*thyroid
7715,32975031,*thyroidectomy
7716,32173759,*graves disease
7716,32173759,*graves orbitopathy
7716,32173759,*th17.1 cell
7716,32173759,*effector t cell
7718,32602151,autofluorescence
7718,32602151,hypocalcemia
7718,32602151,parathyroid gland
7718,32602151,thyroidectomy
7719,34278816,*graves' disease
7719,34278816,*iodothyronine deiodinase
7719,34278816,*poorly differentiated thyroid carcinoma
7720,33080613,dicer1 syndrome
7720,33080613,multinodular goitre
7720,33080613,poorly differentiated thyroid cancer
7720,33080613,thyroid carcinoma
7720,33080613,thyroid nodule
7721,32944926,graves’ disease
7721,32944926,trab
7721,32944926,trab-negative
7721,32944926,hyperthyroidism
7721,32944926,smoking
7722,34028325,radioactive iodine
7722,34028325,graves’ disease
7722,34028325,hyperthyroidism
7722,34028325,lithium
7722,34028325,toxic nodule’ toxic multinodular goiter
7723,32037571,*dysthyroid optic neuropathy
7723,32037571,*optic nerve compression
7723,32037571,*thyroid eye disease
7725,32188795,graves’ disease
7725,32188795,graves’ hyperthyroidism
7725,32188795,potassium iodide
7725,32188795,wolff-chaikoff effect
7727,32316214,goitre
7727,32316214,iodine pregnant women
7727,32316214,iodine schoolchildren
7727,32316214,iodised salt
7727,32316214,urine iodine
7727,32316214,water iodine cois the views of the institutions with which they are affiliated. the authors declare that there is no conflict of interest.
7728,32451608,compressive optic neuropathy
7728,32451608,medial wall
7728,32451608,orbital floor
7728,32451608,spontaneous decompression
7728,32451608,thyroid eye disease
7733,32487052,131i−
7733,32487052,euthyreosis
7733,32487052,factors
7733,32487052,graves’ disease
7733,32487052,hyperthyroidism
7733,32487052,predictors
7733,32487052,radioiodine
7733,32487052,toxic multinodular goiter cois
7735,32532690,hepatitis
7735,32532690,methimazole
7735,32532690,plasmapheresis
7735,32532690,thyrotoxicosis
7737,32245343,*generalized additive model
7737,32245343,*salt iodine concentration
7737,32245343,*thyroid volume
7737,32245343,*urinary iodine concentration
7738,32504380,*magnetic resonance imaging
7738,32504380,*quantitative evaluation
7738,32504380,*thyroid-associated ophthalmopathy
7738,32504380,*treatment response
7739,32020533,iodine deficiency
7739,32020533,north macedonia
7739,32020533,schoolchildren
7739,32020533,thyroid gland ultrasonography
7739,32020533,thyroid volume
7740,31948188,*prevalence
7740,31948188,*school-age children
7740,31948188,*turkey
7740,31948188,*iodine deficiency
7741,32333320,energy vessel sealant device
7741,32333320,neck hematoma
7741,32333320,surgical complications
7741,32333320,thyroidectomy
7742,32139177,*graves' disease
7742,32139177,*antithyroid drugs
7742,32139177,*relapse
7742,32139177,*risk factors
7743,32253727,cognition
7743,32253727,diffusion tensor imaging
7743,32253727,thyroid-associated ophthalmopathy
7743,32253727,vision
7743,32253727,voxel-based morphometry
7744,31973681,*antithyroid medications
7744,31973681,*effectiveness of therapy
7744,31973681,*hyperthyroidism
7744,31973681,*radioactive iodine
7744,31973681,*thyroidectomy
7745,32758269,autoimmune antibody
7745,32758269,basedow’s disease
7745,32758269,hashimoto’s thyroiditis
7745,32758269,histopathological features cois
7746,32640447,*autoimmune diseases
7746,32640447,*costimulatory molecules
7746,32640447,*degranulation
7746,32640447,*mast cells
7746,32640447,*thyroid hormones
7748,32077044,anti-tsh receptor autoantibodies
7748,32077044,autoimmunity
7748,32077044,fine-needle aspiration biopsy
7748,32077044,graves’ disease
7748,32077044,graves’ orbitopathy
7748,32077044,hyperthyroidism
7748,32077044,thyroid
7748,32077044,thyroid nodules
7749,32658864,graves’ disease
7749,32658864,hashitoxicosis
7749,32658864,sudan
7749,32658864,adolescents
7749,32658864,childhood
7750,32474767,asymmetric
7750,32474767,graves’
7750,32474767,orbitopathy
7750,32474767,thyroid
7750,32474767,unilateral cois
7752,32174327,*generative adversarial network
7752,32174327,*orbital decompression
7752,32174327,*postoperative appearance
7752,32174327,*thyroid-associated ophthalmopathy cois declare.
7753,32593739,(131)i
7753,32593739,calculated dose
7753,32593739,dosimetry
7753,32593739,dosimetría
7753,32593739,dosis calculada
7753,32593739,dosis fija
7753,32593739,fixed dose
7753,32593739,hipertiroidismo
7753,32593739,hyperthyroidism
7753,32593739,radionuclide therapy
7753,32593739,radioterapia metabólica
7754,32847555,99mtc-pertechnetate scintigraphy
7754,32847555,graves’ disease
7754,32847555,immune checkpoint inhibitor
7754,32847555,nivolumab
7754,32847555,thyroid-stimulating hormone receptor antibody
7754,32847555,thyrotoxicosis cois
7755,32666542,pds
7755,32666542,slc26a4
7755,32666542,upd7
7755,32666542,growth retardation
7756,32709791,*graves orbitopathy
7756,32709791,*hindi
7756,32709791,*quality of life
7756,32709791,*questionnaire
7756,32709791,*validation cois
7757,31465286,131i
7757,31465286,goiter
7757,31465286,carbimazol
7757,31465286,chloride
7757,31465286,creatinine
7757,31465286,thyroid function tests
7757,31465286,thyrotoxicosis.
7758,33346473,21-oh-antibodies
7758,33346473,addison’s disease
7758,33346473,graves’ disease
7758,33346473,autoimmune polyglandular syndromes
7758,33346473,diabetes mellitus type 1
7759,33038927,autoimmune polyglandular syndrome
7759,33038927,chronic urticaria
7759,33038927,graves’ disease
7759,33038927,premature ovarian failure cois
7763,32154572,graves’ disease
7763,32154572,antithyroid drugs
7763,32154572,gender
7763,32154572,hyperthyroidism
7764,33256801,autoimmune disease
7764,33256801,basedow-graves’s disease
7764,33256801,nutritional assessment
7764,33256801,pediatric disability
7764,33256801,stickler syndrome cois
7765,32499464,*clinical impression
7765,32499464,*euthyroid
7765,32499464,*goiter
7765,32499464,*thyroid disorder
7765,32499464,*thyroid function test cois
7767,32295532,*case report
7767,32295532,*congenital chloride diarrhea
7767,32295532,*deafness
7767,32295532,*neonatal diarrhea
7767,32295532,*pendred syndrome cois
7768,34916318,*clinical trials
7768,34916318,*ophthalmology
7768,34916318,*thyroid disease cois
7771,34726857,bony orbital decompression
7771,34726857,corneal ulcer
7771,34726857,exophthalmos
7771,34726857,keratopathy
7771,34726857,lagophthalmos
7771,34726857,neurotrophic keratitis
7771,34726857,tarsorrhaphy
7771,34726857,thyroid eye disease
7772,33517799,*lid flare
7772,33517799,*beziér lines
7772,33517799,*graves orbitopathy
7772,33517799,*lid contour
7772,33517799,*lid retraction
7773,33109498,autoimmune thyroid disease
7773,33109498,chinese herbal medicine
7773,33109498,graves’ disease
7774,33860819,exophthalmos
7774,33860819,graves’ ophthalmopathy
7774,33860819,low dose radiation therapy
7774,33860819,radiotherapy
7774,33860819,"thyroid eye disease cois o. ott, m. hecht, r. fietkau, b. frey, and f. putz declare that they have no competing interests."
7778,33797646,*131i
7778,33797646,*effective half-life
7778,33797646,*graves’ disease
7778,33797646,*mird
7778,33797646,*tld measurements
7779,33049131,dio2 gene
7779,33049131,graves’ disease
7779,33049131,polymorphisms
7781,31237218,cd40
7781,31237218,cd40 ligand
7781,31237218,graves’ ophthalmopathy
7781,31237218,cytokine
7781,31237218,protein microarray
7781,31237218,tear.
7782,34531272,*graves’ disease
7782,34531272,*hyperthyroidism
7782,34531272,*thyrotoxic periodic paralysis
7782,34531272,*weakness
7783,32844239,epidemiology
7783,32844239,graves’ ophthalmopathy
7783,32844239,proptosis
7783,32844239,thyroid eye disease
7787,33247453,*graves disease
7787,33247453,*edrophonium testing
7787,33247453,*myasthenia gravis
7787,33247453,*ocular myasthenia gravis
7787,33247453,*repetitive nerve stimulation
7787,33247453,*thyroid eye disease
7788,34681884,inflammation
7788,34681884,orbital fibroblasts
7788,34681884,proopiomelanocortin (pomc)
7788,34681884,thyroid eye disease
7788,34681884,α-melanocyte stimulating hormone (α-msh) cois
7789,32057773,*extraocular muscle
7789,32057773,*gene microarray
7789,32057773,*proteomic profiling
7789,32057773,*thyroid-associated ophthalmopathy cois
7792,33676921,corticosteroid therapy
7792,33676921,corticothérapie
7792,33676921,graves’ orbitopathy
7792,33676921,mycophenolate mofetil
7792,33676921,mycophénolate mofetil
7792,33676921,orbitopathie basedowienne
7792,33676921,rituximab
7792,33676921,teprotumumab
7792,33676921,tocilizumab
7793,33367784,*graves disease
7793,33367784,*hla class i
7793,33367784,*stat1
7793,33367784,*autoimmune thyroid disease
7793,33367784,*enterovirus
7793,33367784,*viral infections
7794,32506060,*free triiodothyronine
7794,32506060,*free triiodothyronine to free thyroxine ratio
7794,32506060,*subcutaneous fat area
7794,32506060,*visceral fat area cois
7795,34185860,*basedow's disease
7795,34185860,*childhood onset
7795,34185860,*general anesthesia
7795,34185860,*graves' disease
7795,34185860,*hyperthyroidism
7795,34185860,*thyroid storm
7795,34185860,*thyrotoxicosis
7797,34033291,*graves' disease
7797,34033291,*il-27
7797,34033291,*il-35
7797,34033291,*anti-tpo
7797,34033291,*anti-tg
7798,35008579,graves’ disease
7798,35008579,graves’ orbitopathy
7798,35008579,vegf-a
7798,35008579,microrna-199a
7798,35008579,oxidative stress cois competing financial interests exist.
7802,34484118,*graves’ disease (gd)
7802,34484118,*mendelian randomization
7802,34484118,*autoimmune disease (ad)
7802,34484118,*causal relationship
7802,34484118,*rheumatoid arthritis cois commercial or financial relationships that could be construed as a potential conflict of interest.
7803,34078122,*thyroid-associated ophthalmopathy
7803,34078122,*adipogenesis
7803,34078122,*adipose/connective tissue
7803,34078122,*alternative splicing
7803,34078122,"*rmats cois of interest with respect to the research, authorship, and/or publication of this article."
7804,32529279,intraocular pressure
7804,32529279,neuropathy
7804,32529279,orbitopathy
7804,32529279,thyroid
7804,32529279,visual field defect
7805,33845801,fat decompression
7805,33845801,radiological
7805,33845801,"thyroid-associated ophthalmopathy cois presentation, financial support and proprietary interest statement."
7807,32854466,*graves’ ophthalmopathy
7807,32854466,*choroidal thickness
7807,32854466,*optical coherence tomography
7807,32854466,*proptosis cois
7808,32709794,*activity
7808,32709794,*eugogo
7808,32709794,*thyroid eye disease
7808,32709794,*visa
7808,32709794,*hyperthyroidism
7808,32709794,*severity cois
7809,31804961,hyperthyroidism
7809,31804961,radioactive iodine therapy
7809,31804961,sinusitis
7810,34647609,cd4+ t cell
7810,34647609,th lymphocytes
7810,34647609,treg lymphocytes
7810,34647609,autoimmune thyroid disease
7811,33400175,*anti-thyroid drugs
7811,33400175,*hyperthyroidism
7811,33400175,*outcome
7811,33400175,*radioactive iodine therapy
7812,32737644,laryngopharyngeal reflux
7812,32737644,local neck symptoms
7812,32737644,nodular goiter
7812,32737644,thyroidectomy cois
7813,34144327,*cyclic peptide
7813,34144327,*graves' orbitopathy
7813,34144327,*long-term graves' disease mouse model
7813,34144327,*orbital collagen
7813,34144327,*thyroid dysfunction
7813,34144327,*thyrotropin receptor antibodies
7814,32088116,*autoimmune
7814,32088116,*biological agents
7814,32088116,*graves' disease
7814,32088116,*insulin-like growth factor-i receptor
7814,32088116,*monoclonal antibodies
7814,32088116,*teprotumumab
7815,34855199,csvt
7815,34855199,graves’ disease
7815,34855199,cerebral sinus venous thrombosis
7815,34855199,child
7815,34855199,hyperthyroidism
7816,32474766,gene polymorphisms
7816,32474766,graves' disease
7816,32474766,interleukin-1 (il-1)
7816,32474766,interleukin-6 (il-6)
7816,32474766,tumor necrosis factor-α (tnf-α)
7817,34156783,bony regrowth
7817,34156783,deep lateral orbital decompression
7817,34156783,thyroid eye disease
7817,34156783,ultrasonic osteodestruction
7818,33431733,graves' disease
7818,33431733,painless thyroiditis
7818,33431733,potassium iodide cois
7819,32727578,circular rna
7819,32727578,exosomes
7819,32727578,graves’ disease
7819,32727578,immune activation
7819,32727578,hsa_circrna_000102 cois
7820,33086191,*pdk2
7820,33086191,*glycolysis
7820,33086191,*orbital fibroblasts
7820,33086191,*proliferation
7820,33086191,*thyroid-associated ophthalmopathy
7821,31345156,graves’ ophthalmopathy
7821,31345156,angiotensinconverting enzyme inhibitors
7821,31345156,enalapril
7821,31345156,hyperthyroidism
7821,31345156,mild ophthalmopathy
7821,31345156,palpebral fissure.
7822,34147078,graves’ orbitopathy
7822,34147078,in vivo confocal microscopy
7822,34147078,meibomian glands
7822,34147078,microstructure cois
7823,33268601,graves’ ophthalmopathy
7823,33268601,anti-thyroid-stimulating hormone receptor antibodies
7823,33268601,clinical activity score
7823,33268601,pregnancy
7823,33268601,thyroid stimulating antibody
7825,31953667,graves ophthalmopathy
7825,31953667,lacrimal apparatus
7825,31953667,magnetic resonance imaging
7825,31953667,orbital diseases
7830,32588167,decompression
7830,32588167,diplopia
7830,32588167,exophthalmos
7830,32588167,graves’ ophthalmopathy
7830,32588167,orbit
7830,32588167,proptosis cois
7831,34273482,benign thyroid disorders
7831,34273482,biologically effective dose
7831,34273482,dose-rate effects
7831,34273482,outcome probability
7831,34273482,proportional odds model
7831,34273482,radioiodine therapy
7832,33943012,*t helper 17 cells
7832,33943012,*autoimmune thyroid disease
7832,33943012,*selenium cois
7833,32810095,"postpartum thyroiditis, graves' disease, colour doppler ultrasound."
7835,33329408,*graves’ disease
7835,33329408,*graves’ orbitopathy
7835,33329408,*tsh receptor antibodies
7835,33329408,*hyperthyroidism
7835,33329408,*hypothyroidism
7835,33329408,*radioiodine (131i) treatment
7835,33329408,*smoking cois commercial or financial relationships that could be construed as a potential conflict of interest.
7836,34867823,*graves’ disease (gd)
7836,34867823,*hashimoto thyroiditis (ht)
7836,34867823,*autoimmune thyroid disease
7836,34867823,*gut microbiota
7836,34867823,*meta-analysis cois commercial or financial relationships that could be construed as a potential conflict of interest.
7837,33941360,complications
7837,33941360,graves’ disease
7837,33941360,lugol
7837,33941360,potassium iodide
7837,33941360,thyroidectomy
7838,32122631,computer-assisted surgery
7838,32122631,exophthalmos
7838,32122631,neuronavigation
7838,32122631,orbital decompression
7838,32122631,proptosis
7838,32122631,thyroid-associated ophthalmopathy
7840,34628889,hyperthyroidism
7840,34628889,hypercalcemia
7840,34628889,morbidity
7840,34628889,thyroid related antibodies
7840,34628889,vitamin d3
7841,33832456,autoimmune disease
7841,33832456,biomarker
7841,33832456,graves’ disease
7841,33832456,thyroid eye disease cois manuscript.
7843,35285441,graves disease
7843,35285441,tsi
7843,35285441,cancer
7843,35285441,papillary
7843,35285441,thyroid
7844,34844465,*covid-19
7844,34844465,*graves’ disease
7844,34844465,*sars-cov-2
7844,34844465,*thyroid storm
7844,34844465,"*thyrotoxicosis cois conflicts of interest with respect to the research, authorship, and/or publication of this article."
7845,31805011,*genetic diseases
7845,31805011,*genetics
7845,31805011,*oncology
7845,31805011,*rna processing
7845,31805011,*thyroid disease cois exists.
7848,32498091,*graves’ disease
7848,32498091,*hashimoto’s thyroiditis
7848,32498091,*irak1 polymorphism
7848,32498091,*x chromosome genetic analysis
7848,32498091,*autoimmune thyroid disease
7848,32498091,*thyroid-associated ophthalmopathy
7850,32845332,*graves’ disease
7850,32845332,*hyperthyroidism
7850,32845332,*immunomodulation
7850,32845332,*immunotherapy
7850,32845332,*thyroid hormone
7850,32845332,*thyroid-stimulating hormone receptor
7851,33568133,*graves’ disease
7851,33568133,*susceptibility genes
7851,33568133,*three generations
7851,33568133,*whole exome sequencing cois
7853,33858208,*graves'
7853,33858208,*sars-cov-2 vaccines
7853,33858208,*adverse vaccine reactions
7853,33858208,*autoimmune/inflammatory syndrome induced by adjuvants
7853,33858208,*disease
7854,33673340,*b cells
7854,33673340,*graves’ disease
7854,33673340,*igf-ir
7854,33673340,*igf-ir inhibitors
7854,33673340,*t cells
7854,33673340,*tshr
7854,33673340,*autoimmunity
7854,33673340,*proptosis
7854,33673340,*thyroid-associated ophthalmopathy cois inventions concerning the use of igf-ir inhibitors as therapy in graves’ disease. these patents are held by ucla school of medicine and los anglees biomedical research institute. he is a consultant for horizon therapeutics.
7855,32126013,graves
7855,32126013,hashimoto
7855,32126013,autoimmune thyroid
7858,32515628,corneal biomechanical properties
7858,32515628,corneal hysteresis
7858,32515628,ocular response analyzer
7858,32515628,thyroid associated ophthalmopathy
7861,33855963,thyroid eye disease
7861,33855963,tocilizumab
7862,33613458,*graves’ disease
7862,33613458,*hashimoto autoimmune thyroiditis
7862,33613458,*adolescents
7862,33613458,*autoimmune thyroid diseases
7862,33613458,*children cois commercial or financial relationships that could be construed as a potential conflict of interest.
7864,32930505,müllerectomy
7864,32930505,graves' orbitopathy
7864,32930505,levator disinsertion
7864,32930505,upper eyelid retraction
7864,32930505,upper eyelid surgery
7865,34020391,aitd
7865,34020391,il-10
7865,34020391,regulatory b cells
7867,34243868,graves disease
7867,34243868,hyperthyroidism
7867,34243868,thyroid
7867,34243868,thyroid cancer
7867,34243868,toxic nodule
7868,32785898,*cardiac output
7868,32785898,*echocardiography
7868,32785898,*n-terminal-pro-b-type natriuretic peptide
7868,32785898,*neonatal hyperthyroidism
7868,32785898,*thyroid-stimulating hormone receptor antibody
7869,34742692,*eye proteins/*analysis
7869,34742692,*eye diseases/diagnosis/*metabolism
7869,34742692,*graves' ophthalmopathy
7869,34742692,*mesh
7869,34742692,*molecular diagnostic techniques/methods
7869,34742692,*orbital inflammatory diseases/diagnosis/*metabolism
7869,34742692,*proteome/*metabolism
7869,34742692,*proteomics/methods
7869,34742692,*tear biomarkers/*metabolism
7869,34742692,*tear proteomics
7869,34742692,"*tears/*metabolism cois eyevensys, santen, affibody, kyverna and covrus."
7870,33371640,cytochrome p450 system
7870,33371640,endocrine ophthalmopathy
7870,33371640,glucocorticoid receptor gene polymorphism
7870,33371640,glucocorticoid therapy
7870,33371640,resistance
7871,32636230,drugs: endocrine system
7871,32636230,paediatrics (drugs and medicines)
7871,32636230,thyrotoxicosis cois
7872,32507991,dynamic scheimpflug analyzer
7872,32507991,glucocorticoids
7872,32507991,graves’ orbitopathy
7872,32507991,ocular biomechanics
7873,34684053,creatine kinase
7873,34684053,graves’ disease
7873,34684053,methimazole
7873,34684053,myopathy cois
7875,32741892,graves' disease
7875,32741892,hyperthyroidism
7875,32741892,resting energy expenditure
7875,32741892,resting metabolic rate cois
7881,32472423,*autoantibodies
7881,32472423,*graves’ disease
7881,32472423,*graves’ orbithopathy
7881,32472423,*tsh receptor
7881,32472423,*thyroid
7881,32472423,"*thyroid cancer cois a developer of medical diagnostics including kits for measuring tsh receptor antibodies. j.f., j.s. and b.r.s. are directors of av7 limited. av7 limited has no other competing interests to declare. k1-70 is currently in use as part of a phase i, single ascending intramuscular or single intravenous dose, safety, tolerability, pharmacokinetic and pharmacodynamic study in subjects with graves’ disease (iras id 199697, eudract number 2014-003815-12)."
7882,34130982,diabetes
7882,34130982,endocrinology
7882,34130982,thyroid disease
7882,34130982,thyrotoxicosis cois
7885,34037961,*antiphospholipid antibodies
7885,34037961,*apolipoproteins
7885,34037961,*autoimmune thyroid diseases
7885,34037961,*graves’ orbitopathy
7885,34037961,*interleukine 6
7889,34202024,graves’ ophthalmopathy
7889,34202024,curcumin
7889,34202024,orbital fibrosis
7889,34202024,thyroid eye disease cois
7890,33844165,ablation
7890,33844165,autoimmunity
7890,33844165,graves’ disease
7890,33844165,graves’ orbitopathy
7890,33844165,radioiodine
7890,33844165,thyroid cois
7891,33484567,*graves’ orbitopathy
7891,33484567,*genetics
7891,33484567,*thyroid eye disease
7892,33246456,case report
7892,33246456,hashimoto’s disease
7892,33246456,hashimoto’s thyroiditis
7892,33246456,ophtalmopathy
7892,33246456,orbitopathy cois
7893,32112702,graves’ disease
7893,32112702,adrenal crisis
7893,32112702,autoimmune polyglandular syndrome type ii
7895,34248849,*graves’ disease
7895,34248849,*children
7895,34248849,*environmental substances
7895,34248849,*metabolomics
7895,34248849,*single-nucleotide polymorphisms cois commercial or financial relationships that could be construed as a potential conflict of interest.
7896,32405700,anti-cd20 antibody
7896,32405700,basedow’s disease
7896,32405700,clinical activity score (cas)
7896,32405700,graves’ orbitopathy
7896,32405700,rituximab
7898,34616359,*graves’ disease (gd)
7898,34616359,*rna methyltransferase
7898,34616359,*rna modification
7898,34616359,*methyltransferase like 3 (mettl3)
7898,34616359,*suppressor of cytokine signaling (socs) cois commercial or financial relationships that could be construed as a potential conflict of interest.
7899,33514849,*cd4+ cytotoxic t lymphocytes
7899,33514849,*graves’ orbitopathy
7899,33514849,*single-cell rna sequencing cois
7900,32991886,*fibroblasts
7900,32991886,*orbit
7900,32991886,*polysaccharides
7900,32991886,*prunella vulgaris
7900,32991886,*thyroid-associated ophthalmopathy
7901,32564766,graves' disease
7901,32564766,yersinia enterocolitica
7901,32564766,autoimmune thyroid diseases
7901,32564766,hashimoto's thyroiditis
7901,32564766,meta-analysis
7901,32564766,thyroid dysfunction
7902,32340849,cas
7902,32340849,graves orbitopathy
7902,32340849,graves’ disease
7902,32340849,maladie de basedow
7902,32340849,orbitopathie basedowienne
7902,32340849,anticorps aux récepteurs d’hormone thyréostimulante
7902,32340849,hyperthyroidism
7902,32340849,hyperthyroïdie
7902,32340849,thyroid-stimulating hormone receptor antibodies
7902,32340849,tocilizumab
7903,32293702,graves’ disease
7903,32293702,graves’ orbitopathy
7903,32293702,tsh-receptor antibodies
7903,32293702,radioiodine
7903,32293702,thyroidectomy
7905,34130234,graves’ ophthalmopathy
7905,34130234,lacrimal gland
7905,34130234,magnetic resonance imaging
7905,34130234,t1 mapping
7905,34130234,t2 mapping
7908,34328251,*graves disease
7908,34328251,*hiv
7908,34328251,*immune reconstitution inflammatory syndrome
7908,34328251,*radioactive iodine treatment
7909,33746907,*clinical activity score
7909,33746907,*disease severity
7909,33746907,*ethnically diverse
7909,33746907,*immunosuppression
7909,33746907,*polyautoimmunity
7909,33746907,*psoriasis
7909,33746907,*rheumatoid arthritis
7909,33746907,*thyroid eye disease cois commercial or financial relationships that could be construed as a potential conflict of interest.
7910,33658982,*dna methylation
7910,33658982,*epigenetics
7910,33658982,*graves’ ophthalmopathy
7910,33658982,*orbital fibroblast
7910,33658982,*proteomics cois commercial or financial relationships that could be construed as a potential conflict of interest.
7911,33560351,*3-hydroxy-3-methylglutaryl-coenzyme reductase inhibitors
7911,33560351,*graves disease
7911,33560351,*graves orbitopathy
7911,33560351,*statins
7912,31927748,cytokines
7912,31927748,ocular surface
7912,31927748,tear
7912,31927748,thyroid eye disease
7913,32767605,graves disease
7913,32767605,free region of interest
7913,32767605,shear wave elastography
7913,32767605,ultrasound
7914,32107993,*graves disease
7914,32107993,*technetium (99mtc) pertechnetate thyroid scintigraphy
7914,32107993,*autoimmune disorder
7914,32107993,*color doppler ultrasonography
7914,32107993,*thyroid hormones
7914,32107993,*thyrotropin
7915,34358537,*drug intervention
7915,34358537,*graves’ disease
7915,34358537,*hashimoto’s thyroiditis
7915,34358537,*mathematical model
7915,34358537,*thyroid hormone regulation cois competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
7916,33786753,exophthalmos
7916,33786753,figuration and abstraction
7916,33786753,graves’orbitopathy
7916,33786753,natalie frank
7916,33786753,post-modern american art
7918,34281356,*autoimmune
7918,34281356,*comorbidities
7918,34281356,*thyroid
7919,33663404,*amiodarone
7919,33663404,*dilated thyrotoxic cardiomyopathy
7919,33663404,*heart failure
7919,33663404,*multifocal atrial tachycardia
7919,33663404,*thyroid storm cois
7923,34025584,*graves disease
7923,34025584,*graves ophthalmopathy
7923,34025584,*graves orbitopathy
7923,34025584,*optic neuropathy
7923,34025584,*thyroid eye disease
7923,34025584,*thyroid-associated ophthalmopathy cois thyroid eye disease amsterdam declaration implementation group). the remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
7924,32507887,*graves disease
7924,32507887,*epidemiology
7924,32507887,*hyperthyroidism
7924,32507887,*ulcerative colitis
7925,32315207,*graves’ disease
7925,32315207,*hyperthyroidism
7925,32315207,*antithyroid drugs
7925,32315207,*cardiovascular disease
7925,32315207,*mortality
7925,32315207,*pregnancy
7925,32315207,*radioactive iodine
7925,32315207,*thyroidectomy
7926,33941979,"carbimazole, graves's disease, hyperthyroidism, methimazole, prophylthiouracil,  thiomazole, thyrotoxicosis."
7929,33187482,child health
7929,33187482,iodine
7929,33187482,iodine deficiency
7929,33187482,iodine supplementation
7929,33187482,maternal health
7929,33187482,nutrition
7929,33187482,pregnancy
7929,33187482,psychomotor development
7929,33187482,public health intervention cois
7930,32949299,bovine pericardium
7930,32949299,strabismus surgery
7930,32949299,tendon elongation
7930,32949299,tutopatch® cois
7931,32771076,dexamethasone administration
7931,32771076,hypokalemia
7931,32771076,steroid-induced
7931,32771076,thyrotoxic periodic paralysis
7933,32060570,chronic sinusitis
7933,32060570,eosinophilic angiocentric fibrosis
7933,32060570,igg4-related disease
7933,32060570,immunoglobulin g
7933,32060570,orbit
7934,33711978,ocular duction
7934,33711978,orbital decompression
7934,33711978,strabismus
7934,33711978,thyroid eye disease cois
7935,34465342,biomarker
7935,34465342,hashimoto’s thyroiditis
7935,34465342,lymph node metastasis
7935,34465342,nodular goiter
7935,34465342,pd-1
7935,34465342,papillary thyroid carcinoma cois manuscript is approved by all authors for publication.
7937,33716970,*t2 relaxation time
7937,33716970,*extraocular muscle
7937,33716970,*intravenous methylprednisolone pulse
7937,33716970,*thyroid associated ophthalmopathy
7937,33716970,*treatment response cois commercial or financial relationships that could be construed as a potential conflict of interest.
7939,34144042,autoimmunity
7939,34144042,graves’ disease
7939,34144042,trab
7939,34144042,tsi
7939,34144042,thyroid stimulating hormone receptor autoantibodies
7939,34144042,thyroid stimulating immunoglobulin
7941,32146747,blood flow velocity
7941,32146747,graves disease
7941,32146747,"thyroiditis, autoimmune"
7941,32146747,thyrotoxicosis
7943,33511522,*full-field electroretinography
7943,33511522,*isolated-check visual evoked potential
7943,33511522,*pattern visual evoked potential
7943,33511522,*thyroid-associated ophthalmopathy
7947,34232313,*akt1
7947,34232313,*egfr/pi3k/akt signaling
7947,34232313,*lncrna lpal2
7947,34232313,*mir-1287-5p
7947,34232313,*orbital fibroblast activation
7947,34232313,*thyroid eye disease
7948,33198476,"anaesthesia, thyroid eye disease, thyroid-associated orbitopathy, graves'  ophthalmopathy"
7949,32744317,*cluster of differentiation 74
7949,32744317,*graves disease
7949,32744317,*graves ophthalmopathy
7949,32744317,*immunology & inflammation
7949,32744317,*molecular bases of health & disease
7949,32744317,*subject areas: endocrinology
7949,32744317,*single nucleotide polymorphisms cois manuscript.
7951,33613444,*graves’ ophthalmopathy
7951,33613444,*hub gene
7951,33613444,*lacrimal gland
7951,33613444,*microarray data
7951,33613444,*protein processing in endoplasmic reticulum cois remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
7952,33576183,graves’ orbitopathy
7952,33576183,deviation correction
7952,33576183,dose-effect
7952,33576183,success rates
7952,33576183,superior rectus recession
7953,33343507,*hashimoto autoimmune thyroiditis
7953,33343507,*autoimmunity
7953,33343507,*cancer
7953,33343507,*gut microbiota
7953,33343507,*thyroid cois commercial or financial relationships that could be construed as a potential conflict of interest.
7954,33130479,down syndrome
7954,33130479,graves' disease
7954,33130479,moyamoya disease
7954,33130479,quasi-moyamoya
7954,33130479,thyrotoxicosis
7954,33130479,trisomy 21 cois competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
7955,33000387,block and replace treatment
7955,33000387,hyperthyroidism
7955,33000387,titration regimen
7956,34243871,extraocular muscles
7956,34243871,graves disease
7956,34243871,graves eye disease (ged)
7956,34243871,lacrimal gland
7959,34102155,*graves ophthalmopathy
7959,34102155,*coefficient variation of cell area
7959,34102155,*corneal endothelium
7959,34102155,*diagnostic capacity
7959,34102155,*disease activity
7961,32684074,go treatment
7961,32684074,graves ophthalmopathy treatment
7961,32684074,ted treatment
7961,32684074,thyroid eye disease treatment
7961,32684074,teprotumumab
7962,32133893,*antithyroid
7962,32133893,*graves’ disease
7962,32133893,*carbimazole
7962,32133893,*methimazole
7962,32133893,*pediatric
7962,32133893,*propylthiouracil
7963,34235979,*graves' ophthalmopathy
7963,34235979,*extracellular matrix
7963,34235979,*histone deacetylases
7963,34235979,*orbital fibroblasts
7963,34235979,*platelet-derived growth factor-bb
7964,32739299,*cardiac arrest
7964,32739299,*coronary artery spasm
7964,32739299,*iodine contrast
7964,32739299,*thyrotoxicosis
7966,33468490,*optic nerve
7966,33468490,*orbit cois
7967,32562184,*graves’ disease
7967,32562184,*thyroid-stimulating immunoglobulin
7967,32562184,*thyroid-stimulating hormone receptor autoantibody
7968,32300961,count ivan viii drašković
7968,32300961,graves’ disease
7968,32300961,iodine
7968,32300961,orbitopathy
7968,32300961,spontaneous remission
7968,32300961,tobacco
7970,34855075,mir-155
7970,34855075,microrna
7970,34855075,rennin—angiotensin—aldosterone system
7970,34855075,thyrotoxic heart disease
7972,32666762,thyroid autoimmunity
7972,32666762,vitamin d
7972,32666762,vitamin d supplementation
7973,32858059,autoimmunity
7973,32858059,brahms
7973,32858059,biotin
7973,32858059,graves’ disease
7973,32858059,roche cobas
7973,32858059,trace
7973,32858059,trab
7973,32858059,tsh-receptor antibody
7973,32858059,thermo scientific kryptor
7973,32858059,thyroid stimulating antibody
7974,32134013,*channelopathies
7974,32134013,*tpp
7974,32134013,*hypokalaemia
7974,32134013,*paralysis
7974,32134013,*periodic palsy
7974,32134013,*thyroid hormones
7974,32134013,*thyrotoxicosis cois
7975,33349844,*maternal thyroid function
7975,33349844,*pregnancy
7975,33349844,*thyroid in pregnancy
7976,32693696,thyroid-associated ophthalmopathy
7976,32693696,dose response
7976,32693696,strabismus surgery
7976,32693696,torsion
7977,32249902,*graves’ orbitopathy
7977,32249902,*adipogenesis
7977,32249902,*autophagy
7977,32249902,*chloroquine
7977,32249902,*hydroxychloroquine
7977,32249902,*orbital fibroblasts
7979,31865369,*graves hyperthyroidism
7979,31865369,*tsh-r blocking antibodies
7979,31865369,*tsh-r stimulating antibodies
7979,31865369,*dilution analysis
7979,31865369,*prospective trial
7980,31756165,graves’ disease (gd)
7980,31756165,autoimmune polyglandular syndrome type 3 variant (aps3v)
7980,31756165,autoimmune thyroid disease (aitd)
7980,31756165,rheumatoid arthritis (ra)
7980,31756165,type 1 diabetes mellitus (t1d)
7980,31756165,type 2 diabetes mellitus (t2d)
7981,32804020,chronic sinus
7981,32804020,neck abscess
7981,32804020,polyglactin 910
7981,32804020,post thyroidectomy
7981,32804020,retained suture
7982,33880967,*adpla
7982,33880967,*rna interference
7982,33880967,*tao
7982,33880967,*adipocytes
7982,33880967,"*microneedles cois conflicts of interest with respect to the research, authorship, and/or publication of this article."
7984,32176314,*cd34
7984,32176314,*cd68
7984,32176314,*fgf-b
7984,32176314,*foxp-3
7984,32176314,*graves’ orbitopathy
7984,32176314,*igf-1r
7984,32176314,*ihc
7984,32176314,*ppar-g
7984,32176314,*tgf-b
7984,32176314,*autoimmunity
7984,32176314,*tissue remodeling
7986,31952487,dysthyroid optic neuropathy
7986,31952487,graves’ orbitopathy
7986,31952487,japanese
7986,31952487,orbital decompression
7986,31952487,visual outcome cois
7987,33972303,endocrinology
7987,33972303,neurology (drugs and medicines)
7987,33972303,ophthalmology
7987,33972303,thyroid disease cois
7990,33050937,graves’ disease
7990,33050937,papillary thyroid carcinoma
7990,33050937,prognosis
7990,33050937,recurrence cois
7992,32874077,cascade testing
7992,32874077,thyroid dysfunction
7992,32874077,thyroid stimulating hormone
7993,32321476,extraocular muscles
7993,32321476,histopathology
7993,32321476,ocular myasthenia gravis
7993,32321476,thyroid-associated ophthalmopathy cois
7994,32638278,elastography
7994,32638278,graves
7994,32638278,medial rectus muscle
7994,32638278,optic nerve
7994,32638278,shear wave
7996,31997590,*blood vessels
7996,31997590,*children
7996,31997590,*microvascular imaging
7996,31997590,*ultrasonography
7996,31997590,"*ultrasonography, doppler, color cois"
7999,32447327,*drugs
7999,32447327,*orbit
7999,32447327,*treatment medical cois
8005,33381085,*enalapril
8005,33381085,*graves’ orbitopathy (go)
8005,33381085,*n-acetyl-l-cysteine
8005,33381085,*quercetin
8005,33381085,*vitamin c
8005,33381085,*melatonin
8005,33381085,*oxidative stress
8005,33381085,*β-carotene cois commercial or financial relationships that could be construed as a potential conflict of interest.
8008,32297812,*graves’ disease (gd)
8008,32297812,*hyperlipidemia
8008,32297812,*polycystic ovary syndrome (pcos)
8009,32090526,*diffusion tensor imaging
8009,32090526,*extraocular muscle
8009,32090526,*optic nerve
8009,32090526,*readout-segmented echo-planar imaging
8009,32090526,*thyroid-associated orbitopathy cois
8010,34939881,*covid-19 vaccines
8010,34939881,*graves disease
8010,34939881,*sars-cov-2
8010,34939881,*case report
8010,34939881,*endocrinology
8010,34939881,*immunology
8010,34939881,"*pharmacovigilance cois conflicts of interest with respect to the research, authorship, and/or publication of this article."
8011,33158379,thyroid eye disease
8011,33158379,eyelid disease: eyelid malpositions/trichiasis/ptosis
8011,33158379,neuro ophthalmology
8011,33158379,optic neuropathy
8011,33158379,orbital disease
8011,33158379,strabismus
8012,32969067,131i
8012,32969067,dosimetry
8012,32969067,hyperthyroidism
8018,31915884,chronic sinusitis
8018,31915884,eosinophilic angiocentric fibrosis
8018,31915884,igg4-related disease
8018,31915884,immunoglobulin g
8018,31915884,orbit
8019,32712880,dicer1
8019,32712880,follicular thyroid carcinoma
8019,32712880,met
8019,32712880,macrofollicular variant
8019,32712880,mutation cois
8020,33543610,*tidm4 gene
8020,33543610,*functional mechanism
8020,33543610,*orbital adipose tissue
8020,33543610,*thyroid-associated ophthalmopathy
8023,34704876,*graves’ ophthalmopathy
8023,34704876,*glucocorticoids
8023,34704876,*immunotherapy
8023,34704876,*therapy
8023,34704876,*tocilizumab
8024,34635084,bell’s phenomeon
8024,34635084,fibrosis
8024,34635084,inferior rectus muscle
8024,34635084,thryoid eye disease cois
8026,34212219,histological confirmation
8026,34212219,idiopathic orbital inflammation
8026,34212219,lymphoid hyperplasia
8026,34212219,orbital lymphoma
8026,34212219,specific orbital inflammation
8027,33128233,*graves’ disease
8027,33128233,*hyperthyroidism
8027,33128233,*paediatric
8027,33128233,*quality of life
8027,33128233,*thyroid
8030,33121425,autoimmune hyperthyroidism
8030,33121425,gitelman syndrome
8030,33121425,endocrine
8030,33121425,gene mutation
8030,33121425,hypokalemia
8030,33121425,metabolic alkalosis.
8031,32643429,*b lymphocytes
8031,32643429,*cxcr5
8031,32643429,*cxcl13
8031,32643429,*graves’ orbitopathy
8031,32643429,*chemokine receptor
8032,32457697,*graves' disease
8032,32457697,*eosinophils
8032,32457697,*subacute thyroiditis
8032,32457697,*thyroxine
8032,32457697,*triiodothyronine
8033,34473251,*atp production
8033,34473251,*graves orbitopathy
8033,34473251,*adipogenesis
8033,34473251,*fatty acid uptake
8033,34473251,*mitochondria oxphos
8033,34473251,*orbital adipose tissue
8036,31928169,*escape
8036,31928169,*methimazole
8036,31928169,*potassium iodide
8036,31928169,*pregnancy
8036,31928169,*thyrotoxicosis
8038,33930408,*graves' disease
8038,33930408,*graves' orbitopathy
8038,33930408,*teprotumumab
8038,33930408,*translational science
8038,33930408,*biologics
8038,33930408,*clinical activity score
8038,33930408,*randomized clinical trial
8038,33930408,*review
8038,33930408,*thyroid eye disease
8039,33783712,graves’ ophthalmopathy
8039,33783712,meta-analysis
8039,33783712,rituximab
8039,33783712,treatment
8040,32908802,*graves’ ophthalmopathy
8040,32908802,*lincs
8040,32908802,*adipogenesis
8040,32908802,*orbital adipose stem cells
8040,32908802,*thyroid eye disease
8040,32908802,"*thyroid-associated orbitopathy cois d.t. tse, none; d. pelaez, none; s.t. wester, horizon therapeutics (c)"
8041,32738825,*graves´ disease
8041,32738825,*hashimoto thyroiditis
8041,32738825,*autoimmune thyroid disease
8041,32738825,*cluster analysis
8041,32738825,*polyautoimmunity
8045,33964007,autoimmunity
8045,33964007,covid-19
8045,33964007,graves’ disease
8045,33964007,graves’ orbitopathy
8045,33964007,sars-cov-2
8045,33964007,thyroid cois
8046,34867951,*graves’ disease
8046,34867951,*hashimoto’s thyroiditis (ht)
8046,34867951,*autoimmune thyroid diseases (aitds)
8046,34867951,*exosome
8046,34867951,*proteomics cois commercial or financial relationships that could be construed as a potential conflict of interest.
8047,34412613,graves’ disease
8047,34412613,growth hormone
8047,34412613,insulin-like growth factor-i
8047,34412613,thyroid-related ophthalmopathy cois
8049,32785703,* bacteroides fragilis
8049,32785703,*graves’ disease
8049,32785703,*treg/th17
8049,32785703,*intestinal flora
8049,32785703,*propionic acid
8050,33603715,*graves’ orbitopathy
8050,33603715,*biomarker
8050,33603715,*functional thyrotropin receptor antibodies
8050,33603715,*stimulatory tsh receptor antibodies
8050,33603715,"*thyroid eye disease cois authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest. the jgu medical center has received research-associated funding unrelated to this study from the jgu medical faculty, advancecor, germany, apitope, united kingdom; immunovant, usa, isar, germany, horizon, usa, mediomics, usa, merck, germany, novartis, usa, quidel, usa, river vision, usa, and roche, switzerland. this article was not specifically funded by a company. the funder was not involved in the study design, collection, analysis, interpretation of data, the writing of this article, or the decision to submit it for publication."
8051,34117002,cardiovascular medicine
8051,34117002,emergency medicine
8051,34117002,endocrine system cois
8052,32968297,hyperthyroidism; pregnancy; pprom; thyrotoxicosis. cois
8053,34602013,*graves’ orbitopathy
8053,34602013,*adipokines
8053,34602013,*methylprednisolone
8054,34051850,*go animal model
8054,34051850,*graves’ disease
8054,34051850,*graves’ ophthalmopathy
8054,34051850,*thyroid disease
8054,34051850,*adipogenesis
8054,34051850,*hpmscs cois paper.
8056,32567442,graves ophthalmopathy
8056,32567442,graves orbitopathy
8056,32567442,mri ted
8056,32567442,tendon sparing
8056,32567442,thyroid eye disease
8058,32648002,clinical activity score
8058,32648002,graves’ disease
8058,32648002,graves’ ophthalmopathy
8058,32648002,graves’ orbitopathy
8058,32648002,tsh receptor autoantibodies
8058,32648002,thyroid eye disease
8059,32583374,autoimmune thyroiditis
8059,32583374,graves’ disease
8059,32583374,graves’ ophthalmopathy
8059,32583374,graves’ orbitopathy
8059,32583374,insulin-like growth factor-1 receptor
8059,32583374,thyroid
8059,32583374,thyroid autoimmunity
8059,32583374,thyroid eye disease
8060,32567373,*thyroid-associated ophthalmopathy
8060,32567373,*decompression surgery & interventional medicine
8060,32567373,*gene network analysis
8060,32567373,*graves’ ophthalmopathy
8060,32567373,*therapeutics
8061,34116129,*adipogenesis
8061,34116129,*graves' orbitopathy
8061,34116129,*orbital fibroblasts
8061,34116129,*stat3
8061,34116129,*signal transducer and activator of transcription 3
8061,34116129,*thyroid eye disease
8064,34406498,go
8064,34406498,imaging
8064,34406498,mri
8064,34406498,pet
8064,34406498,ted
8064,34406498,thyroid eye disease cois
8065,34344134,graves ophthalmopathy
8065,34344134,retinal diseases
8065,34344134,smoking cois was reported.
8067,32842335,eye injections
8067,32842335,eyelid diseases
8067,32842335,graves ophthalmopathy
8067,32842335,triamcinolone acetonide
8069,34077777,graves’ disease
8069,34077777,graves’ ophthalmopathy
8069,34077777,single nucleotide polymorphism
8069,34077777,vitamin d receptor
8070,33261249,*hyperthyroidism
8070,33261249,*agranulocytosis
8070,33261249,*methimazole
8070,33261249,*neutropenia
8070,33261249,*thionamides
8071,34594339,*gnrh stimulation test
8071,34594339,*graves’ disease
8071,34594339,*autoimmune polyglandular syndrome type 3
8071,34594339,*isolated gonadotropin-releasing hormone deficiency
8071,34594339,*secondary amenorrhea
8071,34594339,*type 1 diabetes mellitus cois commercial or financial relationships that could be construed as a potential conflict of interest.
8072,33866536,foxp3
8072,33866536,glucocorticosteroids
8072,33866536,orbitopathy
8072,33866536,rorγt
8072,33866536,th17
8072,33866536,treg
8073,34114495,*graves' ophthalmopathy
8073,34114495,*tsh receptor
8073,34114495,*antibody drugs
8073,34114495,*autoantibodies
8073,34114495,*thyroid cancer
8074,33148577,endocrine system
8074,33148577,endocrinology
8074,33148577,thyroid disease
8074,33148577,thyroiditis
8074,33148577,thyrotoxicosis cois
8076,33844898,covid-19
8076,33844898,thyroid disorders
8076,33844898,hyperthyroidism
8076,33844898,hypothyroidism
8076,33844898,subacute thyroiditis
8078,32339726,*adult
8078,32339726,*case report
8078,32339726,*magnetic resonance imaging
8078,32339726,*pathology
8078,32339726,*pituitary blastoma
8079,33882721,*graves'
8079,33882721,*age
8079,33882721,*disease
8079,33882721,*disease prognosis
8079,33882721,*hyperthyroidism
8079,33882721,*sex
8080,32669187,graves disease
8080,32669187,"infant, newborn"
8080,32669187,mothers
8080,32669187,pregnancy complications
8080,32669187,prenatal exposure delayed effects
8083,33505575,africa
8083,33505575,paralysis
8083,33505575,hyperthyroidism
8083,33505575,hypokalemia cois
8085,34526052,3d photography
8085,34526052,blepharoplasty surgery
8085,34526052,digital facial-analysis tool
8085,34526052,endocrine orbitopathy
8085,34526052,lid refinement
8085,34526052,lid repositioning
8085,34526052,ocular surface area cois
8087,32799342,*graves’ disease
8087,32799342,*hyperthyroidism
8087,32799342,*neutropenia
8087,32799342,*white blood cells
8090,33409786,artifacts
8090,33409786,eye diseases
8090,33409786,magnetic resonance imaging
8090,33409786,thyroid diseases
8091,33081749,choroidal thickness
8091,33081749,optical coherence tomography angiography
8091,33081749,retinal nerve fiber layer
8091,33081749,thyroid-associated ophthalmopathy cois publication of this paper.
8092,32855872,*graves' disease
8092,32855872,*murine model
8092,32855872,*orbital inflammation
8092,32855872,"*thyroid eye disease cois none; l. ramos, none; s.k. freitag, none; d.r. bielenberg, none; l.a. kim, none; n.g. lee, none"
8093,32779176,ct
8093,32779176,mri
8093,32779176,ultrasonography
8093,32779176,ectopic thyroid
8093,32779176,multimodality
8093,32779176,thyroid scintigraphy
8095,32546346,*bone mineral density
8095,32546346,*graves’ disease
8095,32546346,*dual energy x-ray absorptiometry
8096,33391187,*graves’ disease
8096,33391187,*autoimmune
8096,33391187,*connective tissue
8096,33391187,*insulin-like growth factor i receptor
8096,33391187,*monoclonal antibody
8096,33391187,*thyroid-associated ophthalmopathy cois inhibitors as therapy in graves’ disease. these patents are held by ucla school of medicine and los angeles biomedical research institute.
8097,33311000,grave’s disease
8097,33311000,hashimoto’s thyroiditis
8097,33311000,igg4 thyroiditis
8097,33311000,igg4-related thyroid disease
8097,33311000,riedel’s thyroiditis
8099,32919017,*long non-coding rna
8099,32919017,*orbital adipose/connective tissue
8099,32919017,*rna sequencing
8099,32919017,*thyroid-associated ophthalmopathy
8102,34106438,*ace2
8102,34106438,*autoimmune
8102,34106438,*covid-19
8102,34106438,*graves’ disease
8102,34106438,*hyperthyroidism
8102,34106438,*raas
8102,34106438,*sars-cov-2
8102,34106438,*thyroid cois
8103,34060524,compressive optic neuropathy
8103,34060524,nasal endoscopy
8103,34060524,orbital decompression
8103,34060524,thyroid eye disease cois
8104,33817897,*fractional amplitude of low-frequency fluctuation
8104,33817897,"*regional homogeneity, degree centrality"
8104,33817897,*resting-state fmri
8104,33817897,*thyroid-associated ophthalmopathy
8105,33599843,diplopia
8105,33599843,exophthalmos
8105,33599843,graves’ orbitopathy
8105,33599843,orbital decompression
8106,33446163,machine learning
8106,33446163,magnetic resonance imaging
8106,33446163,thyroid-associated ophthalmopathy cois
8110,34180765,cystic teratoma
8110,34180765,graves’ disease
8110,34180765,primary papillary thyroid carcinoma
8111,32940167,*graves'
8111,32940167,*clinical trials
8111,32940167,*diplopia
8111,32940167,*ocular ductions
8111,32940167,*orbitopathy
8111,32940167,*rehabilitation
8111,32940167,*squint surgery
8114,32849306,*graves' disease
8114,32849306,*tsh secreting pituitary adenoma
8114,32849306,*tshoma
8114,32849306,*concomitant
8114,32849306,*thyrotropin
8115,32238669,agranulocytosis
8115,32238669,antithyroid drug
8115,32238669,hyperthyroidism
8115,32238669,malignancy
8115,32238669,potassium iodide
8116,31603857,graves’ disease
8116,31603857,children
8116,31603857,hyperthyroidism
8116,31603857,radioiodine ablation
8117,33849364,*graves’ orbitopathy
8117,33849364,*clinical activity score
8117,33849364,*glucocorticoids
8117,33849364,*interleukin-6
8117,33849364,*interleukin-8
8117,33849364,*interleukin–10
8118,34431214,*graves' disease (gd)
8118,34431214,*stat4
8118,34431214,*autoimmune disease
8118,34431214,*mir-363-5p
8118,34431214,*regulatory t cells (tregs) cois
8119,32429706,graves’ disease
8119,32429706,igf-ir
8119,32429706,r1507
8119,32429706,rv001
8119,32429706,tepezza
8119,32429706,teprotumumab
8119,32429706,thyroid eye disease
8119,32429706,thyroid-associated ophthalmopathy
8120,32192806,cancer héréditaire
8120,32192806,carcinome thyroïdien familial
8120,32192806,cowden syndrome
8120,32192806,dicer1 syndrome
8120,32192806,familial adenomatous polyposis
8120,32192806,familial thyroid carcinoma
8120,32192806,hereditary cancer
8120,32192806,polypose adénomateuse familial
8120,32192806,syndrome dicer1
8120,32192806,syndrome de cowden
8122,34867796,*graves’ disease
8122,34867796,*children
8122,34867796,*metabolic pathway
8122,34867796,*serum metabolomics
8122,34867796,*untargeted metabolomics cois commercial or financial relationships that could be construed as a potential conflict of interest.
8123,33443817,*graves’ orbitopathy
8123,33443817,*neferine
8123,33443817,*adipocyte differentiation
8123,33443817,*autophagy
8123,33443817,*inflammation
8123,33443817,*oxidative stress cois topic of the manuscript.
8125,33481154,graves disease
8125,33481154,igf-1r
8125,33481154,r1507
8125,33481154,rv001
8125,33481154,tepezza
8125,33481154,teprotumumab
8125,33481154,thyroid eye disease
8125,33481154,thyroid-associated ophthalmopathy
8130,34122333,*graves’ disease
8130,34122333,*cross-sectional study
8130,34122333,*hyperthyroidism
8130,34122333,*iodine intake
8130,34122333,*thyroid autoimmune antibodies cois commercial or financial relationships that could be construed as a potential conflict of interest.
8131,32501499,*graves disease
8131,32501499,*autoimmune
8131,32501499,*genotyping
8131,32501499,*meta-analysis
8131,32501499,*polymorphism
8131,32501499,*thyroid
8132,34889904,graves’ orbitopathy
8132,34889904,binding protein
8132,34889904,thyrostimulin
8132,34889904,thyrotropin receptor
8132,34889904,variant cois
8133,32823277,*nk cells
8133,32823277,*programmed cell death protein-1
8133,32823277,*autoimmune thyroid disease
8135,33906763,globe prominence
8135,33906763,proptosis
8135,33906763,thyroid eye disease cois therapeutics and osmotica pharmaceuticals.
8136,33858251,foxp3
8136,33858251,graves’ disease
8136,33858251,ethnicity
8136,33858251,meta-analysis
8136,33858251,polymorphism
8136,33858251,susceptibility cois conflict of interest.
8137,32090348,*mri t1 mapping
8137,32090348,*diplopia
8137,32090348,*extraocular muscles
8137,32090348,*fibrosis
8137,32090348,*graves ophthalmopathy
8137,32090348,*intravenous glucocorticoids
8137,32090348,*magnetic resonance imaging
8140,34284740,diffusion tensor imaging
8140,34284740,lacrimal gland
8140,34284740,readout-segmented echo-planar imaging
8140,34284740,thyroid-associated ophthalmopathy cois
8141,33678636,graves’ disease
8141,33678636,graves’ disease associated cholestasis
8141,33678636,cholestasis
8141,33678636,clinical manifestation
8141,33678636,diagnosis
8141,33678636,treatment
8145,33551434,active surveillance
8145,33551434,graves’ disease
8145,33551434,papillary thyroid microcarcinoma
8145,33551434,radioactive iodine therapy
8145,33551434,tumor volume-doubling rate
8146,33193097,*dysthyroid optic neuropathy
8146,33193097,*grave’s disease
8146,33193097,*grave’s ophthalmopathy
8146,33193097,*orbital decompression
8146,33193097,*rituximab
8147,32495527,*chemokine
8147,32495527,*cytokine
8147,32495527,*graves' orbitopathy
8147,32495527,*interleukin-1β
8147,32495527,*tumor necrosis factor-α cois
8148,34488259,decompression
8148,34488259,eyelids
8148,34488259,graves ophthalmopathy cois
8150,33938028,*graves’ disease
8150,33938028,*graves’ ophthalmopathy
8150,33938028,*igg4
8150,33938028,*glucocorticoid therapy
8151,33682498,dexamethasone
8151,33682498,graves’ disease
8151,33682498,drug resistance
8151,33682498,hyperthyroidism
8151,33682498,inorganic iodine
8151,33682498,lithium carbonate
8151,33682498,methimazole cois conflict of interest.
8152,33517506,deep lateral decompression
8152,33517506,graves disease
8152,33517506,graves orbitopathy
8152,33517506,orbital decompression
8152,33517506,orbital surgery
8155,32814653,graves’ orbitopathy
8155,32814653,computed tomography
8155,32814653,computer-assisted image processing
8155,32814653,magnetic resonance imaging
8155,32814653,orbit
8157,33199029,dfnb4
8157,33199029,missense mutations
8157,33199029,next-generation sequencing
8157,33199029,pendred syndrome
8157,33199029,slc26a4 gene
8159,32074519,intractability
8159,32074519,polymorphism
8159,32074519,severity
8159,32074519,vegf receptor (vegfr)
8159,32074519,vascular endothelial growth factor (vegf)
8160,32374820,*mendelian randomization
8160,32374820,*tsh
8160,32374820,*coronary artery disease
8160,32374820,*mediation
8160,32374820,*stroke
8160,32374820,*thyroid function
8161,32893239,basedow disease
8161,32893239,amyotrophic lateral sclerosis
8161,32893239,soluble il-2 receptor
8161,32893239,thyrotoxic myopathy
8161,32893239,tongue atrophy
8163,34479513,cholestatic liver injury
8163,34479513,graves' disease
8163,34479513,methimazole
8163,34479513,rash
8163,34479513,turner syndrome cois
8167,33132244,graves’ disease
8167,33132244,pd-1
8167,33132244,t lymphocytes
8167,33132244,thyroid follicular cells
8169,33423386,graves’ orbitopathy
8169,33423386,glucocorticoids
8169,33423386,long-circulating pegylated liposomal prednisolone
8169,33423386,methylprednisolone
8169,33423386,orbit
8170,32651061,*graves' disease
8170,32651061,*breastfeeding
8170,32651061,*hypothyroidism
8170,32651061,*postpartum thyroid dysfunction
8170,32651061,*postpartum thyroiditis
8170,32651061,*thyrotoxicosis
8171,34238277,cd160
8171,34238277,graves’ disease
8171,34238277,hashimoto’s thyroiditis
8171,34238277,polymorphism cois
8173,33922887,antithyroid drug
8173,33922887,change
8173,33922887,ocular parameters cois
8176,33488527,*graves’ disease
8176,33488527,*autoimmune thyroiditis
8176,33488527,*differential diagnosis
8176,33488527,*thyroid function test
8176,33488527,*thyrotoxicosis cois commercial or financial relationships that could be construed as a potential conflict of interest.
8177,33380308,graves’ disease
8177,33380308,thyroid
8177,33380308,cancer
8177,33380308,nodules
8177,33380308,surgery
8177,33380308,thyroidectomy.
8178,34258936,dysthyroid optic neuropathy
8178,34258936,hospital anxiety and depression
8178,34258936,regional homogeneity
8178,34258936,resting-state fmri
8178,34258936,thyroid-associated ophthalmopathy cois
8179,33693700,*igf-1
8179,33693700,*il-38
8179,33693700,*m22
8179,33693700,*tgf-β1
8179,33693700,*orbital fibroblasts
8179,33693700,*thyroid-associated ophthalmopathy
8180,33386169,amino acid variants
8180,33386169,graves’ disease
8180,33386169,hla class ii
8180,33386169,hashimoto’s thyroiditis cois competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
8181,32825964,graves' disease
8181,32825964,hashimoto's thyroiditis
8181,32825964,prognosis
8181,32825964,thyroid cancer
8183,32025782,angio-oct
8183,32025782,choroid
8183,32025782,oct
8183,32025782,orbitopathy
8183,32025782,thyroid
8184,31900640,4-methylumbelliferone
8184,31900640,adipogenesis
8184,31900640,graves’ orbitopathy
8184,31900640,hyaluronic acid
8185,34315743,endocrinology
8185,34315743,thyroid disease cois
8186,33630733,t2 mapping
8186,33630733,magnetic resonance imaging
8186,33630733,optic nerve
8186,33630733,thyroid-associated ophthalmopathy
8187,31887836,cytokines
8187,31887836,dihydrotestosterone
8187,31887836,graves disease
8187,31887836,mice
8189,33658150,graves ophthalmopathy
8189,33658150,cosmetic reconstructive surgery
8189,33658150,exophthalmos
8189,33658150,ophthalmologic surgical procedure
8189,33658150,orbital decompression
8189,33658150,proptosis
8189,33658150,surgical decompression
8189,33658150,surgical technique
8189,33658150,thyroid eye disease
8189,33658150,thyroid-associated ophthalmopathies
8189,33658150,transantral
8190,34018373,clinical analysis
8190,34018373,extraocular muscles
8190,34018373,magnetic resonance imaging
8190,34018373,thyroid associated ophthalmoathy
8192,33382429,*genetics
8192,33382429,*hyperthyroidism
8192,33382429,*hypothyroidism
8192,33382429,*twin studies
8193,33009740,graves’ disease
8193,33009740,exophthalmos
8193,33009740,neurosurgery
8193,33009740,ophthalmopathy
8193,33009740,thyroid diseases.
8194,32485674,*graves’ disease
8194,32485674,*nf-κb
8194,32485674,*sirt1
8194,32485674,*thyroid
8195,32545570,agranulocytosis
8195,32545570,hyperthyroidism
8195,32545570,plasmapheresis
8195,32545570,thyroidectomy
8195,32545570,thyrotoxicosis cois
8198,32324288,*graves
8198,32324288,*bone
8198,32324288,*disease
8198,32324288,*fractures
8198,32324288,*immunoglobulins
8198,32324288,*menopause
8198,32324288,*osteoporosis
8198,32324288,*thyroid-stimulating
8200,34334593,acromegaly
8200,34334593,adenomatous goiter
8200,34334593,neurofibromatosis type 1
8200,34334593,primary hyperparathyroidism cois
8202,32500462,alemtuzumab
8202,32500462,graves’ ophthalmopathy
8202,32500462,immune-reconstitution inflammatory syndrome
8202,32500462,marine-lenhart syndrome
8203,33853289,autoimmune thyroid disease.
8203,33853289,children and adolescents
8203,33853289,type 1 diabetes
8203,33853289,metabolic disorders
8205,32689994,molecular docking
8205,32689994,network pharmacology
8205,32689994,spica prunellae
8205,32689994,tao
8205,32689994,thyroid-associated ophthalmopathy cois
8206,32363975,orbital decompression
8206,32363975,thyroid eye disease
8206,32363975,transantral orbital decompression
8208,32612577,*foxp3
8208,32612577,*graves' disease
8208,32612577,*autoimmune thyroid disease
8208,32612577,*meta-analysis
8208,32612577,*polymorphism
8209,34598656,*graves'
8209,34598656,"*disease, meta-analysis, radiation absorbed dose, radioiodine, systematic review cois research and training program 2014–2018 and national institute for health research (nihr) and funding from national health service to the nihr biomedical research centre at the royal marsden and the institute of cancer research and nihr royal marsden clinical research facility outside the work of the study. j.i.g. reports personal fees and honoraria from the eanm outside the work of the study."
8211,32983115,*addison's disease
8211,32983115,*cdcp1
8211,32983115,*graves' disease
8211,32983115,*hashimoto's thyroiditis
8211,32983115,*slamf1
8211,32983115,*plasma
8211,32983115,*proximity extension assay
8211,32983115,*type 1 diabetes
8212,34101720,*actemra
8212,34101720,*cellcept
8212,34101720,*rituxan
8212,34101720,*tepezza
8212,34101720,*adverse effects
8212,34101720,*corticosteroids
8212,34101720,*dosage
8212,34101720,*efficacy
8212,34101720,*eye
8212,34101720,*lactation
8212,34101720,*methylprednisone
8212,34101720,*mycophenolate mofetil
8212,34101720,*prednisone
8212,34101720,*pregnancy
8212,34101720,*rituximab
8212,34101720,*safety
8212,34101720,*teprotumumab
8212,34101720,*tocilizumab
8214,32227795,*graves’
8214,32227795,*disease
8214,32227795,*radiation thyroiditis
8214,32227795,*radioactive iodine
8215,34915605,*antithyroid agents
8215,34915605,*diabetes mellitus
8215,34915605,*graves disease
8215,34915605,*hyperthyroidism
8215,34915605,*radioiodine ablation cois was reported.
8216,34863412,cord blood
8216,34863412,embarazo
8216,34863412,enfermedad de graves
8216,34863412,graves’ disease
8216,34863412,hipertiroidismo
8216,34863412,hyperthyroidism
8216,34863412,newborn
8216,34863412,pregnancy
8216,34863412,recién nacido
8216,34863412,sangre del cordón umbilical
8216,34863412,trab
8219,33383445,anti-inflammation
8219,33383445,il-23/il-17 axis
8219,33383445,il-23r
8219,33383445,il-38
8219,33383445,pge(2)
8219,33383445,thyroid-associated ophthalmopathy
8222,32933065,graves’ disease
8222,32933065,hashimoto thyroiditis
8222,32933065,autoimmune thyroid disease
8222,32933065,vitamin d
8222,32933065,vitamin d receptor cois
8223,32537950,clinical activity score
8223,32537950,glucocorticoids
8223,32537950,graves' ophthalmopathy
8223,32537950,response rate cois
8228,34987480,*graves’ disease
8228,34987480,*adhesion molecules
8228,34987480,*carotid intima media thickness
8228,34987480,*hyperthyroidism
8228,34987480,*methimazole
8228,34987480,*propylthiouracil
8228,34987480,*pulse wave velocity
8228,34987480,*vascular atherosclerosis cois commercial or financial relationships that could be construed as a potential conflict of interest.
8229,34287665,*foxo1
8229,34287665,*genetic susceptibility
8229,34287665,*graves’ disease
8229,34287665,*il2ra
8229,34287665,*mir182
8229,34287665,*mir27a
8230,33234032,*cas
8230,33234032,*cd20
8230,33234032,*graves' disease
8230,33234032,*graves' orbitopathy
8230,33234032,*cytokine release syndrome
8230,33234032,*dysthyroid optic neuropathy
8230,33234032,*rituximab
8231,33221730,*genetics
8231,33221730,*immunology
8231,33221730,*orbit cois
8235,33643223,*graves’ orbitopathy
8235,33643223,*t cells
8235,33643223,*immune
8235,33643223,*mucosa
8235,33643223,*paranasal sinus cois commercial or financial relationships that could be construed as a potential conflict of interest.
8236,33504525,clinical diagnostic tests
8236,33504525,hip prosthesis implantation
8236,33504525,neurology (drugs and medicines)
8236,33504525,psychiatry (drugs and medicines)
8236,33504525,rehabilitation medicine cois
8237,32893386,*graves' orbitopathy
8237,32893386,*extra-ocular muscles
8237,32893386,*eye diseases
8237,32893386,*eye muscles
8237,32893386,*muscle mri
8237,32893386,*myasthenia gravis
8237,32893386,*quantitative mri
8239,32522908,graves’ disease
8239,32522908,neonatal thyroid dysfunction
8239,32522908,tsh receptor antibody
8240,34124812,*graves' disease
8240,34124812,*hypercalcemia
8240,34124812,*hyperparathyroidism
8240,34124812,*parathyroid surgery
8240,34124812,*radioactive iodine
8241,33152840,graves ophthalmopathy
8241,33152840,macula lutea
8241,33152840,optic disk
8241,33152840,optic nerve diseases
8241,33152840,regional blood flow
8241,33152840,"tomography, optical coherence"
8243,34963497,antineutrophil cytoplasmic antibody-associated vasculitis
8243,34963497,drug-induced anca-associated vasculitis
8243,34963497,graves’ disease
8243,34963497,hypertrophic pachymeningitis
8243,34963497,myeloperoxidase-antineutrophil cytoplasmic antibody cois
8244,34523298,graves´ disease
8244,34523298,immune reconstitution therapy
8244,34523298,multiple sclerosis
8244,34523298,ocrelizumab
8245,33669123,fnah
8245,33669123,tshr
8245,33669123,central hypothyroidism
8245,33669123,familial non-autoimmune autosomal dominant hyperthyroidism
8245,33669123,radioiodine ablation therapy cois
8249,31972501,*active graves’ orbitopathy
8249,31972501,*newly diagnosed graves’ disease
8249,31972501,*potential markers
8249,31972501,*pro-inflammatory cytokines
8249,31972501,*selenium cois competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
8250,34218976,exophthalmos
8250,34218976,graves hyperthyroidism
8250,34218976,graves ophthalmopathy
8250,34218976,orbital decompression
8250,34218976,quality of life
8252,33295879,*graves’ disease
8252,33295879,*autoimmune hyperthyroidism
8252,33295879,*autoimmune thyroid disease
8252,33295879,*genetic and epigenetic factors
8253,32729365,iodine
8253,32729365,endemic
8253,32729365,goiter
8253,32729365,nodule
8253,32729365,thyroid
8253,32729365,ultrasound
8254,34681587,aitd
8254,34681587,graves’ disease
8254,34681587,autoimmunity
8254,34681587,methimazole
8254,34681587,regulatory b cells
8254,34681587,thyroid cois
8256,33870911,*graves’ orbitopathy
8256,33870911,*perk
8256,33870911,*endoplasmic reticulum stress
8256,33870911,*protein kinase rna-like endoplasmic reticulum kinase
8256,33870911,*thyroid eye disease
8257,34888290,*covid-19
8257,34888290,*covid-19 vaccines
8257,34888290,*graves' disease
8257,34888290,*sars-cov-2
8257,34888290,*autoimmunity
8257,34888290,*thyroiditis cois commercial or financial relationships that could be construed as a potential conflict of interest.
8258,33451885,intraoperative neuromonitoring
8258,33451885,recurrent laryngeal nerve injury
8258,33451885,thyroid surgery
8259,31902232,2a típusú multiplex endokrin neoplasia szindróma
8259,31902232,genetic testing
8259,31902232,genetikai vizsgálat
8259,31902232,medullaris pajzsmirigydaganat
8259,31902232,medullary thyroid cancer
8259,31902232,multiple endocrine neoplasia type 2a
8259,31902232,phaeochromocytoma
8259,31902232,primary hyperparathyroidism
8259,31902232,primer hyperparathyreosis
8260,34047397,*trab
8260,34047397,*fibroblast
8260,34047397,*inducible skin-associated lymphoid tissue (isalt)
8260,34047397,*pretibial myxedema (ptm) cois
8261,32053002,t2 mapping
8261,32053002,thyroid-associated ophthalmopathy
8261,32053002,magnetic resonance imaging
8261,32053002,region of interest
8261,32053002,staging
8262,34130446,*antithyroid agents
8262,34130446,*congenital abnormalities
8262,34130446,*graves disease
8262,34130446,*iodine
8262,34130446,*pregnancy
8262,34130446,*recurrence cois was reported.
8264,32880139,bony orbital decompression
8264,32880139,computerized perimetry
8264,32880139,dysthyroid optic neuropathy
8264,32880139,endonasal orbital decompression
8264,32880139,exophthalmos
8264,32880139,thyroid eye disease
8265,32681301,deep lateral wall resection
8265,32681301,exophthalmos
8265,32681301,graves’ disease
8265,32681301,orbit
8265,32681301,pterional decompression
8266,34690936,*graves’ disease
8266,34690936,*anti-thyroid drug
8266,34690936,*heart failure
8266,34690936,*hyperthyroidism
8266,34690936,*radioiodine ablation cois authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
8267,34647604,cas
8267,34647604,eugogo classification
8267,34647604,nospecs classification
8267,34647604,orbital decompression
8267,34647604,thyroid eye disease
8273,32096552,graves’ orbitopathy
8273,32096552,anti-thymocyte globulin
8273,32096552,dysthyroid optic neuropathy
8276,33980771,22q11.2 deletion syndrome
8276,33980771,graves’ disease
8276,33980771,hypocalcemia
8276,33980771,hypoparathyroidism
8278,31996918,*graves’ disease
8278,31996918,*hashimoto’s thyroiditis
8278,31996918,*igm
8278,31996918,*subacute thyroiditis
8278,31996918,*thyroglobulin
8278,31996918,*thyroglobulin autoantibodies
8282,32227311,addison’s disease
8282,32227311,autoimmune thyroid disease
8282,32227311,diabetes mellitus
8282,32227311,meta-analysis
8282,32227311,polyglandular autoimmune syndrome cois
8283,32252386,*autoimmune thyroid disease (aitd)
8283,32252386,*grave disease (gd)
8283,32252386,*hashimoto thyroiditis (ht)
8283,32252386,*polycystic ovary syndrome (pcos) cois
8284,34149627,*cd40
8284,34149627,*graves’ disease
8284,34149627,*gene
8284,34149627,*precision medicine
8284,34149627,"*variant cois application no: 63/120,514) entitled: “method for predicting patient response to cd40-targeted therapies” which is related to the current manuscript. yt declares that he also submitted two additional patent disclosures that are not related to the content of this manuscript. yt was previously (january 2015 to june 2017) the pi on a basic research project jointly funded by the juvenile diabetes research foundation and pfizer. the current manuscript is not related to that research project. gk consults for immunovant, usa, mediomics, usa, merck, germany, novartis, switzerland, and quidel, usa. the remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest."
8285,33414766,*graves’ disease
8285,33414766,*graves’ ophthalmopathy
8285,33414766,*cholesterol
8285,33414766,*low-density lipoprotein cholesterol
8285,33414766,*parenteral corticosteroids cois commercial or financial relationships that could be construed as a potential conflict of interest.
8287,32627588,deep lateral decompression
8287,32627588,lateral orbital wall distance
8287,32627588,removable surface area
8287,32627588,removable surface length
8287,32627588,sphenoid door jamb thickness
8288,32362875,*adolescents
8288,32362875,*autoimmune thyroid disease
8288,32362875,*children
8288,32362875,*gender difference
8288,32362875,*thyroiditis
8289,31842710,*graves disease
8289,31842710,*hashimoto's thyroiditis
8289,31842710,*active surveillance
8289,31842710,*cost-effectiveness
8289,31842710,*molecular markers
8289,31842710,*thyroid cancer
8290,31840740,*graves’ disease
8290,31840740,*radioactive iodine
8290,31840740,*radioiodine therapy
8290,31840740,"*thyroid radioactive iodine uptake cois association declaration of helsinki, and that all subjects provided written informed consent. the present study was approved by the irb of the second affiliated hospital, harbin medical university. the authors declare that there are no competing interests associated with the manuscript."
8293,33297974,case report
8293,33297974,exophthalmos
8293,33297974,graves’ ophthalmopathy
8293,33297974,malformation
8293,33297974,ocular myasthenia gravis
8293,33297974,poland syndrome
8293,33297974,ptosis cois interest.
8294,33099562,*cystatin c
8294,33099562,*exophthalmos
8294,33099562,*serum
8294,33099562,*thyroxine
8294,33099562,*triiodothyronine cois
8295,33025559,*autoimmune thyroid disease (aitd)
8295,33025559,*graves’ disease (gd)
8295,33025559,*hashimoto’s thyroiditis (ht)
8295,33025559,*mettl3
8295,33025559,*polymorphism
8296,32592913,choroidal thickness
8296,32592913,inactive graves’ orbitopathy
8296,32592913,optical coherence tomography angiography
8296,32592913,retinal vessel density
8296,32592913,spectral domain-optical coherence tomography
8298,34142359,activating tshr pathogenic variant
8298,34142359,case report
8298,34142359,familial non-autoimmune hyperthyroidism
8298,34142359,functional study
8298,34142359,radioiodine ablative treatment
8298,34142359,repeated thyroid surgery
8301,34179589,carotid cavernous fistula
8301,34179589,graves-basedow disease
8301,34179589,graves’ ophthalmopathy
8301,34179589,orbit
8301,34179589,orbital inflammation
8302,34049504,"extraocular paralysis, case report"
8302,34049504,gq1b antibody
8302,34049504,graves’ disease
8302,34049504,limb weakness cois interest.
8304,32958019,graves’ orbitopathy
8304,32958019,predictive factors
8304,32958019,radiotherapy
8304,32958019,timing cois
8305,34277969,*graves’ disease
8305,34277969,*antithyroid drugs
8305,34277969,*hyperthyroidism
8305,34277969,*index patient
8305,34277969,*international surveys
8305,34277969,*long‐term follow‐up
8305,34277969,*radioactive iodine
8305,34277969,*thyroidectomy
8305,34277969,"*treatment options cois calissendorff, mikael lantz, bengt hallengren, helena filipsson nyström, tereza planck, göran wallin: none of the authors have competing financial interests."
8306,32999132,anti-neutrophil cytoplasmic antibody
8306,32999132,hearing loss
8306,32999132,otitis media
8306,32999132,propylthiouracil
8306,32999132,vasculitis
8307,32699051,*colour vision
8307,32699051,*field of vision
8307,32699051,*orbit cois
8308,32656666,bradycardia
8308,32656666,calcitonin
8308,32656666,calcium test
8308,32656666,cut-off
8308,32656666,medullary thyroid cancer cois perceived as prejudicing the impartiality of the research reported.
8309,33488522,*graves’ orbitopathy
8309,33488522,*pcsk9
8309,33488522,*adipogenesis
8309,33488522,*inflammation
8309,33488522,*oxidative stress
8309,33488522,*proprotein convertase subtilisin/kexin type 9
8309,33488522,*thyroid eye disease cois commercial or financial relationships that could be construed as a potential conflict of interest.
8310,31900992,il-13
8310,31900992,il-4
8310,31900992,il-5
8310,31900992,il-6
8310,31900992,autoimmune thyroid diseases
8310,31900992,polymorphism
8311,32729394,*graves'
8311,32729394,*dietary iodine
8311,32729394,*disease
8311,32729394,*inorganic iodine
8311,32729394,*radioiodine
8311,32729394,*therapeutic effects
8312,33327837,"*hyperthyroidism, graves' disease"
8312,33327837,*liver abnormalities
8312,33327837,*liver dysfunction
8314,32911689,graves’ orbital fibroblasts
8314,32911689,graves’ orbitopathy
8314,32911689,igf1r
8314,32911689,igf1r antibodies
8314,32911689,tshr
8314,32911689,tshr antibodies
8314,32911689,hyaluronan
8314,32911689,receptor crosstalk cois targeting tshr and igf-1r.
8315,32376473,*circular rna
8315,32376473,*rna sequencing
8315,32376473,*thyroid-associated ophthalmopathy cois
8316,32573180,*graves’ disease
8316,32573180,*autoimmunity
8316,32573180,*peptides
8316,32573180,*thyroid
8318,32854689,coexistent primary and secondary hyperthyroidism
8318,32854689,graves’ disease
8318,32854689,tsh-secreting pituitary adenoma
8318,32854689,tshoma
8318,32854689,thyrotropinoma cois disorders editorial board.
8319,32199749,*trab
8319,32199749,*antithyroid drugs
8319,32199749,*hyperthyroidism
8319,32199749,*methimazole
8319,32199749,*propylthiouracil cois of interests.
8321,32977740,*graves' orbitopathy
8321,32977740,*hif-1α
8321,32977740,*caveolin-1
8321,32977740,*deiodinase 3
8321,32977740,*enos
8321,32977740,*oxidative stress
8322,33541945,hyperthyroidism
8322,33541945,thyrotoxicosis
8322,33541945,valvar diseases cois
8323,33153489,*adipogenesis
8323,33153489,*gene modification
8323,33153489,*graves’ ophthalmopathy
8323,33153489,*phosphatase of regenerating liver-1
8323,33153489,*placenta-derived mesenchymal stem cells cois
8324,32605565,case report
8324,32605565,graves’ disease
8324,32605565,hypercalcemia
8324,32605565,osteoporosis
8324,32605565,thymic enlargement cois
8325,32342657,*graves’ disease
8325,32342657,*association analysis
8325,32342657,*sex-specific
8325,32342657,*single nucleotide polymorphism cois
8328,31910101,*graves' disease
8328,31910101,*muscle strength
8328,31910101,*quality of life
8328,31910101,*thyrotoxicosis
8328,31910101,*vitamin d
8329,34494503,*pd-1
8329,34494503,*pd-l1
8329,34494503,*pd-l2
8329,34494503,*regulatory t cell
8329,34494503,*severity
8329,34494503,*single nucleotide polymorphism
8330,34074094,*graves disease
8330,34074094,*hashimoto disease
8330,34074094,*immune checkpoint inhibitor
8330,34074094,"*polymorphism, single nucleotide"
8330,34074094,*programmed cell death 1 ligand cois was reported.
8332,34867801,*cd40
8332,34867801,*graves’ disease
8332,34867801,*association analysis
8332,34867801,*expression quantitative trait locus
8332,34867801,*single nucleotide polymorphisms cois commercial or financial relationships that could be construed as a potential conflict of interest.
8337,32088015,endoscopic modified lothrop procedure
8337,32088015,endoscopic sinus surgery
8337,32088015,frontal sinusitis
8337,32088015,graves’ orbitopathy
8337,32088015,orbital decompression cois related with this paper.
8339,32483756,"thyroid stimulating hormone receptor, antagonist, thienopyrimidine, thyroid gland"
8340,31926048,anti-programmed death 1 therapy
8340,31926048,graves’ disease
8340,31926048,"type 1 diabetes cois k.k. and eli lilly japan k.k. hiroshi kagamu is a scientific advisor of immunit research inc; has received honoraria from astrazeneca k.k., bristol‐myers squibb co. and ono pharmaceutical co.; and research funding from boehringer ingelheim pharmaceuticals inc. the other authors declare no conflict of interest."
8341,33935970,*graves’ ophthalmopathy
8341,33935970,*corticosteroids
8341,33935970,*cytokines
8341,33935970,*rituximab
8341,33935970,*teprotumumab
8341,33935970,*tocilizumab cois commercial or financial relationships that could be construed as a potential conflict of interest.
8344,33719776,*thyroid-associated ophthalmopathy
8344,33719776,*blood flow velocity
8344,33719776,*fractal analysis
8344,33719776,*functional slit-lamp biomicroscopy
8345,32820337,*case-control
8345,32820337,*grave's disease (gd)
8345,32820337,*hyperthyroidism
8345,32820337,*intestinal microbiota
8345,32820337,*prospective
8345,32820337,*thyroid-stimulating antibodies (tsab) cois manuscript.
8346,33675209,addison’s disease
8346,33675209,graves’ disease
8346,33675209,adrenal insufficiency
8346,33675209,autoimmune polyglandular syndrome type 2
8346,33675209,"thyrotoxicosis cois design; in the collection, analysis, and interpretation of data; in the writing of the report; or in the decision to submit the report for publication."
8347,33473054,acute respiratory distress syndrome (ards)
8347,33473054,coronavirus disease 2019 (covid-19)
8347,33473054,severe acute respiratory syndrome (sars)
8347,33473054,severe acute respiratory syndrome coronavirus-2 (sars-cov-2)
8347,33473054,thyroid
8348,34831419,*graves’ orbitopathy
8348,34831419,*igf-1
8348,34831419,*rock inhibitor
8348,34831419,*orbital fibroblast
8348,34831419,*prostanoid ep2 agonist
8348,34831419,*three-dimension (3d) cell culture cois
8350,31237221,graves’ ophthalmopathy
8350,31237221,thyroid disorders
8350,31237221,age-related macular degeneration
8350,31237221,amiodarone
8350,31237221,diabetic retinopathy
8350,31237221,ocular metastasis.
8351,34899596,*igf1r
8351,34899596,*tsab
8351,34899596,*tshr
8351,34899596,*adipogenesis
8351,34899596,*hyaluronan
8351,34899596,*thyroid eye disease cois commercial or financial relationships that could be construed as a potential conflict of interest.
8352,33776929,*dosimetry—radiation
8352,33776929,*hyperthyroidism (graves’ disease)
8352,33776929,*hyperthyroidism—diagnosis
8352,33776929,*hypothyroidism
8352,33776929,*radioiodine
8352,33776929,*radioiodine (131i) treatment cois distribute the software generated in this article. the remaining author declares that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
8354,32957802,graves’ orbitopathy
8354,32957802,ethmoid sinus volume
8354,32957802,proptosis reduction
8354,32957802,thyroid eye disease
8355,31978406,anti-thyroid drugs
8355,31978406,graves’ disease
8355,31978406,hyperthyroidism
8355,31978406,lysophosphatidylserine
8355,31978406,phosphatidylserine-specific phospholipase a1
8355,31978406,thyroid hormones
8356,33583620,*endocrinology
8356,33583620,*h1n1 infection
8356,33583620,*influenza
8356,33583620,*thyroid storm cois
8357,32187946,"decompression, surgical"
8357,32187946,diplopia
8357,32187946,esotropia
8357,32187946,graves ophthalmopathy
8357,32187946,ophthalmologic surgical procedures
8358,32471411,early hypothyroidism
8358,32471411,graves’ disease
8358,32471411,radioactive iodine
8358,32471411,therapy cois publication of this paper.
8360,34061946,*addison’s disease
8360,34061946,*additional autoimmune disease
8360,34061946,*autoimmune polyglandular syndrome
8360,34061946,*autoimmune thyroid disease
8360,34061946,*type 1 diabetes mellitus
8361,33998766,case-control study
8361,33998766,dipeptidyl peptidase-4
8361,33998766,"graves' disease cois lectures and received research funding from some organizations as described below. there was no financial support for this study. akinobu nakamura received research funding from mitsubishi tanabe pharma co. and ono pharmaceutical co. ltd. hideaki miyoshi received honoraria for lectures from astellas pharma inc., dainippon pharma co., eli lilly, mitsubishi tanabe pharma co., msd, novartis pharma, novo nordisk pharma, kowa pharmaceutical co., ltd., nippon boehringer ingelheim co., ono pharmaceutical co. ltd. and sanofi, and received research funding from astellas pharma inc., daiichi sankyo, dainippon pharma co., eli lilly, mitsubishi tanabe pharma co., novo nordisk pharma, kowa pharmaceutical co., abbott japan co., nippon boehringer ingelheim co., ono pharmaceutical co. ltd. and taisho toyama pharmaceutical co., ltd. tatsuya atsumi received honoraria for lectures from mitsubishi tanabe pharma co., chugai pharmaceutical co. ltd., astellas pharma inc., takeda pharmaceutical co. ltd., pfizer inc., abbvie inc., eisai co. ltd., daiichi sankyo co. ltd., bristol‐myers squibb co., ucb japan co. ltd., eli lilly japan k.k., and received research funding from astellas pharma inc., takeda pharmaceutical co. ltd., mitsubishi tanabe pharma co., chugai pharmaceutical co. ltd., daiichi sankyo co. ltd., otsuka pharmaceutical co. ltd., pfizer inc. and alexion inc. the other authors declare no conflict of interest."
8363,33138008,*graves’ disease
8363,33138008,*human leukocyte antigen (hla)
8363,33138008,*recurrence
8363,33138008,*subacute thyroiditis cois
8364,34742035,*alemtuzumab
8364,34742035,*autoimmunity
8364,34742035,*crohn's disease
8364,34742035,*graves' disease
8364,34742035,*igg
8364,34742035,*igg4
8364,34742035,*multiple sclerosis
8365,32062033,autoimmunity
8365,32062033,graves' disease
8365,32062033,hashimoto's autoimmune thyroiditis
8365,32062033,single nucleotide polymorphism (snp)
8365,32062033,toll-like receptors (tlrs)
8365,32062033,type 1 diabetes mellitus (t1dm)
8366,33211376,graves' disease
8366,33211376,cohort
8366,33211376,systemic lupus erythematosus
8368,32880061,bavans
8368,32880061,detachable steel wire-rimmed retractor
8368,32880061,kn retractor
8368,32880061,vans
8368,32880061,video-assisted neck surgery
8373,32359703,graves disease
8373,32359703,leukemia lymphocytic chronic b-cell
8373,32359703,neoplasms/secondary
8373,32359703,prostatic neoplasms
8373,32359703,pruritus
8374,32466854,*hypocalcemia
8374,32466854,*thyroidectomy
8374,32466854,*vitamin d deficiency
8376,31980336,*autoimmunity
8376,31980336,*graves' disease
8376,31980336,*t-cells
8376,31980336,*tsh receptor
8376,31980336,*thyroid cois patent application pct/us2016/067775 for using small molecules to block hla-dr3. dr. tomer also submitted 2 additional provisional patent disclosures that are not related to the content of this manuscript. dr. tomer was previously (1/2015–6/2017) the pi on a basic research project jointly funded by the juvenile diabetes research foundation and pfizer. the current manuscript is not related to that research project. the other authors have nothing to declare.
8377,33758937,*graves’ disease
8377,33758937,*programmed cell death 1
8377,33758937,*regulatory t cells
8377,33758937,*thyroid hormone
8378,34470463,*autoimmune thyroid disease
8378,34470463,*intractability
8378,34470463,*polymorphism
8378,34470463,*severity
8378,34470463,*vitamin a
8379,33234057,*16s rrna sequencing
8379,33234057,*graves' disease
8379,33234057,*alpha diversity
8379,33234057,*gut microbiota
8379,33234057,*metabolism cois
8380,34975767,*graves’ disease
8380,34975767,*bacterial translocation
8380,34975767,*intestinal barrier
8380,34975767,*intestinal fatty acid-binding protein
8380,34975767,*leaky gut
8380,34975767,*lipopolysaccharide
8380,34975767,*quality of life cois commercial or financial relationships that could be construed as a potential conflict of interest.
8381,32666771,thyroid ophthalmopathy
8382,33587909,*3-dimension (3d) tissue culture
8382,33587909,*ep2 agonist
8382,33587909,*grave's disease
8382,33587909,*grave's orbitopathy
8382,33587909,*human orbital fibroblast
8382,33587909,*pgf2α agonist
8382,33587909,*rock inhibitor
8382,33587909,*rho-associated coiled-coil containing protein kinase (rock)
8383,33437990,*antinuclear antibodies
8383,33437990,*indirect immunofluorescence
8383,33437990,*systemic autoimmune disease
8384,32061922,*graves' ophthalmopathy fibroblasts
8384,32061922,*insulin-like growth factor 1 receptor
8384,32061922,*receptor crosstalk
8384,32061922,*tsh receptor stimulating antibodies
8384,32061922,*thyroid-stimulating hormone receptor cois of interest.
8385,31969085,*adipogenesis
8385,31969085,*chondrogenesis
8385,31969085,*muscle-derived stem cells
8385,31969085,*myogenesis
8385,31969085,*osteogenesis
8387,32707005,*thyroid eye disease
8387,32707005,*insulin-like growth factor i receptor
8387,32707005,*monoclonal antibody
8387,32707005,*teprotumumab
8387,32707005,*thyrotropin receptor
8389,33476778,*dysthyroid optic neuropathy
8389,33476778,*grave disease
8389,33476778,*grave orbitopathy
8389,33476778,*orbit decompression
8390,33645503,*covid-19
8390,33645503,*epidemics
8390,33645503,*influenza
8390,33645503,*predict
8390,33645503,*virus
8392,33298481,gynaecological cancer
8392,33298481,stroke
8392,33298481,thyrotoxicosis cois
8393,33196862,antithyroid medication
8393,33196862,antithyroid-induced arthritis syndrome
8393,33196862,arthritis
8393,33196862,fever
8393,33196862,thiamazole
8394,33498689,graves’ ophthalmopathy
8394,33498689,eear fluids
8394,33498689,ehyroid-associated ophthalmopathy
8394,33498689,exosomes
8394,33498689,extracellular vesicle
8394,33498689,eytokines cois
8395,33877318,*akt1
8395,33877318,*egfr/pi3k/akt signaling
8395,33877318,*lncrna lpal2
8395,33877318,*mir-1287-5p
8395,33877318,*orbital fibroblast activation
8395,33877318,*thyroid eye disease
8397,32425952,*autoantibodies
8397,32425952,*autoimmune
8397,32425952,*nephropathy
8397,32425952,*phospholipase a2 receptor
8397,32425952,*thyroid disease
8401,33745401,"*“thyroid eye disease, thermal imaging, ocular surface temperature, caruncular  temperature”"
8402,34752648,graves’ disease
8402,34752648,hyperthyroidism
8402,34752648,thyroid-stimulating hormone receptor antibody cois
8404,34680057,*graves’ ophthalmopathy
8404,34680057,*c-jun n-terminal kinase
8404,34680057,*orbital fibroblast
8404,34680057,*p38
8404,34680057,*pirfenidone
8404,34680057,*transforming growth factor-β1 cois
8405,33121876,*graves' disease
8405,33121876,*interferon
8405,33121876,*interleukin
8405,33121876,*thyroid-stimulating hormone receptor antibody
8405,33121876,*tumor necrosis factor
8406,33868176,*graves’ orbitopathy
8406,33868176,*t cell immunity
8406,33868176,*effector t cell
8406,33868176,*fibrocyte
8406,33868176,*orbital fibroblast
8406,33868176,"*thyroid-associated ophthalmology cois (81930024, 81761168037, 81770974, 81800695, 82071003, 82000879, 81570883, 81600766, 31701046, 31600971, and 31500714), the national key r&d program of china (2018yfc1106100, 2018yfc1106101), the shanghai sailing program (18yf1412300), the research grant of the shanghai science and technology committee (20dz2270800, 17dz2260100, 19410761100, and 19dz2331400), the clinical research plan of shdc (shdc2020cr3051b), the project of medical robots (imr-nph202002) from the clinical joint research center of the institute of medical robots, shanghai jiaotong university-shanghai ninth people’s hospital, the collaborative research project of translational medicine collaborative innovation center, shanghai jiaotong university school of medicine (tm201718), the shanghai municipal education commission—gaofeng clinical medicine grant support (20152228), the shanghai jiaotong university translational medicine crossed research grant (zh2018zda12, zh2018qna07), the sample database project of shanghai ninth people’s hospital (ybkb201901), and the joint innovation team for young physicians of shanghai ninth people’s hospital (qc202002).the authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest."
8407,33419752,emergency medicine
8407,33419752,respiratory medicine cois
8408,32519199,association
8408,32519199,graves’ disease
8408,32519199,mica
8408,32519199,thionamide-induced agranulocytosis
8409,32253999,*antithyroid drug
8409,32253999,*hyperthyroidism
8409,32253999,*long-term treatment
8410,34887833,*graves’ disease
8410,34887833,*hla variants
8410,34887833,*ptpn22 gene
8410,34887833,*genetic predictors
8410,34887833,*treatment cois commercial or financial relationships that could be construed as a potential conflict of interest.
8412,34916298,*graves’ disease
8412,34916298,*organoids
8412,34916298,*thyroid
8413,33781112,*graves’ ophthalmopathy
8413,33781112,*tepezza
8413,33781112,*hearing loss
8413,33781112,*teprotumumab
8413,33781112,*thyroid eye disease
8414,34887857,*: autoimmune disease
8414,34887857,*autoimmunity
8414,34887857,*gastric cancer
8414,34887857,*risk
8414,34887857,*standardized incidence rate cois commercial or financial relationships that could be construed as a potential conflict of interest.
8415,34355625,trab
8415,34355625,thyroid function
8415,34355625,hysterosalpingography (hsg)
8415,34355625,infertility
8415,34355625,thyrotoxicosis
8416,32419081,*cd40
8416,32419081,*ctla4
8416,32419081,*graves’ disease
8416,32419081,*pparg
8416,32419081,*ptpn22
8416,32419081,*polymorphism
8417,32372394,children and adolescents
8417,32372394,low-dose radioactive iodine (131i)
8417,32372394,outpatients treatment
8417,32372394,radiation exposure
8418,34949642,*graves’ disease
8418,34949642,*autoimmune
8418,34949642,*fibrocyte
8418,34949642,"*thyroid cois therapeutic targeting of igf-i receptor in autoimmune diseases (to t.j.s. and held by the university of california, los angeles, and the lundquist institute). he is a consultant for horizon therapeutics."
8419,32874051,orbital decompression
8419,32874051,pneumocephalus
8419,32874051,thyroid eye disease cois
8420,32797475,graves’ disease
8420,32797475,antioxidant parameters
8420,32797475,hyperthyroidism
8420,32797475,lipid peroxidation
8420,32797475,thyroid orbitopathy
8422,33653401,children
8422,33653401,glucocorticoid pulse therapy
8422,33653401,graves’ disease
8422,33653401,thyroid antibodies
8422,33653401,thyroid function cois
8427,34381538,acromegaly
8427,34381538,case report
8427,34381538,empty sella
8427,34381538,grave´s disease
8427,34381538,hyperthyroidism cois
8429,32246145,*graves’ disease
8429,32246145,*hashimoto’s thyroiditis
8429,32246145,*genetic risk
8429,32246145,*heterogeneity
8429,32246145,*large chinese cohort
8430,33322192,*graves’ orbitopathy
8430,33322192,*exophthalmos
8430,33322192,*intraocular pressure
8430,33322192,*topical medications cois
8432,32328068,*graves' disease
8432,32328068,*hashimoto's thyroiditis
8432,32328068,*follicular helper t cells
8432,32328068,*lymphoid tissue–inducer-like cells
8432,32328068,*regulatory t cells
8432,32328068,*thyroid autoimmune disease
8433,33597925,*erk
8433,33597925,*graves’ ophthalmopathy
8433,33597925,*ras homolog family member a (rhoa)
8433,33597925,*rho‑associated protein kinase (rock)
8433,33597925,*y-27632
8433,33597925,*myofibroblast
8433,33597925,*p38
8433,33597925,*simvastatin cois commercial or financial relationships that could be construed as a potential conflict of interest.
8437,34271828,*ait
8437,34271828,*trab
8437,34271828,*amiodarone
8437,34271828,*autoimmunity
8437,34271828,*thyrotoxicosis
8438,32545596,grave´s disease
8438,32545596,hashimoto’s thyroiditis
8438,32545596,non-celiac wheat sensitivity
8438,32545596,celiac disease
8438,32545596,gut microbiota
8438,32545596,iodine
8438,32545596,iron
8438,32545596,probiotics
8438,32545596,thyroid
8438,32545596,thyroid cancer cois
8439,32338082,*b-cell activating factor
8439,32338082,*cytokines
8439,32338082,*graves’ disease
8439,32338082,*hashimoto’s thyroiditis
8439,32338082,*autoimmune thyroid disease
8440,33912135,*graves’ disease
8440,33912135,*rna sequencing
8440,33912135,*t cell receptor sequencing
8440,33912135,*persistent graves’ disease
8440,33912135,*refractory graves’ disease
8440,33912135,*regulatory t cell cois commercial or financial relationships that could be construed as a potential conflict of interest.
8441,32116430,goiter
8441,32116430,thyroid
8441,32116430,thyroidectomy
8442,32121432,somatostatin analog
8442,32121432,cancer
8442,32121432,carcinoid
8442,32121432,lanreotide
8442,32121432,neuroendocrine tumor
8442,32121432,octreotide
8442,32121432,pasireotide
8442,32121432,"pituitary adenoma cois novartis, and pfizer as speaker fees, served on an advisory board, and received lecture fees and sponsorship for travel and accommodation in international scientific meetings from ipsen, novartis, and pfizer. none of them had role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript, or in the decision to publish the results."
8443,32572659,hypothyroidism
8443,32572659,goitre
8443,32572659,hyperthyroidism
8443,32572659,physiology
8443,32572659,thyroid carcinoma
8444,33040848,ct
8444,33040848,cancer
8444,33040848,goiter
8444,33040848,mr imaging
8444,33040848,surgical implications
8444,33040848,thyroid
8444,33040848,thyroid nodules cois
8445,32342248,hypoparathyroidism
8445,32342248,recurrent nerve injury
8445,32342248,thyroid carcinoma
8445,32342248,thyroid surgery
8445,32342248,thyroidectomy
8446,32234570,*central neck lymph node dissection
8446,32234570,*hypocalcemia
8446,32234570,*hypoparathyroidism
8446,32234570,*thyroidectomy
8447,31941844,adipogenesis
8447,31941844,caffeine
8447,31941844,graves’ orbitopathy
8447,31941844,oxidative stress
8447,31941844,thyroid eye disease
8448,33167878,bowel perforation
8448,33167878,gastrointestinal mucormycosis
8448,33167878,mucormycosis
8448,33167878,rhizopus microsporus
8448,33167878,streptococcus pyogenes
8448,33167878,toxic shock syndrome cois
8449,34653776,*graves' disease
8449,34653776,*sars-cov-2
8449,34653776,*type 1 diabetes mellitus
8449,34653776,*vaccine
8450,32896170,*graves’ disease
8450,32896170,*zinc transporter
8450,32896170,*children
8450,32896170,*non-toxic nodular goiter
8450,32896170,*thyroid tissue
8451,34956094,*contrast-enhanced ultrasound (ceus)
8451,34956094,*partially cystic papillary thyroid carcinomas (pcptcs)
8451,34956094,*partially cystic thyroid nodules
8451,34956094,*thyroid carcinomas
8451,34956094,*thyroid ultrasonography cois commercial or financial relationships that could be construed as a potential conflict of interest.
8452,33208049,*graves' disease
8452,33208049,*hla-dr3 mice
8452,33208049,*t cells
8452,33208049,*tetramer assay
8453,32734637,*asian
8453,32734637,*cosmesis
8453,32734637,*minimally invasive video-assisted thyroidectomy
8453,32734637,*neck scar
8453,32734637,*thyroidectomy
8454,35130216,"thyroidectomy, harmonic scalpel, classical ligation, suture hemorrhage, recurrent  laryngeal nerve injury."
8457,33939906,thyroid nodule
8457,33939906,ablation techniques
8457,33939906,ethanol
8457,33939906,nodular goiter
8458,32950466,covid-19
8458,32950466,free t3
8458,32950466,free t4
8458,32950466,hypothyroidism
8458,32950466,hypothyroïdie
8458,32950466,orbitopathie
8458,32950466,orbitopathy
8458,32950466,sars-cov-2
8458,32950466,t3l
8458,32950466,t4l
8458,32950466,tsh
8458,32950466,thyrotoxicose
8458,32950466,thyrotoxicosis
8459,33754530,anaplastic thyroid carcinoma
8459,33754530,leucocytosis; goitre
8461,33665799,turkey
8461,33665799,elderly people
8461,33665799,goitre
8461,33665799,hyperthyroidism
8461,33665799,hypothyroidism
8461,33665799,iodized salt
8462,34721289,*clnm
8462,34721289,*lasso
8462,34721289,*llnm
8462,34721289,*ptc
8462,34721289,*cn0 cois commercial or financial relationships that could be construed as a potential conflict of interest.
8463,32303903,*hereditary non-autoimmune hyperthyroidism
8463,32303903,*inverse agonist and antagonists
8463,32303903,*somatic and germline mutation
8463,32303903,*tsh receptor
8463,32303903,*toxic adenoma
8463,32303903,*toxic multinodular goitre cois
8465,33202999,*case-control studies
8465,33202999,*cohort studies
8465,33202999,*hearing loss
8465,33202999,*hyperthyroidism
8465,33202999,*sudden cois
8466,33339489,frank hartley
8466,33339489,clubfoot
8466,33339489,exstrophy of the bladder
8466,33339489,facial neuralgia
8466,33339489,goiter
8467,33964951,ck19
8467,33964951,follicular
8467,33964951,hbme1
8467,33964951,niftp
8467,33964951,papillary cois
8468,33402480,braf mutation
8468,33402480,microrna
8468,33402480,papillary thyroid cancer cois
8469,33466826,cohort
8469,33466826,diet
8469,33466826,iodine
8469,33466826,pregnancy
8469,33466826,"thyroid cois develop the myfood24 online dietary assessment system for use in research, teaching and for health. the remaining authors have nothing to declare. the funders had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript or in the decision to publish the results."
8470,33459001,*hashimoto disease
8470,33459001,*adolescent
8470,33459001,*child
8470,33459001,*goiter
8470,33459001,*hypothyroidism cois
8471,33213335,*hyperthyroidism
8471,33213335,*raiu test
8471,33213335,*graves' disease
8471,33213335,*multinodular
8471,33213335,*pathology
8471,33213335,*thyroid scan
8471,33213335,*toxic
8472,32518973,benign neoplasm
8472,32518973,goiter
8472,32518973,thyroid cancer
8473,32733376,*children
8473,32733376,*hypertrichosis
8473,32733376,*pituitary hypertrophy
8473,32733376,*severe autoimmune hypothyroidism
8473,32733376,*symptoms
8474,32267105,* metastasis
8474,32267105,* multinodular goiter
8474,32267105,*thyroid carcinoma
8475,33412925,*goiter
8475,33412925,*statins
8475,33412925,*thyroid cancer
8475,33412925,*thyroiditis
8475,33412925,*thyrotoxicosis
8478,33812374,macroadenoma
8478,33812374,pituitary
8478,33812374,pregnancy
8478,33812374,thyrotoxicosis cois
8479,32697397,doppler ultrasound
8479,32697397,graves disease
8479,32697397,graves orbitopathy
8479,32697397,central retinal artery
8479,32697397,ophthalmic artery
8479,32697397,toxic goiter
8480,33980057,*decision aid tool
8480,33980057,*levothyroxine dosage
8480,33980057,*patient tailored
8480,33980057,*pharmacokinetic modeling
8480,33980057,*thyroidectomy cois
8482,32149464,* thyroid surgery
8482,32149464,*ent
8482,32149464,*hyperthyroidism
8482,32149464,*thyroid
8482,32149464,*thyroid cancer
8483,31868128,*alu element
8483,31868128,*tg
8483,31868128,*congenital hypothyroidism
8483,31868128,*goiter
8483,31868128,*novel mutation
8483,31868128,*thyroglobulin cois
8484,32939627,ectopic thyroid tissue
8484,32939627,follicular adenoma
8484,32939627,goiter
8484,32939627,lung
8484,32939627,thoracoscopic surgery
8486,32909177,ancient rome
8486,32909177,fine arts
8486,32909177,goiter
8486,32909177,hans christian gram
8486,32909177,history
8486,32909177,hyperthyroidism
8488,33619709,mri
8488,33619709,genetic diseases
8488,33619709,goitre
8488,33619709,haemochromatosis
8488,33619709,iron
8488,33619709,iron overload
8488,33619709,liver biopsy
8488,33619709,thyroid
8489,32372240,egypt
8489,32372240,endemic goiter
8489,32372240,hashimoto’s thyroiditis
8489,32372240,papillary thyroid carcinoma
8489,32372240,thyroid cancer
8490,32377868,goiter
8490,32377868,graves’ disease
8490,32377868,hashimoto’s thyroiditis
8490,32377868,iodine-induced hyperthyroidism
8490,32377868,thyroid autonomy
8491,34378152,*congenital hypothyroidism
8491,34378152,*dyshormonogenesis
8491,34378152,*goiter
8491,34378152,*thyroid cancer
8492,33135832,*māori health
8492,33135832,*head and neck
8492,33135832,*thyroid surgery
8493,33319230,*hypothyroidism
8493,33319230,*chronic diseases
8493,33319230,*comorbidity
8493,33319230,*network analysis
8494,34637944,early diagnosis
8494,34637944,hamartoma syndrome
8494,34637944,hereditary
8494,34637944,multiple
8494,34637944,neoplastic syndromes
8494,34637944,pten phosphohydrolase
8494,34637944,phenotype
8496,33905626,thyroid cancer
8496,33905626,mrna expression
8496,33905626,polymorphism
8496,33905626,transforming growth factor-β
8497,33779362,thyroid
8497,33779362,hypocalcaemia
8497,33779362,meta-analysis
8497,33779362,prevalence
8497,33779362,risk factor cois conflicts of interest.
8499,33910357,complications − recurrent nerve
8499,33910357,hypoparathyroidism − lethality
8499,33910357,thyroid surgery
8500,34479126,diffuse thyroid diseases
8500,34479126,grave’s diseases
8500,34479126,hashimoto’s thyroiditis
8500,34479126,shear wave elastography
8500,34479126,ultrasonography
8501,33008929,*amiodarone-induced thyroid dysfunction
8501,33008929,*autoimmunity
8501,33008929,*destructive thyroiditis
8501,33008929,*hyperthyroidism
8501,33008929,*toxic multinodular goiter
8501,33008929,*toxic thyroid adenoma
8502,32458745,*goiter
8502,32458745,*iodine
8502,32458745,*iodine deficiency
8502,32458745,*salt
8502,32458745,*universal salt iodization cois
8503,34841823,*cohort studies
8503,34841823,*goiter
8503,34841823,*hyperthyroidism
8503,34841823,*hypothyroidism
8504,33072219,relapse risk
8504,33072219,benign focal pathology
8504,33072219,nodular goiter
8504,33072219,thyroid gland
8505,33028642,*ewing's sarcoma
8505,33028642,*multinodular goiter
8505,33028642,*neoplasm of the genitourinary tract
8506,34425332,gene expression
8506,34425332,klln
8506,34425332,multinodular goiter
8506,34425332,pten
8506,34425332,papillary thyroid carcinoma
8507,33914231,*goiter
8507,33914231,*iodine
8507,33914231,*iodized salt
8507,33914231,*thyroid
8507,33914231,*thyroid autoimmunity cois
8508,33749812,bethesda classification
8508,33749812,thyroid cancer
8508,33749812,thyroid nodule
8509,32838791,*breast cancer
8509,32838791,*genetic pleiotropy
8509,32838791,*hyperthyroidism
8509,32838791,*mammographic density cois
8510,32930933,congenital hypothyroidism
8510,32930933,duox2
8510,32930933,newborn screening
8510,32930933,tg
8510,32930933,tpo
8510,32930933,tshr
8511,32765423,*congenital hypothyroidism
8511,32765423,*dyshormonogenesis
8511,32765423,*genes
8511,32765423,*goiter
8511,32765423,*iodine
8511,32765423,*screening
8511,32765423,*thyroid hypoplasia
8512,34382851,cervical stitch sinus
8512,34382851,deep neck infection
8512,34382851,diabetes
8512,34382851,suture granuloma
8512,34382851,thyroidectomy
8512,34382851,wound
8512,34382851,wound healing
8514,31960358,mitochondria
8514,31960358,oxidative stress
8514,31960358,ros
8514,31960358,selenium
8514,31960358,thyroid
8516,34121740,autoimmune disease
8516,34121740,hashimoto's thyroiditis
8516,34121740,hypocalcemia
8516,34121740,thyroid peroxidase antibody
8516,34121740,thyroidectomy cois
8517,32505587,resistance to thyroid hormone
8517,32505587,thrb gene
8517,32505587,thyroid hormone receptor beta cois
8518,34426423,endoscopy
8518,34426423,surgery
8518,34426423,thyroid disease
8518,34426423,thyroiditis cois
8519,34051706,*goiter
8519,34051706,*nodule
8519,34051706,*thyroid
8520,32582023,*hashimoto's thyroiditis
8520,32582023,*hashitoxicosis
8520,32582023,*autoimmune thyroiditis (ait)
8520,32582023,*goiter
8520,32582023,*thyroid autoantibodies
8521,33901280,"*8-oxo-7,8-dihydro-2’-deoxyguanosine"
8521,33901280,"*8-oxo-7,8-dihydroguanosine"
8521,33901280,*graves disease
8521,33901280,*hyperthyroidism
8521,33901280,*oxidative stress
8521,33901280,*toxic nodular goiter
8522,34093427,*langerhans cell histiocytosis
8522,34093427,*chemotherapy
8522,34093427,*spontaneous thyroid hemorrhage
8522,34093427,*thyroid
8522,34093427,*thyroidectomy cois commercial or financial relationships that could be construed as a potential conflict of interest.
8525,33796075,*gh
8525,33796075,*igf-i
8525,33796075,*acromegaly
8525,33796075,*comorbidity
8525,33796075,*complication
8525,33796075,*pituitary adenoma cois commercial or financial relationships that could be construed as a potential conflict of interest.
8526,32792004,denosumab rebound
8526,32792004,fracture
8526,32792004,hypercalcemia
8526,32792004,hyperparathyroidism
8526,32792004,osteoporosis cois
8527,34219897,hyperthyroidsm
8527,34219897,thyroid neoplasms
8527,34219897,thyrostatic drugs cois interest. this article does not include any studies with human participants or animals performed by any of the authors.
8528,34937506,thyroid disorders
8528,34937506,male infertility factor
8528,34937506,pathospermia
8529,34248839,*congenital hypothyroidism
8529,34248839,*familial origin
8529,34248839,*high throughput molecular screening
8529,34248839,*oligogenicity
8529,34248839,*thyroid dyshormonogenesis cois commercial or financial relationships that could be construed as a potential conflict of interest.
8531,33052461,edge
8531,33052461,localization
8531,33052461,oxidative stress
8531,33052461,thyroid
8531,33052461,tumor
8532,34431326,covid-19
8532,34431326,sars-cov-2
8532,34431326,goiter
8532,34431326,surgery
8532,34431326,thyroid cancer
8532,34431326,thyroidectomy
8533,32178945,aberrant left subclavian artery
8533,32178945,non-recurrent inferior laryngeal nerve
8533,32178945,right-sided aortic arch
8533,32178945,thyroid surgery cois disclosed on this work.
8534,34196952,cost-effectiveness analysis
8534,34196952,intraoperative nerve monitoring
8534,34196952,recurrent laryngeal nerve palsy
8534,34196952,total thyroidectomy
8534,34196952,visual nerve identification
8535,32606189,thyroid
8535,32606189,malignancy
8535,32606189,microcalcifications
8535,32606189,nodule
8535,32606189,shape cois
8538,34889796,disfigurement
8538,34889796,horner syndrome
8538,34889796,steroids
8538,34889796,thyroidectomy cois
8541,33004747,follicular thyroid adenoma
8541,33004747,follicular thyroid carcinoma
8541,33004747,ultrasound signal cois
8542,32253953,*interventional ultrasonography
8542,32253953,*ablation techniques
8542,32253953,*high-intensity focused ultrasound ablation
8542,32253953,*nodular goiter
8542,32253953,*ultrasound imaging
8543,33459000,*graves disease
8543,33459000,*adolescent
8543,33459000,*antithyroid agents
8543,33459000,*child
8543,33459000,*hyperthyroidism cois
8544,33250466,alkaline phosphatase
8544,33250466,body pain
8544,33250466,muscle weakness
8544,33250466,normocalcemic hyperparathyroidism cois
8547,33194956,*kashmir
8547,33194956,*hypothyroidism
8547,33194956,*thyroid dysfunction
8547,33194956,*tribal population
8547,33194956,*urinary iodine
8548,32897650,*dicer1
8548,32897650,*cytology
8548,32897650,*fine-needle aspiration
8548,32897650,*follicular neoplasm
8548,32897650,*papillary thyroid carcinoma
8548,32897650,*poorly differentiated thyroid carcinoma
8548,32897650,*thyroid
8549,32430544,benign goiter
8549,32430544,case number threshold
8549,32430544,routine data
8549,32430544,vocal cord palsy
8549,32430544,volume outcome
8550,32458504,mitochondria
8550,32458504,mitochondria-eating protein
8550,32458504,mitophagy
8550,32458504,oncocytic cell tumor
8550,32458504,thyroid cois
8551,33541277,deficiency
8551,33541277,goiter
8551,33541277,magnitude
8551,33541277,micronutrient
8551,33541277,prevalence
8551,33541277,urine iodine cois
8553,32621001,*endocrine dysfunction
8553,32621001,*hemorrhagic stroke
8553,32621001,*ischemic stroke
8553,32621001,*pituitary
8554,31952842,*cervical embryonal rhabdomyosarcoma
8554,31952842,*dicer1-related multinodular goiter
8554,31952842,*ovarian sex-cord stromal tumors
8554,31952842,*pleuropulmonary blastoma
8554,31952842,"*sertoli-leydig cell tumors of the ovary cois private company with a mission to develop liquid biopsy diagnostics for rare cancers which includes dicer1-related cancers described in this work. none of the diagnostics under development are discussed in this work. dr. stewart provides contract telegenetics services to genome medical, inc."
8555,34670545,hyperthyroidism
8555,34670545,icm
8555,34670545,iodinated contrast media
8555,34670545,iodine-induced
8555,34670545,tachycardia cois
8556,32189188,*distant metastases
8556,32189188,*ft-ump
8556,32189188,*mi-ftc
8556,32189188,*radioiodine therapy
8556,32189188,*wdt-ump
8557,32081771,*biomarker
8557,32081771,*follicular thyroid adenoma
8557,32081771,*follicular thyroid carcinoma
8557,32081771,*roc curve analysis
8557,32081771,*real-time pcr
8557,32081771,*microrna cois
8560,33119125,dielectric properties
8560,33119125,open-ended coaxial line
8560,33119125,thyroid nodules
8561,32974689,ablation techniques
8561,32974689,high-intensity focused ultrasound ablation
8561,32974689,interventional ultrasonography
8561,32974689,nodular goiter
8561,32974689,ultrasonic imaging
8565,34191415,thyroid cancer
8565,34191415,endoscopic
8565,34191415,goiter
8565,34191415,surgery
8565,34191415,thyroidectomy
8566,33932399,*change
8566,33932399,*expression
8566,33932399,*s hla-g
8566,33932399,*thyroid cancer
8566,33932399,*mir-199b-5p
8567,32088313,*congenital hypothyroidism
8567,32088313,*genotype-phenotype analysis
8567,32088313,*next-generation sequencing
8567,32088313,*thyroid peroxidase cois
8568,31867598,*tg
8568,31867598,*tpo
8568,31867598,*congenital hypothyroidism
8568,31867598,*goiter
8570,32757959,* dioscorea bulbifera l
8570,32757959,*8-epidiosbulbin e acetate
8570,32757959,*diosbulbin b
8570,32757959,*hepatotoxicity
8570,32757959,*metabolic activation
8572,34706470,*anxiety
8572,34706470,*depression
8572,34706470,*obesity
8572,34706470,*personality
8572,34706470,*temperament
8573,34008223,dicer1
8573,34008223,follicular thyroid carcinoma
8573,34008223,histology
8573,34008223,macrofollicular variant
8573,34008223,mutation
8576,34050759,*adolescents
8576,34050759,*goiter
8576,34050759,*hyperthyroidism
8576,34050759,*hypothyroidism
8576,34050759,*thyroid
8576,34050759,*type 2 diabetes
8577,33210503,adenoma
8577,33210503,cyst
8577,33210503,follicular cancer
8577,33210503,thyroid gland
8577,33210503,ultrasound examination
8578,33331320,adenoma
8578,33331320,diagnosis
8578,33331320,hürthle cell tumor
8578,33331320,thyroid gland
8580,33329389,*diagnosis
8580,33329389,*hyperthyroidism
8580,33329389,*pathogenesis
8580,33329389,*pituitary adenoma
8580,33329389,*thyroid-stimulating hormone-secreting pituitary adenoma
8580,33329389,*treatment cois commercial or financial relationships that could be construed as a potential conflict of interest.
8581,34695620,pericardial effusion
8581,34695620,pleural effusion
8581,34695620,pleural hemangioma
8581,34695620,recurrent
8585,33180037,tshr mutation
8585,33180037,hyperthyroidism
8585,33180037,neonatal
8585,33180037,nonautoimmune
8586,32484412,diode
8586,32484412,laser
8586,32484412,metastatic
8586,32484412,thyroid
8586,32484412,trachea
8589,33722923,18f-fdg
8589,33722923,pet/ct
8589,33722923,breast metastasis
8589,33722923,follicular thyroid carcinoma
8589,33722923,iodine scan
8590,33393527,follicular carcinoma
8590,33393527,malignant
8590,33393527,neoplasm
8590,33393527,ovary
8590,33393527,struma ovarii
8590,33393527,teratoma cois
8591,33405016,*dysphagia
8591,33405016,*dysphonia
8591,33405016,*reflux disease
8591,33405016,*swallowing
8591,33405016,*thyroid
8591,33405016,*thyroid weight
8591,33405016,*thyroidectomy
8591,33405016,*voice cois
8592,33690170,*braf
8592,33690170,*mmp2
8592,33690170,*cancer
8592,33690170,*invasion
8592,33690170,*mutation
8592,33690170,*oncogene
8592,33690170,*thyroid cancer
8593,33970434,global health
8593,33970434,goiter
8593,33970434,telemedicine
8593,33970434,thyroid cancer
8593,33970434,thyroid ultrasound
8593,33970434,"ultrasound cois technology have financial stake in medical innovation and technology which works on developing technology to bring medical imaging to rural areas. all other authors have no financial disclosures. the manuscript and its contents were produced by the university of rochester and medical imaging ministries of the americas authors without financial conflict. the medical innovation and technology authors previewed the document, and any changes were subject to approval from the university of rochester and medical imaging ministry of the americas authors."
8594,32228164,*dicer1
8594,32228164,*child
8594,32228164,*follicular thyroid carcinomas
8594,32228164,*multinodular goiter
8596,33557336,alternative diet
8596,33557336,diet
8596,33557336,iodine
8596,33557336,iodine deficiency
8596,33557336,vegetarian diet cois
8597,34069656,mediterranean diet
8597,34069656,sars-cov-2 infection
8597,34069656,dietary habits
8597,34069656,healthcare professionals cois
8598,32631402,graves’ disease
8598,32631402,hyperthyroidism
8598,32631402,scintigraphy
8598,32631402,thyroid uptake
8598,32631402,thyrotoxicosis cois
8600,34418036,"synchronous thyroid malignancies, papillary thyroid carcinoma, lymphoma"
8601,32166365,*child
8601,32166365,*congenital hypothyroidism
8601,32166365,*gland
8601,32166365,*intrathyroid thymus
8601,32166365,*nodules
8601,32166365,*thyroid
8601,32166365,*thyroiditis
8601,32166365,*ultrasonography
8602,33676861,*endoscopic surgery
8602,33676861,*minimally invasive surgery
8602,33676861,*toetva
8602,33676861,*thyroidectomy
8603,34219881,fine-needle biopsy
8603,34219881,galectin-3
8603,34219881,reverse transcriptase polymerase chain reaction
8603,34219881,thyroid neoplasms
8603,34219881,thyroid nodule
8604,33319473,*oligometastasis
8604,33319473,*small cell lung cancer
8604,33319473,*thyroid metastasis
8606,32731688,follicular thyroid adenoma
8606,32731688,follicular thyroid cancer
8606,32731688,recurrent laryngeal nerve palsy
8606,32731688,elective lymph node dissection
8606,32731688,follicular variant of papillary thyroid cancer
8607,32645970,covid-19 infection
8607,32645970,dietary habits
8607,32645970,lockdown
8607,32645970,obesity cois
8608,32703500,braf mutation
8608,32703500,fine-needle aspiration
8608,32703500,papillary thyroid carcinoma
8608,32703500,thyroid nodule
8613,34230069,hyperthyroidism
8613,34230069,molecular imaging
8613,34230069,thyroid functional autonomy
8613,34230069,thyroid nodules
8614,33507638,men 2
8614,33507638,thyroid gland surgery
8614,33507638,thyroid nodule
8614,33507638,thyroidectomy
8615,31566142,intestinal microbiota
8615,31566142,autoimmune thyroid diseases
8615,31566142,gut dysbiosis
8615,31566142,hyperthyroidism
8615,31566142,hypothyroidism
8615,31566142,thyroid hormones.
8618,34855191,rathke
8618,34855191,cleft cysts
8618,34855191,headache
8618,34855191,hyperprolactinaemia
8618,34855191,hypopituitarism
8618,34855191,pituitary incidentaloma
8619,33028431,*iodine deficiency
8619,33028431,*iodine supplementation
8619,33028431,*lipiodol capsules
8619,33028431,*thyroid disease
8619,33028431,*women
8620,33077306,epithelial mesenchymal transition
8620,33077306,papillary thyroid carcinoma
8620,33077306,six1
8620,33077306,tgf-β/smad2/3 cois
8621,32436480,*adults
8621,32436480,*iodine fortification
8621,32436480,*serum iodine
8621,32436480,*thyroid autoimmunity
8621,32436480,*urinary iodine
8623,33007517,ccna1 gene
8623,33007517,cyclin a1
8623,33007517,diagnostic
8623,33007517,molecular marker
8623,33007517,papillary thyroid cancer
8623,33007517,protein expression
8624,33656790,afirma genomic sequencing classifier
8624,33656790,atypia of undetermined significance
8624,33656790,de quervain's thyroiditis
8624,33656790,molecular tests
8625,33176840,autosomal genetic disease
8625,33176840,gene mutation
8625,33176840,thyroid hormone
8625,33176840,thyroid hormone receptor β
8625,33176840,thyroid hormone resistance cois
8626,34803909,*biomarker
8626,34803909,*complement c4-a
8626,34803909,*papillary thyroid carcinoma
8626,34803909,*plasminogen
8626,34803909,*prediction cois commercial or financial relationships that could be construed as a potential conflict of interest.
8627,33750374,complication
8627,33750374,gasless trans-axillary endoscopic thyroidectomy
8627,33750374,hypoglossal nerve palsy cois
8628,33445950,thyroid surgery − transoral endoscopy – toetva − case report of the first toetva  patient at university hospital brno
8629,33213237,intratracheal ectopic thyroid
8629,33213237,adenomatous hyperplasia
8629,33213237,diagnosis
8629,33213237,ectopic
8629,33213237,thyroid
8629,33213237,treatment cois conflict of interest.
8631,33868182,*autoimmune thyroid disease
8631,33868182,*epigenetic effect
8631,33868182,*resistance to thyroid hormone
8631,33868182,*thyroid dysgenesis
8631,33868182,*thyroid hormone receptor
8631,33868182,*variant of unknown significance cois commercial or financial relationships that could be construed as a potential conflict of interest.
8632,32037778,*fine needle aspiration cytology
8632,32037778,*focus number
8632,32037778,*malignancy
8632,32037778,*predictivity
8632,32037778,*thyroid nodules
8635,31808043,*fasting glucose
8635,31808043,*observational studies
8635,31808043,*randomized controlled trials
8635,31808043,*time restricted feeding
8635,31808043,*weight loss
8636,32286703,*dapk
8636,32286703,*dna methylation
8636,32286703,*pten
8636,32286703,*diagnosis
8636,32286703,*thyroid nodules
8637,32816208,dropouts
8637,32816208,obesity
8637,32816208,treatment failure
8637,32816208,weight management cois
8638,33346472,covid-19
8638,33346472,russia
8638,33346472,epidemic
8638,33346472,iodine deficiency
8638,33346472,iodized salt
8640,33112496,dicer1
8640,33112496,autopsy
8640,33112496,prostate
8640,33112496,rhabdomyosarcoma
8641,32760349,*lymph node metastasis
8641,32760349,*papillary thyroid cancer
8641,32760349,*thyroglobulin antibodies
8641,32760349,*thyroid nodule
8641,32760349,*thyroidectomy
8644,33310924,*iodine supply
8644,33310924,*iodized salt
8644,33310924,*jódellátottság
8644,33310924,*jódozott só
8644,33310924,*pregnant women
8644,33310924,*várandós anyák
8644,33310924,*“silent” prophylaxis
8644,33310924,*„silent” profilaxis
8645,33921293,gluten sensitivity
8645,33921293,gut microbiota
8645,33921293,gut mycobiota
8645,33921293,mental status cois
8646,33740798,anxiety
8646,33740798,depression
8646,33740798,primary hyperparathyroidism
8647,33333891,rthβ
8647,33333891,thrb
8647,33333891,hypercholesterolemia
8647,33333891,hypothyroidism
8647,33333891,resistance to thyroid hormones
8647,33333891,thyroid
8647,33333891,thyroid hormone receptor cois
8648,32687189,* saliva iodine
8648,32687189,*iodine status
8648,32687189,*thyroid function
8649,32676935,covid-19; sars-cov-2
8649,32676935,subacute thyroiditis
8649,32676935,viral thyroiditis cois
8650,33773966,congenital hypothyroidism
8650,33773966,gland in situ
8650,33773966,monoallelic mutations
8650,33773966,thyroid dysgenesis
8650,33773966,thyroid transcription factors
8651,34803920,*cardiac arrhythmias
8651,34803920,*hypothyroidism
8651,34803920,*levothyroxine
8651,34803920,*osteoporosis
8651,34803920,*replacement therapy
8651,34803920,*thyroid cois commercial or financial relationships that could be construed as a potential conflict of interest.
8652,33631011,*duox system genes
8652,33631011,*clinical phenotype
8652,33631011,*congenital hypothyroidism
8652,33631011,*targeted region sequencing
8652,33631011,*thyroid gland
8653,32500518,*covid-19
8653,32500518,*endocrine emergencies
8653,32500518,*endocrine surgery
8653,32500518,*thyroid cancer cois
8655,32811342,*elderly
8655,32811342,*hyperthyroidism
8655,32811342,*methimazole
8655,32811342,*radioiodine
8656,34400129,economic impact
8656,34400129,hypocalcemia
8656,34400129,hypocalcémie
8656,34400129,hypoparathyroidism
8656,34400129,hypoparathyroïdie
8656,34400129,impact économique
8656,34400129,quality of life
8656,34400129,qualité de vie
8656,34400129,thyroidectomy
8656,34400129,thyroïdectomie
8657,33582938,china
8657,33582938,morbidity
8657,33582938,thyroid nodules
8657,33582938,urinary iodine concentration cois
8659,33147928,dose effect
8659,33147928,iodine
8659,33147928,thyroid nodule
8659,33147928,u-shaped curve
8659,33147928,urine
8660,31983029,*lateral lymph node metastasis
8660,31983029,*papillary thyroid carcinoma
8660,31983029,*predictive model
8660,31983029,*risk stratification
8660,31983029,*treatment strategy
8661,31789139,ccl5
8661,31789139,cav-1
8661,31789139,chemokine
8661,31789139,hashimoto’s thyroiditis
8661,31789139,pparγ
8661,31789139,pioglitazone.
8663,34594299,*autoimmune thyroid antibodies
8663,34594299,*fine needle aspirate (fna)
8663,34594299,*microcalcification
8663,34594299,*thyroid cancer
8663,34594299,*tumor size cois commercial or financial relationships that could be construed as a potential conflict of interest.
8664,33460435,*dicer1 mutation
8664,33460435,*thyroid cancer genes
8664,33460435,*thyroid nodules
8665,33106852,*hypothyroidism
8665,33106852,*levothyroxine
8665,33106852,*meta-analysis
8665,33106852,*systematic review
8665,33106852,*thyroidectomy
8665,33106852,*weight gain
8666,32988358,thyroid carcinoma
8666,32988358,aggressive
8666,32988358,breast carcinoma
8666,32988358,diagnostic algorithm
8666,32988358,radiopharmaceuticals
8666,32988358,synchronous
8667,34376229,cardiac metastasis
8667,34376229,case report
8667,34376229,follicular thyroid carcinoma
8667,34376229,hurthle cell carcinoma
8667,34376229,multisite metastases
8667,34376229,pancreatic metastasis
8667,34376229,unusual metastases cois
8668,33111192,*toetva
8668,33111192,*tort
8668,33111192,*transoral endoscopic thyroidectomy
8668,33111192,*transoral robotic thyroidectomy
8670,34010443,desiccated thyroid extracts
8670,34010443,hypothyroidism
8670,34010443,iodine
8670,34010443,levothyroxine
8670,34010443,liothyronine
8670,34010443,selenium
8670,34010443,survey
8670,34010443,thyroid hormones
8671,33772338,thyroid
8671,33772338,malignancy
8671,33772338,nodule
8671,33772338,ultrasonography
8672,33406977,*salt iodization
8672,33406977,*thyroid autoantibodies
8672,33406977,*thyroid dysfunction
8673,31928176,*tibetan
8673,31928176,*iodine nutrition
8673,31928176,*oxygen-deficient plateau
8673,31928176,*thyroid disorders
8675,33645517,ptc
8675,33645517,tpoab
8675,33645517,tgab
8675,33645517,extrathyroidal extension
8675,33645517,lymph node metastasis
8676,32696176,*gli3 gene
8676,32696176,*glis3 gene
8676,32696176,*thyroid dysgenesis
8676,32696176,*thyroid hemiagenesis
8676,32696176,*whole-exome sequencing cois
8677,34126658,autoantibody
8677,34126658,autoimmune thyroiditis
8677,34126658,pediatrics
8677,34126658,thyroid cancer
8677,34126658,thyroid nodule
8678,33643218,*radiofrequency ablation
8678,33643218,*technique
8678,33643218,*thermal ablation
8678,33643218,*thyroid nodules
8678,33643218,*ultrasound cois commercial or financial relationships that could be construed as a potential conflict of interest.
8680,32276716,*graves’ disease
8680,32276716,*outpatient surgery
8680,32276716,*pediatric surgery
8680,32276716,*thyroid cancer
8680,32276716,*thyroid nodule
8680,32276716,*thyroidectomy cois conflicts of interest to disclose.
8681,34539567,*biallelic variant
8681,34539567,*characteristic
8681,34539567,*hypothyroidism
8681,34539567,*oligogenic variant
8681,34539567,*whole-exome sequencing cois commercial or financial relationships that could be construed as a potential conflict of interest.
8682,34284528,cns tumor
8682,34284528,plurihormonal pituitary adenoma
8682,34284528,sella turcica
8683,33827539,hyperparathyroidism
8683,33827539,intrathyroidal parathyroid
8683,33827539,parathyroid cancer
8683,33827539,surgical approach
8683,33827539,thyroid cancer cois
8684,33683595,*chek2
8684,33683595,*dna repair
8684,33683595,*familial non-medullary thyroid carcinoma (fnmtc)
8684,33683595,*founder pathogenic variant
8684,33683595,*thyroid
8686,33104041,*hyperthyroidism
8686,33104041,*parkinson’s disease
8686,33104041,*hypothyroidism
8686,33104041,*neurodegenerative disorder
8686,33104041,*pathophysiology
8686,33104041,*thyroid disease
8686,33104041,*thyroid dysfunction
8689,33254347,"diagnosis, surgical procedures, operative"
8689,33254347,root of neck neoplasms cois relevant financial relationships with commercial interests to disclose.
8690,34644122,*chloride channel
8690,34644122,*chloride exchanger
8690,34644122,*drug discovery
8690,34644122,*epithelium
8690,34644122,"*solute carrier proteins cois applications for chloride transport modulators, which are owned by their respective universities."
8691,33920190,*ages
8691,33920190,*mage
8691,33920190,*rage
8691,33920190,*glycation
8691,33920190,*oxidative stress
8691,33920190,*thyroid gland pathology cois
8693,33751486,autoimmune thyroid disease
8693,33751486,children and adolescents
8693,33751486,dna methylation
8693,33751486,hashimoto thyroiditis
8693,33751486,melting curve analysis
8693,33751486,ptpn22
8694,33035689,*cell free mtdna
8694,33035689,*nd4/nd1
8694,33035689,*thyroid cancer
8694,33035689,*mtdna copy number
8694,33035689,*mtdna integrity
8695,32430758,*ovarian sertoli-leydig cell tumors
8695,32430758,*slcts
8696,34171097,*cancer
8696,34171097,*carcinoma
8696,34171097,*follicular
8696,34171097,*mutation
8696,34171097,*thyroid
8696,34171097,*whole-genome
8697,32910988,*cysteine cathepsins
8697,32910988,*non-canonical trafficking
8697,32910988,*nuclear forms
8697,32910988,*proliferation-promoting
8697,32910988,*thyroid cancer cois competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
8698,33004735,ablation techniques
8698,33004735,consensus
8698,33004735,guideline
8698,33004735,nodular goiter
8698,33004735,thyroid neoplasms cois
8700,34080176,*hysterosalpingography
8700,34080176,*iodine excess
8700,34080176,*lactation
8700,34080176,*oil-soluble iodinated contrast
8700,34080176,*pregnancy
8701,33096991,*autoimmune thyroid disease
8701,33096991,*cardiac tamponade
8701,33096991,*hypothyroidism
8701,33096991,*pericardial effusion
8701,33096991,*turner syndrome cois
8702,32675393,papillary thyroid carcinoma
8702,32675393,genetic variation
8702,32675393,lncrna
8702,32675393,thyroid function
8703,32072403,fscn1
8703,32072403,immunohistochemistry
8703,32072403,methylation
8703,32072403,promoter
8703,32072403,thyroid cancer
8705,33124651,*tsh
8705,33124651,*congenital hypothyroidism
8705,33124651,*cutoff
8705,33124651,*newborn screening
8707,32188421,maternal and neonatal complications
8707,32188421,pregnancy
8707,32188421,urinary iodine concentration cois
8708,32851577,*cd71
8708,32851577,*primary immune deficiency
8708,32851577,*tfr1
8708,32851577,*a mutation in tfrc
8708,32851577,*combined immunodeficiency cois
8709,32899424,mir-146b
8709,32899424,mir-181b
8709,32899424,mir-21
8709,32899424,mir-221
8709,32899424,mir-222
8709,32899424,papillary thyroid carcinoma
8709,32899424,plasma cois
8710,32842364,detection rate
8710,32842364,fluorescence intensity
8710,32842364,influencing factor
8710,32842364,parathyroid glands
8711,32714280,*cushing's disease
8711,32714280,*dicer1
8711,32714280,*corticotropinoma
8711,32714280,*disease-modifying gene
8711,32714280,*pituitary neuroendocrine tumor
8712,34740022,*acromegaly
8712,34740022,*igf-1
8712,34740022,*risk factors
8712,34740022,*thyroid nodules
8714,31964247,*cost-effectiveness
8714,31964247,*decision-analytic modeling
8714,31964247,*effectiveness
8714,31964247,*iodine deficiency-related diseases
8714,31964247,*systematic review
8715,33036505,axillary approach
8715,33036505,"surgical procedures, minimally invasive"
8715,33036505,thyroid neoplasms
8715,33036505,thyroidectomy
8717,32075540,*china
8717,32075540,*iodine
8717,32075540,*prevalence
8717,32075540,*thyroid disorders
8717,32075540,*universal salt iodization
10213,23646218,benign thyroid hypertrophy
10213,23646218,giant goiter
10213,23646218,goiter
10213,23646218,multinodular goiter
10213,23646218,thyroidectomy
10222,23136541,nodular goiter
10222,23136541,peri-operative treatment
10222,23136541,surgical intervention. cois
10223,23998691,hyperthyroidism
10223,23998691,hypothyroidism
10223,23998691,menopause
10223,23998691,nodular goiter
10223,23998691,thyroid hormone function
10238,22362641,congenital hypothyroidism
10238,22362641,dyshormonogenetic goiter
10238,22362641,euthyroid
10238,22362641,follicular lesion
10238,22362641,follicular neoplasm
10241,24847400,large goiter
10241,24847400,morbidity
10241,24847400,thyroidectomy
10251,23688788,complications
10251,23688788,goiter
10251,23688788,levothyroxine
10251,23688788,lobectomy
10251,23688788,mng
10251,23688788,multinodular
10251,23688788,recurrence
10251,23688788,resection
10251,23688788,thyroid
10251,23688788,thyroidectomy
10260,24117750,minimally invasive surgery
10260,24117750,retrosternal goiter
10260,24117750,robot-assisted surgery
10261,24227901,lingual thyroid goiter
10261,24227901,thyroid ectopias
10261,24227901,transoral robotic surgery
10286,24239133,bocio endotorácico
10286,24239133,esternotomía
10286,24239133,intrathoracic goiter
10286,24239133,mediastino posterior
10286,24239133,posterior mediastinum
10286,24239133,sternotomy
10286,24239133,thoracotomy
10286,24239133,thyroidectomy
10286,24239133,tiroidectomía
10286,24239133,toracotomía
10308,25047208,extracervical scarless neck thyroidectomy (esnt)
10308,25047208,minimal neck incision thyroidectomy (mnit)
10308,25047208,minimally invasive video-assisted thyroidectomy (mivat)
10308,25047208,nodular goitre
10308,25047208,thyroid cancer
10317,24239215,chirurgie oculo-motrice
10317,24239215,chirurgie palpébrale
10317,24239215,corticosteroids
10317,24239215,corticothérapie
10317,24239215,dysthyroid orbitopathy
10317,24239215,décompression orbitaire
10317,24239215,eyelid surgery
10317,24239215,graves’ disease
10317,24239215,graves’ orbitopathy
10317,24239215,maladie de basedow
10317,24239215,multidisciplinaire
10317,24239215,multidisciplinary
10317,24239215,oculomotor surgery
10317,24239215,orbital decompression surgery
10317,24239215,orbitopathie basedowienne
10317,24239215,orbitopathie dysthyroïdienne
10317,24239215,radiation therapy
10317,24239215,radiothérapie
10346,24043977,airway stenting
10346,24043977,radiofrequency ablation
10346,24043977,thyroid goiter
10404,23993801,airway obstruction
10404,23993801,caesarean section
10404,23993801,fibreoptic intubation
10404,23993801,thyroidectomy
10426,24211307,carcinome papillaire de la thyroïde
10426,24211307,goitre multi-nodulaire
10426,24211307,hyperthyroidie
10426,24211307,hyperthyroidism
10426,24211307,multinodular goiter
10426,24211307,panuveitis
10426,24211307,panuvéite
10426,24211307,papillary thyroid carcinoma
10426,24211307,vascularite veineuse
10426,24211307,venous vasculitis
10431,23337610,graves’ disease
10431,23337610,hyperthyroidism
10431,23337610,suicide
10440,23838540,deafness
10440,23838540,enlarged vestibular aqueduct
10440,23838540,pendred syndrome
10440,23838540,pendrin
10440,23838540,slc26a4
10446,24211158,anxiety disorders
10446,24211158,autoimmune thyroiditis
10446,24211158,depression
10446,24211158,goiter
10446,24211158,hashimoto's thyroiditis
10450,23685895,nob1
10450,23685895,papillary thyroid carcinoma
10450,23685895,clinical significance
10450,23685895,immunohistochemistry
10450,23685895,quantitative rt–pcr
10482,23650151,delhi
10482,23650151,iodine deficiency disorders
10482,23650151,iodized salt
10482,23650151,urinary iodine excretion
10486,24327568,fine-needle cytology
10486,24327568,mantel zone lymphoma
10486,24327568,micrornas
10486,24327568,primary thyroid lymphoma
10486,24327568,thyroid cancer
10490,24043280,goiter
10490,24043280,neonatal graves’ disease
10490,24043280,respiratory failure
10490,24043280,thyroid
10491,23690528,airway management
10491,23690528,anesthesia
10491,23690528,general
10491,23690528,thyroidectomy
10496,23428758,agreement
10496,23428758,bocio
10496,23428758,concordancia
10496,23428758,goitre
10496,23428758,interobservador
10496,23428758,interobserver
10499,23645248,oestrogen
10499,23645248,progenitor cells
10499,23645248,thyroid nodules
10499,23645248,thyroid stem cells
10501,24082285,radioiodine
10501,24082285,hyperthyroidism
10515,24144816,benign multinodular goiter
10515,24144816,complications
10515,24144816,incidental thyroid cancer
10515,24144816,jóindulatú multinodularis golyva
10515,24144816,szövődmények
10515,24144816,tapasztalatok
10515,24144816,total thyreoidectomia
10515,24144816,total thyroidectomy
10516,23303305,endocrinology
10516,23303305,intensive care
10516,23303305,neonatology
10543,24249820,laryngeal nerve palsy
10543,24249820,methimazole
10543,24249820,pediatric graves’ disease
10543,24249820,reversible
10543,24249820,vocal cord paralysis
10583,24222113,braf mutations
10583,24222113,"hras, kras and nras mutations"
10583,24222113,kras codon 59 deletion
10583,24222113,follicular-patterned thyroid lesions
10592,22987562,carotid sheath dissection
10592,22987562,intraoperative neuromonitoring
10592,22987562,recurrent laryngeal nerve
10592,22987562,thyroid surgery
10592,22987562,vagal nerve stimulation
10628,24376294,endemic goitre
10628,24376294,parathyroid surgery
10628,24376294,video-assisted parathyroidectomy
10628,24376294,video-assisted thyroidectomy
10642,23473435,bisturí armónico
10642,23473435,bocio multinodular
10642,23473435,budget impact
10642,23473435,harmonic scalpel
10642,23473435,impacto económico
10642,23473435,multinodular goitre
10642,23473435,thyroidectomy
10642,23473435,tiroidectomía
10677,22351646,fine-needle aspiration
10677,22351646,malignant melanoma
10677,22351646,thyroid cyst wall atypia
10697,25103076,graves disease
10697,25103076,thyroidectomy
10697,25103076,volume
10717,24629864,graves' disease
10717,24629864,childhood
10717,24629864,hyperthyroidism
10720,23918194,nerve monitoring
10720,23918194,parathyroid surgery
10720,23918194,recurrent laryngeal nerve
10720,23918194,thyroid surgery
10730,24034725,adaptive thresholding
10730,24034725,contrast enhancement
10730,24034725,image segmentation
10730,24034725,morphology
10730,24034725,planar scintigraphy
10730,24034725,radioiodine therapy
10730,24034725,thyroid volume estimation
10730,24034725,ultrasonography
10733,24411211,acute pericarditis
10733,24411211,graves' disease
10733,24411211,thyroid crisis
10772,22511831,decompression
10772,22511831,optic neuropathy
10772,22511831,radiation
10772,22511831,steroid
10772,22511831,thyroid eye diseases cois
10781,24070662,anti–thyroid peroxidase antibodies
10781,24070662,autoimmune thyroiditis
10781,24070662,hashimoto's thyroiditis
10781,24070662,quality of life
10781,24070662,thyroidectomy
10789,24199816,basedow graves’ disease
10789,24199816,cas
10789,24199816,proptosis
10789,24199816,thyroid
10796,24704350,graves ophthalmopathy
10796,24704350,diplopia
10796,24704350,exophthalmos
10796,24704350,keratitis
10796,24704350,natural orifice transluminal endoscopic surgery
10802,22991383,laser ablation
10802,22991383,multinodular goiter
10802,22991383,thyroid nodules
10804,24291390,at
10804,24291390,angiogenesis
10804,24291390,anti-tpo
10804,24291390,anti-tg
10804,24291390,autoantibody
10804,24291390,ci
10804,24291390,edn1
10804,24291390,ednra
10804,24291390,endothelin 1
10804,24291390,endothelin family
10804,24291390,endothelin receptor type a
10804,24291390,gd
10804,24291390,graves' disease
10804,24291390,hwe
10804,24291390,hardy–weinberg equilibrium
10804,24291390,icam1
10804,24291390,intercellular adhesion molecule 1
10804,24291390,mmi
10804,24291390,or
10804,24291390,odds ratio
10804,24291390,ophthalmopathy
10804,24291390,ptu
10804,24291390,polymorphism
10804,24291390,snps
10804,24291390,tnfα
10804,24291390,trab
10804,24291390,tsh
10804,24291390,tsh receptor antibody
10804,24291390,tumor necrosis factor α
10804,24291390,utr
10804,24291390,untranslated region
10804,24291390,vegf
10804,24291390,anti-thyroglobulin
10804,24291390,anti-thyroid
10804,24291390,anti-thyroid peroxidase
10804,24291390,confidence interval
10804,24291390,methimazole
10804,24291390,propylthiouracil
10804,24291390,single nucleotide polymorphisms
10804,24291390,thyroid-stimulating hormone
10804,24291390,vascular endothelial growth factor
10808,23518423,brain infarction
10808,23518423,encephaloduroarteriosynangiosis (edas)
10808,23518423,graves’ disease
10808,23518423,hyperthyroidism
10808,23518423,moyamoya disease
10843,23868574,goiter
10843,23868574,iodized salt
10843,23868574,thyroid
10843,23868574,urinary iodine excretion
10870,24311524,orbit
10877,23482353,medicare
10877,23482353,age-associated disease
10877,23482353,comorbidity
10877,23482353,disease onset
10877,23482353,older people
10877,23482353,time trends
10883,24154901,autoimmune thyroiditis
10883,24154901,inferior thyroid artery
10883,24154901,thyroid doppler sonography
10884,23329888,asian populations.
10884,23329888,graves' disease
10884,23329888,hla-b*46
10884,23329888,meta-analysis cois
10894,23477757,embarazo
10894,23477757,enfermedad de graves
10894,23477757,gestational transient thyrotoxicosis
10894,23477757,graves’ disease
10894,23477757,hiperemesis gravídica
10894,23477757,hipertiroidismo
10894,23477757,hyperemesis gravidarum
10894,23477757,hyperthyroidism
10894,23477757,pregnancy
10894,23477757,tirotoxicosis gestacional transitoria
10904,22952313,graves
10904,22952313,graves disease
10904,22952313,hyperthyroidism
10904,22952313,myasthenia gravis
10904,22952313,ophthalmoplegia
10904,22952313,ptosis
10904,22952313,thyroid
10948,23535627,asian continental ancestry group
10948,23535627,graves ophthalmopathy
10948,23535627,psychiatric status rating scales
10973,22416184,autoimmunity
10973,22416184,cag-a
10973,22416184,graves’ disease
10973,22416184,hashimoto’s thyroiditis
10973,22416184,helicobacter pylori
10973,22416184,hyperthyroidism
10973,22416184,hypothyroidism
10974,23709442,graves’ orbitopathy
10974,23709442,tsh-receptor autoantibody
10974,23709442,disease activity
10974,23709442,severity cois
10975,23835254,anestesia
10975,23835254,anesthesia
10975,23835254,cirugía de descompresión orbitaria
10975,23835254,embarazo
10975,23835254,graves-basedow
10975,23835254,oftalmopatía
10975,23835254,ophthalmopathy
10975,23835254,orbital decompression surgery
10975,23835254,orbitopathy
10975,23835254,orbitopatía
10975,23835254,pregnancy
10995,24119625,graves' disease
10995,24119625,moyamoya syndrome
10995,24119625,antithyroid therapy
11011,23796613,(131)i
11011,23796613,children
11011,23796613,edad pediátrica
11011,23796613,enfermedad de graves
11011,23796613,graves disease
11011,23796613,i(131)
11011,23796613,radioiodine therapy
11011,23796613,radioyodo
11012,23538281,cáncer de tiroides
11012,23538281,enfermedad de graves
11012,23538281,graves’ disease
11012,23538281,pequeñas-moléculas
11012,23538281,receptor de la tsh
11012,23538281,small molecules
11012,23538281,tsh-receptor
11012,23538281,thyroid
11012,23538281,thyroid cancer
11012,23538281,thyrotropin (tsh)
11012,23538281,tiroides
11012,23538281,tirotropina (tsh)
11024,24646903,enfermedad de la superficie ocular
11024,24646903,graves’ ophthalmopathy
11024,24646903,lentes de contacto mini esclerales
11024,24646903,mini-scleral contact lenses
11024,24646903,ocular surface disease
11024,24646903,oftalmopatía de graves
11036,23962080,autoimmune thyroid disease
11036,23962080,intractability
11036,23962080,polymorphism
11036,23962080,severity
11036,23962080,thyrotropin receptor
11077,24231095,graves' ophthalmopathy
11077,24231095,bulbar conjunctiva
11077,24231095,dry eye
11077,24231095,impression cytology
11077,24231095,in vivo confocal microscopy
11078,24135759,adipogenesis
11078,24135759,orbital fibroblasts
11078,24135759,proliferation
11078,24135759,thyroid eye disease
11080,22985335,graves’ disease
11080,22985335,hypoparathyroidism
11080,22985335,thyroid cancer
11080,22985335,thyroidectomy
11080,22985335,thyrotoxicosis
11097,23806737,ca-125
11097,23806737,ct
11097,23806737,hyperthyroidism
11097,23806737,meigs syndrome
11097,23806737,pleural effusion
11097,23806737,tfts
11097,23806737,tg-ab
11097,23806737,tpo-ab
11097,23806737,tsh
11097,23806737,tsh receptor
11097,23806737,tshr
11097,23806737,tshr-ab
11097,23806737,thyroid cancer
11097,23806737,us
11097,23806737,cancer antigen-125
11097,23806737,computed tomography
11097,23806737,thyroglobulin autoantibodies
11097,23806737,thyroid function tests
11097,23806737,thyroid peroxidase autoantibodies
11097,23806737,thyrotropin
11097,23806737,thyrotropin receptors
11097,23806737,thyrotropin receptors autoantibodies
11097,23806737,ultrasound
11115,23060717,acquired lower eyelid epiblepharon
11115,23060717,graves ophthalmopathy
11115,23060717,lower eyelid epiblepharon repair
11115,23060717,lower eyelid retraction cois
11119,23728841,dicer1
11119,23728841,family history
11119,23728841,multinodular goiter
11119,23728841,ovarian sertoli-leydig cell tumors
11119,23728841,tumor surveillance
11137,24029729,graves' disease
11137,24029729,rhesus monkeys
11137,24029729,thyrotropin receptor a-subunit
11143,24629859,fetal diseases
11143,24629859,goiter
11143,24629859,graves disease
11143,24629859,humans
11143,24629859,hyperthyroidism
11143,24629859,hypothyroidism
11143,24629859,maternal–fetal exchange
11143,24629859,pregnancy
11143,24629859,thyroid diseases: drug therapy
11143,24629859,thyroxine: administration and dosage
11155,24307850,agranulocytosis
11155,24307850,graves disease
11155,24307850,guillain-barre syndrome cois
11166,23757290,disease intractability
11166,23757290,disease severity
11166,23757290,hashimoto’s disease
11166,23757290,il-10
11166,23757290,single nucleotide polymorphism
11187,24177168,autoimmune thyroid diseases
11187,24177168,erythropoietin
11187,24177168,intractability
11187,24177168,severity
11187,24177168,single nucleotide polymorphism
11188,23954851,antioxidants
11188,23954851,biomarkers of oxidative stress
11188,23954851,chondroitin sulfate
11188,23954851,graves' disease
11207,23849367,asian patients
11207,23849367,hypokalemia
11207,23849367,paralysis
11207,23849367,thyrotoxicosis
11207,23849367,weakness
11226,24227294,gwas
11226,24227294,causal variants
11226,24227294,colocalisation
11226,24227294,genetic association
11228,22907781,graves' disease
11228,22907781,minimal-incision thyroidectomy
11228,22907781,minimally invasive surgery
11228,22907781,postoperative complications
11228,22907781,thyroid
11253,24289805,gpr174
11253,24289805,graves' disease
11253,24289805,poland
11253,24289805,x chromosome
11253,24289805,association
11253,24289805,autoimmune disease
11253,24289805,rs3827440
11253,24289805,single nucleotide polymorphism
11254,23756266,drug-induced cholestasis
11254,23756266,plasmapheresis
11254,23756266,thyrotoxicosis
11268,23954255,autoimmune thyroid disease
11268,23954255,ci
11268,23954255,caga
11268,23954255,edta
11268,23954255,ethylene diamine tetraacetic acid
11268,23954255,ft3
11268,23954255,ft4
11268,23954255,gd
11268,23954255,graves disease
11268,23954255,h. pylori
11268,23954255,hla
11268,23954255,helicobacter pylori
11268,23954255,human leukocyte antigen
11268,23954255,igg
11268,23954255,immunoglobulin g
11268,23954255,or
11268,23954255,pcr
11268,23954255,spss
11268,23954255,statistical product and service solutions
11268,23954255,tpoab
11268,23954255,trab
11268,23954255,tsh
11268,23954255,tgab
11268,23954255,confidence intervals
11268,23954255,cytotoxin-associated gene a
11268,23954255,dntp
11268,23954255,deoxy-ribonucleoside triphosphate
11268,23954255,free thyroxine
11268,23954255,free triiodothyronine
11268,23954255,odds ratio
11268,23954255,polymerase chain reaction
11268,23954255,thyroglobulin antibody
11268,23954255,thyroid peroxidase antibody
11268,23954255,thyroid stimulating hormone
11268,23954255,thyrotrophin receptor antibody
11276,24124099,diplopia
11276,24124099,endoscopic orbital floor decompression
11276,24124099,inferomedial orbital strut
11276,24124099,orbital decompression
11294,23839980,endoscopic orbital decompression
11294,23839980,graves' orbitopathy
11294,23839980,complications
11294,23839980,exophthalmos
11294,23839980,sinonasal
11302,22972028,*pingmu decoction
11302,22972028,*apoptosis
11302,22972028,*adipocytes
11302,22972028,*graves' ophthalmophathy
11323,24311923,epidemiology
11323,24311923,graves ophthalmopathy
11323,24311923,korea
11323,24311923,prevalence
11323,24311923,risk factors cois
11340,24411304,hashimoto's thyroiditis
11340,24411304,metastatic burden
11340,24411304,metastatic disease
11340,24411304,multi-nodular goiter
11340,24411304,thyroglobulin
11340,24411304,thyroid cancer
11340,24411304,thyroidectomy
11340,24411304,thyroiditis
11346,23827012,anticorps anti-cytoplasme des polynucléaires neutrophiles
11346,23827012,antineutrophil cytoplasmic antibodies
11346,23827012,benzylthio-uracile
11346,23827012,benzylthiouracil
11346,23827012,graves’ disease
11346,23827012,maladie de basedow
11346,23827012,vascularite
11346,23827012,vasculitis
11348,23667180,complex traits
11348,23667180,endocrinology
11348,23667180,genetics
11348,23667180,genome-wide
11348,23667180,thyroid disease
11351,25443353,hashimoto's thyroiditis
11351,25443353,autoimmune thyroiditis
11351,25443353,encephalopathy
11351,25443353,hallucinations
11351,25443353,steroids
11360,22787382,bullous systemic lupus erythematosus
11360,22787382,drug-induced lupus erythematosus
11360,22787382,graves disease
11360,22787382,methimazole
11375,24456861,atrophic renal parenchyma-like tumor
11375,24456861,comparative genomic hybridization
11375,24456861,humara
11375,24456861,kidney
11375,24456861,thyroid-like renal tumor
11376,23919315,graves' disease
11376,23919315,cardiomegaly
11376,23919315,forensic autopsy
11376,23919315,forensic science
11376,23919315,hyperthyroidism
11376,23919315,sudden unexpected death
11405,24011567,graves’ disease
11405,24011567,incidental malignancy
11405,24011567,surgical therapy
11429,23681867,endocrine diseases
11429,23681867,pharmacotherapy
11435,23901889,b lymphocytes
11435,23901889,graves' disease
11435,23901889,t lymphocytes
11450,23973401,cryptococcal meningitis
11450,23973401,lupus
11450,23973401,opportunist infection
11451,23578170,anti-gal
11451,23578170,increased immunogenicity
11451,23578170,tumour vaccine
11451,23578170,wound healing
11451,23578170,α-gal epitopes
11455,24095912,autoimmun thyreoiditis
11455,24095912,autoimmune thyroiditis
11455,24095912,diabetes mellitus
11455,24095912,fertility
11455,24095912,meddőség
11455,24095912,selenium
11455,24095912,szelén
11467,24334133,autoimmunity
11467,24334133,autoimmunitás
11467,24334133,infertility
11467,24334133,meddőség
11467,24334133,pajzsmirigy
11467,24334133,post partum periódus
11467,24334133,postpartum period
11467,24334133,pregnancy
11467,24334133,terhesség
11467,24334133,thyroid
11478,23845451,(131)i-iodide
11478,23845451,cáncer folicular de tiroides
11478,23845451,enfermedad metastásica
11478,23845451,follicular thyroid cancer
11478,23845451,metastatic disease
11478,23845451,radioiodine therapy
11478,23845451,spect
11478,23845451,terapia con yodo radioactivo
11478,23845451,yodo radioactivo (131)i cois this work there are no financial or ethical conflicts of interest.
11481,23664858,cox
11481,23664858,cox-2
11481,23664858,il
11481,23664858,il-1β
11481,23664858,nf
11481,23664858,nf-κb
11481,23664858,pg
11481,23664858,pge(2)
11481,23664858,tao
11481,23664858,cyclooxygenase
11481,23664858,interleukin
11481,23664858,nuclear factor
11481,23664858,orbital fibroblast
11481,23664858,pirfenidone
11481,23664858,prostaglandin
11481,23664858,thyroid-associated ophthalmopathy
11483,23958483,octreotide
11483,23958483,somatostatin analogs
11483,23958483,tsh-secreting pituitary tumor
11483,23958483,thyrotropinoma
11489,23958398,antibodies
11489,23958398,apoptosis
11489,23958398,proliferation
11489,23958398,ros-signaling
11489,23958398,tsh receptor
11489,23958398,thyrocyte
11533,24335091,thyroid carcinoma
11533,24335091,cancer
11533,24335091,endocrine surgery
11533,24335091,follicular carcinoma
11533,24335091,neoplastic thrombus
11545,24250332,jaundice
11545,24250332,thionamides
11545,24250332,thyrotoxicosis
11554,24291398,cox-2
11554,24291398,cellular antioxidant defense mechanisms
11554,24291398,cerebral cavernous malformations
11554,24291398,free radicals
11554,24291398,krit1
11554,24291398,reactive oxygen species
11554,24291398,c-jun
11559,22386642,ait
11559,22386642,amiodarone
11559,22386642,bmi
11559,22386642,body mass index
11559,22386642,chd
11559,22386642,congenital heart defects
11559,22386642,cyanosis
11559,22386642,drug toxicity
11559,22386642,hyperthyroidism
11559,22386642,lvef
11559,22386642,t3
11559,22386642,t4
11559,22386642,tsh
11559,22386642,amiodarone-induced thyrotoxicosis
11559,22386642,congenital heart disease
11559,22386642,left ventricular ejection fraction
11559,22386642,thyroid stimulating hormone
11559,22386642,thyroxine
11559,22386642,triiodothyronine
11564,23553532,thyroid disorders
11564,23553532,epidemiology
11564,23553532,otolaryngology
11564,23553532,specialty
11564,23553532,thyroid nodule
11564,23553532,thyroidectomy
11583,24273003,cd-44
11583,24273003,hbme-1
11583,24273003,fine needle aspiration cytology
11583,24273003,galectin-3
11583,24273003,papillary thyroid carcinoma
11592,23838336,angiosarcoma
11592,23838336,haematoma
11592,23838336,haemothorax
11592,23838336,pleural metastasis
11597,23569858,granuloma
11597,23569858,thyroid
11597,23569858,tuberculosis cois
11606,24189283,at
11606,24189283,autoimmune thyroiditis
11606,24189283,ccl
11606,24189283,cd
11606,24189283,cia
11606,24189283,cs
11606,24189283,csf
11606,24189283,cxcl
11606,24189283,cxcl10
11606,24189283,cxcr3
11606,24189283,circulating cxcl10 levels
11606,24189283,cryoglobulinemia
11606,24189283,gad
11606,24189283,gd
11606,24189283,go
11606,24189283,graves
11606,24189283,graves' disease
11606,24189283,graves' ophthalmopathy
11606,24189283,graves’ disease
11606,24189283,graves’ ophthalmopathy
11606,24189283,gtx
11606,24189283,hepatitis c virus infection associated mixed cryoglobulinemia
11606,24189283,ifn
11606,24189283,ifn-γ-induced protein 10
11606,24189283,il
11606,24189283,ip-10
11606,24189283,jia
11606,24189283,juvenile idiopathic arthritis
11606,24189283,mc
11606,24189283,mc+hcv
11606,24189283,mcp-1
11606,24189283,mdc/ccl22
11606,24189283,mig
11606,24189283,mmi
11606,24189283,mp
11606,24189283,nf-kb
11606,24189283,nk
11606,24189283,npsle
11606,24189283,ppar-γ
11606,24189283,ptc
11606,24189283,papillary thyroid cancer
11606,24189283,peroxisome proliferator-activated receptor-γ
11606,24189283,psa
11606,24189283,psoriatic arthritis
11606,24189283,ra
11606,24189283,rankl
11606,24189283,rantes
11606,24189283,ret/ptc
11606,24189283,rheumatoid arthritis
11606,24189283,sf
11606,24189283,sle
11606,24189283,ss
11606,24189283,ssc
11606,24189283,st
11606,24189283,sjögren syndrome
11606,24189283,systemic lupus erythematosus
11606,24189283,systemic sclerosis
11606,24189283,t helper
11606,24189283,t1d
11606,24189283,tarc/ccl17
11606,24189283,tfc
11606,24189283,tnf
11606,24189283,tng
11606,24189283,tr
11606,24189283,th
11606,24189283,thyroid follicular cells
11606,24189283,thyroiditis
11606,24189283,toxic nodular goiter
11606,24189283,type 1 diabetes
11606,24189283,cerebrospinal fluid
11606,24189283,chemokine (c–c motif) ligand
11606,24189283,chemokine (c–x–c motif) ligand
11606,24189283,chemokine (c–x–c motif) receptor 3
11606,24189283,cluster of differentiation
11606,24189283,collagen-induced arthritis
11606,24189283,corticosteroid
11606,24189283,glutamic acid decarboxylase
11606,24189283,hyperthyroid gd
11606,24189283,interferon
11606,24189283,interleukin
11606,24189283,macrophage-derived chemokine/ccl22
11606,24189283,methimazole
11606,24189283,methylprednisolone
11606,24189283,mixed cryoglobulinemia
11606,24189283,monocyte chemotactic protein-1
11606,24189283,monokine induced by ifn-γ
11606,24189283,natural killer
11606,24189283,neuropsychiatric sle
11606,24189283,normal t cell expressed and secreted
11606,24189283,nuclear factor-kappa b
11606,24189283,rearranged in transformation/ptc
11606,24189283,receptor activator of nuclear factor kappa-b ligand
11606,24189283,scxcl10
11606,24189283,synovial fluid
11606,24189283,synovial tissue
11606,24189283,teleradiotherapy
11606,24189283,thymus and activation regulated chemokine/ccl17
11606,24189283,tumor necrosis factor
11624,23808516,bronchoscopy
11624,23808516,cardiothoracic surgery
11624,23808516,critical care medicine
11624,23808516,intervention techniques
11624,23808516,ventilation
11629,24484950,ectopic thyroid
11629,24484950,laryngeal location
11629,24484950,surgical treatment
11629,24484950,leczenie chirurgiczne
11629,24484950,lokalizacja krtaniowa
11629,24484950,tarczyca ektopowa
11654,23572163,differentiated thyroid carcinoma
11654,23572163,follow-up
11654,23572163,neck ultrasound
11654,23572163,radioiodine remnant ablation
11654,23572163,recurrence
11654,23572163,thyroglobulin
11659,24292913,case-based learning
11659,24292913,self-directed learning
11659,24292913,soft skills
11670,23240978,cowden syndrome
11670,23240978,pten
11670,23240978,ganglioneuromas
11670,23240978,hamartomatous polyps
11670,23240978,mosaicism
11679,23780707,clinicopathological characteristics
11679,23780707,incidental
11679,23780707,nonincidental
11679,23780707,papillary thyroid microcarcinoma
11679,23780707,surgical treatment
11685,23881987,lymphoma
11685,23881987,primary thyroid lymphoma
11685,23881987,thyroid
11685,23881987,thyroid malignancy
11685,23881987,thyroid surgery cois article.
11689,24077472,case-control studies
11689,24077472,congenital hypothyroidism
11689,24077472,iran
11689,24077472,logistic regression
11689,24077472,propensity score
11696,22431287,cowden disease
11696,22431287,cowden syndrome
11696,22431287,pathology
11696,22431287,surgical management
11696,22431287,thyroid
11698,24629858,dehal1 gene
11698,24629858,iyd
11698,24629858,congenital hypothyroidism
11698,24629858,iodide recycling
11698,24629858,mass spectrometry
11698,24629858,mental retardation
11698,24629858,neonatal screening
11704,23693108,"carcinoma, papillary, follicular"
11704,23693108,thyroid neoplasms
11708,24067547,t3
11708,24067547,amiodarone-induced thyrotoxicosis
11708,24067547,heart
11708,24067547,hyperthyroidism
11708,24067547,hypothyroidism
11708,24067547,thyroid hormone
11708,24067547,thyrotoxicosis
11708,24067547,triiodothyronine
11720,23933148,congenital hypothyroidism
11720,23933148,deletion
11720,23933148,inversion
11720,23933148,mutation
11720,23933148,thyroglobulin gene
11753,24301304,circulating biomarkers
11753,24301304,microrna
11753,24301304,papillary thyroid cancer
11753,24301304,recurrence
11753,24301304,tissue biomarkers
12114,21274344,pendred syndrome
12114,21274344,congenital hypothyroidism
12114,21274344,pseudo−pendred syndrome
12114,21274344,thyroid peroxidase defect
12144,21274318,thyrotropin receptor
12144,21274318,germline mutation
12144,21274318,nonautoimmune hyperthyroidism
12363,21274321,congenital hypothyroidism
12363,21274321,thyroxine
12432,21052505,clinical course
12432,21052505,optic nerve diseases
12432,21052505,risk factors
12432,21052505,thyroid-associated orbitopathy cois
12537,21274336,hyperthyroidism
12537,21274336,isolated
12537,21274336,neonatal
12537,21274336,sialadenitis
12537,21274336,submandibular
12570,21716594,biological assay
12570,21716594,graves disease
12570,21716594,"immunoglobulins, thyroid-stimulating"
12570,21716594,"receptors, thyrotropin"
12570,21716594,thyrotropin-binding inhibitory immunoglobulin cois
12615,20379454,depression
12615,20379454,graves ophthalmopathy
12615,20379454,quality of life cois
12632,20195406,graves disease
12632,20195406,thyroid neoplasms
12632,20195406,ultrasonography cois
12753,20157407,congenital fibrosis syndrome of the extraocular muscles
12753,20157407,congenital retraction
12753,20157407,epiblepharon
12753,20157407,lower eyelid retraction
12753,20157407,thyroid-associated ophthalmopathy
12802,22148004,destructive thyroiditis
12802,22148004,graves disease
12802,22148004,interferons
12850,20835551,immunohistochemistry
12850,20835551,ndrg1
12850,20835551,thyroid carcinoma
12850,20835551,thyroid gland
12850,20835551,tissue microarray
12920,20808683,mutation
12920,20808683,thyroid hormone receptor
12920,20808683,thyroid hormone receptors beta
12920,20808683,thyroid hormone resistance syndrom
12920,20808683,thyroid neoplasms
13131,25058777,sternotomy
13131,25058777,substernal goiter
13131,25058777,surgery
13131,25058777,treatment
13132,25047203,us elastosonography
13132,25047203,indeterminate nodules
13132,25047203,thyroid
13132,25047203,thyroid nodules
13132,25047203,thyroid ultrasound
13135,24622964,adenomatous multinodular goiter
13135,24622964,airway obstruction
13135,24622964,mediastinum
13135,24622964,neck mass
13135,24622964,pediatric
13137,25297557,plummer's disease
13137,25297557,cat
13137,25297557,hyperthyroidism
13137,25297557,thyroid
13137,25297557,thyrotoxicosis
13139,25976851,sternotomy
13139,25976851,substernal goiter
13139,25976851,thyroidectomy
13140,25363013,amniocentesis
13140,25363013,intrauterine therapy
13140,25363013,l-thyroxine
13140,25363013,labor dystocia
13140,25363013,polyhydramnios
13141,26327954,histology
13141,26327954,pre-sternale
13141,26327954,surgery
13141,26327954,thyroid enlargement
13142,25555013,riedel thyroiditis
13142,25555013,amiodarone-induced thyroiditis
13142,25555013,subacute thyroiditis
13152,25752670,complications
13152,25752670,electrocautery
13152,25752670,substernal goiter
13152,25752670,thyroidectomy
13152,25752670,ultrasonic devise
13158,26955411,granuloma
13158,26955411,multinodular goiter
13158,26955411,tuberculosis
13161,25157987,cervical approach
13161,25157987,complications
13161,25157987,elderly
13161,25157987,mediastinal goiter
13161,25157987,thyroidectomy
13165,24931349,goiter
13165,24931349,recurrent laryngeal nerve
13165,24931349,thyroid
13165,24931349,thyroid hormone
13165,24931349,thyroidectomy
13172,26161201,immunohistochemical examination
13172,26161201,goiter
13172,26161201,systemic amyloidosis
13182,26443487,deafness
13182,26443487,genetics
13182,26443487,genome
13182,26443487,hearing loss
13182,26443487,sequencing
13192,25499094,developing countries
13192,25499094,endemic goiter
13192,25499094,iodine deficiency
13192,25499094,thyroidectomy
13194,25242682,anaplastic thyroid carcinoma
13194,25242682,goiter
13194,25242682,survival
13198,24880605,cervico-mediastinal goiter
13198,24880605,recurrent laryngeal nerve palsy
13198,24880605,substernal goiter
13198,24880605,thyroid surgery
13198,24880605,total thyroidectomy
13203,26389933,epidemiology
13203,26389933,metabolic syndrome
13203,26389933,prevalence
13203,26389933,risk factor
13208,24519672,iodine deficiency
13208,24519672,children
13208,24519672,goiter prevalence
13210,25594634,multinodular goiter
13210,25594634,recurrence classification description: endocrinology
13210,25594634,thyroidectomy
13213,25981745,multinodular goiter
13213,25981745,proliferation
13213,25981745,proteomics
13213,25981745,ttf1
13221,25614405,doppler sonography
13221,25614405,calcification
13221,25614405,diffuse large b-cell lymphoma
13221,25614405,head and neck ultrasound
13221,25614405,nodular goiter
13221,25614405,sonography
13221,25614405,thyroid lymphoma
13224,26293122,basedow
13224,26293122,graves
13224,26293122,autoimmunity
13224,26293122,chemokines
13224,26293122,thyroid
13225,25629792,endemic
13225,25629792,goiter
13225,25629792,iodine
13225,25629792,pregnancy
13225,25629792,thyroid
13226,25667715,atrioventricular
13226,25667715,hyperthyroidism
13226,25667715,multinodular goiter
13229,25047199,epidemiology
13229,25047199,goitre
13229,25047199,iodine deficiency
13229,25047199,nodular goitre
13229,25047199,nodules
13229,25047199,review
13230,25613936,endemic goiter
13230,25613936,enquête épidémiologique
13230,25613936,epidemiological survey
13230,25613936,goitre endémique
13230,25613936,hormones thyroïdiennes
13230,25613936,iode urinaire
13230,25613936,iodine deficiency disorders
13230,25613936,thyroid hormones
13230,25613936,troubles dus à la carence en iode
13230,25613936,urinary iodine
13236,25592327,graves’ disease
13236,25592327,hyperthyroidism
13236,25592327,hypocalcemia
13236,25592327,recurrent laryngeal nerve palsy
13236,25592327,thyroidectomy
13236,25592327,toxic multinodular goiter
13237,25047207,goitre
13237,25047207,iodine deficiency
13237,25047207,iodine prophylaxis
13239,24651704,graves' disease
13239,24651704,autoimmune
13239,24651704,inflammation
13243,25047210,nodular goitre
13243,25047210,radioiodine
13243,25047210,recombinant human thyrotropin
13243,25047210,thyroid diseases
13244,25047201,alcohol
13244,25047201,environmental risk factors
13244,25047201,goitre aetiology
13244,25047201,insulin resistance
13244,25047201,oral contraceptives
13244,25047201,parity
13244,25047201,smoking
13244,25047201,twins
13248,25047205,cytology
13248,25047205,fine needle aspiration
13248,25047205,molecular diagnostics
13248,25047205,thyroid cancer
13249,24595624,airway management
13249,24595624,airway obstruction
13249,24595624,endotracheal intubation
13249,24595624,goiter
13249,24595624,intubation
13249,24595624,nodular
13251,24462913,autoinmunidad tiroidea
13251,24462913,bipolar disorder
13251,24462913,bocio
13251,24462913,goitre
13251,24462913,hipertiroidismo
13251,24462913,hipotiroidismo
13251,24462913,hyperthyroidism
13251,24462913,hypothyroidism
13251,24462913,lithium
13251,24462913,litio
13251,24462913,thyroid
13251,24462913,thyroid autoimmunity
13251,24462913,tiroides
13251,24462913,trastorno bipolar
13254,25047206,non-toxic goitre
13254,25047206,patient-reported outcome measure
13254,25047206,quality of life
13255,26337337,cardiac surgical procedures
13255,26337337,coronary artery bypass
13255,26337337,retrosternal goitre
13255,26337337,thyroidectomy
13257,25047202,nodular goitre
13257,25047202,nuclear medicine
13257,25047202,positron emission tomography
13257,25047202,scintigraphy
13258,25047204,fna
13258,25047204,cytology
13258,25047204,diagnostic pitfalls
13258,25047204,morphology
13258,25047204,nodular goitre
13263,25633667,compound heterozygous mutations
13263,25633667,congenital hypothyroidism
13263,25633667,cryptic splice site
13263,25633667,mutation
13263,25633667,thyroglobulin gene
13269,24628230,horner's syndrome
13269,24628230,carotid dissection
13269,24628230,multinodular goiter
13269,24628230,trigeminal autonomic cephalgia
13270,24589354,adenomatous goiter
13270,24589354,human thyroid
13270,24589354,leakiness
13270,24589354,nog mouse
13270,24589354,thymic lymphoma
13270,24589354,transplantation
13275,24706172,goitre
13275,24706172,risk factors
13275,24706172,sternotomy
13275,24706172,thyroid gland
13275,24706172,thyroidectomy
13276,24703798,graves' disease
13276,24703798,pericarditis
13276,24703798,thyrotoxicosis
13278,25896315,thyroid cancer
13278,25896315,thyroidectomy
13278,25896315,toxic nodular goiter
13282,26261619,intra-thyroid thyroglossal duct cyst (ittdc)
13282,26261619,nodule
13282,26261619,thyroid gland
13282,26261619,ultrasound (us)
13283,25047200,goitre
13283,25047200,oesophagus
13283,25047200,radioiodine
13283,25047200,swallowing
13283,25047200,thyroidectomy
13283,25047200,trachea
13283,25047200,upper airway obstruction
13284,27057257,inferior laryngeal nerve
13284,27057257,non-recurrent
13284,27057257,total thyroidectomy
13285,24759378,retrosternal goiter
13285,24759378,complications to surgery
13285,24759378,intrathoracic goiter
13285,24759378,nodular goiter
13285,24759378,recurrent laryngeal nerve injury
13285,24759378,substernal goiter
13285,24759378,surgical treatment
13304,26069028,allergy
13304,26069028,endocrinology
13304,26069028,nutrition
13310,26163018,acromegaly
13310,26163018,goiter
13310,26163018,thyroid autoimmunity
13310,26163018,thyroid nodules
13316,26039459,branchial cyst
13316,26039459,cervical sinus
13316,26039459,iodine deficiency
13316,26039459,thyroid goiter
13324,26826478,hypoparathyroidism
13324,26826478,outcome
13324,26826478,recurrent laryngeal nerve palsy
13324,26826478,surgery
13324,26826478,thyroid
13324,26826478,à venir
13328,24774362,acute pericarditis
13328,24774362,brown adipose tissue
13328,24774362,spodick's sign
13332,25167783,graves disease
13332,25167783,qol
13332,25167783,surgery
13332,25167783,thypro
13332,25167783,toxic goiter
13337,25667686,etiology
13337,25667686,ectopic intrathoracic goiter
13337,25667686,mediastinal cyst
13347,24530085,algorithmes
13347,24530085,algorithms
13347,24530085,anesthésie générale
13347,24530085,difficult intubation
13347,24530085,general anesthesia
13347,24530085,impossible mask ventilation
13347,24530085,intubation difficile
13347,24530085,thyroidectomy
13347,24530085,thyroïdectomie
13347,24530085,tracheostomy
13347,24530085,trachéotomie
13347,24530085,ventilation au masque impossible
13348,26504073,hashimoto's thyroiditis
13348,26504073,thyroid cancer
13348,26504073,intraglandular dissemination
13348,26504073,multinodular thyroid
13348,26504073,nodular goitre
13348,26504073,papillary carcinoma
13351,25113865,old people
13351,25113865,parathyroidectomy
13351,25113865,primary hyperparathyroidism
13351,25113865,thyroid nodules
13354,25389240,imp3
13354,25389240,immunohistochemistry
13354,25389240,nucleophosmin
13354,25389240,papillary carcinoma
13354,25389240,thyroid
13355,26824209,clinicopathologic characteristics
13355,26824209,familial
13355,26824209,papillary carcinoma
13355,26824209,thyroid carcinoma
13359,26194563,goiter
13359,26194563,medical diagnosis
13359,26194563,painting
13359,26194563,parmigianino
13365,25102228,adrenomedullin 2
13365,25102228,goiter
13365,25102228,immunohistochemistry
13365,25102228,intermedin
13365,25102228,iodine-deficiency
13369,26834286,cardiomyopathy
13369,26834286,extracorporeal membrane oxygenation
13369,26834286,heart failure
13369,26834286,hyperthyroidism
13369,26834286,"thyrotoxicosis cois financial, or other relationship with any healthcare-related business or other entity whose products or services are discussed in this paper."
13372,26405494,plunging goitre
13372,26405494,cervical region
13372,26405494,western algeria
13376,26514949,antithyroid drug
13376,26514949,graves’ disease
13376,26514949,maladie de basedow
13376,26514949,relapse
13376,26514949,récidive
13376,26514949,traitement médical antithyroïdien
13384,25661375,autophagy
13384,25661375,autophagy-related protein light chain 3 (lc3)-ii
13384,25661375,papillary thyroid cancer
13388,25847147,goiter
13388,25847147,hypoparathyroidism
13388,25847147,parathyroid
13388,25847147,substernal
13388,25847147,thyroidectomy
13397,26322488,aggregate risk
13397,26322488,cumulative risk
13397,26322488,goitrogens
13397,26322488,perchlorate
13397,26322488,probabilistic risk assessment
13397,26322488,regulatory rationality
13404,25824071,graves’ orbitopathy
13404,25824071,guidance
13404,25824071,referral pathways
13404,25824071,thyroid eye disease
13411,24456910,benign tumor
13411,24456910,chirurgie cervicale
13411,24456910,glande submandibulaire
13411,24456910,neck surgery
13411,24456910,submandibular gland
13411,24456910,thyroid
13411,24456910,thyroïde
13411,24456910,tumeur bénigne
13414,24974154,central neck dissection
13414,24974154,lymph node metastasis
13414,24974154,papillary thyroid carcinoma
13414,24974154,thymosin beta 10
13419,26662651,myocardial scintigraphy
13419,26662651,sestamibi
13419,26662651,thyroid autoimmune disease
13419,26662651,thyroid cancer
13419,26662651,thyroid nodules
13424,26610563,khyber pakhtunkhwa
13424,26610563,pakistan
13424,26610563,community engagement
13424,26610563,goitre
13424,26610563,iodine deficiency
13424,26610563,iodised salt
13424,26610563,urinary iodine concentration
13428,26414819,drainage
13428,26414819,hemostasis
13428,26414819,thyroidectomy
13428,26414819,valsalva maneuver
13431,26074258,complications
13431,26074258,inferior
13431,26074258,intraoperative neurophysiological monitoring
13431,26074258,laryngeal nerve
13431,26074258,recurrent laryngeal nerve palsy
13431,26074258,thyroid gland
13435,24713328,dissociative amnesia
13435,24713328,dissociative disorder
13435,24713328,graves' disease
13435,24713328,hyperthyroidism
13440,25043767,airway
13440,25043767,goiter
13440,25043767,hemorrhage
13440,25043767,tpa
13440,25043767,thyroid
13441,26254997,benign goiter
13441,26254997,hashimoto thyroiditis
13441,26254997,quality of life
13441,26254997,thyroidectomy
13444,25722226,antithyroid drugs
13444,25722226,glucocorticoids
13444,25722226,graves’ disease
13444,25722226,graves’ orbitopathy
13444,25722226,radioiodine
13444,25722226,thionamides
13444,25722226,thyroidectomy
13446,25726089,graves’ disease
13446,25726089,postoperative complications
13446,25726089,total thyroidectomy
13447,25366513,drinking-water
13447,25366513,goitre
13447,25366513,iodine excess
13447,25366513,iodised salt
13447,25366513,prevalence
13449,25745526,thyroid
13449,25745526,papillary carcinoma
13449,25745526,tuberculosis
13450,24726024,bocio
13450,24726024,cervicotomy
13450,24726024,cervicotomía
13450,24726024,esternotomía
13450,24726024,goitre
13450,24726024,mediastinal
13450,24726024,mediastino
13450,24726024,sternotomy
13455,25342401,airway management
13455,25342401,endotracheal intubation
13455,25342401,goitre
13455,25342401,retrosternal
13455,25342401,thyroidectomy
13457,25194170,catatonia
13457,25194170,graves' disease
13457,25194170,hyperthyroidism
13457,25194170,postpartum psychosis
13457,25194170,psychosis
13464,24795511,iodine deficiency disorder
13464,24795511,iodized salt
13464,24795511,thyroid functions
13464,24795511,urinary iodine concentration
13471,25914194,diagnostic accuracy
13471,25914194,fine-needle aspiration biopsy
13471,25914194,histopathology
13471,25914194,thyroid nodule
13471,25914194,ultrasonography
13476,25197416,ectopic thyroid tissue
13476,25197416,bilateral thyroid goiter
13476,25197416,the recurrent laryngeal nerve
13476,25197416,thyroiditis
13476,25197416,ultrasound
13486,25563504,drinking water
13486,25563504,iodine-deficiency disorders
13486,25563504,table salt
13486,25563504,urinary iodine content
13487,25066642,cáncer de tiroides
13487,25066642,enfermedad nodular tiroidea
13487,25066642,hormona paratiroidea
13487,25066642,nodular thyroid disease
13487,25066642,tsh
13487,25066642,thyroid cancer
13489,24670538,papillary thyroid carcinoma
13489,24670538,cyclo-oxygenase-2
13489,24670538,matrix metalloproteinase-9
13489,24670538,vascular endothelial growth factor
13501,26185318,adenolipoma
13501,26185318,cowden syndrome
13501,26185318,ganglioneuroma
13501,26185318,gastrointestinal polyps
13501,26185318,hamartoma
13501,26185318,pten
13501,26185318,pten-hamartoma tumor syndrome
13501,26185318,papillary carcinoma
13501,26185318,storiform collagenoma
13501,26185318,thyroid
13503,26457492,brafv600e mutation
13503,26457492,kras mutation
13503,26457492,rassf1a methylation
13503,26457492,fine-needle aspiration biopsy
13503,26457492,nodular goiter
13519,24525284,anesthésie péridurale cervicale
13519,24525284,cervical epidural anesthesia
13519,24525284,perioperative risk
13519,24525284,risque périopératoire
13519,24525284,thyroidectomy
13519,24525284,thyroïdectomie
13520,26117483,compression of tracheobronchial tree
13520,26117483,intrathoracic goitre
13520,26117483,pulmonary tuberculosis
13521,24962366,adenoid cystic pattern
13521,24962366,fine-needle aspiration
13521,24962366,hyaline globule
13521,24962366,spindle-cell thymoma
13521,24962366,type a thymoma
13527,25326671,intraoperative neuromonitoring
13527,25326671,palsied recurrent laryngeal nerve
13527,25326671,secondary thyroidectomy
13531,24876155,emergency department
13531,24876155,respiratory
13550,26834925,delayed diagnosis
13550,26834925,historical tumors
13550,26834925,socioeconomic level
13568,25421156,autoimmunity
13568,25421156,environment
13568,25421156,genetics
13568,25421156,graves’ disease
13568,25421156,hyperthyroidism
13575,25596664,age
13575,25596664,glucocorticoids
13575,25596664,graves’ disease
13575,25596664,graves’ orbitopathy
13575,25596664,natural history
13575,25596664,radiotherapy
13578,25637365,corticoides
13578,25637365,corticosteroids
13578,25637365,graves ophthalmopathy
13578,25637365,irradiación
13578,25637365,irradiation
13578,25637365,oftalmopatía de graves
13578,25637365,orbitopatía tiroidea
13578,25637365,radioterapia
13578,25637365,radiotherapy
13578,25637365,thyroid orbitopathy
13582,25313112,restrictive strabismus
13582,25313112,strabismus surgery
13589,24835350,corneal biomechanical properties
13589,24835350,corneal hysteresis
13589,24835350,thyroid eye disease
13589,24835350,visa classification
13600,25744236,calcification
13600,25744236,contrast-enhanced ultrasound
13600,25744236,roc curve
13600,25744236,thyroid nodules
13601,26730171,dysfunction
13601,26730171,esophagopathy
13601,26730171,graves’ disease
13601,26730171,heartburn
13601,26730171,odynophagia
13606,24661105,antibodies
13606,24661105,graves' disease
13606,24661105,hla drb1 haplotype
13606,24661105,phenotype
13606,24661105,severity
13613,26105719,antithyroid drugs
13613,26105719,basedow’s disease
13613,26105719,graves’ disease
13613,26105719,birth defects
13613,26105719,epidemiology
13613,26105719,incidence
13613,26105719,pregnancy
13613,26105719,spontaneous abortion
13613,26105719,stillbirth
13613,26105719,thy rotoxicosis
13613,26105719,thyroid disease
13621,25953846,epidemiology
13621,25953846,orbit
13626,24841498,dysthroid optic neuropathy
13626,24841498,orbital radiotherapy
13626,24841498,thyroid eye disease
13628,24510380,fish
13628,24510380,fna
13628,24510380,pax8/pparg
13628,24510380,ret/ptc
13628,24510380,thyroid cancer
13630,24891174,clinical practice guidelines
13630,24891174,clinical practice survey
13630,24891174,hyperthyroidism
13630,24891174,management
13633,25736544,25-hydroxyvitamin d
13633,25736544,graves’ disease
13633,25736544,hyperthyroidism
13633,25736544,prognosis
13633,25736544,radioiodine therapy
13634,25378983,graves disease
13634,25378983,renal infarction cois
13636,24830583,association
13636,24830583,graves’ disease
13636,24830583,polymorphisms
13636,24830583,toll like receptor
13643,25305147,estrogen
13643,25305147,fsh
13643,25305147,lh
13643,25305147,progesterone
13643,25305147,thyroid neoplasms
13649,24833206,euthyroidism
13649,24833206,graves disease
13649,24833206,methimazole
13649,24833206,remission
13654,25430040,graves' disease
13654,25430040,toll-like receptor
13654,25430040,association
13654,25430040,polymorphisms
13657,25746910,diabetes
13657,25746910,graves'
13657,25746910,ophthalmopath severity
13664,25239229,founder mutation
13664,25239229,haplotype analysis
13664,25239229,iran
13664,25239229,linkage analysis
13664,25239229,pendred syndrome
13664,25239229,slc26a4 gene
13667,26007334,graves’ disease
13667,26007334,vitamin d
13667,26007334,meta-analysis
13667,26007334,meta-regression
13667,26007334,sensitivity analysis
13683,25766333,graves’ disease
13683,25766333,magnetic resonance hydrography
13683,25766333,magnetic resonance imaging
13683,25766333,ureteral myxedema
13687,24409943,graves’ disease
13687,24409943,graves’ ophthalmopathy
13687,24409943,radioiodine
13687,24409943,thyroid eye disease
13692,25286078,graves' disease
13692,25286078,hashimoto's thyroiditis
13692,25286078,interleukin-4
13692,25286078,meta-analysis
13692,25286078,polymorphism
13695,24823620,brown adipose tissue (bat)
13695,24823620,glucose metabolism
13695,24823620,hyperthyroidism
13695,24823620,muscle
13695,24823620,positron-emission tomography and computed tomography (pet-ct)
13701,24505195,decompression
13701,24505195,exophthalmos
13701,24505195,graves ophthalmopathy
13701,24505195,orbit cois
13708,25253825,graves disease
13708,25253825,intrathyroid vascularity
13708,25253825,painless thyroiditis
13708,25253825,power doppler sonography
13708,25253825,superficial structures
13714,24994866,inflammatory cytokine
13714,24994866,lacrimal gland
13714,24994866,ocular surface
13714,24994866,tears
13714,24994866,thyroid-associated ophthalmopathy
13717,24970896,131i
13717,24970896,camera based uptake
13717,24970896,thyroid uptake probe
13721,25670394,autoimmune disease
13721,25670394,graves’ disease
13721,25670394,interleukin-23
13721,25670394,single nucleotide polymorphism
13732,25361748,orbit
13740,24502333,dysthyroid optic neuropathy
13740,24502333,graves orbitopathy
13740,24502333,intraocular pressure
13740,24502333,orbital decompression
13740,24502333,superior ophthalmic vein
13741,25244551,diplopia
13741,25244551,graves’ disease
13741,25244551,orbital decompression
13741,25244551,repeat
13741,25244551,thyroid ophthalmopathy
13742,25188661,hiv
13742,25188661,antiretroviral therapy
13742,25188661,hyperthyroidism
13742,25188661,hypothyroidism
13742,25188661,thyroid
13748,25596774,basedow
13748,25596774,graves’ disease
13748,25596774,hashimoto
13748,25596774,ischémie sclérale
13748,25596774,ophtalmopathie
13748,25596774,ophthalmopathy
13748,25596774,plication
13748,25596774,plissement
13748,25596774,recession
13748,25596774,recul
13748,25596774,scleral ischemia
13748,25596774,surgical technique
13748,25596774,technique chirurgicale
13753,25444029,adolescent
13753,25444029,graves disease
13753,25444029,infarction
13753,25444029,magnetic resonance imaging
13753,25444029,middle cerebral artery
13753,25444029,muscular diseases
13767,26505217,gaze-evoked amaurosis
13767,26505217,optic neuropathy
13767,26505217,thyroid eye disease
13779,24646814,clec16a
13779,24646814,graves’ disease (gd)
13779,24646814,hashimoto’s thyroiditis (ht)
13779,24646814,autoimmune thyroid diseases (aitds)
13779,24646814,complex genetics
13779,24646814,complex immunity
13779,24646814,infection
13779,24646814,innate immunity
13779,24646814,resistance
13779,24646814,single-nucleotide polymorphisms (snps)
13779,24646814,tolerance
13782,25543543,autoimmunity
13782,25543543,graves’ disease
13782,25543543,polymorphisms
13782,25543543,thyroid-stimulating hormone receptor
13784,24697361,autoimmune thyroid diseases
13784,24697361,ctla-4
13784,24697361,meta-analysis
13784,24697361,single nucleoside polymorphisms
13784,24697361,susceptibility
13794,26499253,creatinine
13794,26499253,estimated glomerular filtration rate
13794,26499253,standardized cystatin c
13794,26499253,thyroid hormone
13796,25558015,cancer de la thyroïde
13796,25558015,graves’ disease
13796,25558015,maladie de basedow
13796,25558015,nodule non-palpable
13796,25558015,non-palpable nodule
13796,25558015,thyroid cancer
13796,25558015,ultrasonography
13796,25558015,échographie
13801,24560831,cellulitis
13801,24560831,ecthyma gangrenosum
13801,24560831,graves’ disease
13801,24560831,pseudomonas aeruginosa
13816,25294349,"illness and disease, chronic"
13816,25294349,"illness and disease, experiences"
13816,25294349,interpretative phenomenological analysis (ipa)
13816,25294349,qualitative analysis
13816,25294349,quality of life
13816,25294349,rehabilitation
13816,25294349,"research, qualitative"
13823,25775381,epo
13823,25775381,erythrocytosis
13823,25775381,hif-1α
13823,25775381,hyperthyroidism
13825,25058606,cytokines
13825,25058606,graves disease
13825,25058606,thyroid
13826,25692426,fine needle aspiration biopsy
13826,25692426,hashimoto's thyroiditis
13826,25692426,papillary thyroid carcinoma
13828,26240504,biological assay
13828,26240504,chronic inactive graves' orbitopathy
13828,26240504,mc4-tsi
13828,26240504,thyroid-stimulating immunoglobulin
13828,26240504,thyrotropin-binding inhibitory immunoglobulin cois was reported.
13834,25342622,cd44
13834,25342622,cox-2
13834,25342622,hyaluronic acid
13834,25342622,orbital fibroblast
13834,25342622,thyroid-associated ophthalmopathy
13835,25028161,association
13835,25028161,graves’ disease
13835,25028161,toll like receptor
13835,25028161,case-control study
13835,25028161,single nucleotide polymorphisms
13836,24627146,il-1β
13836,24627146,hyaluronic acid
13836,24627146,hyaluronic acid synthase
13836,24627146,mitogen-activated protein kinase
13836,24627146,orbital fibroblast
13836,24627146,pirfenidone
13836,24627146,thyroid-associated ophthalmopathy
13840,25892161,thyroid eye disease
13840,25892161,decompression
13840,25892161,diplopia
13840,25892161,orbit
13840,25892161,proptosis
13849,26321629,magnetic resonance imaging
13849,26321629,methylprednisolone pulse therapy
13849,26321629,proptosis
13849,26321629,thyroid-associated ophthalmopathy
13849,26321629,volume
13850,24742542,graves' disease
13850,24742542,polymorphism
13850,24742542,transforming growth factor β1
13851,25576458,graves’ orbitopathy
13851,25576458,ich guideline
13851,25576458,intravenous steroids
13851,25576458,medical dictionary for regulatory activities (meddra)
13851,25576458,safety
13852,24486115,autoinmunidad tiroidea materna
13852,24486115,children born from mothers with autoimmune thyroid disease
13852,24486115,enfermedad de graves en el embarazo
13852,24486115,hijo de mujer con enfermedad tiroidea autoinmunitaria
13852,24486115,hipotiroidismo
13852,24486115,hypothyroidism
13852,24486115,pregnancy in graves disease
13852,24486115,thyroid autoimmunity in pregnancy
13859,25770161,epidemiology
13859,25770161,eye
13859,25770161,ophthalmology
13864,25223473,a1555g
13864,25223473,hearing loss
13864,25223473,heteroplasmy
13864,25223473,mt-rnr1
13864,25223473,pendred syndrome
13864,25223473,slc26a4
13866,25759125,autoantibody
13866,25759125,graves'
13866,25759125,disease
13866,25759125,latent virus
13866,25759125,pathogenesis
13866,25759125,plasma cell differentiation
13870,24714170,carcinoma
13870,24714170,goiter
13870,24714170,thyroidectomy
13873,25937486,"anti-neutrophil cytoplasmic antibodies,"
13873,25937486,"drug-induced,"
13873,25937486,"graves’ disease,"
13873,25937486,"propylthiouracil,"
13873,25937486,small vessel vasculitis
13877,24989709,diplopia
13877,24989709,image-guided surgery
13877,24989709,proptosis
13877,24989709,strabismus
13877,24989709,thyroid eye disease
13877,24989709,visual acuity
13877,24989709,visual field
13883,25290043,deafness
13883,25290043,iran
13883,25290043,slc26a4
13883,25290043,enlarged vestibular aqueduct
13883,25290043,genetic linkage
13883,25290043,goiter
13883,25290043,mutation screening
13885,25768836,graves’ disease
13885,25768836,autoantibodies
13885,25768836,glycoprotein-hormone receptor
13885,25768836,small molecule ligands
13885,25768836,thyroid cancer
13885,25768836,thyroid-stimulating hormone receptor cois received no payment in preparation of this manuscript.
13902,25257150,<sup>131</sup>i
13902,25257150,dose/response analysis
13902,25257150,graves’ disease
13902,25257150,hyperthyroidism
13902,25257150,radioiodine
13905,26028555,graves' disease
13905,26028555,hypothyroidism
13905,26028555,postpartum thyroid disease
13905,26028555,pregnancy
13905,26028555,thyrotoxicosis
13906,25836060,depression
13906,25836060,graves’ orbitopathy
13906,25836060,diplopia
13906,25836060,elevation
13906,25836060,vertical strabismus
13913,24938857,graves’ disease
13913,24938857,intraoperative blood loss
13913,24938857,thyroidectomy
13916,25207976,ipilimumab
13916,25207976,myositis
13916,25207976,thyroid eye disease
13916,25207976,thyroid orbitopathy
13917,25121573,asia-pacific
13917,25121573,graves’ orbitopathy
13917,25121573,survey
13925,24697978,contour
13925,24697978,eyelid surgery
13925,24697978,keratopathy
13925,24697978,lagophthalmos
13925,24697978,symmetry
13926,25208306,reactivation
13926,25208306,thyroid-associated orbitopathy
13926,25208306,traum
13931,25134846,b-cell epitopes
13931,25134846,graves’ disease
13931,25134846,igg subclasses
13931,25134846,intramolecular epitope spreading
13931,25134846,thyroglobulin autoantibodies
13932,25120780,autoimmune thyroid diseases (aitds)
13932,25120780,graves’ disease (gd)
13932,25120780,hashimoto’s thyroiditis (ht)
13932,25120780,t helper 22 (th22) cell
13932,25120780,interleukin 22 (il-22)
13933,24903731,autoimmune co-morbidity
13933,24903731,autoimmune gastritis
13933,24903731,autoimmune thyroid diseases
13933,24903731,coeliac disease
13933,24903731,thyroid-associated orbitopathy
13940,25046415,autoimmune thyroid disease
13940,25046415,intractability
13940,25046415,polymorphism
13940,25046415,severity
13940,25046415,vitamin d
13947,25741204,children
13947,25741204,congenital hypothyroidism
13947,25741204,diffuse thyroid disease
13947,25741204,nodule
13947,25741204,thyroid disease
13947,25741204,ultrasonography
13948,25109914,graves-kór
13948,25109914,graves’ disease
13948,25109914,graves’ orbitopathy
13948,25109914,biological therapy
13948,25109914,biológiai terápia
13948,25109914,endokrin orbitopathia
13948,25109914,selenium
13948,25109914,szelén
13949,24938636,alemtuzumab
13949,24938636,autoimmunity
13949,24938636,sickle cell disease
13949,24938636,stem cell transplant
13949,24938636,thyroid dysfunction
13950,24838983,autoimmunity
13950,24838983,echocardiography
13950,24838983,hyperthyroidism
13950,24838983,pulmonary hypertension
13954,24674955,stroke
13954,24674955,cerebrovascular disease
13954,24674955,hematologic disease
13954,24674955,hyperthyroidism
13954,24674955,steroids
13954,24674955,thrombotic angiopathy
13958,25039242,biological treatment
13958,25039242,graves’disease
13958,25039242,endocrine orbitopathy
13958,25039242,hyperthyroidism
13958,25039242,thyroid
13962,24862674,focus
13962,24862674,harmonic
13962,24862674,knot tie technique
13962,24862674,sutureless
13962,24862674,thyroidectomy
13962,24862674,ultracision
13963,25839128,cd28
13963,25839128,cd4(+)cd28(−) t cells
13963,25839128,graves’ disease
13963,25839128,t-lymphocyte subsets
13967,25207388,electromagnetic image guidance
13967,25207388,graves’ ophthalmopathy
13967,25207388,orbital decompression
13971,25373929,graves’ disease
13971,25373929,hyperthyroidism
13971,25373929,laser doppler fluxmetry
13971,25373929,postocclusive reactive hyperaemia
13971,25373929,skin microcirculation
13973,24726178,antithyroid medication
13973,24726178,graves’ disease
13973,24726178,neonatal thyroid dysfunction
13973,24726178,outcome
13977,25122677,histone modifications
13977,25122677,interferon
13977,25122677,thyroiditis cois
13984,24784317,autoimmune thyroid diseases
13984,24784317,t regulatory cells
13984,24784317,forkhead box p3
13984,24784317,gene polymorphism
13985,25283079,midkine (mk)
13985,25283079,multi-nodular goiter (mng)
13985,25283079,nuclear factor-kappa b (nf-κb)
13985,25283079,papillary thyroid cancer (ptc)
13985,25283079,receiver operating characteristic (roc) curves
13985,25283079,synchronous metastasis
13988,26163757,gene expression profiling
13988,26163757,granulomatosis with polyangiitis
13988,26163757,microarray analysis
13988,26163757,molecular pathology
13988,26163757,orbit pathology
13988,26163757,orbital pseudotumor
13989,24793198,ct analysis
13989,24793198,deep lateral wall
13989,24793198,exophthalmos reduction
13989,24793198,orbital decompression
13989,24793198,orbital fat
13991,25648436,antibiotics
13991,25648436,mediastinitis
13991,25648436,negative pressure therapy
13991,25648436,streptococcus
13991,25648436,thyroidectomy
13994,25615025,cytotoxic t-lymphocyte antigen-4
13994,25615025,polymorphism
13994,25615025,thyroid-associated ophthalmopathy
13995,24617953,graves' ophthalmopathy
13995,24617953,drug therapy
13995,24617953,glucocorticoid
13995,24617953,meta-analysis
13997,24801540,autoimmunity
13997,24801540,children
13997,24801540,cytokines
13997,24801540,serum
13997,24801540,thyroid
14004,26523178,basedow disease
14004,26523178,papillary carcinoma
14004,26523178,thyroid
14011,25455307,graves' disease
14011,25455307,sensory ataxia
14011,25455307,sensory evoked potentials
14011,25455307,thyrotoxicosis
14012,25132194,contact lens sensor
14012,25132194,glaucoma
14012,25132194,intraocular pressure
14012,25132194,thyroid eye disease
14018,26593863,autoimmune thyroid disease (aitd)
14018,26593863,graves’ disease (gd)
14018,26593863,hashimoto's thyroiditis (ht)
14018,26593863,maladie de basedow (gd)
14018,26593863,maladies thyroïdiennes auto-immunes (mait)
14018,26593863,polymorphisme de nucléotide unique (snp)
14018,26593863,récepteur à la vitamine d (vdr)
14018,26593863,single nucleotide polymorphism (snp)
14018,26593863,thyroïdite de hashimoto (ht)
14018,26593863,vitamin d receptor (vdr)
14020,25876459,graves' orbitopathy
14020,25876459,quality of life
14020,25876459,strabismus surgery
14020,25876459,success criteria
14033,26034078,immunology
14033,26034078,orbit
14034,25847746,anti tsh-receptor antibody
14034,25847746,immunoassay
14034,25847746,pre
14035,25550791,graves’ hyperthyroidism
14035,25550791,nuocytes
14035,25550791,cytokines
14035,25550791,transcription factors
14038,26373794,graves' disease (gd)
14038,26373794,hashimoto's thyroiditis (ht)
14038,26373794,il1f7
14038,26373794,il37
14038,26373794,autoimmune thyroid diseases (aitds)
14038,26373794,single nucleotide polymorphisms (snps)
14047,26180468,diplopia
14047,26180468,graves’ disease
14047,26180468,restrictive strabismus
14047,26180468,strabismus surgery
14047,26180468,thyroid orbitopathy cois
14049,25900177,graves’ disease
14049,25900177,hashimoto’s thyroiditis
14049,25900177,oxidative status
14049,25900177,prolidase
14054,25859801,dsa = digital subtraction angiography
14054,25859801,gd = graves disease
14054,25859801,graves disease
14054,25859801,mmd = moyamoya disease
14054,25859801,mra = mr angiography
14054,25859801,t3 = triiodothyronine
14054,25859801,t4 = thyroxine
14054,25859801,tia = transient ischemic attack
14054,25859801,tsh = thyroid stimulating hormone
14054,25859801,disease progression
14054,25859801,ft3 = free triiodothyronine
14054,25859801,ft4 = free thyroxine
14054,25859801,moyamoya disease
14054,25859801,stroke
14054,25859801,vascular disorders
14056,25736545,dysthyroid optic neuropathy
14056,25736545,thyroid eye disease
14056,25736545,thyroid stimulating immunoglobulins
14062,25988433,exophthalmos
14062,25988433,graves’ orbitopathy
14062,25988433,globe luxation
14062,25988433,malar hypoplasia
14062,25988433,orbital decompression
14063,24434244,graves' ophthalmopathy
14063,24434244,quality of life
14063,24434244,questionnaire
14066,25176403,indirect calorimetry
14066,25176403,metabolic syndrome
14066,25176403,resting energy expenditure
14066,25176403,tetraiodothyronine
14066,25176403,thyroid stimulating hormone
14066,25176403,triiodothyronine
14067,26256985,tsh receptor autoantibody
14067,26256985,total thyroidectomy
14067,26256985,thyroid benign mass
14067,26256985,thyroid cancer
14067,26256985,thyroid-associated orbitopathy cois
14069,25159204,graves' orbitopathy
14069,25159204,adipogenesis
14069,25159204,heme oxygenase-1
14069,25159204,inflammation
14069,25159204,orbital fibroblasts
14069,25159204,oxidative stress
14069,25159204,tanshinone iia
14073,24990808,autoimmune thyroid disease
14073,24990808,intractability
14073,24990808,mir-125a
14073,24990808,polymorphism
14073,24990808,severity
14077,26141364,endonasal approach
14077,26141364,endoscopic assisted
14077,26141364,optic nerve
14077,26141364,orbit
14077,26141364,paranasal sinuses
14077,26141364,skull base
14082,24798189,autoimmune thyroid disease
14082,24798189,graves'
14082,24798189,hashimoto's thyroiditis
14082,24798189,disease
14082,24798189,single nucleotide polymorphism
14082,24798189,tumor necrosis factor α-induced protein 3
14086,25708657,foxp3
14086,25708657,graves' disease
14086,25708657,regulatory t cell
14086,25708657,single nucleotide polymorphism
14092,24460515,dry eye syndrome
14092,24460515,graves’ disease
14092,24460515,graves’ orbitopathy
14096,26041458,graves’ disease
14096,26041458,tsh receptor antibody
14096,26041458,antithyroid drugs
14096,26041458,hyperthyroidism
14096,26041458,pregnancy
14098,25320726,drug induced liver injury (dili)
14098,25320726,endocrinology
14098,25320726,hepatotoxicity
14098,25320726,idiosyncratic hepatic injury
14098,25320726,risk factors cois
14102,26116233,graves' disease (gd)
14102,26116233,histone acetylation
14102,26116233,histone modifications
14102,26116233,peripheral blood mononuclear cells (pbmcs)
14114,25120331,drug-related side effects and adverse reactions
14114,25120331,graves disease
14114,25120331,methimazole
14114,25120331,pancreatitis cois
14117,26344731,eyelid retraction
14117,26344731,optic neuropathy
14117,26344731,orbit
14117,26344731,restrictive myopathy
14117,26344731,thyroid eye disease
14119,25310344,adult strabismus
14119,25310344,diplopia
14119,25310344,operation dosage
14119,25310344,orbit
14119,25310344,thyriod eye disease
14121,26564931,cyclotropia
14121,26564931,double maddox rod test
14121,26564931,strabismus surgery
14121,26564931,thyroid eye disease
14124,24510024,extraocular muscles
14124,24510024,magnetic resonance imaging
14124,24510024,orbit
14124,24510024,thyroid-associated orbitopathy
14124,24510024,ultrasound
14125,26113403,autoimmune disease
14125,26113403,graves’ disease
14125,26113403,interleukin 7
14125,26113403,soluble interleukin 7 receptor
14131,25936345,cd40
14131,25936345,ctla-4
14131,25936345,genetic polymorphism
14131,25936345,graves' disease
14132,24712973,linear morphoea
14132,24712973,localised scleroderma
14135,24777217,graves’ disease
14135,24777217,adverse drug reactions
14135,24777217,disease management
14135,24777217,methimazole
14135,24777217,pediatric
14137,25617714,dna methylation
14137,25617714,dnmts
14137,25617714,graves' disease
14137,25617714,icam1
14137,25617714,mbds
14137,25617714,medip-chip
14147,25256279,anca
14147,25256279,hyperthyroidism
14147,25256279,propylthiouracil
14147,25256279,vasculitis
14151,25172242,ccl2
14151,25172242,cxcl10
14151,25172242,chemokines
14151,25172242,extra-ocular muscles
14151,25172242,graves' ophthalmopathy
14154,25444703,goitre ovarien
14154,25444703,meigs syndrome
14154,25444703,ovarian goiter
14154,25444703,ovarian tumor
14154,25444703,struma ovarii
14154,25444703,syndrome de meigs
14154,25444703,teratome
14154,25444703,thyroid
14154,25444703,thyroïde
14154,25444703,tumeur ovarienne
14154,25444703,tératome
14155,25457466,compressive optic neuropathy
14155,25457466,graves' orbitopathy
14155,25457466,spontaneous decompression
14166,26415610,alkaline phosphatase
14166,26415610,graves disease
14166,26415610,hypocalcemia
14166,26415610,thyroidectomy
14170,25059686,decompression
14170,25059686,orbital surgery
14170,25059686,piezosurgery
14170,25059686,proptosis
14170,25059686,thyroid associated orbitopathy
14172,24576228,graves’ disease
14172,24576228,hyperthyroidism
14172,24576228,hypothyroidism
14172,24576228,prenatal care
14172,24576228,thyroidectomy
14173,25814196,aetiopathogenesis of warthin's tumour
14173,25814196,autoimmune diseases
14173,25814196,lymphatic-rich stroma
14173,25814196,warthin's tumour
14175,24478186,cd20
14175,24478186,cd4
14175,24478186,cd8
14175,24478186,foxp3
14175,24478186,graves’ disease
14175,24478186,hashimoto's thyroiditis
14175,24478186,regulatory t cells
14180,25455505,bone metastases
14180,25455505,cirugía
14180,25455505,dosimetry
14180,25455505,dosimetría
14180,25455505,metástasis ósea
14180,25455505,surgery
14180,25455505,thyroid
14180,25455505,tiroides
14180,25455505,rtsh
14184,26425054,graves disease
14184,26425054,plasmapheresis
14184,26425054,thyrotoxicosis cois
14193,25412700,graves' disease
14193,25412700,hashimoto's thyroiditis
14193,25412700,th17 cells
14193,25412700,interleukins
14193,25412700,regulatory t cells
14197,26600899,struma ovarii
14197,26600899,histopathology
14197,26600899,ovarian goiter
14197,26600899,ovarian teratoma
14197,26600899,thyroid
14198,25576242,adipokines
14198,25576242,graves׳ disease
14198,25576242,hashimoto׳s thyroiditis
14198,25576242,leptin
14198,25576242,pamp׳s
14200,24956560,cytokine
14200,24956560,graves disease
14200,24956560,graves ophthalmopathy
14200,24956560,parp-1
14200,24956560,polymorphism
14202,25989711,autoimmune thyroid disease
14202,25989711,graves' disease
14202,25989711,hashimoto's thyroiditis
14202,25989711,interferon regulatory factor 8
14205,25647271,autoimmune thyroid disease (aitd)
14205,25647271,graves’ disease (gd)
14205,25647271,hashimoto’s thyroiditis (ht)
14205,25647271,interleukin-21 (il-21)
14205,25647271,interleukin-21 receptor (il-21r)
14206,25281394,gd
14206,25281394,kir3dl1
14206,25281394,nk
14206,25281394,nkg2a
14206,25281394,nkg2d
14206,25281394,nkp30
14208,25434508,chester-erdheim disease
14208,25434508,diabetes insipidus
14208,25434508,diabetes insípida
14208,25434508,enfermedad de chester-erdheim
14208,25434508,hipopituitarismo
14208,25434508,histiocitosis de células de langerhans
14208,25434508,hypopituitarism
14208,25434508,langerhans cell histiocytosis
14216,25586901,marinelli
14216,25586901,thyroid nodules
14216,25586901,combined therapy
14216,25586901,dosimetry
14216,25586901,microwave ablation
14216,25586901,radioiodine therapy
14218,24958412,benign and malignant thyroid nodules
14218,24958412,contrast-enhanced sonography
14218,24958412,maximum intensity
14218,24958412,microvessel density
14218,24958412,superficial structures
14223,25161183,cancer
14223,25161183,elastography
14223,25161183,thyroid nodules
14227,26406404,papillary thyroid carcinoma
14227,26406404,mutation
14227,26406404,thyroperoxidase
14229,25960045,follicular thyroid neoplasia
14229,25960045,differential diagnostics
14229,25960045,goitre
14229,25960045,immunohistochemistry
14229,25960045,stem cell marker
14240,26048691,alström syndrome
14240,26048691,follicular variant of papillary thyroid carcinoma
14240,26048691,thyroid cancer
14240,26048691,thyroid goitre
14242,25328134,cancer
14242,25328134,contrast agents
14242,25328134,follicular adenoma
14242,25328134,goiter
14242,25328134,quantitative parameter
14242,25328134,thyroid
14242,25328134,time-intensity curve
14242,25328134,ultrasonography
14243,26191283,cytokeratin 17
14243,26191283,immunohistochemistry
14243,26191283,lymph node metastasis
14243,26191283,papillary thyroid carcinoma
14246,25400776,papillary thyroid carcinoma (ptc)
14246,25400776,percentage of brafv600e alleles
14246,25400776,preoperative risk stratification
14246,25400776,pyrosequencing
14247,25940693,autonomously functioning thyroid nodule
14247,25940693,meta-analysis
14247,25940693,nodular goitre
14247,25940693,scintigraphy
14247,25940693,thyroid
14247,25940693,thyroid-stimulating hormone
14252,25707564,graves disease
14252,25707564,hypocalcemia
14252,25707564,multinodular goiter
14252,25707564,papillary carcinoma of thyroid
14252,25707564,parathyroid
14252,25707564,parathyroid adenoma
14252,25707564,recurrent laryngeal nerve
14252,25707564,thyroid
14253,25054230,aa amyloidosis
14253,25054230,chronic renal disease
14253,25054230,cystic fibrosis
14253,25054230,goiter
14253,25054230,intestinal disorders
14253,25054230,proteinuria
14256,25868389,ffpe
14256,25868389,nanostring analysis
14256,25868389,biomarkers
14256,25868389,circadian clock
14256,25868389,papillary thyroid carcinoma cois
14257,26578494,cribriform variant
14257,26578494,papillary carcinoma
14257,26578494,sonography
14257,26578494,thyroid
14257,26578494,ultrasound
14259,26437373,antiepileptic drugs
14259,26437373,goiter
14259,26437373,metabolic risk
14259,26437373,subclinical hypothyroidism
14259,26437373,thyroid hormones
14262,25120855,africa
14262,25120855,surgical camp
14262,25120855,uganda
14277,27057249,harmonic focus curved shears
14277,27057249,hemostasis
14277,27057249,thyroid
14277,27057249,thyroidectomy
14289,24993783,child
14289,24993783,differentiated thyroid cancer
14289,24993783,goitre
14289,24993783,hypoparathyroidism
14289,24993783,lobectomy with isthmusectomy
14289,24993783,medullary thyroid cancer
14289,24993783,recurrent laryngeal nerve paralysis
14289,24993783,thyroidectomy
14291,24434360,autoimmunity
14291,24434360,hashimoto
14291,24434360,thyroiditis
14296,25524940,papillary thyroid carcinoma
14296,25524940,rt-pcr
14296,25524940,mir-146a
14296,25524940,mir-146b
14298,25017947,cost-benefit
14298,25017947,goiter
14298,25017947,thyroid cancer
14298,25017947,thyroidectomy
14302,24866072,incidental carcinoma
14302,24866072,microcarcinoma
14302,24866072,thyroid
14303,24862663,hypocalcemia
14303,24862663,parathyroid hormone
14303,24862663,thyroidectomy
14307,25601586,thyroid cancer
14307,25601586,complications of thyroid surgery
14307,25601586,intraoperative neuromonitoring
14307,25601586,patient outcomes
14307,25601586,recurrent laryngeal nerve injury
14322,25217004,percutaneous tracheostomy
14322,25217004,tracheostomy
14324,25889269,goiter
14324,25889269,nitrate
14324,25889269,nitrite
14324,25889269,thyroid cancer
14324,25889269,thyroid function
14328,26327979,hashimoto′s thyroitidis
14328,26327979,acute
14328,26327979,sickle cell anemia
14330,26905714,association
14330,26905714,hashimoto's thyroiditis
14330,26905714,histopathology
14330,26905714,medullary carcinoma of thyroid.
14335,25946974,nicotinamide phosphoribosyltransferase
14335,25946974,nodular goiter
14335,25946974,reverse transcriptase polymerase chain reaction
14335,25946974,thyroid cancer
14335,25946974,thyroid gland
14335,25946974,visfatin
14338,24550235,calcitonin
14338,24550235,fine-needle aspiration cytology
14338,24550235,medullary thyroid carcinoma
14342,24388198,cadmium toxicity
14342,24388198,preneoplastic lesions
14342,24388198,thyroid gland
14344,25556330,hyperthyroidism
14344,25556330,potassium chloride repletion
14344,25556330,thyrotoxic hypokalemic periodic paralysis
14344,25556330,ventricular arrhythmia
14345,25156133,graves’ disease
14345,25156133,hyperthyroidism
14345,25156133,hyperthyroïdie
14345,25156133,iode 131
14345,25156133,maladie de basedow
14345,25156133,radioiodine dose
14345,25156133,thyroid
14345,25156133,thyroïde
14346,25934417,hypoparathyroidism
14346,25934417,intra-operative parathyroid hormone
14346,25934417,parathyroid hormone decline
14346,25934417,total thyroidectomy
14357,25824846,drug overdose
14357,25824846,hyperthyroxinemia
14357,25824846,levothyroxine overdose
14357,25824846,thyroid crisis
14357,25824846,thyrotoxicosis
14358,25598424,differential diagnosis
14358,25598424,hydatid cyst
14358,25598424,thyroid
14358,25598424,unusual location
14359,25476178,ct
14359,25476178,hyperthyroidism
14359,25476178,incidental thyroid nodule
14359,25476178,mr imaging
14359,25476178,radioactive iodine scan
14359,25476178,thyroid cancer
14359,25476178,ultrasonography
14365,26210625,children
14365,26210625,hyperthyroidism
14365,26210625,hypothyroidism
14365,26210625,incidental
14365,26210625,nodule
14365,26210625,overt
14365,26210625,thyroid
14365,26210625,ultrasonography
14373,25873114,antiandrogens  prolactin
14389,24760746,graves' disease
14389,24760746,hashimoto's thyroiditis
14389,24760746,autoimmune thyroiditis
14389,24760746,erythrovirus b19
14389,24760746,parvovirus b19
14394,26347012,angiogenesis
14394,26347012,atherosclerosis
14394,26347012,cholesterol
14394,26347012,pleiotropic effect
14394,26347012,statins
14397,25480825,cancer
14397,25480825,nodules
14397,25480825,oncology
14397,25480825,pediatrics
14397,25480825,therapeutics
14397,25480825,thyroid cois article.
14401,24578322,double salt fortification
14401,24578322,human health
14401,24578322,micronutrient assessment
14401,24578322,mineral deficiency
14410,24768495,fine needle aspiration
14410,24768495,thyroid
14410,24768495,thyroid bed
14411,26374222,adenomatous hyperplasia
14411,26374222,brenner tumor
14411,26374222,mucinous cystadenoma
14411,26374222,papillary thyroid carcinoma
14411,26374222,serous cystadenoma
14411,26374222,struma ovarii
14411,26374222,strumal carcinoid
14412,25755717,cd147
14412,25755717,rna interference
14412,25755717,thyroid cancer-experimental
14412,25755717,genetics
14412,25755717,glycolysis
14412,25755717,pathology-thyroid
14413,24493789,barriers
14413,24493789,discharge
14413,24493789,outpatient
14413,24493789,thyroidectomy
14414,26823860,braf
14414,26823860,papillary thyroid cancer
14414,26823860,ras
14414,26823860,ret
14419,26406959,thyroid cancer
14419,26406959,diagnosis
14419,26406959,fine needle aspiration biopsy (fnab)
14419,26406959,transforming growth factor-β 1
14422,26475096,ectopic lymphoid tissue
14422,26475096,hashimoto's thyroiditis
14422,26475096,human parvovirus b19
14422,26475096,pathogenesis
14422,26475096,positive regulatory domain zinc finger protein 1
14424,24750986,difficult thyroidectomy
14424,24750986,difficulty scale
14424,24750986,graves disease
14424,24750986,hashimotos thyroiditis
14424,24750986,risk adjustment
14424,24750986,thyroid
14429,26408676,thyroid sarcoma
14429,26408676,clinical sign
14429,26408676,review
14429,26408676,thyroid imaging
14431,25487217,131i therapy
14431,25487217,benign thyroid disease
14431,25487217,dosimetry
14437,26417067,ccm
14437,26417067,ros
14437,26417067,autophagy
14437,26417067,endothelial‐to‐mesenchymal transition (endmt)
14437,26417067,mtor
14438,25639351,saccharomyces cerevisiae
14438,25639351,antioxidants
14438,25639351,avenanthramides
14438,25639351,biofactors
14438,25639351,cerebral cavernous malformation
14438,25639351,metabolic engineering
14438,25639351,phenolic compounds
14438,25639351,plant secondary metabolites
14442,26302664,*iodine intake
14442,26302664,*iodized salt
14442,26302664,*nutrición yódica
14442,26302664,*sal yodada
14442,26302664,*urinary iodine concentrations
14442,26302664,*yoduria
14444,25829390,ambulatory surgical procedures
14444,25829390,outpatient
14444,25829390,perioperative complications
14444,25829390,revisits
14444,25829390,surgery
14444,25829390,thyroid surgery
14444,25829390,thyroidectomy
14445,25041837,galectin-3
14445,25041837,hbme-1
14445,25041837,immunohistochemistry
14445,25041837,thyroid nodules
14449,25593151,dietary intake
14449,25593151,dietary supplements
14449,25593151,folate
14449,25593151,folic acid
14449,25593151,"vitamin b-9 cois the scientific advisory boards of conagra, inc., mccormick spice, the mushroom council, the california walnut commission, and bay state milling; and is a consultant to nestle, inc. kl wiemer and kb miller are employees of general mills, inc. o dary, ma philbert, v tarasuk, and cl taylor, no conflicts of interest. cl keen serves on advisory boards of advocare, herbalife, mars, inc., mccormick spice, and theralogix. jc king serves on the scientific advisory board for conagra; has received research funding from the almond board of california, the california walnut commission, thrasher foundation, harvest plus, the nestle foundation, usda, and nih; and has provided consultation to the alliance for potato research and education and ilsi north america. pc gaine and ab jarvis were employees of ilsi north america when the manuscript was prepared. rl bailey is a government liaison to the ilsi north america committee on fortification."
14451,25968604,founder effect
14451,25968604,mutation
14451,25968604,structural modeling
14451,25968604,tpo
14451,25968604,thyroid dyshormonogenesis
14453,25193578,adjuvant therapy
14453,25193578,differentiated thyroid carcinoma
14453,25193578,radioiodine ablation
14453,25193578,total thyroidectomy
14453,25193578,urinary iodine
14454,25175810,new sporadic neoplastic syndrome
14454,25175810,papillary and medullary carcinomas
14454,25175810,urothelial
14455,25917998,levothyroxine
14455,25917998,preoperative localization
14455,25917998,primary hyperparathyroidism
14455,25917998,sestamibi scintigraphy
14455,25917998,ultrasound
14461,25837167,braf
14461,25837167,dna
14461,25837167,biomarker
14461,25837167,papillary thyroid carcinoma
14461,25837167,plasma cois
14462,24582076,cleft lip and palate
14462,24582076,ex utero intrapartum treatment (exit)
14462,24582076,fetal diagnosis
14462,24582076,micrognathia
14462,24582076,prenatal consultation
14465,26119458,acoustic radiation force impulse
14465,26119458,elastography
14465,26119458,thyroid nodule
14465,26119458,ultrasound
14468,25111330,chinese population
14468,25111330,fine-needle aspiration biopsy
14468,25111330,genetic alterations
14468,25111330,thyroid nodules
14473,25836323,dicer1
14473,25836323,embryonal rhabdomyosarcoma
14473,25836323,ovary
14473,25836323,pediatric tumors
14473,25836323,mirna
14475,26342107,papillary thyroid carcinoma
14475,26342107,undifferentiated thyroid carcinoma
14475,26342107,vegf
14475,26342107,mir-205
14475,26342107,microrna
14479,26041374,h271d
14479,26041374,resistance to thyroid hormones
14479,26041374,thyroid hormone receptor beta gene (thrβ)
14481,25155806,dairy product
14481,25155806,iodized salt
14481,25155806,urinary iodine
14482,25486933,cerebrovascular disorders
14482,25486933,endothelium
14482,25486933,genetics
14482,25486933,hemorrhage
14482,25486933,stroke
